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I Summary 
 
Without compartmentalisation, there would be no life, as cells require spatial organization to perform 
all metabolic processes to sustain it. Compartmentalisation, or physical separation of biological 
reactions requires defined reaction spaces and active control over all molecules that enters or leaves 
them. Nature utilises for this purpose cell membranes and a plethora of different membrane proteins, 
which act as tunnels allowing and controlling molecular flow across the membrane. In a similar manner 
mimicking nature, by molecular self-assembly, allows us to produce artificial cells as simplified models 
for better understanding specific parts of cells. Our knowledge allows us today to go a step further, as 
we can use natural or artificial enzymes and trans-membrane channel proteins to create artificial 
organelles (nanoreactors) capable of supporting selective reactions and replacement the deficient 
structures or organelles. That is why the nanoreactors are gaining more and more interest for specific 
applications in the field of nano-medicine, analytics and advanced functional materials.  
To achieve the desired compartmentalization, it was needed to advance from the artificial assemblies, 
with passive membrane transport, based on permanently open pores. First attempts in this direction 
are represented by the design of single stimuli triggered transport via structures capable of opening 
upon acidification or reduction. The second step will be to have reversible triggered transport 
structures, like cells have. To have reliable artificial replacements of the dysfunctional cell structures 
is needed.  
This thesis, is achieving this necessary step by the development of a biovalve which can open and close 
on demand in a similar manner that the trans-membrane proteins work. This is a significant advance 
in the design of new cell-like polymeric compartmentalised structures with sustainable specific 
function. This new system can be switched on and off by demand, theoretically endlessly, opening new 
ways in the development of artificial structures to replace the non-functional ones in living cells. 
This biovalve was obtained by modifying trans-membrane proteins (Omp F) capable of passive 
transport of a range of molecules, with selected pH sensitive peptides capable of opening and closing 
its pore. This new biovalve functionality was tested by reconstituting it in an artificial membrane of a 
nanoreactor that delimits an inner empty space in which selected enzymes were entrapped. The 
specific substrate for the entrapped enzyme was added on top of the assembled nanoreactors mixture, 
outside of the closed polymeric compartments. At physiological pH the biovalve opens, and the 
substrate molecules diffuse passively in the inner space of the nanoreactor entrapping the enzyme 
molecules. The enzymatic reaction takes place and the (fluorescent) product formation is monitored. 
At low pH the biovalve closed blocking the access of the substrate molecules and no fluorescent 
product can be detected.  
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The optimal variant proved to be K89R270C-Gala3 modified OmpF, that is open at physiological pH and 
completely closed at lower pH (only 1.4 units lower). The bio-valve showed its functionality after 
reconstitution both in liposomes and polymeric nanoreactors, showing the robustness of our new 
obtained structure. Moreover, the stimuli response overruled the pH dependent activity of the enzyme 
and the nanoreactor increased the enzyme stability and increased its stability towards pH changes. 
 
 
II Zusammenfassung 
 
Ohne Kompartmentalisierung, gäbe es kein Leben, da alle Lebensformen eine räumliche Organisation 
benötigen um ihren Metabolismus zu kontrollieren. Kompartmentalisierung ist die physische 
Abtrennung von (biologischen) Reaktionen. Es erschafft wohldefinierte Reaktionsräume, welche es 
erlauben zu kontrollieren, was in sie vordringt und was sie wieder verlässt und wann es dies tut. 
In der Natur entwickelten sich zu diesem Zwecke Zellmembranen und eine Vielzahl an 
Membranproteinen, welche als Tunnel fungieren und damit den Stofffluss durch die Membran 
kontrolliert. 
Molekulare Selbstassemblierung erlaubt künstliche Zellen als vereinfachte Modelle um 
Zellbestandteile besser verstehen zu können. Nun ist unser Wissen soweit fortgeschritten, dass wir 
einen Schritt weitergehen können und aus bestehenden Enzymen, Katalysatoren etc. und 
Membranproteinen künstliche Organellen bzw. Nanoreaktoren herstellen können, welche spezifische 
Reaktionen erlauben, sogar Defekte in Zellen kompensieren können. Nanoreaktoren werden daher 
immer interessanter und versprechen ihre Verwendung in der Nanomedizin, Analytik oder in Hightech 
Funktionsbeschichtungen finden zu können. 
Um die erwünschte Funktionalität zu erreichen, reicht es jedoch nicht, aktive Bestandteile in eine 
schützende Hülle zu verpacken. Selbst die Einführung von Poren, die einen Grössenausschluss 
ermöglichen, ist nicht immer genug. Zur Kontrolle der Reaktionsräume gehört auch eine zeitliche 
Steuerung. Fortgeschrittenere Systeme verwenden daher einen molekularen Stöpsel von dem 
Poreneingang abzulösen und damit ein einziges Mal von Aus auf An zu schalten. Dies kann durch z.B: 
einen niederen pH-Wert, reduktive Bedingungen etc. geschehen. Der nächste logische Schritt ist es 
auch zeitliche Kontrolle über den Stofffluss durch die Membran zu erlangen, ähnlich wie es biologische 
Zellen tun. 
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In dieser Doktorarbeit, geht es um eben diesen Schritt, der Entwicklung eines molekularen Ventils, 
welches nach Bedarf geöffnet und geschlossen werden kann, ähnlich Transmembranproteinen. Dies 
ist ein entscheidender Fortschritt, in der Erschaffung von zellartigen, polymeren Nanoreaktoren, da es 
eine langfristige Steuerung verspricht. Theoretisch kann es unendlich oft An und Aus geschaltet 
werden, gesteuert über einen spezifischen Parameter. Dies ermöglicht neuartige Nanoreaktoren und 
die Reparatur von dysfunktionalen Organellen. 
Dies wurde bewerkstelligt indem eine permanent offene Pore des Transmembranproteins OmpF 
(welches weitgehend unselektiv kleine Moleküle bis ca. 600 Da durchlässt) mit verschiedenen Peptiden 
modifiziert wurde, welche sich je nach pH-Wert ihre Konformation ändern und somit eine molekulare 
Tür erschaffen. Dieses Modul wurde getestet indem es in eine synthetische Membran eingebaut wurde 
welche wiederum Enzyme umschliesst und somit einen einfachen Nanoreaktor darstellt. Dazu wurden 
von Aussen enzym-spezifische Substrate hinzugegeben. Bei einem physiologischen pH-Wert, sind die 
Poren offen und erlauben dem Enzymsubstrat durch die Membran zu diffundieren. Dadurch kann die 
Reaktion im Inneren des Nanoreaktors erfolgen und es entsteht ein Fluorophor, dessen Konzentration 
laufend gemessen werden kann. Bei niedrigem pH-Wert ändert sich die Konformation vom Peptid und 
die Pore schliesst sich. Dadurch kommt die Reaktion zum Erliegen und kein weiteres Fluorophor 
entsteht. 
Am geeignetsten erwies sich K89R270C-Gala3 OmpF, welches von einer komplett offenen Pore zu 
einer komplett geschlossenen Pore wechseln kann, bei einer pH-Änderung von nur 1.4 Einheiten. Diese 
Funktionalität zeigte sich sowohl in Lipid- als auch Polymermembranen, was für die Robustheit des 
Systems spricht. Darüber hinaus erlaubt dieser Effekt erlaubt es, die pH-Abhängigkeit des Enzymes zu 
überstimmen und beschützt zudem das Enzym vor seinem Zerfall, wodurch das System mehr pH-
Wechsel überlebt und länger lagerbar wird. 
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V Abbreviations  
 
AB:  amphiphilic diblockcopolymer  
ABA: amphiphilic triblockcopolymer (A6B40A6 would have 2x6 hydrophilic and 40 
hydrophobic monomers as blocks) 
ABCP:  amphiphilic blockcopolymer 
ABTS:  2,2'-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid) 
ALOX:  aluminium oxide 
ATRP:  atom transfer radical polymerisation 
a.u.:  arbitrary units (typically related to voltage of light detectors) 
tBuOH:  tert.-butanol 
BCA: bicinchoninic acid (assay for determining protein concentrations) 
BSA: bovine serum albumin (a water-soluble protein with a single cysteine group on its 
surface) 
CHAPS:  3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate (CAS: 331717-45-4) 
Chol-PEG: pegylated cholesterol (CAS: 69068-97-9) 
cmc:  critical micelle forming concentration 
CPM:  counts per molecule 
CR:  count rate 
Da:  Dalton [g/mol] 
DDM:  dodecylmaltoside (CAS: 69227-93-6) 
DLS:  dynamic light scattering (details see the end of this chapter) 
DM  decylmaltoside (CAS: 82494-09-5) 
DMF:  dimethylformamid 
DMSO:  dimethylsulfoxide 
DOL:  degree of labelling 
DP:  degree of polymerisation (number of repeating units) 
DSPC:  1,2-distearoyl-sn-glycero-3-phosphocholine (saturated lipid) 
ELP:  elastine like peptide (solubility is temperature dependent) 
Encap. eff.: encapsulation efficiency 
eq.:  equivalents 
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F2:  fraction of detected dye within the vesicle 
FCS:  fluorescence correlation spectroscopy 
GALA3:  MI-CH2-CO-NH-(LAEA)3-COOH 
GPC:  gel permeation chromatography 
HPLC:  high pressure liquid chromatography 
HRP:  horseradish peroxidase 
In:  Initiator for radical reactions 
L:  ligand for metal complexes 
LB:  Miller Lysogeny Broth (for growing bacteria cultures in solution or plates) 
LPO:  lactoperoxidase 
M:  molecular mass 
MALDI:  matrix assisted laser desorption ionisation 
Me6Tren: tris[2-(dimethylamino)ethyl]amine; a strong binding ligand 
MI:   maleic imide 
MP: membrane protein (a protein with hydrophobic surfaces for integration into cell-
membranes) 
MS:  mass spectrometry 
MTBE:  methyl-tert. butyl-ether 
MWCO: molecular weight cutoff (lowest MW where 90% of the molecules remain within 
dialysis or filter) 
Ndye:  number of dye molecules 
n.d.:  not determined 
NIPAAM: N-isopropylacrylamid 
POPC: natural phosphatidylcholine/ 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (CAS: 
8002-43-5) 
NR:  nanoreactor 
NR+:  active vesicles with WT-OmpF, or unmodified OmpF inserted 
NR-:  active vesicles without OmpF 
NRC:  active vesicles with OmpF-C inserted 
OG:  octyl-glucopyranoside; a detergent 
OG488:  Oregon Green 488 MI (CAS: n.A.) 
OPOE:  octyl-polyethyleneoxide; a detergent 
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OmpF: outer membrane protein F (prefixes of the type X#Y indicate the position where 
amino acid X was replaced by Y) 
OmpF-C: OmpF conjugate (OmpF-M with something attached to its thiol groups) 
OmpF-M: OmpF mutant (as opposed OmpF-WT) 
OmpF-WT: natural occurring variant of OmpF 
PBS:  phosphate buffered saline 
PCR:  polymerase chain reaction (reproduction and mutation of plasmids) 
PDI: polydispersity index (In case of polymers: 1 = no weight distribution; controlled 
polymerisations PDI=1 – 2; in case of particles it is defined differently and >0.2 refers 
to small size distribution) 
PDMS:  polydimethylsiloxane 
pI:  isoelectric point (= pH at which a protein or peptide has a net charge of 0) 
PICsome: poly ion complex polymersomes 
pKa:  acid dissociation constant (= logarithmic acid strength) 
PMDETA: pentamethyl-diethylenetriamine; a ligand 
PMOXA: poly(methyl-oxazoline) 
PNIPAAM: poly(N-isopropyl acrylamide) 
POPS: 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-L-serine (sodium salt); an unsaturated 
lipid with a negative net charge 
Rh:  hydrodynamic radius 
SLS:  static light scattering 
SM:  sphingomyelin; an unsaturated lipid 
τ2:  diffusion time of the vesicle (τ1 diffusion time of free dye) 
TDOC sodium taurodeoxycholate hydrate (CAS: 207737-97-1); a cholesterol derivative and 
detergent 
TEM:  transmission electron microscopy 
TF:  triplet fraction (of an excitated fluorophore) 
TFA:  trifluor acetic acid 
TG-I:  ThioGlo-1 (CAS: 137350-66-4) 
THF:  tetrahydrofuran 
TIPS:  tri-isopropyl-silane 
TLC:  thin layer chromatography (silica coated plates) 
TrisCl:  tris(hydroxymethyl)aminomethane hydro chloride 
16 
TrtX  TritonX-100; polyethylene glycol tert-octylphenyl ether (CAS: 9002-93-1) 
vol%  volume percent 
wt%  weight percent 
2YT:  LB medium with double the amount of yeast extract and tryptone 
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1.1 Application of nanotechnology 
 
Nanotechnology can be any technology based on nanoscale structures. It is therefore a vast, 
interdisciplinary field combining chemistry, biology, material sciences and physics ranging from very 
simple concepts such as nanoscale grains of reagents over nanostructured surfaces to complex 
nanoreactors (elaborated below). While huge progress was made in this field, such as microchips being 
downsized to nanotechnology,[1] many concepts are yet too complicated to be realised in particular 
nanoreactors and nanobots. 
Most of the applied nanotechnology relies on simple concepts such as surface modifications and nano-
composites. The most prominent examples are air-tight plastic;[2] water-repellent[3] and scratch-proof 
surfaces;[4] but also more complex structures with unique absorption, electric and optical properties.[5] 
Another growing subcategory are bioinspired systems such as surface-coatings applying the lotus-
effect[6] and ultra-strong materials based on the example of the structure of oyster[7] and silk[8]. 
However, nature had always a knack for intricate structures and finely tuned interactions, which we 
still struggle to understand and even more so to reproduce in a simplified form. Even the most complex 
artificial systems are compared to their source of inspiration like a child’s drawing compared to the 
real object. 
Nanoreactors and -sensors belong to the particularly challenging research goals. While 
nanotechnology has been used to create especially fine powder mixtures with faster reactions due to 
a larger surface[9] e.g. for rocket engines,[10] a nanoreactor would require at least a catalyst and a 
defined reaction space. In order to qualify as nanotechnology, either the catalyst itself or its supporting 
structure would need to be on the nanoscale (Fig. 1). The latter could be anything that contains the 
catalyst, protects it from the environment, or alters diffusion to and from the catalyst. In case of metal-
clusters and zeolites the size and shape results often in a unique reactivity and selectivity,[11] these 
structures are mostly catalysts on their own.[12] A more recent approach is to encapsulate the catalyst 
in nano-compartments creating artificial cells or more precisely artificial organelles. This promising 
branch of nanoreactors is elaborated in the following chapters as it is the foundation of this thesis. 
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Fig. 1: schematic of a nanoreactor; the nanoreactor is a catalyst in a confined space that allows the 
reactant to enter and the product to leave but does not allow any antagonist (catalyst poison), 
undesired reactant or side-product to enter/leave. 
 
 
1.1.1 Nanoreactors  
 
While chemistry is a very old, yet incredibly fast growing field, many reactions found in nature are still 
extremely challenging to reproduce (e.g. nitrogen fixation[13] or photocatalytic water oxidation[14] 
under ambient conditions). Nature’s success and probably its very origin is based half on catalysis and 
half on compartmentalisation.[15] Catalysis tunnels through activation energy barriers, effectively 
opening new reaction pathways and providing different products. Compartmentalisation on the other 
hand is the ability of cells and organelles, but also of enzymes themselves to select substrates, bringing 
them into proximity, so that they can react preventing side reactions and removing the product 
avoiding thereby back reaction and catalyst poisoning (blocking the active centre with reaction 
products). Forcing two reagents into proximity similar to the transition state of a reaction can be seen 
as a form of catalysis increasing the reaction speed and altering the selectivity. Moreover, cells are 
able to control when reactions take place and to what extent. 
While catalysis made huge progress in the last 100 years, the other half (creating well defined reaction 
spaces) saw far less progress. Nanotechnology is promising to change this by creating artificial cells 
and organelles serving as nanoreactors. Nanoreactors are in the broadest sense nanoscale 
compartments with a catalytically active entity encapsulated inside. The compartment has to serve a 
purpose, such as controlling access of the reaction site (changing selectivity and controlling the 
activity), and/or shielding the catalyst from the environment. However, there is no strict limit to the 
nanoscale, as multiple units could be combined to a macroscopic structure. Biological cells are 
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macroscopic and contain typically organelles for special purposes, such as energy production, the 
Mitochondria contain otherwise hazardous radicals so that they do not harm the cell as a whole.[16] 
Nanoreactors were originally regarded as artificial cells, but resemble more closely organelles in their 
size, their specialisation and lack of controlling and reproducing units. However, many approaches are 
based on polymeric vesicles (see 1.2 Nanostructures; Fig. 2) whose membranes relate in their 
assembly mammalian cell membranes. This type of nanoreactor will be the only one further discussed 
in the rest of this thesis. 
Encapsulating catalysts, in particular enzymes can change the catalytic behaviour and frequently 
improve their stability.[17] A long shelf-life and high resilience towards the environment makes 
nanoreactors promising tools for nanosensors (as described in the following chapter).[17b, 17d, 18] 
While nanoreactors can be used for drug delivery (in the sense of enzyme replacement therapy, as 
discussed in 1.1.3 Drug Delivery), they are not designed to release their cargo, unlike vesicles and 
micelles made specifically for drug delivery. Although it is fairly straightforward to encapsulate 
enzymes or catalysts shielding them from the environment (preventing aggregation, degradation 
through direct contact to harsh environments, catalyst poison, proteases or immune response…), 
creating precise structures with well-defined reaction spaces is an entirely different story: Controlled 
encapsulation of different entities in the same cavity, attaching entities on only one side of a 
membrane or controlling the orientation within the membrane are major challenges.[19] One of the 
most pressing challenges is diffusion control: controlling what enters or leaves the reaction space and 
when it does. 
Polymersome (artificial vesicles/hollow spheres, described in 1.2 Nanostructures) nanoreactors have 
to date no practical application, since the technology is still in its infancy, but also due to the fact that 
their production is currently hard to scale up and the incorporated biomolecules are rather costly to 
produce. Thus, they are ill-suited for large scale reactions. However, they are very interesting for 
special purposes. They would allow complex and very selective reactions on small scale or they could 
be used whenever compartmentalisation is required either to protect the inside (the catalyst or 
reactive intermediates) or outside (immune response, harmful intermediates…). This would be 
particularly of interest for samples with very complex matrices (many substances that could interfere) 
or sensitive environments (human body). They are thus lending themselves to applications such as 
nanosensors and biomedical uses. 
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1.1.2 Nanosensors 
 
While nanosensors are in principle a broad topic ranging from AFM-tips over quantumdots,[20] to 
labelled DNA that identifies targeted DNA via charge transfer.[21] Nano-sensors in context of this thesis 
refer to nanoreactors that react with certain substrates or indicate their location. They could be used 
for example as dipsticks or as countermeasures against theft and counterfeit. A key aspect is the long-
term stability of these nanoreactors. Encapsulation of enzymes has been proven to significantly 
increase their lifespan.[17c, 22] Moreover, encapsulating gels could prevent the drying process that would 
denaturate the involved enzymes.[17a, 17b] 
 
 
1.1.3 Drug delivery 
 
Drug delivery is the art of directing biologically active molecules such as drugs or enzymes to specific 
parts of the body. Excretion, digestion, immune response and misplacement of these entities are 
among the most important complications.[23] The common solution is to bind the active entities (mainly 
drug molecules or enzymes) together[24] and to shield the active entities if required from the body’s 
defences, in particular enzymes and antibodies. The most common solutions for protecting molecules 
include: micelles, dendrimers and vesicles.[25] They may moreover solubilise otherwise too 
hydrophobic drugs and prevent them from distributing indiscriminately over the body. The added size 
plays an important role too, since smaller molecules (<10nm) diffuse more readily whereas larger 
molecules cannot pass through the filtering system of the kidneys and are therefore not excreted by 
them. Particles larger than 100nm are cleared by the reticuloendothelial system (being swallowed by 
macrophages).[26] Beyond the extended circulation time within the bloodstream, there is another 
important advantage of nanoparticles in the range of 10-100nm, regarding cancer tissue. Due to the 
rapid and chaotic growth of tumours, blood vessels are often built with defects. These cracks allow 
larger particles to diffuse into the tumour and accumulate there, whereas healthy tissue is far less 
exposed. This effect is called EPR-effect (enhanced permeability and retention).[26] It allows releasing 
the payload of the nanoparticles in the tumour tissue, decreasing the collateral damage of the often 
very damaging anti-tumour medicine (which hinders cell growth, which affects primarily fast growing 
cells). The latter does only damage to healthy cells, if it is released in healthy tissue, or is able to diffuse 
from the tumour to healthy tissue before it is absorbed into cells.  
On the other hand, molecules of more than 100nm are targeted by phagues[26] and hence recognized 
by the human immune system as a foreign body and triggering therefore its defence mechanism. In 
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particular liposomes (elaborated in the following chapter) suffer absorption of blood-plasma proteins 
on their surface. Of these proteins, opsonins tag the nanoparticles to be phagocytosed by Kupffer 
cells.[27] For this reason the surface of the drug carrier may be modified to increase the compatibility 
with the organism e.g. PEGylation for “stealth”[28]. Also, the surface may be spiked with functional 
groups that resemble those found in specific tissue such as RGD-cyclic peptides[29] giving it the 
appearance of a certain cell type or by antibodies binding to specific tissue.[30] In either case the aim is 
to accumulate the drug carrier in the target tissue. Once the drug is released it tends to diffuse into 
the cells nearby. Although nanoreactors and polymersomes are fairly new, they are close to be 
employed as drug delivery vehicles.[31] The advantage of such systems would be that several properties 
could be united: a certain size for EPR-effect and surface functionalisation causing accumulation of the 
drug in target tissue combined with release or activation of the drug by a combination of different 
stimuli such as pH, [32] redox-potential[33] and temperature, [34] but also external forces[35] applied to the 
body part in question.[36] A further advantage of these carriers would be that they could harbour at 
least two different drugs that work by different mechanisms thereby overcoming e.g. tumour drug-
resistance[37] working as a combination therapy.[38] Finally, it facilitates the combination of drug 
delivery with sensor applications: so-called Theragnostics (derived from therapy and diagnostics).  
Comparing polymersomes for drug delivery with nanoreactors, the latter are more suited for enzyme 
replacement therapy, which is a promising concept, but usually suffers from poor uptake of the 
enzymes and even more so from activity loss in biological environments (blocked e.g. by antibodies, 
digested by proteases…).[39] A polymersome as a shell could solve both problems at once. Cellular 
uptake of polymersomes has been achieved and even the delivery of enzymes retaining their activity 
was reported.[40] As useful as these modular systems are, the disadvantage of these systems in 
pharmaceutics is that every variation requires a new admission procedure. Yet, polymersomes are 
close to be employed in drug delivery.[31] and were further investigated for numerous applications 
including on site production of antibiotics[41] or treatment of reactive oxygen species.[42] 
 
 
1.2 Nanostructures 
 
Among the potential structures, membranes, micelles, vesicles and dendrimers are the most notable 
examples. While in context of this thesis only vesicles are truly relevant, most of these structures are 
related and hence tend to coexist. The exception are dendrimers, which are formed through a multi-
step chemical synthesis and result due to the branching of the building blocks in tree or spherical 
structures (with the density increasing towards the surface).[43] Due to their shape, they offer a great 
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surface for attaching drug-molecules, catalysts etc. and solubilise them, or shield enzymes, by 
attaching branches of PEG. 
Micelles, membranes and vesicles share the same basic processes in their formation. They are the 
structures that will be further explored in this chapter. All three are based on the self-assembly of 
amphiphilic molecules. The driving force behind is the reduction of the exposed hydrophobic surface 
in aqueous environments. Which structure is ultimately formed depends on various factors. 
Amphiles consist of a polar- and an apolar group. Especially in case of lipids, the polar/hydrophilic 
section is often referred to as head and the apolar/hydrophobic section as tail since it is significantly 
longer. Isolated amphiphiles are typically not very soluble in water. 
 
 
Fig. 2: Overview of the relevant structures; all but the Dendrimer are the result of the self-assembly of 
ABCPs. The ABCP-concentration increases from top to bottom, with the highest concentration being 
the lyotropic crystalline phase (dried/precipitated structures) followed by gels of fused vesicles. The 
diagram does not necessarily represent the precise pathway, nor does it represent all possible self-
assemblies. 
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1.2.1 Micelles and Worms 
 
Both lipids and amphiphilic blockcopolymers (ABCPs) form micelles in the size of 10-100nm (latter 
rather ABCPs, due to their greater length).[44] Only materials that have a purely hydrophobic surface 
can be encapsulated in micelles. Apart from encapsulating drugs and proteins, micelles are employed 
extensively in green chemistry.[45] In these cases water is used as solvent and the reactions benefit 
through high local concentration due to the lipophilic substrates. Furthermore the catalyst recycling is 
often simple and straightforward.[45] To mention some examples: Heck-,[46] Suzuki-,[46] metathesis-[47] 
and ATRP[47] reactions were carried out in micellar reactors. Micelles are also used for the generation 
of catalytically active metal nanoparticles.[48] Speaking of green chemistry it is often impossible to tell 
which of these systems are genuine nanoreactors, since the research groups were often only 
interested in the functionality and not in the structure. Micellar nanoreactors are thus facile to produce 
but suffer of the restriction to hydrophobic loads and the dependence of the stability on the 
amphiphile concentration. 
Worms have the same cross section as micelles but lack the rotational symmetry. Instead, the slabs of 
aggregated amphiphiles are stacked on each other. Due to their small diameter, but high mass, they 
could be interesting for drug delivery regarding cellular uptake and retention time.[49] 
Both structures are not suited for the scope of this thesis, but relevant as side products potentially 
influencing the experiments. Especially micelles tend to coexist with vesicles, as they are formed prior 
vesicle-formation. 
 
 
1.2.2 Membranes 
 
Two dimensional assemblies of amphiphiles form monolayers that are usually formed at interfaces, 
mainly water-air border. They have typically a hydrophobic core and a hydrophilic surface. In case of 
lipids the individual lipids are assembled in parallel. Often the membrane folds on itself so that the 
amphiphiles contact tail to tail forming a double membrane (Fig. 2 and Fig. 4). If the assemblies become 
even more crowed, the layers can be stacked to multiple layers and even precipitate as solids (Fig. 
2).[50] 
Due to the weak intermolecular interactions, macroscopic membranes are very weak, but they can be 
stabilised on surfaces. Such supported membranes are of particular interest in combination with 
inserted membrane proteins (MPs, further reading, see chapters 1.3.1 self-assembly and 1.5 
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permeability) for filtration[51] and nanosensors as they are able to restrict diffusion from one side to 
the other and are able to maintain the functionality of nonporous membrane proteins such as 
transport proteins and sensor-proteins.  
At the end of the plane, membranes have edges where the hydrophobic surface would be exposed. 
However, it can be assumed that the amphiphiles are forming conformations similar as found in 
micelles and worms to minimise the exposure. Alternatively, they can fuse their ends together and 
form tubes or vesicles (see the following chapter). 
Membranes were found to catalyse reactions without additional catalysts through a hydrophobic 
effect (similar to micelles). It has been suggested that the reactivity of hydroxyl ions increases within 
membranes because of their limited possibilities to carry a solvate hull inside the membrane, thus 
appearing as naked ions.[48] 
 
 
1.2.3 Vesicles and Tubes 
 
If the membrane is sufficiently large, another possible way of reducing the edge exposure emerges, 
namely the membrane fusing with itself on its edges forming tubes or vesicles. These structures feature 
in addition to their hydrophobic membrane an aqueous internal compartment. Vesicles are hence 
hollow spheres surrounded by a membrane without beginning or end. 
Vesicles are particularly suited for nanoreactors due to their cell-like nature. Based on liposomes the 
assembly is identical to mammalian cells (disregarding the numerous membrane proteins). They are 
thus a good starting point for biomimicry. Depending on the used amphiphiles the resulting vesicles 
are referred to as liposomes (using lipids) or polymersomes (using amphiphilic blockcopolymers).  
PICsomes[52] are a special case, where the self-assembly does not depend on the hydrophobic effect, 
but on the combination of two oppositely charged molecules forming poly-ion-complexes 
compensating the over-all charge. Strictly speaking, they are not composed of ABCPs, but do consist 
of blockcopolymers whose blocks are immiscible. Due to their nature, they are porous and unable to 
insert MPs. 
Vesicles keep their cargo in the hydrophilic core but also possess the ability of inserting hydrophobic 
entities within the hydrophobic part of the membrane formed by the amphiphiles trying to hide their 
hydrophobic parts from the aqueous environment.[31] The first liposomes were described in 1965[53] 
and the first polymersomes in 1995.[54] 
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Please note: depending on the context liposome, vesicle, or polymersome will be used. Similarly, Lipid, 
amphiphile and amphiphilic blockcopolymer/ABCP will be used, with vesicle and amphiphile referring 
to cases that apply for both liposomes and polymersomes. Else it will be referred specifically to lipids 
and ABCPs respectively.  
The typical vesicle size lies between 50nm[55] and 200µm[56] diameter (both lipid or polymer based 
vesicles). Larger vesicles1 are formed through electroformation.[57] Vesicles can do the same chemistry 
as micelles, in that they offer a similar hydrophobic domain, but have the advantage of possessing both 
a hydrophilic and hydrophobic region. Considering the possibility of functionalizing the outside as well, 
vesicles offer three distinct and separated regions for reactions (the hydrophilic inside- and outside 
areas and the hydrophobic membrane itself). 
Tubes relate to vesicles as worms relate to micelles as they share the same cross-section but not the 
rotational symmetry. Thus, amphiphiles aggregate as in the cross section of vesicles but are stacked 
together forming a tube. While tubes may be too small for nanoreactors, they are none the less 
interesting for drug delivery.[58] 
Vesicles on the other hand are due to their structure the most versatile class for nanoreactors and are 
ultimately the only structure considered for the experimental part of this thesis. They provide a stable 
compartment with an almost impenetrable membrane which is moreover suited for embedding 
membrane proteins. 
 
  
                                                          
1 For our b-PMOXA-b-PDMS-b-PMOXA the vesicle size achieved by film rehydration does not exceed ca. 200nm.  
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1.3 Permeability of vesicle membranes. 
 
The self-assembled structures possess a temperature dependent permeability, since the interactions 
of the hydrophobic segments are temperature dependent.[59] Similar to the glass transition 
temperature (TG) of solid polymers, which makes polymers soft, there is a certain temperature, when 
the membrane becomes more fluid.[60] Liposomes tend to be more fluid since they are built of lipids 
with shorter hydrophobic blocks that are moreover often unsaturated resulting in bent conformations 
(cis-fatty acids) and overall less densely packed membranes.[61] Similar assumptions can be made for 
polymersome membranes, however the factors influencing their stability and permeability still require 
more fundamental studies.2 However, one of the main research topics for polymersomes is how to 
introduce permeability or stimuli responsiveness for applications as nano-rectors, sensors or 
applications in medicine. 
 
 
1.3.1 Release 
 
While the functionality of nanoreactors is typically defined by what was encapsulated, the membrane 
can be functionalised as well with equal impact on the functionality. This is particularly true for 
modifications that change the permeability of the membrane. For stimuli responsiveness often the 
same approaches were tried as those that found use in drug delivery.[62] However, with the additional 
limitation that the overall architecture need to remain intact rather than reversible disassembly 
leading to a chaotic rearrangement of the ABCP. 
In case of drug delivery the majority of the release is triggered by disruption of the structure by polarity 
changes, which include swelling of the hydrophobic part, reversible dissolution or even decomposition 
(e.g. by splitting the hydrophilic from the hydrophobic blocks).[62a, 63] They are thus able to release their 
payload, but due to fundamental changes in the architecture of the macromolecular assemblies, the 
process is often irreversible in that the cargo remains outside and the size-distribution of the structures 
changes.[62a, 63-64] The triggers for these changes include pH-changes,[65] temperature-changes,[66] 
fragmentation by reduction[67] or a combination of salt and pH response.[68]  
 
                                                          
2 It would be interesting to know how AB in ABA distribute within a polymersome and influence insertion of 
MPs, the stability of vesicles and how they interact with detergents. Similarly, it would be interesting to know if 
and how detergents interact differently with polymersomes compared to liposomes; however, unlike the prior 
question it cannot be easily measured via labelling experiments, since it is not only a question of distribution 
but could possibly affect the entire equilibrium of structures in solution. 
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1.3.2 Induced porosity 
 
In polymersomes, an important factor influencing the permeability is the combination of blocks. The 
different diameter of the polymer blocks may create porosity or force the amphiphile to adapt 
different shapes. The polymer chain might coil up, angle up to the hydrophilic block, or the amphiphiles 
form interlocking structures. All of these possibilities reduce the thickness of the membrane. It can 
therefore be observed that polymersomes have membrane of similar thickness as liposomes, although, 
the amphiphiles are considerably longer.[69] 
So far membranes have been made permeable for substrates by deliberately creating defects 
disturbing the dense packing of the hydrophobic blocks[70] or generating holes through decomposition 
of domains.[63a, 71] Also, the packing of the hydrophobic blocks can be temporarily disturbed by creating 
charges.  
A possible solution to the problem of drastic structural changes is crosslinking of the ABCPs. Then, 
even if the hydrophobic block turns completely hydrophilic (through changes in pH, temperature),[63a, 
71-72] the vesicular structure remains. The membrane thus transforms into a swelled state, or into a gel-
state allowing up to 10nm/25kDa macromolecules to pass through.[63a, 63b, 71] Many crosslinked systems 
have less dense membranes than other polymersomes, thus they are often permeable to small 
molecules even without swelling.[63b, 73] This effect has been used for nanoreactors.[74] 
A more refined method of controlling the pore size takes advantage of the fact that hydrophobic 
molecules can be embedded within the membrane, forming channels across the membrane. To date 
the molecules of choice are membrane proteins. 
 
 
1.3.3 Membrane proteins 
 
The ideal NR allows only the smaller enzyme substrate and product to diffuse through its membrane, 
once the correct stimuli is applied, thereby avoiding side-reactions and catalyst 
deactivation/degradation by excluding substances that are chemically similar to the substrate. Hence, 
establishing control over diffusion is still by far the most challenging and essential task. 
Nature developed for the purpose of diffusion control a great variety of sophisticated membrane 
proteins with either active or passive transport.[75] They contribute up to 80% of the dry-weight of the 
membrane and 30% of the cells genome is reserved for them underlining their relevance.[76] A great 
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variety of different types of Membrane proteins have been developed by nature, some allow passive 
diffusion of small molecules (e.g. OmpF),[77] others the passive diffusion of specific molecules (AqpZ, 
Valinomycin).[78] Both types can be referred to as porins. In contrast hereto, many pores allow diffusion 
only after being triggered by a signal molecule (acetylcholine receptor M2),[78b], or actively translocate 
the molecules to the other side, via gradient driven diffusion as cotransport/symporter (SGLT)[79] or 
antiporter (MRP)[80] and specific pumps (ATPase)[81] and transporters of specific large molecules 
(ABC).[82] 
This lends itself to defined permeability of polymersome membranes that does not disrupt the 
nanoarchitecture through insertion of MP. Once reconstituted in polymersome membranes ,MPs such 
as AqpZ, LamB, OmpF, Tsx and FhuA[83] and membrane penetrating peptides such as gramicidin[51b, 84] 
have essential impact on membrane permeability towards small molecular weight molecules and 
ions.[85]. The choice of membrane protein determines reactivity and selectivity of NRs.[86]. However, 
most of the investigated MPs are porins without stimuli response and limited selectivity towards the 
molecules allowed to diffuse through the pore. Mostly the restriction is based on a molecular weight 
cut-off caused by the pore diameter.  
Membrane proteins are adapted for thinner membranes (5nm), but polymer-membranes are far from 
being static, meaning that they can adjust their shape and thus their thickness. Furthermore, 
polymerisation produces different chain-lengths. It has been proposed that the shorter chains tend to 
aggregate around the proteins in order to reduce the strain on the system.[87] Theoretical calculations 
indicate the importance of the chain flexibility.[87-88] Furthermore, PDMS is known for its flexibility 
allowing the membrane to adapt.[89] It can nevertheless imply a significant strain on the protein 
structure. Paradoxically it was found that this increased the activity of the NADH:Ubiquinone 
Oxidoreductase.[90] 
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Table 2: List of reported membrane proteins inserted in blockcopolymer membranes 
Block 
copolymer 
Polymer 
type 
Membrane protein Study Reference 
PMOXA-b-
PDMS-b-
PMOXA 
Triblock 
ABA 
AqpZ 
Water-selective 
permeability  
Kumar et al. 2007[91] 
Wang et al. 2012[92] 
Grzelakowski et al. 2015[93] 
mobility of various MPs 
in polymer membranes Itel et al. 2015[94] 
NtAqp1 
CO2 -selective 
permeability  Uehlein et al. 2012[95] 
bR Proton transport  Ho et al. 2004[96] 
FhuA 
Reduction triggered 
release  Onaca et al. 2008[33a] 
GlpF 
selective detection of 
sugars Zhang et al. 2016[97] 
Gramicidin 
Monovalent cation-
selective permeability Lomora et al. 2015[84b] 
Ionomycin 
Divalent cation-selective 
permeability Lomora et al. 2015[84a] 
KcsA 
mobility of various MPs 
in polymer membranes Itel et al. 2015[94] 
LamB 
Virus assisted DNA 
loading into 
polymersomes  Graff et al. 2002[98] 
MspA 
membrane–protein 
interaction Morton et al. 2015[99] 
NADH-ubiquinone 
reductase (complex 1) 
Complex 1 activity – 
electron transfer Graff et al. 2010[90] 
OmpF 
Size-selective 
permeability  
Nardin et al. 2000[100] 
Ranquin et al. 2005[101] 
Grzelakowski et al. 2009[102] 
Dobrunz et al. 2012[103] 
Langowska et al. 2013[41] 
Langowska et al. 2014[104] 
mobility of various MPs 
in polymer membranes Itel et al. 2015[94] 
HRP kinetics Baumann et al. 2017[18] 
Stimuli responsive OmpF 
modifications 
Ihle et al. 2011[105] 
Einfalt et al. 2015[32a] 
Edlinger et al. 2017[17d] 
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Block 
copolymer 
Polymer 
type 
Membrane 
protein 
Study Reference 
PMOXA-b-
PDMS-b-PEO 
Triblock 
ABC 
AQP-0  Directed insertion of Aquaporin 
Stoenescu et al. 2004[19b] 
PEtOz-b-PDMS-
b-PEtOz  
Triblock 
ABA 
bR and 
ATPase 
ATP production 
Choi et al. 2005[106] 
PIB-b-PEO-b-PIB  
Triblock 
BAB 
FhuA  Size-selective permeability 
Muhammad et al. 2011[107] 
PEO-b-PB 
Diblock 
AB 
AQP-0 Water-selective permeability  Kumar et al. 2012 [108] 
αHL Ion conductivity Zhang et al. 2013[109] 
PMOXA-b-PDMS 
Diblock 
AB 
MloK1 K+- selective permeability 
Kowal et al. 2014[110] 
PMOXA-b-PDMS 
/DPPC 
1) MloK 
Inserting MPs exclusively in 
Polymer-domains Kowal et al. 2015[111] 
 
1) = same diblock AB as domains in lipid-membranes 
 
 
1.3.4 Modified MPs 
 
Most nanoreactors have no stimuli-responsiveness. Up to date only few of the artificial systems for 
diffusion control (in lipo- and polymersomes) go a step further in the design, as for example channel 
proteins having an attached responsive molecular cap based on a labile bond, which hinders the 
diffusion of molecules through the pore until it is cleaved off. Stimuli responsive protein pores were 
designed to react to external changes in pH (OmpF[32a]) or reduction potential (FhuA[33] and OmpF).[32a] 
Other groups introduced mutations in order to create charge repulsion in the channel interior 
(OmpF),[105] or introduced an ELP-loop whose water solubility is temperature dependent (αHL[34]). 
Only few of these approaches allow a reversible response; moreover, the stimuli responsiveness 
cannot be readily altered or transferred to a system based on a different MP. Moreover, charge 
repulsion alone lacks conformational changes to block other molecules than those bearing the same 
charge. A more versatile approach is to attach a stimuli responsive group via straight forward click 
chemistry at the channel entrance or its narrowest point.  
So far, this was only reported to have worked for irradiation triggered systems, in particular ion 
channels (αHL,[35a] nAChR, GrA, IGluR, MscL, ChR2 and Shaker K+ Channel[35b]). However, up to date only 
the reversibility of the stimuli responsiveness was investigated and none of them was used in the 
context of NRs, probably since selective ion channels are unsuitable for the transport of enzymatic 
substrates. 
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As described, many elaborate designs were conceived, yet a simple, modular and scalable solution is 
desired to achieve a nanoreactor system with a reversible pore opening and closing. The advantage of 
a system with a reversible plug is that it is not restricted to a single activation, but can be deactivated 
again and that, over many cycles, allows long-term usage of nanoreactors/sensors. While the stimuli-
response does not stop any reaction within the polymersome directly, it allows the suppression of the 
in- and out-flow, thereby controlling reaction and release of product.  
 
 
2 Aim of the thesis 
 
Great attention has been dedicated to the fabrication of nanomaterials with precisely defined 
architectures and functionality in various domains such as sensors, drug delivery and nanoreactors 
(NRs).[62b, 112] For these particular applications it is important to create well defined reaction spaces 
which enable control over timing and selectivity of the reactions by controlling what enters and when 
it enters the compartment.[83, 112a] In this context the development of a gate that opens and closes on 
demand would be a major advance. Such a gate needs to be able to allow molecules to diffuse through 
independently of their chemical nature in its open state (excluding for example diffusion control by 
charge repulsion). 
Like most work in this field, the concepts are bioinspired, attempting to replicate the function of cell 
membranes and their membrane proteins. Such a nano-device has to consist at least of a tunnel that 
can be inserted into various membranes of artificial cells/organelles and a stimuli responsive part 
acting as a gate. Many membrane proteins would serve well as tunnel, however MPs are in their nature 
restrictive towards the substrates that are allowed to diffuse across the membrane, by setting a 
molecular weight cutoff with their minimal tunnel diameter and due to their net charge create further, 
unintended restrictions. Therefore, making elaborate modifications to one specific membrane protein 
in order to achieve the goal, would merely create a niche-solution. Thus, a modular approach 
consisting of various stimuli responsive groups that can be linked to various different membrane 
proteins would be desirable (Fig. 5); as it would enable a plethora of different gates tailored according 
to the individual applications; allowing choosing a class of substrates and a stimulus by combining the 
right modules. 
This novel approach will be exemplified in this thesis on well-established OmpF membrane proteins in 
combination with various stimuli responsive groups. In order to achieve this, the challenge of finding 
both a suitable experimental set-up and at the same time finding an adequate analytical method had 
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to be overcome. Suitable membranes had to be found; various methods of inserting OmpF had to be 
tried and various dyes and enzymes had to be encapsulated enabling the detection of diffusion (release 
experiments or enzyme assay see). 
 
 
Fig. 5: concept of blocking and opening the pore (magenta) via stimuli responsive group (green) 
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1 Vesicle formation 
1.1 Self-assembly 
 
While at first glance it might seem irrelevant how vesicles are formed, as long as they are obtained 
through an established procedure, it can be very frustrating when minuscule changes result in drastic 
changes. The choice of the amphiphile and the conditions during self-assembly, can have vast influence 
on the resulting structures, their size and stability but also whether or not cargo can be encapsulated 
or MPs can be inserted. Thus, having a basic understanding of the processes involved can help to avoid 
or fix problems. 
As elaborated later on, the process of self-assembly is very complex and depends on a multitude of 
different parameters. While most of the mentioned structures (but also gels[1]) have been thoroughly 
studied, many aspects of the self-assembly processes are still poorly understood due to the lack of 
confirmed structures of the intermediates and their heterogeneity. It can be assumed that the 
aggregation processes relate to the following pattern: 
 
1) Due to the hydrophobic nature of the amphiphiles (even more so ABCPs), the solubility can be 
very low. For the same reasons and the resulting interaction with itself, the solubilisation of 
individual amphiphiles is slow and results in a gradual increase in concentration. If the bulk of 
solid amphiphile consists of layers of dried membranes (lyotropic phase), the layers can be 
rehydrated and membrane-patches can go into solution.[1a, 2]  
2) In both cases, the dissolved particles are in a thermodynamically very unfavourable situation. 
In the prior case amphiphiles minimise their exposure of their hydrophobic segments, by 
accumulating at the water-air-interface (hydrophobic part facing air). In the latter case 
membrane-patches conceal their hydrophobic edges, by fusing together to larger structures, 
in particular tubes and vesicles. The latter occurs when the lamellar liquid crystalline phases 
swell to such an extent that the membranes distance themselves by more than 100-300nm 
(when the interlamellar distance roughly equals the persistence length).[3] 
3) After an amphiphile specific surface concentration is reached, a secondary process becomes 
energetically, more and more favourable: Due to the hydrophobic effect or more precisely an 
unfavourable mixing enthalpy and low mixing entropy[4] amphiphilic particles aggregate in 
water (micro phase separation) with their hydrophobic surfaces resulting in micelles hiding 
their hydrophobic part behind the hydrophilic head-groups; avoiding precipitation. In case of 
detergents, this phaenomenon is known as critical micelle forming concentration (cmc). 
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4) At even higher concentrations the exposed surface of the micelles is reduced by fusion to 
larger micelles.  
5) At a certain point, micelles cannot grow anymore without becoming hollow at their core. At 
this point they collapse to small patches of membranes or fuse together forming worms (the 
latter in case of the amphiphile preferring cone form over cylinders). 
6) The size and concentration of membranes continues to grow. Membranes are fusing together 
to larger membranes, tubes or vesicles. [5] These processes reduce not only the number of 
micelles, but the total number of particles in solution and the total exposed surface.[6] This 
process most likely has highly unstable intermediates such as bilayer fragments or ill-defined 
multilayer aggregates.[7] The growth of vesicles changes the curvature of the membrane. This 
change is connected with hydration and change of the density of the amphiphiles.[7] An abrupt 
change in vesicle size could generate defects in the amphiphile packing or fissures and holes. 
7) At even higher concentrations (over 40wt%)[8] vesicles can be packed, partially fuse to complex 
gels or even evolve to lamellar gels.[1a]  
 
 
Cargo becomes usually encapsulated during the vesicles formation, by dissolving the cargo directly in 
the buffer that is used for film rehydration or detergent removal (see chapter 1.3.3). Later it can only 
be added if the vesicles are damaged, e.g. by sonication, freeze-thaw-cycles etc. In that case the 
damaged vesicles are usually concentrated and rediluted in a buffer containing the cargo (in the hope 
that the vesicles repair themselves).[9] 
As discussed later in this chapter (1.5), Membrane proteins (MPs) are of great interest for 
polymersome nanoreactors. These proteins are amphiphiles themselves, with a vast hydrophobic 
(often cylindrical) surface that interacts with the membrane and one or two hydrophilic surfaces, which 
protrude out of the membrane. Unlike normal proteins, they need to be stabilised in solution with 
detergents in order to prevent aggregation, precipitation or denaturation. These detergents not only 
form a steric hindrance for self-assembly, but also interfere with membranes though insertion into 
membranes, or stabilisation of ABCPs in solution via their micellar structures. 
Membrane proteins can be inserted in similar fashion to encapsulation of cargo:[9] 
- Adding MPs to the amphiphile prior vesicle formation: in that case the MP must survive organic 
solvents, detergents or drying 
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- Adding them to the amphiphile during vesicle formation: the detergent stabilising the 
hydrophobic MP is thereby diluted so that the naked MP attracts amphiphiles. The 
disadvantage is that the MP can form aggregates or precipitate instead. 
- Adding them after vesicle formation: in that case the vesicle membrane must be damaged via 
sonication, freeze-thaw cycles or detergent addition; the latter being of particular interest 
since the membrane protein remains stabilised in solution until the detergent becomes 
removed via dialysis or adsorbent addition. This method has however the most parameters to 
optimise. The disadvantage here is that the vesicles might not recover and precipitate instead 
or form micelles or that the detergent is removed too quickly resulting in the loss of the MP.  
- In rare cases, MPs can insert into membranes directly by displacing amphiphiles. This works in 
particular for very small MPs, that are sufficiently stable in solution. Gramicidine is a well-
known example.[10]  
 
Polymersomes are more challenging to insert, due to their thicker membranes and stronger interaction 
of their hydrophobic segments. In case of liquid-crystalline structures (PS-block,[11] or PICsomes[12]) or 
polymersomes with crosslinked ABCPs, insertion becomes impossible. On the other hand, ABCPs with 
flexible, amorphous hydrophobic segments facilitate insertion. It has also been suggested that higher 
polydispersity[13] closes the gap in hydrophobic mismatch between polymersome membranes and 
MPs. 
Please note that there are several theoretically possible mechanisms how membranes and vesicles 
may grow: 
- Single amphiphiles (especially from micelles but also directly out of water) may insert 
- Membrane fragments may be incorporated when the vesicle-membrane has a crack at which 
the fragment can fuse to 
- Aggregates can collide forcing fast reorganisation. 
The precise mechanism of self-assembly will be dependent on the amphiphile, the concentration of it, 
the concentration of the various types of aggregates and probably numerous less obvious parameters 
(shape and amount of the reservoir of undissolved amphiphile; temperature; type of agitation; oxygen 
content in water…). 
Since polymeric amphiphiles have usually longer hydrophobic chains than lipids, they are less soluble 
and feature a lower critical micelle forming concentration (cmc). Thus, the amphiphiles are more 
willing to self-assemble, however they do so slower, due to their significantly greater molecule size. 
II Theoretical background 
43 
The question which process is available is relevant for the stability of the structures but also for 
encapsulation of entities and insertion of membrane proteins. Since the concentration of free 
amphiphiles is in most scenarios negligible low, the vesicles can change their size either through fusion 
or fission. This explains, why further encapsulation cargo after vesicle formation is unlikely.[6] 
Obviously, diluting self-assembled structures creates a perturbation of the equilibrium. Polymersomes 
have proven to be far more resistant in that respect than liposomes.[14] 
In case the vesicle formation is a one-way process, then there is no equilibrium between the 
structures, preserving their size, but preventing repair of damaged structures (e.g. vesicles breaking 
down and aggregating and the remains in solution eventually becoming micelles). This would make 
weakening the membrane by detergent addition for protein insertion a bad choice. 
In case of an equilibrium, encapsulated entities may be released and inserted entities could change 
their orientation, which would result in an unacceptable lack of control for the production of 
nanoreactors. In particular, in case of polymersomes, these processes are too slow, to cause problems, 
unless detergents are present and act as catalysts. In this case, even new processes and outcomes are 
possible. 
If vesicles are formed primarily by insertion of single amphiphiles, then insertion of membrane 
proteins becomes near impossible as membrane proteins would be predominantly in 
(detergent)micelles and small patches of membranes. Thus, membrane proteins are typically inserted 
during the vesicle-formation, or by damaging vesicles just enough to allow membrane proteins to 
insert, while the vesicles repair themselves (which in turn probably requires the presence of micelles 
as reservoirs for amphiphiles). In either case, detergents have to be removed at the end to ensure 
stability of the vesicles. 
 
 
1.2 Factors influencing resulting structures 
 
While there is a general trend to shift from micelles over membranes to vesicles with increasing 
concentration of the amphiphile,[4, 15] the ratio between its hydrophilic and hydrophobic surface, but 
also its shape and flexibility determine the possible curvatures of the resulting structures and its 
chemical nature in general (discussed later) do determine the formed structures.[16] Moreover, the 
polydispersity (PDI),[4, 17] contamination by the homopolymer,[17b] other impurities and moisture of the 
ABCP[16] may make two ABCPs behave completely different, although they are identical on paper. In 
particular, the frequent coexistence of micelles and vesicles has been attributed to the polydispersity 
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of the ABCPs.[18] On the other hand, shorter ABCPs could accumulate on the inside curvature, especially 
when bilayers are formed thereby reducing strain.[19] 
Micellar structures are prevailing, when the hydrophilic block dominates (over 50%). 40-50% leads to 
rod-like structures, whereas vesicles are formed at3 25-40%.[20] However, there are many other factors 
determining the self-assembly process, including formation procedure[15b], in case of film rehydration: 
the thickness of the polymer film to be rehydrated and thus the polymer concentration in ethanol, the 
vial, its rotation speed and the drying rate.[4, 15b] Similarly, the rehydration speed is important and 
depending on further factors. Thus ionic strength of the rehydration buffer,[4, 15b, 17b] its pH[15b] and the 
temperature[4, 15b, 17b] and stirring time.[21] The list should not be regarded as complete. 
The minimal vesicle size is restricted by the maximal curvature of the membrane. This is determined 
through the ability of the amphiphile to adapt a conical shape. The shape of the self-assembled 
structures is hence dependent on the composition of the amphiphile (see Table 1). In general, an 
amphiphile with a strong tendency to a cone over a cylinder results in micelles, whereas a preference 
for cylinder shape results in membranes. Note: a slight cone shape would facilitate the curvature of a 
membrane to a sphere, but this would only be true for the outer half of the bilayer, whereas the inner 
half would have to adapt a conical shape tapering in the opposite direction. 
The minimal vesicle size is important since in many cases the size distribution of vesicles features a 
vast number of small vesicles and few larger ones (which will disappear after purification). Since 
vesicles size has a great impact on encapsulation efficiency and possibly the curvature of the 
membrane influences the insertion efficiency of MPs as well, two batches of ABCPs with different 
minimal vesicles size are not comparable. 
Aside from the hydrophilic to hydrophobic block-length ratio, the packing parameter [P] is a tool to 
predict the preferred self-assembled structure (see Table 1, Equation 1).[22] It is a unit-less number that 
puts the volume (Vc) of the hydrophobic block into relation to the ideal area per molecules (A0) and 
the critical length (lc) of the amphiphiles (dependent on the elongation; a U-turn would divide it by 
two). Vesicles are found when 0.5<[P]>1.[23] 
𝑃 =
𝑉𝑐
𝐴0∙𝑙𝑐
        (1) 
  
                                                          
3 There is no newer publication evaluating the ratios, but in our group, we found significant outliers with e.g. b-
PMOXA10-b-PDMS87-b-PMOXA10 with 23% and b-PMOXA20-b-PDMS41-b-PMOXA20 with 97.5%. Both formed 
vesicles. We further found that very low hydrophilicity resulted in slow film rehydration and very high 
hydrophilicity resulted in a high micelle population or a slow transition into vesicles. Results not published.  
II Theoretical background 
45 
The vesicle size tends to increase when higher polymer concentrations are used. However, the size 
distribution of the vesicles becomes broader. It is determined through the competing effects surface-
area-reduction and entropy loss. The total surface-area decreases with increasing vesicle size, 
considering the diminishing total number of vesicles. In order to enforce a specific vesicle size, the 
vesicles can be extruded using a membrane with pores of diameter close to the diameter of the 
smallest vesicles.[5b] 
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Table 1: Selection of potential structures formed by self-assembly and their dependence on the 
packing parameter and composition[23] 
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1.3 Methods of vesicle-formation 
 
The synthesis of micelles is straightforward: either they are made through direct-dissolution or through 
film-rehydration. In the latter case the amphiphile is spread through evaporation on a surface and is 
consecutively redissolved under agitation. For vesicle formation there are three main methods:[24] 
Kinetic trapping: a polymer becomes dissolved in an organic solvent and is precipitated in excess of 
water. The organic solvent has to be miscible with water and should be volatile enough to be removed 
or has to be able to be removed via dialysis or adsorbent addition. 
Thermodynamic trapping: similar to kinetic trapping, with the difference, that water is added to an 
organic polymer solution. The unfavourable medium is thus added slowly, reducing the solubility 
slowly, ideally allowing an equilibrium to be formed; hence the distinction in the names of the two 
trapping methods. 
Film-rehydration: first a film of the amphiphile has to be made through dissolution and evaporation. 
Then the film is slowly dissolved in water or aqueous buffer solution. The agitation is caused through 
rotating the vial, stirring, shaking, vortexing or even sonication. 
The first two methods have the disadvantage, that the removal of the organic solvent is often difficult 
and incomplete. The remains are thus able to interfere with biological systems or cause swelling and 
fluidation of the membrane. The latter can cause slow vesicle-fusion.[25] Furthermore precipitation- 
and dilution methods are not suitable for proteins. Lastly, vesicles can also be achieved by dissolving 
the amphiphiles in water using detergents and then removing the detergents again (which could be 
seen as a variation of thermodynamic trapping). This method is particularly of interest for inserting 
membrane proteins, which have to be stabilised in detergents.[26] However, the involved detergents 
can interact unfavourably with the membranes and be almost as difficult to remove as solvents. 
The precise method can have a significant impact on the resulting structures and their size. The 
presence of detergents or organic solvents tends to decrease the vesicle size and increase the micelle 
population. Therefore, cosolvent methods produce usually smaller vesicles than film rehydration. 
Similarly, agitation of the solution plays an important role as it affects the concentration gradient at 
the interface of the solid amphiphile bulk, the extreme would be electroformation which is used to 
create giant vesicles (20-50µm in diameter).[1a] 
For this thesis, primarily film rehydration was considered, as OmpF is stable enough to be dried along 
with ABCPs and withstands ethanol. Detergent removal is a milder alternative and tends to inserts MPs 
better, but also results in smaller vesicles and more micelles. 
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2. Properties of vesicle-membranes 
2.1 Metastability 
 
As evident it may be that vesicles are formed through self-assembly, it is often overlooked that they 
can fuse together or disassemble again, for example upon concentration changes, since the self-
assembly is an equilibrium process. In case of polymersomes, this may be hindered, due to the strong 
interaction between the amphiphiles within the membrane, a low solubility of individual amphiphiles 
and potentially their preference to form membranes over vesicles. The conditions under which the 
structures disassemble again are of particular importance in medical and pharmaceutical applications, 
since extreme dilutions4 are required there.[27] It should be noted further that the concentration of 
other solutes influences the stability. Phospholipid vesicles may be stabilized through sugars[7], 
whereas the presence of salt outside of vesicles induces osmotic pressure. 
It is noteworthy that, vesicles do not form spontaneously, unlike micelles. They are thermodynamically 
unstable and thus metastable (similar to many proteins, whose folding is often kinetically determined 
and do not fold back once denatured[28]).[7] Their preparation is often a non-equilibrium process. The 
results are therefore not necessarily reproducible.  
 
 
2.2 Stabilisation of vesicles 
 
In order to increase the stability of vesicles the thickness of the membrane may be increased by using 
longer amphiphiles;[29] the interactions between the amphiphiles within the membranes could be 
enhanced by increasing the crystallinity of the assembly.  
In liposomes, this would mean using longer hardened fatty acids over shorter unsaturated fatty acids. 
The best approach of creating stronger membranes is by using additives. Their bilayers can be 
stabilised by introducing structures that connect all parts of the bilayer e.g. cholesterol added to 
lipids,[30] but also membrane proteins inserted.[31] These additives are less likely to diffuse out of the 
assembly than the actual amphiphiles. Such transmembrane structures can bind amphiphiles next to 
them by reducing the likelihood of amphiphiles leaving the vesicle (comparable to dissolving non-
volatile compounds thereby reducing the solvents vapour pressure). Cholesterol is also known to 
increase the fluidity of liposomes.[30a, 32] 
                                                          
4 Considering that an adult has around 5L blood, an injection of e.g. 100µL would translate to 50 000x dilution 
of the vesicles. 
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Lastly, fusion of vesicles can be prevented by adding charges to the surface causing charge repulsion 
among the vesicles. PEGylation can help as well. Both are used for liposomes in drug-delivery.[33] In 
order to PEGylate the vesicle surface, anchor groups are required (Fig. 1.2). In case of liposomes 
cholesterol is better suited than a lipid for this purpose, similarly in case of polymersomes triblock-
copolymers are typically better suited than diblock copolymers (Fig. 1 3, 4) due to their size, reducing 
the likelihood of the anchor becoming detached form the vesicle. 
In case of polymersomes far more options are available: The length of the hydrophobic block can be 
changed to a much greater degree and even the very chemical nature of the hydrophobic block can be 
altered, e.g. by using polystyrene (PS) over poly(dimethylsiloxane) (PDMS). Polystyrene is much stiffer, 
can be crystalline and its phenyl-sidechains are able to entangle. Moreover, it is possible to introduce 
interactions between the ABCP other than van der Waals forces such as hydrogen bonds, e.g. by using 
Kevlar-like segments, or even charge compensation as in PICsomes. However, these PICsomes cannot 
be used to insert membrane proteins due to their lack of hydrophobic segment. In general, such 
modifications greatly reduce the ABCPs ability to dissolve in the first place. Even polystyrene based 
ABCP require a cosolvent to lower the high glass transition temperature to provide sufficient chain 
mobility.[34] All these modifications directly affect the permeability of the membrane as well and 
potentially change the self-assembly mechanism up to the point that the structures are no longer in 
an equilibrium with each other. 
 
 
2.3 Polymersomes vs Liposomes 
 
Please note: lipids refers to amphiphilic lipids only (and not lipids for energy storage also known as 
fat). These lipids usually belong to the category of phospholipids which possess two fatty acids bound 
to glycerol and one phosphatidylcholine as polar headgroup attached to the third alcohol-group. 
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Fig. 1: the lipid POPC (1), Chol-PEG600 (2) and ABCP of the type AB (3) and ABA (4) based on PDMS 
and PMOXA 
 
Lipids are natural products (Fig. 1.1) and are therefore extracted from biological sources, although 
they can be modified e.g. by hardening, or recombination of fatty acids. Synthesis of well-defined lipids 
requires protecting groups. The synthesis of fatty acids with precise lengths is even more demanding. 
Thus, those lipids used for membrane formation are typically a mixture of more or less similar fatty 
acids pairs. Moreover, they can come with different polar headgroups as well.  
Liposomes suffer from leakage attributable to defects in the membrane and from its instability.[35] It 
should be noted however, that liposomes possess a more fluid membrane which allows faster 
response to perturbations. They are thus more likely to be damaged but also more likely to recover 
from damage than polymersomes, as they are able to allow single amphiphiles exchange 
(ergodicity).[36] This does not mean that polymersomes cannot repair themselves, but it may occure on 
a timescale larger than observed. Similarly, liposomes are less sensitive to most detergents. One may 
compare the stability of liposomes and polymersomes with gel and glass: one being softer but able to 
recover from deformation, whereas the other is unyielding until it shatters.5 
While liposomes are typically mixtures of various lipids and additives, polymersomes usually consist 
only of one type of amphiphilic blockcopolymer (Fig. 1 2,3), which however varies in length due to its 
synthesis. The self-assembly of polymersomes is likely the most versatile approach for creating 
nanocapsules. Polymersomes offer several advantages over liposomes: 
  
                                                          
5 This finding will be discussed in detail in later in this thesis. It may also be different for ABCPs other than the 
PDMS/PMOXA we used. 
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Polymersome membranes are generally thicker and can be more stable due to stronger interactions 
between the amphiphiles.[37] Liposome membranes have a thickness of 3-5nm, whereas polymersomes 
have a thickness of 4-20nm (the thickness correlates to the molecular weight of the amphiphiles, or 
more precisely the molecular weight of the hydrophobic block by the factor M2/3 [38]).[39] The 
membranes of polymersomes are up to 10x more mechanically stable than those of liposomes and far 
less permeable, allowing better control over diffusion across the membrane.[40] Polymersomes and 
PICsomes o are often stable enough to be concentrated through centrifugation.[12b] They are moreover 
often stable at room temperature for months.[15b] The higher stability and lower permeability of 
polymersomes is a result of its higher rigidity and membrane thickness. This makes them very 
interesting for NRs, but the thicker membrane can make it difficult to incorporate membrane proteins 
that are adapted for much thinner membranes and a somewhat different chemical environment.  
Polymersomes are built by well-defined amphiphiles, which contain usually two or three polymer 
blocks. The control over their precise length varies with the chosen polymerisation method. The choice 
of the blocks is synthetically straightforward and offers nearly endless possibilities. Various monomers 
can be used in the polymerisation and their blocklengths and overall length can be adjusted, thus 
controlling the hydrophilic content (allowing to alter the self-assembly behaviour)[41] and the thickness 
of the resulting membrane.[39] Lastly, in case of polycondensations and ATRP,[42] the endgroups can and 
have successfully been selected and used as anchor points for further modification.[43] 
Unlike lipids, ABCP can be therefore designed individualised according to the requirements. They can 
be functionalized to bear targeting moieties or linkers for click-chemistry. The latter allows 
immobilisation of the vesicles, fixation of catalysts/enzymes and other post processing. Moreover, it is 
possible to fixate vesicle membranes through (radical-) polymerisation of the individual ABCPs. The 
hydrophilic block retains most of its flexibility, but loses most of its ability to diffuse within the 
membrane, if the polymerisation occurs at the very end of the ABCP.[44] This increases however the 
risk of cross-linking vesicles with other vesicles. Membranes can also be stabilized through 
polymerisation of monomers (by copolymerising monomers similar to those building the blocks of the 
amphiphile, differing by an additional polymerizable group),6 which are embedded in the hydrophobic 
block.[45] Both techniques would stabilize pores and smaller defects from rupturing the membrane. 
These methods take however the possibility of later introducing membrane proteins, since the ABCP 
can no longer be displaced. 
However, polymersomes have also some disadvantages:  
                                                          
6 This double bond requires to be protected or otherwise to be inert to the polymerisation method applied for 
the amphiphile synthesis. 
II Theoretical background 
52 
Lipids developed in order to form vesicles and membranes, whereas ABCPs have to be carefully 
designed to do the same. Lipids have less problems in becoming rehydrated and form thus self-
assembled structures rapidly, whereas ABCPs have a tendency to remain solid due to their poorer 
solubility.7 Similarly, many ABCPs do not support the insertion of membrane proteins. For example, 
poly(styrole) would form to strong interactions between each hydrophobic block and PICsomes are by 
their nature not hydrophobic, thus they would repel membrane proteins As mentioned above, 
polymersomes have thicker membranes (up to 7x thicker than the membrane protein, have been 
used)[39] and the interactions between the amphiphiles can be much stronger than between lipids. 
Moreover, some ABCPs have hydrophobic blocks that will not be miscible with MPs. It is often already 
a challenge to find the right lipid mixture. Designing artificial amphiphiles is therefore a major 
challenge. Even designs that worked before may fail due to minor changes in the synthesis (presumably 
by deviation in PDI, number of diblocks in triblocks and other contaminations). The PDI or 
polydispersity-index is a measure for the deviation in chain-length of individual ABCP from the average. 
The higher its value is, the less homogeneous the ABCP. 
Lastly, amphiphilic blockcopolymers differ more from the commonly used detergents than lipids do. 
This may be the reason why polymersomes discussed in this thesis are more sensitive to detergents. 
Thus, polymersomes may behave differently from a mechanistic perspective in particular regarding 
insertion of membrane proteins.  
In summary, liposomes are easier to produce and it is easier to insert membrane proteins into 
liposomes. However, they are less stable and more permeable than polymersomes. Regarding this 
thesis, liposomes are more preexperiments and polymersomes the final goal. 
 
  
                                                          
7 Due to the molecular mass, dissolution can be much slower, but the lower solubility of individual ABCPs and in 
case of PMOXA the known tendency of forming insoluble crystals can reduce the overall solubility. 
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2.4 Diblock- and Triblockcopolymers  
 
Polymersomes are typically made of a diblockcopolymer (AB). The shorter hydrophilic block (A) is 
typically made of poly(acrylic acid) (PAA), polyethyleneglycol (PEG), poly N-isopropyl methylacrylamid 
(PNIPAAM), poly N-hydroxypropyl methacrylamide (PHPMA) or polyoxazolidines in particular 
polymethyloxazolidine (P<M>OXA), whereas the hydrophobic block (B) consist of polystyrene (PS), 
polybutadiene (PBD) or polydimethylsilicone (PDMS).[46] PEG, PMOXA and PHPMA are considered to 
be biocompatible and protein repellent and are therefore interesting for medical applications.[47] None 
of these blockcopolymers would be possible, without modern living polymerisation techniques.  
 
Triblockcopolymers (ABA) could form stronger vesicles, since they do not need to form a bilayer, 
where both sheets can slide laterally. However, it has been suggested that triblockcopolymers may 
form U-Turns and behave thus like AB-amphiphiles (Fig. 2).[48] The synthesis has moreover the problem, 
that some diblockcopolymers may be formed through capping (side-reactions, that stop a 
polymerisation), which are then almost impossible to separate. This results in an additional 
heterogeneity similar to the PDI, which may have adverse effects on the vesicle-formation. 
There are some asymmetric triblockcopolymers (ABC) that have been used as amphiphiles. When A 
and C are poorly miscible, the larger block tends to form the outside of the polymersomes.[49]. This was 
partially conceived to take the asymmetric nature of lipid bilayers into account, which are an important 
factor for the orientation of inserted membrane proteins. It has been shown with ABC-amphiphiles 
that this behaviour can be emulated.[50] 
The hydrophilic block does not usually contribute to the stabilisation of the structure; it can even 
destabilise it, in case of charge repulsion. Thus, it should be kept very short (unpublished experiments 
in our group indicate that in an ABA-blockcopolymer less than 5% of the monomers have to be 
hydrophilic in order to obtain vesicles).  
AB, ABA and ABC can all assemble in different ways each (Fig. 2). The hydrophobic block may remain 
straight and form liquid crystalline phases or entangle in an amorphous phase. Moreover, the 
hydrophobic blocks may be angled to the hydrophobic block. In case of AB-blockcopolymers a further 
parameter occurs: the blocks may form a bilayer or be interdigitated. In case of ABA-ABCPs, the ABCPs 
could go through the membrane, forcing them to remain in a straight conformation, or have both 
hydrophilic groups coming out at the same side, making them effectively AB-type ABCPs (as marked in 
green in Fig. 4). All these factors determine the stability, density and thickness of the membrane. It can 
be also assumed that this affects the permeability and readiness of the membrane to incorporate 
membrane proteins. Which conformation prevails is largely determined by the nature of the ABCPs: 
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it’s stiffness, ability to interact with itself (and the temperature) and the relative thickness of each 
segment. Lastly, it should be pointed out, that in case of ABC-type ABCPs A and C are rarely miscible, 
thus forcing them into the membrane conformation with three distinct regions. This can be used for 
inserting MPs in only one orientation.[51] 
 
 
Fig. 2: Possible ways of amphiphilic diblock- and triblock copolymers assemble to form a membrane. 
The first example is the typical bilayer as found in lipid-membranes [52] 
 
3 Characterisation methods 
 
While analysis of diffusion is the key aspect of the characterisation methods, in this thesis, a variety of 
other parameters had to be investigated as well, in order to create reproducible data and being able 
to compare the sample with controls. These parameters can be grouped into structure-analysis and 
concentration-measurement. 
 
 
3.1 Structure 
 
In order to create the required nanoreactors, it has to be confirmed that self-assembly results in 
vesicles and not micelles etc. Therefore, it has to be proven that the structures are spherical and hollow 
and thus able to encapsulate hydrophilic cargo. For comparable results, the size of the vesicles and 
their size distribution has to be determined as well. This is particularly important regarding the 
encapsulation efficiency (elaborated later), but can also affect the stability of the structures, since 
doubling the vesicle diameter increases its volume 8-fold (since it doubles in all three dimensions, thus 
results being proportional to 23); this further changes the stress of curvature on the membrane and 
the membrane thickness decreases relative to the vesicle size. This disproportionate increase of 
diameter to volume holds significance in many other fields e.g. biology and aerodynamics, where it 
often poses size-limitations. 
 
 
II Theoretical background 
55 
3.1.1 Light Scattering 
 
Light scattering (LS) is an analytical method based on the fact that nanostructures scatter light. In case 
of coherent light (typically a laser) it results in partial light cancelling due to interference caused by 
scattering of two or more bodies. The received light intensity fluctuates due to the movement of the 
particles. The detected fluctuations in intensity are referred to as correlation function. This fluctuation 
is dependent on the vesicle size (hydrodynamic radius Rh). With a single exponential fit, the average 
radius is obtained and distribution as long as the particles differ significantly in size a size distribution 
can be obtained using a multiple exponential fit. 
Measuring the scattering at different angles allows the calculation of the radius of gyration (Rg). The 
first measurement mode is called dynamic light scattering (due to the autocorrelation required to 
measure the fluctuations in the scattering intensity) whereas the second is referred to as static light 
scattering (investigating angular dependence rather than temporary fluctuations of the light 
scattering).[53] The ratio between the two radii (Rh/Rg) indicates the shape of the scattering particles: 
0.5-0.7 solid spheres, 0.7-1 hollow spheres, >1 coils…. This method gives thus information about the 
size and shape of the structures. Moreover, it can hint whether or not the structure is hollow. With 
calibration it can also give molecular weights.[54] 
 
 
3.1.2 Transition Electron Microscopy 
 
Transition Electron Microscopy (TEM) is a straightforward approach of determining size and shape of 
the nanostructures. Very unlike LS, it provides direct results that require little interpretation. While LS 
gives average values, TEM shows individual structures (giving thus more information, but making 
averaging difficult). It is thus very good for spotting mixtures of micelles, vesicles and worms, or 
aggregates of vesicles, but it does not truly represent the state in solution. The sample preparation 
(including a drying step) changes the size of the structures and can introduce artefacts such as salt 
crystals or aggregation. Furthermore, often it can hardly be distinguished between solid spheres and 
deflated vesicles.8  
A variation to circumvent the problem of deformation by sample preparation is cryoTEM in which the 
sample is frozen and only a slice is investigated, allowing the determination of the thickness of 
                                                          
8 Common knowledge in the group, but unpublished 
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membranes. However, the method is more complicated and salts have to be removed first, which may 
result in osmotic stress as vesicles are usually made in buffered media. 
 
 
3.1.3 Fluorescence Correlation Spectroscopy 
 
While Fluorescence Correlation Spectroscopy (FCS) is superficially similar to LS in that diffusion is 
investigated in order to obtain the hydrodynamic radius, it requires completely different 
circumstances, as fluorescence is observed. In order to detect a particle, it has to diffuse into the 
confocal volume illuminated by a laser, become excited and emit fluorescence before leaving said 
volume. The measurement records an overall fluorescence (count rate: CR) and so-called counts per 
molecule (CPM) which represents the fluorescence of an individual particle. Again, as in light 
scattering, the fluctuation of the detected fluorescence correlates to the Brownian motion, and yields 
the hydrodynamic radius of the observed particle.[55] Unlike LS it can give far more information 
depending on how the fluorophores are employed: 
- Encapsulated cargo labelled: attaching a fluorophore reduces the diffusion speed of the 
fluorophore proportional to the size of the particle it is attached to; however, encapsulation 
of e.g. labelled enzymes reduces the diffusion speed to the speed of the vesicle or micelle 
containing the cargo. It thus allows determination of the vesicle size without actually attaching 
a fluorophore to it. Moreover, the CPM allows to calculate the number of encapsulated 
particles, by dividing it though the CPM of free dye. Often a second fraction is observed, which 
diffuses much faster, consisting of not-encapsulated or released cargo. It can be thus used also 
for release studies. The CR itself is the sum of all fluorescent particles per time unit and 
represents the concentration of the sample (of all involved species).  
- Membrane labelling: the membrane can be labelled by attaching the fluorophore to a small 
fraction of the amphiphiles, or by addition of a hydrophobic fluorophore which accumulates 
in the membrane (something very easy and fast to do). It does not give any other information 
than the size of the vesicle or micelles and their concentration. It is therefore rather applied in 
fluorescence microscopy, a technique, which most FCS devices are capable of doing as well. It 
should be noted, that the resolution of fluorescence microscopy is of limited use in case of 
nanostructures.[56] 
- Membrane proteins labelling: analogue to labelling the cargo it gives information about the 
number of labelled groups per vesicle, the vesicle size and the sample concentration. However, 
labelling of membrane proteins prior to insertion into the membrane might interfere with the 
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insertion process. Thereafter, the membrane proteins become less accessible, moreover the 
membrane might accumulate unreacted fluorophore or the labelling might interfere with the 
functionality of the membrane protein, as the exposed parts are usually also the active parts.  
- Fluorescence Cross Correlation Spectroscopy (FCCS): by using two different dyes, with 
different excitation and emission wavelengths, co-encapsulation can be investigated. 
While FCS is a very powerful and versatile method, it does come along with a remarkable set of 
drawbacks: 
It is an indirect method that cannot distinguish between vesicles and aggregation of micelles of the 
same size, or whether the fluorophore is encapsulated or embedded in the membrane (unless the dye 
is polarity sensitive or allows FRET9).[57] As every other method it is limited to a certain concentration 
range, however the high sensitivity requires high dilutions that could render self-assembled structures 
instable. Likewise, released fluorophores can be easily outshined by the vast number of fluorophores 
encapsulated in vesicles making release studies difficult if not impossible. Another major issue to be 
addressed is the non-trivial choice of fluorescent dye. FCS requires very stable dyes that resist photo 
bleaching. The fluorophore needs also to be selected according to its colour, size and hydrophobicity. 
The more the excitation is shifted to red, the larger and more hydrophobic the fluorophore tends to 
become. Even partial hydrophobicity can cause massive problems, such as dye entering preferably 
membranes, or even micelles. Additionally, insertion into membranes tends to weaken them 
significantly eventually resulting in vesicle decomposition.10 Lastly, it can be complicated to label 
enzymes, due to differences in polarity, multiple labelling or blocking of the active site, but also due to 
poor accessibility of the anchoring groups. Similarly, stabilising detergents are likely to interfere with 
labelling.  
 
 
3.1.4 Summary 
 
For quick estimates whether a sample contains vesicles and of what size, DLS is used. For more reliable 
data various concentrations and angles are measured. Also, TEM gives complementary data regarding 
purity and size distribution. FCS is best used to study changes in structure or performing release 
                                                          
9 Förster Resonance Energy Transfer: excited fluorophores are able to lower their energy through internal 
conversion and transfer it without direct contact to other fluorophores in case that it matches the excitation 
energy. This allows for in instance to excite cyan fluorescing protein and detect the fluorescence of yellow 
fluorescent protein that is 5 Å afar of the excited protein. 
10 Common knowledge in the group, but unpublished 
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experiments and for quantifying the composition of vesicles. It is however ill suited for quick 
measurements and does not show all particles. 
 
 
3.2 Quantity  
 
As mentioned above, FCS can be used to determine the concentration of vesicles and the 
concentration of their cargo; however, it requires labelling of the samples. Therefore, alternatives have 
to be envisioned. 
 
 
3.2.1 Scattering  
 
Under the premises that the samples are known to be homogeneous in size, size distribution and 
prevailing structures, the relative concentration can be determined by comparing their respective 
ability to scatter light. This facile method requires nothing more than a regular fluorimeter and can be 
also used to record structural changes over time, since decomposition of vesicles decreases the 
scattering. This can be used for instance to check thermal stability or tolerable detergent 
concentrations (if the dead time between addition and structural change is taken into account as well), 
however the data should be complemented with analysis of the resulting structures. 
 
 
3.2.2 Encapsulation efficiency 
 
The encapsulation efficiency is a measure for the success of enclosing cargo within vesicles. It is usually 
defined as the ratio of the encapsulated concentration to the initial concentration. While e.g. enzymes 
in the size of a few nanometers could theoretically be encapsulated in vesicles of 100nm diameter and 
more in vast numbers, in reality the encapsulation efficiency is much lower. This is partially due to the 
solubility limit, charge repulsion between the solute and apparently also other factors. This can be 
seen as for example otherwise identical vesicles with 100 and 200nm in diameter do not harbour the 
same concentration of the encapsulated cargo. Experiments in our group proved repeatedly that only 
0.1-1% of the initial concentration is found within the vesicles. With smaller vesicles, the concentration 
can easily decrease by an order of magnitude. 
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The encapsulation efficiency can be determined by destroying the vesicles and measuring the activity 
of its released cargo compared it to the initial activity (after having ensured that the activity of the 
vesicles is negligible). This can be used not just to confirm hollow structures but also as a quick test to 
determine which fraction has activity after purification (e.g. vesicles vs. micelles) 
 
 
3.3 Permeability measurement 
 
In order to assess the permeability of the OmpF-conjugate, it needs to be inserted into a membrane. 
This can have in principle two forms: 
- Flat membranes: free floating membranes covering tiny holes or being supported by a grid or 
resting on a gel. This approach would allow conductivity measurements and sampling directly 
from either side of the membrane. However, creating a homogeneous membrane, without 
gaps, or multiple layers is near impossible. 
- Formation of vesicles or closed tubes. This experimental set-up allows only release 
experiments and enzyme kinetics. 
In either case, a molecule has to be observed diffusing from one side of the membrane to the other. 
Flat membranes were only considered second to vesicles, with reproducibility and experimental 
difficulties in mind. Closed tubes are rare and do not provide significant advantages over vesicles but 
would introduce new parameters and room for errors. Thus, they were not further considered in this 
thesis. 
 
 
3.3.1 Release experiments 
 
The most straightforward approach would be to encapsulate a dye and detect its release. Yet, 
absorption and fluorescence usually do not change whether the dye is encapsulated or not. Still, there 
are two main possibilities: 
First: the fluorescence can be measured in FCS, which discriminates between different diffusion 
speeds, or second: a self-quenching concentration of a fluorophore can be used.  
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FCS gives potentially more interesting information, such as vesicle-size, but the strong laser tends to 
bleach the fluorophores and dry the sample over time. As mentioned before, it might not be as 
sensitive as it could be because of the total fluorescence. 
Using self-quenched fluorophores, the released dye enters a low concentration regime and becomes 
thus fluorescent. This avoids the problem observed in FCS that the released dye becomes outshined 
by encapsulated dye. 
Release experiments have their limitations: it can be very difficult to encapsulate enough of the 
fluorophore, it might go into the membranes and thereby destabilise the vesicles or cause them to 
become leaky, thus the samples have usually to be measured directly after purification. Another 
important aspect is the selection of the fluorophore, as it could be too large to go through the 
membrane proteins or be plagued by unfavourable charge interactions. This applies also to FCS. 
 
 
3.3.2 Enzyme kinetics 
 
Choosing the indirect approach of encapsulating enzymes offers several advantages: Since the 
fluorophore is added in an inactive form outside of the vesicles, the samples can be prepared and 
stored for a while without having to fear premature release of dye. Several different dyes/enzyme 
substrates can be tested with the same sample and their concentration can be varied as well. Enzymes 
are less likely to interfere with the membrane formation than most dyes. Since the dye is added on the 
outside and has to diffuse through the membrane and be converted on the inside, it allows slower 
reactions that are not limited by the dye-capacity of the vesicles. The enzyme substrate may be added 
repeatedly and parameters such as the pH can be changed using the very same sample. 
Of course, there are a couple of disadvantages as well: The encapsulation efficiency of enzymes is 
generally low (1%),11 due to their size and charge. The costly nature of most enzymes aggravates this 
matter. On the other hand, enzymes can be very sensitive tools so that even traces of unencapsulated 
enzymes prove detrimental for the experiment. Some enzymes are less suitable, due to hydrophobic 
patches on their surface, which might result in a preference to membranes or micelles. The prior case 
further complicates purification. 
 
                                                          
11 Common knowledge in the group, but unpublished 
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1 Design of OmpF conjugates as biovalves 
1.1 Choice of OmpF Mutants 
 
OmpF was chosen for its known crystal structure and remarkable stability (temperature up to 70°C, 
solvents, detergents and pH range from 5.5-8.5)[1] and for its pore dimensions allowing molecules of 
up to 600 Da to pass through.[1] The pore size is thus large enough for most enzyme substrates, smaller 
dyes, or some smaller pharmaceuticals to pass through, but small enough that a single short peptide, 
or dye[2] could block the pore. Furthermore, it served as a model pore before, and modifications of 
specific amino acid residues in the OmpF channel were shown to influence the translocation of small 
molecular weight molecules.[1b, 2-3] 
In order to attach the responsive group to the channel protein, first OmpF was genetically modified to 
introducing cysteine residues at key locations in the OmpF amino acid sequence. The mutation sites 
D12C (aspartate, the 12th amino acid of the OmpF amino acid sequence replaced by cysteine) K89C 
(lysine) and R270C (arginine) located inside the pore in the eyelet-region were replaced by cysteines 
(Fig. 2). These locations allow the attachment of molecular groups that can block the molecular flow 
at the beginning of the pore or point outwards without obstructing the pore, in different conditions 
(Fig. 1).[1a, 3-4]  
 
 
 
Fig. 1: A. Three-dimensional representation of OmpF-C after binding of the pH responsive peptide 
Gala3 (green) attached in helical structure (compact state) to cysteine residues (blue) of OmpF-M 
showing closing of the pore: view from the side (1), and from the top (2). B. Schematic representation 
of the OmpF-pore in “closed state”, with Gala3 blocking the entrance of the pore (1), and in “open 
state”, with the attached Gala3 freely moving in its random-coil state (2). Note that for the sake of 
simplicity only one peptide is displayed.  
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The original idea was to use a single mutation as anchor point. Since to this date the accessibility of a 
single X→C mutation site cannot be 100% guaranteed, three different mutation sites have been 
chosen: D12C, K89C and R270C. The double mutants D12,K89C, D12,R270C and K89,R270C served only 
as back-up-plan. Since all three mutation sites are in the same region, each anchor-point should work 
equally, however the degree of labelling might vary, due to possible interactions with charged amino 
acid sidechains. Using a double mutant would increase the degree of labelling (DOL) and offer better 
conditions to block the OmpF pore because two peptides will occupy more space inside the pore. 
 
Fig. 2: location of the mutation sites (highlighted only in one of the three channels of the OmpF 
trimer) 
 
Initial experiments indicated that K89C and R270C work equally well as anchor point. At that time, the 
determination of the DOL was still not reliable and preliminary experiments indicated only 50% 
labelling thus the rest of the studies were centred on the double mutants. At the time, all experimental 
parameters were fixed only R270C- and K89R270C-OmpF were still available. To attach a peptide (or 
oligomer) to the thiols of the cysteine residues in the OmpF-M, Michael addition (Fig. 3) was chosen 
due to its straightforward approach, fewer side-reactions compared to disulphide bonds formation 
with the cysteine residues, or to direct alkylation of the cysteine residues with halogenoalkanes.[5] In 
addition, the chosen glycine maleic imide linker (the connection between OmpF-M and the peptide) is 
a small molecule (138 Da) and expected to have no impact on substrate translocation through the pore 
due to its small size. 
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Fig. 3: Michael addition of the Gala3 peptide to the cysteine side chains of the OmpF-M  
 
The mutation was performed via polymerase chain reaction of the entire plasmid. The K89C-mutation 
was introduced first, then the R270C-mutation was introduced by the same procedure. After 
purification via gel-electrophoresis, the product was isolated and sequenced, confirming the mutation 
(Table 1, in Materials and Methods). The double mutant of the porin, K89C-R270C-OmpF (OmpF-M) 
was then overexpressed in Omp8 E.coli. Its excess over naturally occurring OmpF-WT made further 
separation unnecessary. OmpF-M could not be distinguished from OmpF-WT or single mutants K89C-
OmpF and R270C-OmpF, indicating a successful expression and good purity, because of the lack of 
additional bands in the Coomassie stained gel (Fig. 8, 9, in Materials and Methods). An OmpF-M 
concentration of 0.75±0.25mg/mL (extract without further concentration steps) was determined by 
BCA total protein assay®. 
The presence of thiol groups and their accessibility was evaluated by binding them with the thiol-
reactive fluorophore acrylodan. As expected, OmpF-WT did not reveal any fluorescence intensity upon 
addition of acrylodan, indicating the lack of nonspecific binding of the fluorophore to the porin. On the 
contrary, the fluorescence intensity of acrylodan when added to the thiol-bearing mutants (K89C-
OmpF, R270C-OmpF and OmpF-M), clearly indicates successful thio-functionalization of the porin. 
Moreover, the fluorescence intensity of acrylodan when bound to the double mutant K89R270C-OmpF 
was similar to that resulting from a double concentration of R270C-OmpF bound to acrylodan (Figure 
13 and 15), indicating that both thiol groups are accessible, and can bind to small molecular weight 
molecules. 
 
  
III Preparation of nano-reactors 
68 
1.2 Designing of the stimuli-responsive group 
 
In order for the OmpF-conjugate to work as a valve, the oligomer or peptide needs to meet multiple 
requirements: 
It must be water soluble in one state and insoluble in another state or remain water-soluble but change 
its conformation drastically. Regarding pH-responsive systems, a noteworthy complication is that it 
needs to remain water soluble between pH 6.5 and 7.5[6] in order for the Michael addition to work. In 
addition, it should have a low tendency to aggregate in solution. Similarly, low solubility can become a 
problem during synthesis or purification. Besides pH responsive groups, temperature (dehydration of 
PNIPAAM or ELPs in heat), light (cis/trans isomerisation) or reduction sensitive groups could 
theoretically be used in a reversible manner. Light sensitive groups do not change solubility but switch 
between a straight and a bent conformation. Due to the size of the pore only small chromatic groups 
could be used and it relies on a single isomerisation due to size restrictions. However, this has 
successfully been used, but only for ion channels.[7] For these reasons the focus of research lay on the 
other potential stimuli, with the exception of reduction sensitive systems. The latter would rely on 
bending caused by reversible cyclisation by disulphide bond formation, which would interfere with the 
thiol groups of the OmpF-mutants. Lastly, it should be noted that material properties are all size/mass 
dependent. Thus, very short peptides may not display any stimuli responsiveness at all. This aspect will 
be elaborated in later chapters. 
The second requirement is length. Since the OmpF pore has the size of 7-11 Å[1a], a linear oligomer 
with a total length of 9 Å should be able to block the pore, however even in the unlikely case that the 
oligomer remains linear, it could point outwards or lie flat against the pores internal surface. On the 
other hand, polymers would be hard to attach to the inside of the pore and most probably block it 
permanently independent of the absence or presence of the stimulus. Regarding these two 
requirements, a length of 20-50Å was expected to be the most promising. 
Lastly, the synthesis of the groups needs to remain practical. The synthesis of systems triggered by 
light, or reduction potential can be expected to exceed 5 reaction steps, which all require different 
conditions and work ups, without promising a high over all yield, or modularity, which would be 
important to create libraries, nor does it allow to effectively vary the length of the stimuli responsive 
group. PAA and PNIPAAM on the other side are easy to synthesise in various lengths, but synthesis of 
oligomers in the length of 20-30Å, in particular with low polydispersity is without established 
procedures. All these problems do not exist for peptides, but their synthesis and purification are more 
complex, yet well established. 
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1.3 Oligomers as stimuli-responsive groups 
 
It was originally intended to use oligomers synthesised via ATRP as stimuli responsive groups, 
replicating the stimuli responsive pore of Chiu et al,[8] only in a scaled down version so that it fits the 
OmpF-pore. In their publication, they presented a blockcopolymer which formed vesicles in a very 
different fashion and featured phase separation providing domains of acrylic acid, which acted as pores 
on their own (Fig. 4). 
 
Fig. 4: Illustration from the original publication of Chiu et al 2008[8] and the original description: 
Illustration of multivesicle assemblies equipped with pH-responsive transmembrane channels from 
two-stage double emulsion of poly(AAc-co-DSA). The AAc-rich regions and the bilayer islets within the 
vesicle membrane are not drawn to scale. 
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As an alternative to the pH-responsive oligo(acrylic acid), oligo(NIPAAM) as temperature sensitive 
oligomer was considered as well. In both cases ATRP should allow mild reaction conditions, enable 
good control over the chain-length and allow having an anchoring group on one end only, by using an 
ATRP-initiator with a protected maleic imide. 
While it could be assumed that oligomers are more challenging to attach than shorter molecules to 
the inside of the OmpF pores (= grafting to), grafting to was still considered superior to grafting from. 
Performing the ATRP from the anchor points (= grafting from) within the pore would have ensured a 
high DOL and an even distribution, but the oligomerisation would probably be affected by the 
constrictions of the pore (transition state, diffusion of the monomers…) which are expected to reduce 
the reaction speed and probably reduce the expected length of the oligomer. The reaction progress 
would be difficult to follow and there would be no way of purifying the oligomers. Moreover, in case 
of oligo(acrylic acid) a deprotection step is required as acrylic acid does not polymerise well as such. 
The advantage over the stimuli responsive peptides would be its simple design, the relative ease of 
production and purification. Still, two potential pitfalls could be expected: firstly, no well-defined 
oligomers of the targeted length were described in literature, as ATRP is meant for polymerisation and 
not oligomerisation and secondly, downscaling the length of the stimuli responsive polymers to 
oligomers might change the physical properties. 
 
 
1.3.1 The ATRP Initiator 
 
The indicator was of the bromo-isobutyryl-type featuring a protected maleic imide for later attachment 
of the oligomer to thiol groups of the OmpF mutant. It was obtained in three steps in moderate to 
good yield (90%, 75%, 71% respectively; Fig. 5). The yield of the first step was twice as high as in the 
original publication (90% compared to 42%).[9] 
The maleic imide had to be protected for the ATRP as it would react as an alkene terminating the 
reaction (due to its low electron density) and rendering the anchor useless. The final deprotection is 
achieved through a retro-Diels-Alder reaction, which requires only heating the compound thus splitting 
the furan off, reversing the first step. The initiator is very reliable and stable as long as it is pure, 
however traces of HBr stemming from the 3rd reaction step appears to catalyse the decomposition of 
the compound. It was once observed that initiator became useless within 3 weeks stored at 4°C 
whereas in pure form it is stable for years. 
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6h reflux
PhMe
 
1. 0°C
2. RT
3. 4h reflux
MeOH
 
1. 3h 0°C
2. 12h 25°C
THF
 
Fig. 5: Synthesis of the initiator. 
 
 
1.3.2 Oligo(acrylic acid) 
Since there was almost no literature available dealing with the synthesis of well-defined oligomers, a 
series of experiments (see Table 1 and Fig. 6) was conducted to find appropriate stoichiometry 
(monomer:initiator:CuBr:CuBr2:ligand), ligand, solvent, temperature and reaction time. The yield 
refers to the recovered oligomers featuring the anchor group and does not take into account the 
subsequent deprotection steps. 
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Table 1: selection of ATRP experiments involving oligo(acrylic acid) 
Experiment 
[M]:[In]:[CuBr]:
[CuBr2]:[L] 
Ligand Solvent T [°C] t [h] Yield  [%] PDI DP 
1 100:1:1:0.1:1 PMDETA PhMe 75 1 61 1.28 22 
2 
100:1:1:0.1:1 PMDETA Anisol 75 15 19 1.18 31 
3 75:1:1:0.1:1 PMDETA DMF 75 15 9 1.33 33 
4 
20:1:1:0.1:1 PMDETA PhMe 75 
20.
5 
36 1.51 16 
5 20:1:1:0.1:1 PMDETA Anisol 75 15 75 1.1 6 
6 12:1:1:0.1:1 PMDETA Anisol 75 17 2 1.11 2 
7 20:1:1:0.1:1 PMDETA MTBE 55 21 66 1.36 15 
8 15:2:1:0:1 Me6Tren tBuOH 20 3 74.5 1.33 7 
9 8:2:1:0:1 Me6Tren tBuOH 20 3 98 1.37 3.5 
10 15:1:1:0:1 Me6Tren tBuOH 30 3 84 1.27 6 
11 15:1:1:0.1:1 Me6Tren tBuOH 30 3 69 1.79 12 
12 16:1:1:1:1 Me6Tren tBuOH 30 4 31 2.03 16 
13 15:1:1:1:2 Me6Tren MTBE 30 3 49 3.22 15 
14 15:1:1:1:2 Me6Tren PhMe 20 4 31.1 1.85 30 
15 
20:1:1:0.1:1.1 Me6Tren PhMe 20 3 46.1 
2.63/1.
3 
21.
5 
 
Table 1 shows the relation between reacting conditions (monomer M, initiator In and ligand L) and 
yield, polymerisation index (PDI/size distribution) and degree of polymerisation (PD; number of 
monomers linked together). Blue: important changes in the experiment; red: undesirable results; 
green: good results. 
The starting point was standard ATRP conditions: Initiator/CuBr/PMDETA 1:1:1, with 0.1 eq. of CuBr2 
as retardant (reversibly binding free radicals and thereby avoiding termination side-reactions) all 
dissolved in toluene and reacted at 75°C (Table 1., experiment 1). Experiments 1-3 (Table 1) used the 
standard conditions but tested various solvents. Experiments 4-7 shifted the focus from kinetic control 
of the degree of polymerisation to stoichiometric control and tested the solvent effect as well. 
The other experiments used a stronger ligand for the ATRP catalyst. Experiment 8 was the recreation 
of the published experiment.[10] Experiment 9 and 10 tested, the effect of the monomer ratio. 
Experiments 10-15 tested the effect of the presence of Cu(II) on the ATRP. Experiment 13-15 tested 
the influence of the solvent again. 
Under normal circumstances, the PDI can be kept at a minimum, by stopping the reaction after 40% 
monomer conversion. Since in this case a very specific polymerisation degree was required, the kinetic 
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would have to be measured in order to adjust the number of monomers and reaction time. However, 
the characterisation of the oligomer via NMR was hampered by overlapping signals from aromatic 
solvents (mainly the CH3-group). Therefore, the solvent became an important variable in the 
experiment. Moreover, the choice of solvents changes the kinetics and some solvents were able to 
interact with the ATRP catalyst (anisole, DMF, tBuOH and MTBE) and some solvents were particularly 
hard to remove (toluene, anisole, DMF). 
Typically, the reaction speed increases with the polarity of the solvent. Peculiarly anisole resulted in 
higher DP and lower yield in kinetic controlled experiments and in lower DP (2 vs 1) and higher yield in 
case of stoichiometric controlled experiments (5 vs 4). In both cases it had better PDI than experiments 
in toluene. Interestingly, MTBE was in between toluene and anisole regarding yield, DP and DPI 
(experiments 4, 5, 7). DMF seemed to decrease reaction speed and control (exp. 3 vs 1; presumably 
through coordination to copper). Note, that the yields are based on the isolated oligomer in relation 
to the amount of initiator used and not on the monomer conversion. 
The experiments based on kinetic control did not provide the DP desired (6-15), although the standard 
conditions provided decent yield and PDI. Anisole worked well even though the copper concentration 
of 0.05N pushed the systems at its limits (partial precipitation). In terms of chain length and conversion 
MTBE seems to be the best choice for PMDETA catalysed polymerisations (exp. 7 vs 4). The latter was 
restricting the reaction temperature to 55°C but allowed fast solvent removal.  
Due to the weak ligand to metal binding, a stronger ligand was tried in the hope of creating a more 
robust system. Me6Tren (choice based on a paper about NIPAAM oligomerisation[10]) tolerates polar 
solvents, even alcohols and water. Its copper complex was also catalysing the ATRP significantly faster 
(ca. 10x at 30°C). Unlike PMDETA it resulted nearly always in full conversion. Sill, experiments 5 and 8 
had very similar results. This marks a turning point as Me6Tren works better for shorter DP, whereas 
PMDETA works better for higher DP and results in a lower DPI. 
Since it was difficult to stop the ATRP in the right moment and since the majority of monomer remained 
unconverted, it was tested as well, how well limiting the conversion via monomer depletion worked. 
Limiting the DP with restricting the number of monomers worked surprisingly well. In case of PMDETA 
anisole and MTBE were the best solvents (experiment 5 and 7). The downside was that the method 
works better for higher DPs (experiment 5 vs 6). 
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Attempting to decrease the reaction speed of Me6Tren by using apolar solvents and high amounts of 
CuBr2 failed, resulting in low yields and high PDI-values (experiment 11-15). Note: experiment 15 
apparently lost control during the reaction resulting first in a rather well defined PDI of 1.4 and then 
broadening to 2.6. In the GPC-graph both peaks were overlapping. 
As it turned out, the best option was not to reduce the reaction speed at all. The best solvent was 
apparently tBuOH and the best reaction temperature 30°C (below there was a tendency of the solvent 
to crystallize or to precipitate the solute). This procedure allowed DP down to 4, although only starting 
from a DP of 6, the deprotection started to work reliably (longer oligomers were possible as well, but 
the other method using PMDETA achieved better PDI values). It should be noted that short oligomers 
behaved very differently. Oligomers with less than ca. 20 repeating units were oils and could therefore 
not be precipitated. These oils had astonishing vapor-pressure-reducing abilities which impeded the 
removal of toluene and anisole at the rotavap (even with only 10wt% oligomer). The safest method of 
removing the solvent, turned out to be the use of flash chromatography. 
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Fig. 6: The synthesis and deprotection of oligo(tert.-butylacrylate) and the other stimuli responsive 
oligomers. A: synthesis of oligo(acrylic acid); B: its deprotection step 1; retro-Diels-Alder reaction; C: 
its deprotection step 2; de-tert-butylation; D: synthesis of oligo(NIPAAM); E: synthesis of oligo(4-
vinylpyridine); the latter two must only undergo the first deprotection step. 
 
The retro Diels-Alder reaction works well in toluene giving nearly quantitative yield, but the solvent 
has an unexpectedly low gas-pressure, making evaporation with a rotavapor impossible (requiring high 
vacuum, or better a Kugelrohr distillation apparatus and high vacuum). Replacing the solvent with 
isooctane works but it is only poorly dissolving the polymer. 
The de-t-Butylation was successful, except for oligo(tert.-butylacrylate) with chain lengths below 6. In 
these cases, a side reaction occurred, which we assume is a polymerisation of the maleic imid, since 
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the product became insoluble in water. It is in general a tricky step, since the initiator is bound through 
a primary ester, features a polymerisable alkene and since the product is hydroscopic. The removal of 
solvent can therefore result in the destruction of the product. Even traces of acid (TFA or HBr) seem to 
reduce the shelf-life of the product dramatically (stored at 4°C). The product apparently polymerised 
itself, as it became poorly water soluble, the alkene signal in 1H-NMR disappeared slowly and the 
detected mass in MALDI experiments (Fig. 7) increased multiple times while the signal intensity 
decreased several orders of magnitude resulting moreover in a distorted mass-spectrum: 
 
 
Fig. 7: two examples of oligo(acrylic acid); the left one had according to 2D-NMR analysis 7 repeating 
units whereas MALDI results imply an average PD of 12 (ranging from 4 to 17 repeating units). The 
right example had according to 1D-NMR a PD of 12 and was apparently already degrading as the MALDI 
measurement was performed. In both cases no endgroup could be identified. 
 
It can be assumed that the bromine group is detrimental to the shelf-life of the oligomer. It may 
hydrolyse over time forming HBr, which in turn could catalyse the degradation of the oligomer, or it 
could split off forming radicals, which in turn polymerise the maleic imide and can cause other side 
reactions. 
It was considered to remove the bromine after the ATRP via reduction, but even the protected maleic 
imide could react as well. An alternative would be to replace the bromine via an SN1-reaction. 
Considering that the replacing nucleophile should result in a stable bond and not change the polarity, 
KCN was the best option. However, due to its highly toxic nature, numerous safety precautions would 
have had to be enforced and the remaining cyanide would still need to be separated and destroyed. 
The latter requires oxidants which would harm the oligomer if it was not separated beforehand. 
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Due to the short living nature of the oligomer, later experiments with OmpF were conducted with 
peptides. Only after establishing a reliable assay for the functionality of the bioconjugates, the 
oligomers were revisited. 
 
 
1.3.3 Oligo(NIPAAM) 
 
PNIPAAM (see Fig. 6D) is known to exhibit a lower critical solution temperature above which the 
hydrated state becomes unstable, thus causing the polymer to precipitate from water. The ATRP was 
basically identical to the one used for oligo(acrylic acid); in fact the procedure used for oligo(acrylic 
acid) was based on a paper applying the ATRP on NIPAAM;[10] the reaction and purification proved to 
be quite different from those experienced in producing oligo(acrylic acid). The reaction speed was 
somewhat lower and the yield 3-4x lower. On the plus side, the monomer did not require a post-
polymerisation deprotection-step. The oligomers could always be precipitated, very unlike oligo(acrylic 
acid), where short oligomers failed to crystalize. The oligomers did not lower the vapour pressure of 
the solvents, facilitating drying, but the monomer could not be evaporated. Moreover, the oligomers 
become stuck on silica. Thus, only multiple precipitations or dialysis in n-propanol (only solvent found 
to dissolve oligomer, while not attacking the cellulose acetate membrane) worked. Due to residual 
monomer, overlapping in the 1H-NMR spectra the DP are rather qualitative by nature. 
 
 
Table 2: ATRP with NIPAAM 
Experiment [M]:[In]:[CuBr]:[CuBr2]:[L] Ligand Solvent T [°C] t [h] Yield [%] PDI PD 
1 20:2:1:0:1 Me6Tren tBuOH 30°C 3 28 1.19 10 
2 12:2:1:0:1 Me6Tren tBuOH 25°C 4 41 1.28 6 
3 12:2:1:1:0.1:1 Me6Tren tBuOH 30°C 4 9 1.34 6 
4 15:1:1:0.1:1.1 Me6Tren tBuOH 25°C 4.15 23 n.d. 18 
5 8:1:1:0.1.1 Me6Tren tBuOH 30°C 3 24 1.23 8 
 
As seen in Table 2 it was much harder to obtain decent yields with NPAAM compared to acrylic acid 
esters (Table 1). Important changes in the experiment are marked in blue; red marks undesirable 
results and green good results. Experiments 1 and 2 are to test influence of the monomer ratio, 3-5 
tested the influence of Cu(II) and 4 and 5 tested the influence of the monomer ratio again (the PDI of 
4 was not determined, as the product was not in the desired length, nor desired yield). As before with 
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oligo(acrylic acid) it was found that ATRP with Me6Tren worked best without CuBr2 and an 
initiator/catalyst ratio of 2:1. However, the influence of Cu(II) was vastly diminished. 
Due to the experimental difficulties and the consideration that changes in charge would have a 
stronger effect on stimuli response, oligo(NIPAAM) was dropped in favour of oligo(acrylic acid) and 
acidic peptides. Furthermore, heating liposomes deforms and eventually destroys them. 
 
 
1.3.4 Oligo(vinyl-4-pyridine) 
 
Since the originally used oligo(acrylic acid) did not reveal a sufficient change in polarity for unblocking 
the OmpF pore within the acceptable pH range,12 a different oligomer was considered. Regarding 
availability, reactivity and a pKa value in the middle of the range, 4-vinylpyridine was chosen (see Fig. 
6E). 
The ATRP and purification were plagued by poor solubility, despite the fact that monomer was 
supposed to be soluble in most organic solvents (toluene, CHCl3, dioxane, THF, DMSO, DMF, MeOH, 
EtOH, tert.-butanol and acetic acid). It was not soluble in anisole despite its similarity to toluene. Thus, 
the solvent was changed to DMF. Synthesis of oligomers in the desired length worked 
([M]:[In]:[CuBr]:[CuBr2]:[Me6Tren] 100:1:10:1:1.1 at 40°C). The degree of polymerisation appears to be 
around 6 for 3h reaction time and 15 for 6h. The reaction mixture was slightly turbid at the beginning 
and became more opaque over time. Moreover, the monomer and even more so the oligomer act as 
ligand and thus interfere with the reaction and copper removal. Furthermore, the product got stuck 
on ALOX (which was supposed to remove copper catalyst). As it turned out it could be washed out 
eventually with a large amount of THF, which could also be used for its recrystallization procedure.13 A 
better method of removing the copper was precipitating the oligomer in 10mM NaHCO3 pH=8.0 with 
1mM EDTA (for removing the copper), although it still dissolves too much product. In general, it 
appears that with a higher chain length the solubility in ethanol and basic water increases and the 
solubility in THF decreases (and the amount stuck on ALOX increases). 
The choice of reaction conditions and work-up could surely left room for improvement thus the PDI 
was not determined, although it has to be expected to be broader than oligo(acrylic acid) due to the 
interactions with the catalyst. Hence, it was deemed applicable, but not promising enough to further 
invest time in it. 
                                                          
12 For the used dyes and enzymes, the acceptable pH range is ca. 5.5-7.5. 
13 The formation of crystals is unlikely, but the crude product can be precipitated in higher purity 
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1.4 Stimuli-responsive peptides  
 
As an alternative, stimuli-responsive peptides were envisioned. Peptide synthesis offers several 
advantages over ATRP:  
It allows precise control over both the length and composition of the stimuli responsive group. This 
increases the reproducibility as no longer mixtures are involved. Regarding the rather narrow OmpF 
pore one amino acid more or less could determine whether the peptide can be attached or if it blocks 
the pore at all or if it blocks it permanently, irrespective of its protonation state. 
Using stimuli responsive group that are not based on ATRP would confirm that the bromine group is 
the cause of the oligomers low shelf-life. Indeed peptide-based stimuli responsive groups bearing the 
same maleic imide group proved to be much more stable, although after a year even there the 
anchoring group became inactive and their solubility decreased.  
Peptides allow adjustment of the pH-response via exchanging the pH-responsive groups. Histamine 
(pKa=7.0), Lysine (pKa=10.5), aspartic acid (pKa=3.9) and glutamic acid (pKA=4.3) lend themselves to 
be used as such groups. Cysteine would be interesting from its pKa-value (8.3), but it is too nucleophilic 
and would react with the anchoring group. 
Changing to peptides has however also some disadvantages. The synthesis is more complicated and 
time consuming. More importantly, the purification of peptides is demanding. This is particularly true 
for short peptides, with repeating amino acid sequences and multiple charges.  
A peptide of 12 amino acids would be ca. 48Å in its linear form, or 15Å in shape of an α-helix. A random 
coil could be anything in between. Thus, peptides with 6-12 amino acids were envisioned as stimuli 
responsive groups. The following peptides were ordered: 
 
Table 3.: list of investigated peptides 
Name sequence 
amino 
acids 
length 
linear [Å] 
length 
helix [Å] 
LAEA3 
(Gala3) 
LAEALAEALAEA 12 48 15 
H6 HHHHHH 6 24 8 
HF3 HFHFHF 6 24 8 
HL3 HLHLHL 6 24 8 
HLG4 HLGHLGHLGHLG 12 48 15 
GHLL3 GHLLGHLLGHLL 12 48 15 
III Preparation of nano-reactors 
80 
 
LAEA saw most extensive investigation since it was reported before to work as a stimuli responsive 
group.[11] Since it is based on the GALA sequence (WEAALAEALAEALAEHLAEALAEALEALAA), the peptide 
was referred to Gala3 due to its three repeats of LAEA (see Fig. 2). 
All other tested peptides (Table 3) contained histamine in place of asparagine, due to its pKa of 7 
offering the greatest change in protonation between pH 8 and 5 among all considered amino acids (for 
calculations on protonation as a function of pH see chapter VI Theoretical calculations). The main 
variable in the peptides was the polarity. The more hydrophobic the unprotonated peptide becomes, 
the stronger the expected stimuli response. However, it reduces the solubility at the pH where the 
Michael addition takes place. This possibly prevents some of the peptides from being used. Glycine 
was used in between pH-responsive amino acids, since it increases the flexibility of the peptide and 
reduces the risk of rigid formations aggregating. 
Another factor is the number of pH-responsive groups per peptide. Since the protonation state will not 
change completely in the physiological relevant pH range a certain number is required to take effect. 
We chose the lower limit at 3. Taking the synthesis into account, each responsive amino acid had non-
responsive, hydrophobic neighbours. Such a peptide would already be at the lower end of the targeted 
length. 
 
 
2 Methods for determining the degree of labelling 
 
Since the peptides are of limited solubility, detergents are interfering and the thiol groups inside the 
OmpF pore might be hard to access. Proving successful labelling is important. However, the peptide 
bound to the thiol group itself cannot be detected. Thus, only the remaining reagent or thiol groups 
may be detected, making every attempt of determining the DOL an indirect measurement. 
For this purpose, predominantly, addition of fluorophores to remaining thiol groups was investigated. 
The ideal fluorophore should be cheap, photostable, well soluble in water (for the reaction, but also 
for its removal) and small enough so that it can reach the thiol groups without having to denaturate 
the OmpF sample. Moreover, the Stokes-shift should be large and both emission and fluorescence 
should be accessible for fluorescence correlation spectroscopy (FCS). 
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2.1 Reagent recovery 
 
The most straightforward approach would be after the Michael addition to separate the product from 
the excess of the reagent via HPLC and determine both concentrations, however, this concept has 
several flaws: 
- Detection: it would require a preparative HPLC to use a BCA assay for determining the protein 
concentration. For smaller concentrations, it would rely on the HPLC detectors which in turn 
would require calibration (specific for the currently analysed reagent). In this case the 
detection limit might be too high. 
- Separation: the reagent might become insoluble and precipitate or stick to the OmpF without 
being actually bound to it. 
- Detergents: OmpF requires detergents for stabilisation in solution. Similarly, the stimuli 
responsive group may require detergent for its solubilisation. Thus, dilution and inconsistent 
detergent reduction could significantly affect the accuracy. Furthermore, HPLC is likely to 
separate the stabilising detergent from the peptides. 
 
 
2.2 Fluorescence correlation spectroscopy 
 
The most accurate method would be to conjugate the remaining thiol groups with Bodipy FL or similar 
fluorophores and measure the conjugate in FCS, as it would allow to discriminate the conjugate from 
the free dye due to the difference in diffusion time. However, OmpF requires detergents to remain in 
solution. These detergents build micelles which also enclose the used fluorescent dye as they are all 
rather hydrophobic. Various ways were tested to drive the free fluorophore out of the micelles: 
- Dilution of the sample below the cmc (in the hope that the more hydrophobic OmpF binds 
enough detergents to stay in solution) worked in principal but was not reliable nor clean 
enough. 
- Addition of biobeads for removing superfluous detergent had a similar result but precipitated 
OmpF fast. 
- Size exclusion chromatography and dialysis did not separate the OmpF from the dye containing 
micelles as both seem to be of similar size. 
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2.3 Ellmans Reagent 
 
Ellmans reagent (Fig. 8) is one of the most prominent and most frequently used reagent of detecting 
thiol groups and thus measuring the DOL. 
 
Fig. 8: the reaction of the Ellmans reagent with a thiol group forming the dye on the right. 
It is a relatively small molecule that splits of a dye in an active form which can be quantified measuring 
the absorption. However, the detection limit is too high (ca. 50µM)[12] for the thiol concentrations 
found in the relevant samples.14 This is a general problem since absorption measurements are far less 
sensitive than fluorescence measurements. However, fluorescence measurements are known to be far 
less reliable regarding the quantification of the samples concentration. 
 
 
2.4 Thioglo Series 
 
The Thioglo series (Fig. 9) is a collection of fluorophores that react with thiols and increase thereby 
their fluorescence considerably (apparently unfavourable resonance structures that reduce 
fluorescence are eliminated by the reaction). That way the excess in fluorophore does not need to be 
removed. In case of Thioglo-1[13] the thiol concentration could be reliably measured (linear 
dependence) in a range of 10 nM to 1 µM. However, it turned out that the unbound fluorophore had 
still considerable fluorescence. 
 
                                                          
14 1% free thiol groups in a 0.5g/L sample of OmpF (37kDa) would correspond to 135nM. Measuring OmpF in 
vesicles, would require 2-3 orders of magnitude lower concentrations, thus except for FCS, all experiments 
would require analysing OmpF-solutions directly. 
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Fig. 9.: The Thioglo-series 
 
Fig. 10.: labelling K89C-SH and K89C-Gala3 OmpF with Thioglo-115 and measuring the fluorescence at 
400nm excitation (peak emission 490nm). PBS refers to control containing the same amount of Thioglo 
and BSA refers to BSA reacting instead of OmpF with Thioglo. 
 
As can be clearly seen in Fig. 10, there is a clear difference in fluorescence between reacted and 
unreacted Thioglo-1 and hence a clear difference between labelled OmpF and unlabelled OmpF. The 
latter being able to react like BSA with Thioglo-1, despite the thiol groups being not at the outer surface 
of OmpF. 
  
                                                          
15 65µL 10µM Thioglo added to 300nM R-SH and filled up to 500µL with PBS; shaken for 2.5h at 25°C. and then 
measured as soon as the bubbles disappear (avoiding exposure to light as much as possible). 
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Due to the considerable background fluorescence, it was attempted to purify the samples via washing 
in 10kDa amicon centrifugation tubes or desalination minicolumns in the hope of obtaining a higher 
sensitivity for quantification of the DOL. However, both methods reduce the fluorescence and hence 
sensitivity greatly, presumably through precipitation of OmpF. In case of the sample preparation via 
size exclusion chromatography (minicolumns), the calibration curves became non-linear, but had a 
significantly lower statistic error (Fig. 11). This effect may be explained through more efficient 
detergent removal. 
 
 
Fig. 11: various concentrations of BSA reacted with Thioglo-1 and then passed through a minicolumn. 
 
Moreover, the size exclusion chromatography produced two fluorescent fractions one with a 
maximum emission at 440nm and one at 540nm instead of the anticipated 500nm. This is presumably 
due to a gradient of stabilising detergent (OG, octyl glucopyranoside), rather than due to bound and 
unbound fluorophore, since in the sample prior size exclusion chromatography did not hint 
overlapping emission peaks. It is also noteworthy that the emission is maximum at 1% OG and steeply 
declines at higher detergent concentrations.  
The initial thioglo experiments suffered also from a very poor signal to noise ratio (which could be 
partially explained through photo-bleaching) and the lack of a calibration or standard. Since the 
apparent difference in fluorescence between unreacted OmpF and labelled OmpF was very small, it 
was considered that Thioglo-I did not react with all remaining thiol-groups over-night. This left two 
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options: denaturate OmpF and thereby adding compounds that could quench the fluorescence or try 
to digest it. OmpF is very resistant to denaturation and even digestion with proteases and Proteinase 
K proved ineffective and introduced apparently some thiol-containing contaminations which increased 
the fluorescence rendering the assay useless. Similarly, it was tried to replace unreacted OmpF with 
BSA for calibration, which also featured exactly one thiol group. However, it also increased the 
fluorescence beyond expectations. This could be caused either by thiol containing contaminations or 
more likely indicate that the thiol in OmpF is accessible, but only a fraction reacts reducing the 
sensitivity of the Thioglo-assay. 
Working with Thioglo, the first inconvenience was that the supplier did not disclose the structure of 
the fluorophore. It could be found and later suppliers did provide it, but the experiments started 
without knowing whether or not Thioglo would be able to diffuse inside the OmpF pore and have 
enough room to react with the thiol group. Regarding the structure especially the non-linear 
arrangement of Thioglo-I could prove detrimental, but experiments indicated that it reacted. Adding 
to the supplier-related inconveniences was the fact that once the assay was almost established and 
ready to be used, the supplier announced that the Thioglo-I was discontinued. Since Thioglo-1 was 
discontinued Thioglo-3 was tested as replacement. It had however the same problems and it appears 
to be less suited due to its size.  
 
 
2.5 Acryolodan  
 
Fig. 12: Molecular structure of Acrylodan.  
 
Acrylodan (Fig. 12) works similar to the Thioglo-series but was apparently never used for quantification 
of thiol groups but rather as a molecular probe which reacts to the polarity of the surrounding (allowing 
to gain information about proteins, e.g. if the labelled spot is within a membrane or outside, but also 
indicating structural changes). Its sensitivity towards the polarity of the environment, could be an 
inherent disadvantage, but since the change in fluorescence is coupled with a shift in emission, its 
influence on the measurement can be mitigated. Compared to the thioglo-series it is far smaller, 
cheaper, turned out to be more photostable and had a much greater difference between the emission 
of the labelled and free fluorophores (ca. 12x stronger fluorescence after the reaction). Thus, even 
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without further purification it had a higher sensitivity and was hence used for quantitative 
measurements of the DOL (calculations in chapter Materials and Methods 3.2.8). 
It was tried to determine the DOL of acrylodan-OmpF directly through measuring the absorption of 
OmpF and acrylodan at 280 and 372nm respectively. However, the absorption is too weak at the 
obtained sample quantities.  
Its main disadvantage is that the calibration curve deviates more from a line than TG-I at the same 
range. It also appears to have a higher statistical error than TG-I due to its sensitivity to polarity, which 
manifests into detection of traces of ethanol from previous washing of the cuvette etc. Thus, variations 
in detergent concentration or traces of ethanol from washing cuvettes significantly increased 
fluorescence, but also shifted the emission maxima. Such contaminations were easy to spot and 
exclude as data-points 
Acrylodan was cheaper, better available, smaller and reacted faster and had a far higher thiol-
conversion than the thioglo-series. Furthermore, the difference in fluorescence between unreacted 
and reacted acrylodan was far greater than in the case of Thioglo. All this contributed to a higher 
difference between unreacted OmpF and modified OmpF. It was also susceptible to bleaching even in 
the rather dim lab but could be easily avoided using blackened vials. 
 
 
2.6 Mass spectroscopy 
 
The only method theoretically able to measure the DOL directly (without having to calibrate) and 
accurately is mass spectroscopy. It would be thus the best method for quantification of the DOL, but 
membrane proteins are difficult to measure in mass spectroscopy. Membrane proteins have a large 
hydrophobic surface for binding to membranes, which will obviously interact with itself and detergents 
making it near impossible to measure the entire protein in gas phase. [14] Thus, the samples need to be 
fragmented. The entire procedure is tedious as the sample needs to be purified via running an SDS-
gel, cutting out the band and milling it, performing in-gel digestion, extracting it, purifying and desalting 
it via reversed phase chromatography. Unfortunately, the peptide-fragment bearing the attached 
stimuli responsive group could not be found in the mass spectrum. Thus, this method became an 
indirect method as well, comparing the peptide fragment bearing unreacted thiol groups with other 
peptide fragments of the same sample. While the ratio between these peptides could change during 
the purification procedure, it turned out to be still the most accurate method available to quantify the 
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DOL (calculation in chapter Materials and Methods 3.2.9). However, due to the lengthy sample 
preparation and since it required the help of an external expert, this method was rarely used. 
 
 
2.7 Discussion DOL 
 
All the different OmpF mutants and OmpF conjugates were tested via the acrylodan method. First it 
was established that the single mutants had accessible thiol groups by comparing WT-OmpF with 
R270C-OmpF (Fig. 13 left) and R270C-OmpF with K89C OmpF. Then the double mutants were 
compared to the single mutants (Fig. 13 right). As expected the fluorescence increased only to a 
significant extent when thiols were present. Both K89C- and R270C-OmpF behaved identical in this 
respect and the double mutant K89,R270C-OmpF had twice the fluorescence at the same 
concentration as could be expected from the single mutants (Fig. 13 right). However, D12,K89C and 
D12,R270C-OmpF behaved like a single mutant (Fig. 14). Together with the other results it indicates 
that K89C and R270C thiol groups are available for labelling but not D12C. This might be due by E2 and 
K46 which flank D12C, or possibly tyrosine Y14 shields it. The fluorescence of these double mutants 
labelled with acrylodan was therefore at the same level as for the single mutants. 
 
 
Fig. 13: left: comparing the mixture of acrylodan and WT-OmpF with the mixture of acrylodan and 
R270C-OmpF (procedure in materials and methods). Right: Comparison between the fluorescence of 
K89R270C-OmpF with R270C-OmpF both labelled with acrylodan. Note: The concentration of 
K89R270C-OmpF was divided by two to show the overlap. Also, on the left the point for 0 mg/L of 
OmpF is identical for both samples. 
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Fig. 14: left: comparison between K89C- and D12K89C-OmpF; right: comparison between R270C- and 
D12R270C-OmpF (concentration calculated as if it was a single mutant). Both prove that D12C was not 
labelled.  
 
Calibration was performed by binding acrylodan to an aliquot of the same OmpF-M, in order to correct 
for bleaching, quenching and shifting of the fluorophore emission wavelength. Rather than measuring 
triplicates of a fixed concentration, the samples and standards concentrations were varied between 
2.0 and 5.0 mg/mL. Within the measuring range both sets of measuring points provide two parallel 
lines. These points can be used for the calculation of the DOL and their results be averaged. 
The reason for using a concentration range rather than triplicates, was that the detection window is 
dependent on the (unknown) concentration of the available thiol groups and hence not directly 
dependent on the protein concentration itself. Thus, the concentration of acrylodan could not be 
adjusted to the sample. Hence, it was kept as for labelling 5mg/L OmpF, which corresponds to the 
highest found thiol concentration. 
0mg/L is below the best fit line, since acrylodan undergoes changes in its fluorescence upon reaction 
with thiol groups and should therefore not be included. The calibration curve changes its slope at 
2mg/L and below (Fig. 15). At such low concentrations of free thiol-groups the free acrylodan will 
remain an excess, which could potentially interact with bound acrylodan groups via π- π-interactions 
or even with other aromatic amino acids.[15] At this point the concentration is too low for the 
measurement. It can be assumed that the fluorescence of bound acrylodan is lost in the background.  
While even without thiol groups the fluorescence increased somewhat with increasing OmpF 
concentration, it was far lower than for thiol containing mutants. The slight increase in fluorescence 
may be attributed to non-covalent interactions with aromatic amino acid residues.[15], or may be to a 
slight increase in the detergent concentration. 
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Fig. 15: Acrylodan assay of R270C-Gala3 OmpF (left, red spheres) K89R270C-Gala3 OmpF (right, red 
spheres) using R270C-OmpF/K89R270C-OmpF respectively as standard (black squares); the DOL was 
calculated to be 80% for R270C-Gala3 and 68% for K89R270C-Gala3.  
 
In order to increase the measuring speed and excluding ethanol or other washing contaminations well-
plates were used. They were however prone to measuring errors due to bubble formation from the 
detergents in solution. Even considering all these error sources a relatively high statistical error 
remained. In particular, each experiment had at least one outlier and some measurements had for 
unknown reasons far higher errors than other measurements indicating the existence of another error 
source. Interestingly, there must have been also a systematic error. For instance, the acrylodan assay 
indicated for K89R270C-Gala3 a DOL value of 68% ± 9%, whereas the mass spectrometry (Table 4) gave 
88% (92% and 96% for each anchor group). A possible explanation is that in the case of the double 
mutant bearing only one peptide, that this peptide would reduce the fluorescence of the acrylodan 
binding to the other thiol-group. However, it appears more likely that incorrect assumptions have been 
made for calibrations. As seen for concentrations below 2mg/L, assuming a linear dependence of 
fluorescence on concentration is dangerous. Even when taking these limitations into account, 
subtracting the background fluorescence may be trickier than expected. While applying a least square 
fit and using the parameters of the trendline does automatically remove the background fluorescence, 
but only as long as it remains constant. However, if it would e.g. increase with the protein 
concentration due to non-specific interactions, then an error would remain, which would become 
worse for the higher the degree of labelling is. Regarding the fact that in many experiments the 
calibration line was deviating in an S-shape, albeit only slightly, this error source appears very plausible 
and likely the cause of the deviation between mass-spectrometry and acrylodan-measurements.  
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Table 4.: Comparison of acrylodan assay with mass spectroscopy 
 
  
DOL 
Acrylodan 
DOL Mass 
Spectrometry 
K89C-Gala3 76%16 94% 
R270C-Gala3 80% 92% 
K89,R270C-Gala3 68% 96%17 
 
 
A DOL value of 68% ± 9% for K89R270C-Gala3 was obtained, indicating a successful binding of Gala3 to 
the modified OmpF (Fig. 15; Table 4). This value implies that 50% of the pores have one Gala3 attached 
and 20% have two Gala peptides attached, under the assumption that both the K89C and R270C anchor 
points are equally reactive (Eq. 1, Table 5).  
 
The following calculations were used to calculate from a given DOL (P) how many pores would be 
labelled twice (N2) or only once (N1). 
 
P=2(1-p)p+p2   (1a) 
N0=(1-p)(1-p)  (1b) 
N1=2(1-p)  (1c) 
N2= p
2    (1d) 
 
P: over all DOL (average of both thiol groups); p: individual DOL; Nn: probability N that n groups have 
peptides attached 
 
                                                          
16 since K89C-OmpF was no longer available D12K89C was used instead (D12C was proven inactive see Fig. 14) 
17 Mass spectrometry does not measure the overall DOL, thus only K89R270C-Gala3 was measured, and the 
overall DOL was calculated from the individual DOLs using this equation: 
𝑃 = 𝑝1(1 − 𝑝2) + (1 − 𝑝1)𝑝2 + 𝑝1 ∙ 𝑝2 
With P the overall DOL and pi the DOL for a specific mutation site (sum of the probabilities that exclusively one 
mutation site is labelled and the probability that both mutation sites are labelled). 
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Table 5: Anticipated DOL of OmpF-C (P) as a function of the DOL of the individual thiol groups (p) 
p N0 N1 N2 N1or2 P 
30% 49% 42% 9% 51% 51% 
40% 36% 48% 16% 64% 64% 
45% 30.30% 49.50% 20.30% 69.80% 69.80% 
50% 25% 50% 25% 75% 75% 
60% 16% 48% 36% 84% 84% 
70% 9% 42% 49% 91% 91% 
80% 4% 32% 64% 96% 96% 
90% 1% 18% 81% 99% 99% 
 
Note: the blue row was calculated backwards from the measured DOL of K89,R270C-Gala3 OmpF 
 
Mass spectrometry was used as a complementary method to evaluate DOL of the Ompf-C. For this 
purpose, OmpF-C and OmpF-M were purified via SDS-gel electrophoresis and digested within the gel, 
resulting in various peptides. Mass spectrometry is a direct and absolute method for quantification, 
however, long hydrophobic peptides are particularly difficult to ionize and transfer into the gas phase. 
Such peptide sequences are typical for membrane proteins such as OmpF.[14] Thus, it was necessary to 
perform an indirect measurement by comparing the ratio between the intensities of the mass peaks 
of the cysteine-bearing OmpF fragments (without Gala3) with another peptide without cysteine, and 
calibrating it with OmpF-M. (Eq. 2 in chapter Materials and Methods 3.2.9) This eliminated the 
dependency on the protein concentration, as the other peptide served as an internal standard. The 
measurements indicate that 94% ± 5% of the thiol groups within the double mutant OmpF-M bound 
Gala 3 (92% ± 5% of K89C- and 96% ± 5% of R270C anchor points had the Gala3 peptide attached) 
(Table 4). While both mass spectrometry and acrylodan assays indicate successful thio-
functionalization of the OmpF-M, the DOL value determined with acrylodan assay is lower than 
determined by mass spectrometry. This might be caused by the polarity dependence of acrylodan. If 
thioglo-1 would have been still available, the measured DOL would have most likely been higher as can 
be anticipated from Fig. 15. However, Thioglo-1 had a lower difference in fluorescence between bound 
and unbound state, resulting in a higher background fluorescence and lower overall sensitivity. 
In addition, the acrylodan assay cannot take into account the case when only one of the thiol groups 
within the OmpF-M pore is available, the second one being already bound to Gala3, which might 
influence the polarity of the surroundings of the acrylodan and hinder acrylodan binding to the 
remaining cysteine.  
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After a valid method of determining the thiol concentration of OmpF was established and the 
successful introduction of thiol mutants was confirmed, the labelling with various stimuli responsive 
groups was tested and the parameters for the Michael addition optimised. 
 
Table 6: overview over the conjugation experiments (selection; all using maleic imid-linker) 
Experiment 
OmpF 
mutant 
Oligomer/ Eq. per 
thiol 
group 
DOL18 Remark 
peptide 
1 D12,K89C Gala3 120 76%  
2 D12,K89C HLG4 122 27%  
3 D12,K89C HLG4 100 49% Same procedure but at pH 6.5 
4 D12,K89C HLG4 100 36% Same procedure but at 37°C 
5 R270C Gala3 30 37%  
6 R270C Gala3 60 80%  
7 K89,R270C Ini 300 83% Same procedure as for Gala3 
8 K89,R270C (acrylic acid)6 300 50%  
9 K89,R270C (acrylic acid)8 300 40%  
10 K89,R270C (acrylic acid)12 300 38%  
11 K89,R270C Gala3 60 68%  
12 K89,R270C H6 60 0%  
13 K89,R270C HF3 60 49% pH 6.5 
14 K89,R270C HF3 60 n.d.19 pH 7.4 
15 K89,R270C HL3 60 86%  
16 K89,R270C HLG4 60 54%  
17 K89,R270C GHLL3 60 40%  
 
As shown in Table 6. A variety of peptides was successfully attached to three different mutants. In red 
DOL below 40% are marked and in green DOL above 80% are marked. In the first attempts the stimuli 
responsive groups were dissolved directly in buffer and added to the OmpF solution (same as in 7-10 
but attached to R270C-OmpF). This worked for oligo(acrylic acid) due to its high polarity, however most 
peptides were less soluble in water and had a tendency to precipitate again despite the presence of 
OG which stabilised OmpF in solution. For this reason, the stimuli responsive peptides were dissolved 
in DSMO and added dropwise to a vigorously stirred OmpF solution.  
For the conjugation experiments the number of equivalents of peptide, the amount of DMSO dissolving 
the peptide, the reaction time and temperature were varied. Dissolving the peptide in DMSO improved 
the DOL significantly. The reaction speed might be slowed down through transport phenomena 
involving micelles. Thus, the concentrations of DMSO and detergent can have a great effect on the 
                                                          
18 DOL according to acrylodan experiments, thus referring to the overall DOL of all available thiol groups. 
19 The DOL was not determined (n.d.) in this case as the solution was opaque and could not properly be 
purified. It has to be assumed that the DOL was low and that unreacted peptide was dragged along with the 
stabilising detergent. 
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reaction rate. Furthermore, very hydrophobic peptides have the tendency to aggregate and precipitate 
even in presence of micelles (HLG4, H6, HF3, GHLL3). Increasing the number of equivalents or the 
reaction time resulted in no significant improvement. In general, increasing the number of equivalents 
beyond 10 per thiol group (or 60 per trimeric double mutant) brought no improvement (compare 5, 6 
and 1). Higher concentrations only promoted precipitation. This trend can be clearly seen from HLG4 
over HL3 to HF3 which proved to be the least soluble peptide after H6. 
In case of oligo(acrylic acid) more equivalents were used since the compound deactivated itself fast 
resulting in an unknown concentration. Moreover, its solubility was significantly higher (until it 
deteriorates during storage). Increasing the temperature decreased the DOL and increasing the 
amount of DMSO up to 10vol% increased the DOL. For basic peptides, a pH of 6.5 improved the DOL 
significantly (compare 2 and 3), due to its increased solubility (as intended for the stimuli responsive 
behaviour). However, lower pH inhibits the Michael addition which work only at a pH range of 6.5-7.5. 
Above the pH it becomes unselective; below the thiols are not nucleophilic enough and going even 
lower with the pH the linker can even hydrolyse. While oligo(acrylic acid) had superior solubility, it 
appears that its charge reduced the probability of labelling both pores. The longer the oligo(acrylic 
acid) was the lower the achieved DOL became (compare 7 to 10). 
 
 
Table 7.: comparison between DOL measurements with acrylodan and mass spectrometry 
    DOL via acrylodan assay   DOL via mass spectrometry 
Experiment Sample P p calculated   p K89C p R270C P calculated 
8 K89R270C-(acrylic acid)6 50 71  96.2 n.d. 92.5 
9 
K89R270C-(acrylic acid)8 83 91 
 
52 n.d. 27 
10 
K89R270C-(acrylic acid)12 40 63 
 
84 n.d. 70.6 
11 K89R270C-GALA3 68 82  92 96.5 88.8 
13 K89R270C-HF3 49 70  40 93 37.2 
15 K89R270C-HL3 86 93  91 n.d. 82.8 
16 K89R270C-HLG4 54 73  93.1 99.6 92.7 
17 K89R270C-GHLL3 40 63  92.7 n.d. 86 
 
Table 7 represents a selection of OmpF conjugates that were measured both with acrylodan and mass 
spectrometry.: DOL below 40% are marked in red; and those above 80% in green. Acrylodan and mass 
spectrometry cannot be directly compared since acrylodan gives an over-all-DOL whereas mass 
spectrometry measures the DOL of an individual mutation site. This already lets the DOL of acrylodan 
measurements appear significantly smaller. Thus, in order to compare the DOL of both methods, for 
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the DOL of the acrylodan-measurement a theoretical DOL (p) was calculated estimating the DOL of a 
specific mutation site (assuming K89C and R270C have both the same DOL). For mass spectrometry, 
the opposite was done (P), calculating the overall degree of labelling (if only K89C could be determined 
then the same DOL was assumed for R270C). 
Mass spectrometry worked very well and gave reproducible results (with only two low DOLs found), 
but the sample preparation did not always work, in particular with old samples. In such cases the 
peptide fragment with the free thiol group was not visible. This occurred most frequently with the 
peptide fragment bearing the R270C mutation. Since this issue occurred mostly with OmpF-
oligo(acrylic acid)-conjugates, it could not be verified if in case of oligo(acrylic acid) only one thiol per 
pore was labelled. If this was the case then K89C must have been more accessible than R270C. Either 
way it is noteworthy that both methods of DOL measuring had the greatest fluctuations with OmpF- 
oligo(acrylic acid)-conjugates. 
The DOL could now be measured and the results were reproducible indicating a low statistic error. 
However, especially the peptide fragment around R270C was apparently difficult to ionise, resulting 
often resulting in a missing peak and thus the DOL of this anchor point could not be measured. 
Whenever the peak could be seen, the measurement appeared to produce dependable data. Similarly, 
it occurred for both mutation sites that the measured concentration of the internal standard was 
occasionally too high resulting in negative DOLs. Not even the mass spectrometry expert of the group 
focussed on mass spectrometry could give an explanation for these two behaviours. Our best guess is 
that the digestion, washing and purification processes are not fully reproducible thus at times creating 
longer peptide fragments that remain unionised or smaller peptide fragments that are washed out and 
lost before ionisation. Interestingly the negative DOLs appeared always at the end of multiple samples. 
Thus, if multiple bands were cut out of SDS-gel and the digestion and purification done in parallel, the 
first three samples were never affected but the later ones may have suffered from delays which caused 
minor but deviations from the established protocol. 
 
 
3 Vesicles 
 
As mentioned in the introduction, the next step is to insert the OmpF-C into vesicles so that various 
assays can be used to assess the diffusion through the pores in dependence of the stimuli. However, 
this step requires several smaller steps: 
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- Find a lipid-mixture or ABCP, that produces vesicles. Improve the procedure until the vesicles 
are the only species, have adequate size (75-500nm), are homogeneous. 
- Assure that the vesicles withstand the experimental conditions (stable over the observed time, 
pH, temperature, any potentially interfering molecules…) 
- Test whether OmpF can be inserted and optimise the insertion. This step is particularly tricky, 
since a plethora of parameters have to be considered (see sections on insertion of MPs), which 
do not only affect the success of the insertion but can also alter the shape and stability of the 
vesicles. Moreover, it has to be done in parallel with the third major step: developing a reliable 
assay (detection of diffusion proves correct insertion). To further complicate the task, the 
assay can also interfere with the vesicle-formation and vesicle-stability… 
- Testing the stimuli responsiveness of the OmpF-C containing vesicles. 
 
 
3.1 Liposomes 
 
Liposomes lend themselves as testing platform due to the readiness of membrane-lipids to form 
vesicles. They are well suited for the insertion of membrane proteins since their membranes are closest 
to their natural counterpart and are well established as a model for artificial cell membranes. Their 
drawback is the limited stability of the self-assembled structures. Thus, the experimental question is 
not just which lipid is suited the most, but rather which mixture, regarding the number of possible 
additives stabilising the membranes. In particular, the DSPC mixture was made in the intention of 
creating a liposome platform resembling as closely as possible liposomes in order to safe ABCP in pre-
experiments. 
 
 
3.1.1 Natural phosphatidylcholine 
 
Natural phosphatidylcholine (from egg yolk) proved to have the greatest willingness to form vesicles 
from all tested amphiphiles. Direct dissolution of POPC bits was sufficient and vesicles formed as soon 
as the particles dissolved. Compared to other lipids it produced more vesicles, larger vesicles and even 
without extrusion, more homogeneous vesicles (Fig. 16). Both film rehydration and direct dissolution 
produced very similar vesicles, but for encapsulation experiments film rehydration was used in the 
hope that better defined starting conditions result in a more reliable encapsulation. 
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Experiments encapsulating dye and observing it in FCS revealed that most dyes destroyed the vesicles, 
but if vesicles were formed, then they were relatively stable for hours at room temperature despite 
the rather hydrophobic nature of the dyes and at a pH as low as 1.0 (no observed change in diffusion 
time or counts per molecule). However, it is only stable in the fridge for a week. Acidified it lasts about 
one day in the fridge, probably due to osmotic pressure. The main problem is that the vesicles are not 
thermally stable, thus incubation with proteinase K at 37°C is not possible (as a means of removing 
free HRP, elaborated in the chapter enzyme kinetics). 
 
Fig. 16: POPC liposomes formed via film rehydration20 
 
 
3.1.2 SM/POPS/cholesterol 
 
This lipid mixture of sphingomyelin, 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-L-serine and 
cholesterol (an often-used mixture in our lab) was tested in the hope of achieving higher thermal 
stability by the use of cholesterol which stabilises the lipid-bilayer and by adding POPS thereby 
introducing a negative charge to the vesicles which should prevent aggregation. 
This mixture is particularly suited for detergent removal for two reasons: First the additional charge 
helps to diminish the negative effect of the presence of detergents on the vesicle formation 
(detergents tend to cause higher heterogeneity, more micelles, smaller vesicles, less stable vesicles…). 
Secondly, cholesterol is poorly water soluble, thus no homogeneous mixture can be expected by 
merely adding all ingredients to water. Detergent removal is also of particular interest for the insertion 
of membrane proteins into vesicle membranes. 
                                                          
20 3mg of POPC were dissolved in 1mL ethanol and then dried in a 20mL glass vial. Then 1mL PBS was added 
and the solution was shaken for 3h. 
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Compared to POPC (which is very similar to SM but differs in the location of the double bond) the 
vesicle formation with this mixture is far more laborious as it requires far more components to be 
weighted and the detergent removal takes considerably longer than film-rehydration. Moreover, 
samples obtained from this mixture featured a much higher polydispersity (average diameter 1000nm) 
and required thus extrusion. The mixture had moreover the tendency to block filters so that the 
extrusion required the pressure of a barrel extruder. This is a further indication for a very 
heterogeneous mixture. After extrusion (1x1000nm, 2x400nm, 5x200nm filter) the PD was moderate 
(0.2) and the average diameter 200nm (Fig. 17). Please note, that the vesicles in the TEM appear in 
irregular polyhedral shapes due to the sample preparation involving drying and vacuum causing 
distortion on softer vesicles. The vesicles had a similar stability towards pH and a considerably 
improved stability towards temperature. The samples could be dialysed for three days at room 
temperature without effecting the diameter or polydispersity. However, detergent removal is not 
suited for the encapsulation of rather hydrophobic cargo, since it would accumulate in micelles rather 
than vesicles and the chance that the intended cargo becomes inserted into the membrane increases 
too.  
 
 
Fig. 17: Liposomes formed via detergent removal (procedure described in materials and methods). 
 
Encapsulating HRP (see chapter enzyme kinetics) did not affect the vesicle appearance but inserting 
OmpF had the tendency to increase the vesicles diameter by 5-10%. While the vesicles were clearly 
more stable than POPC-liposomes, they were still not stable enough for 1 day at room temperature 
for measuring light scattering. After the dialysis, the liposomes degenerated to fast at room 
temperature, aggregating, precipitating and releasing encapsulated HRP. Thus, the samples could not 
be fully characterised, instead only a fast, dynamic light scattering (DLS) measurement via Zetasizer 
and transition electron microscopy (TEM)-pictures were used (See Appendix).  
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3.1.3 DSPC/POPS/cholesterol 
 
To address the problem of the low thermal stability POPC/SM was replaced by DSPC (1,2-distearoyl-
sn-glycero-3-phosphocholine), which does not feature unsaturated carbons and has thus a transition 
temperature of 55°C.[16] This makes pure DSPC very unwilling to form vesicles at room temperature 
and within formed membranes DSPC will be very unwilling to change its conformation resulting in a 
very low membrane fluidity. Thus, it requires elevated temperatures for vesicle-formation and the 
vesicles should be very stable at room temperature. Two additives were chosen that should increase 
the fluidity of the self-assembling membranes without sacrificing its stability. POPS introduces charges 
that should prevent aggregation and help vesicle formation. Moreover, its unsaturated nature creates 
perturbation increasing the fluidity of the membrane. Cholesterol is known[17] to increase the fluidity 
of membranes but also stabilises them by interconnecting their bilayer.[17] Right from the beginning it 
was considered to use PEGylated cholesterol. The PEGylation should serve two purposes. It should 
create a barrier that prevents aggregation and it should keep hydrophobic entities such as FCS-active 
dyes and HRP from inserting into the membrane and thereby preventing them from weakening the 
self-assembled structure. Cholesterol was the ideal anchoring point for PEG since it was already 
planned as ingredient of the mixture and since it forms much more stable anchors than any lipid due 
to its length connecting both layers of the liposome. 
In the first attempt, the maximal ratio of cholesterol was used, however it turned out that the 100% 
PEGylation prevented vesicle-formation resulting in only few and odd shaped vesicles (Fig. 18). Adding 
it later to the mixture at the point of film rehydration a relatively high number of vesicles were formed 
but their formation came to an abrupt end resulting in a great number of small vesicles with holes. 
Under normal circumstances huge holes in vesicles result in their immediate disassembly, so that they 
can rarely be seen in TEM, but in this case the membranes were still stable enough so that even after 
drying and under vacuum the samples the holes could be observed. 
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Fig. 18: 100% pegylated cholesterol added to DSPC; left before the drying of the lipid film;21 right 
during the rehydration (4h after start, after observing the development of turbidity) 
 
As a consequence of these results, unmodified cholesterol was added to reduce the density of PEG-
chains. Compared to other lipid mixtures the formation was slow (17-20h vs 1h) and it required 
temperatures that would gradually destroy most unsaturated lipid vesicles. It turned out that the 
addition of cholesterol and POPS facilitated the extrusion, however extrusion was only possible at the 
same temperature as the vesicle formation (40°C).  
These vesicles proved to be the most stable liposomes I am aware of. The vesicles can be treated for 
12h at 37°C without any signs of degradation or deterioration and the vesicles could be stored at room 
temperature for up to three months (Fig. 19). The slow degradation is probably the result of slow 
oxidation. 
 
 
                                                          
21 3mg DSPC and 1 eq. of Chol-PEG600 were dissolved in 1mL ethanol and dried in a 20mL glass vial. Then 1mL 
of citrate buffer was added and the solution was stirred at 25°C for up to 30h. 
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Fig. 19: left DSPC vesicles directly after extrusion (process described in materials and methods); right 
after 12h at 37°C 
 
It is also noteworthy that most liposomes encapsulating FCS dyes reached encapsulation efficiencies 
well above 100% implying that the dyes were no longer dissolved but accumulated in the lipid-
membrane. The DSPC-mixture did not show this behaviour making it suited for FCS measurements. 
However, it was found that the encapsulation efficiency could be very low as observed for some 
polymersomes. It was therefore considered that the PEGylation would be affecting both sides of the 
membrane thus reducing the inner cavity. Thus, it was tried to add the Chol-PEG only once the first 
vesicles were formed through film rehydration (Fig. 20). That way very similar but larger vesicles were 
formed and the encapsulation efficiency increased somewhat (Rh 57 to 69nm; encapsulation efficiency 
45 to 56%). Still the presence of FCS dyes reduced the size of the vesicles considerably (without Rh ca. 
100nm).  
 
 
Fig. 20: Liposomes made of DSPC/POPS/cholesterol through film rehydration using citrate buffer 
containing 100nM sulforhodamin B FCS dye. Left Chol-PEG added before film rehydration; right Chol-
PEG added 4h after start of vesicle-formation (beginning of turbidity) 
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It was also tested, whether sonication could speed up vesicle-formation and what effect it would have 
on the resulting vesicles (Fig. 21). It turned out that the vesicles were somewhat smaller (Rh 50nm), 
but far more heterogeneous according to light scattering. Furthermore, the encapsulation efficiency 
of sulforhodamin B or Oregon Green 488 went down considerably (34%, 1% respectively). 
 
 
Fig. 21: film rehydration speeds up via 2h sonication; left: encapsulating 100nM sulforhodamine B 
and right: encapsulating 10nM Oregon Green 488. 
 
It was not further investigated how much of the Chol-PEG actually inserted, nor the stability of the 
resulting vesicles, since the encapsulation of dye did not improve enough, nor were the FCS 
experiments as promising as the HRP kinetics, which could work even with very low encapsulation 
efficiencies (regarding the latter see Enzyme kinetics and Appendix). 
The lipid mixture had also some notable weaknesses. While being ridiculously stable at room 
temperature, the vesicles were damaged fast and precipitated through dialysis at room temperature 
indicating a particular vulnerability to osmotic pressure. Keeping the osmotic pressure constant solved 
this problem. It could be said that these vesicles are particularly hard but have at room temperature 
no self-healing abilities and have thus a glass like fragility. 
It was also tried to form vesicles from this mixture via detergent removal, but the change in polarity 
causes demixing and precipitation ultimately resulting in very heterogeneous vesicles and many 
aggregates which were moreover impossible to extrude without a barrel extruder. 
The vesicles were moreover considerably more sensitive towards detergents. In that respect, they 
were in midway between polymersomes and regular liposomes. This was observed when OmpF was 
added during film rehydration. OmpF in 3% OG could be added to regular liposomes without causing 
significant changes in the self-assembly process. For the DSPC-mixture it had to be reduced to 0.5% 
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OG. For polymersomes this residual detergent concentration was still too high resulting in small 
vesicles and numerous micelles. 
The greatest disadvantage was that OmpF was very difficult to insert. This fact can probably be 
attributed to the PEGylation and higher crystallinity and rigidity of the membrane which were 
beneficial for dye encapsulation and overall stability. 
 
3.2 Polymersomes 
 
The advantage of polymersomes over liposomes was not only their superior stability but also the fact 
that hardly any mixtures had to be considered. While AB-ABCPs would form bilayers too, ABAs can 
form a thick monolayer (see chapter II,). Polymersomes do not require additives for further 
stabilisation and most potential additives would rather weaken the self-assembled structures (in 
particular due to a mismatch in length). Additives come hence only into play when trying to insert 
membrane proteins. Therefore, experiments with polymersomes depend first and foremost on the 
length of the hydrophobic block of the ABCP and the ratio of the hydrophilic block. All the following 
examples were PMOXA-PDMS-PMOXA based and (disregarding the individual chain-lengths) of the 
same molecular structure. Since vesicular structures can be found at hydrophilic/hydrophobic ratios 
of 10-45% the shortest ABCPs was A4B22A4. Shorter hydrophilic blocks can hardly be made nor would 
they have a significant influence, yet the ABCPs are considerably longer than the thickest lipid-bilayers. 
The longest ABCPs were 3x as long (overall length). They tend to be more stable, but the longer the 
hydrophobic block becomes the harder it gets to dissolve the ABCP and to insert MPs into their 
membranes. 
Note: if not stated otherwise, the vesicles were all prepared via film rehydration as described in 
materials and methods. 
 
 
3.2.1 A4B22A4 
 
The shortest ABCP in this list dissolved rapidly, with little residue in water in comparison to the other 
ABCPs. For vesicle-formation direct dissolution, film rehydration and the ethanol method (kinetic 
trapping with ethanol as solvent) were tested. These methods revealed trends that were found with 
the other ABCPs as well. Direct dissolution worked only poorly despite the relatively good solubility, 
resulting in a very heterogeneous mixture with only few vesicles (Fig. 23). The ethanol method 
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produced vesicles very fast, but of smaller size. Film rehydration produced the best results (with rather 
big vesicles with a Rh of 100nm according to light scattering and 120nm according to FCS) and allowed 
the best encapsulation efficiencies for FCS-dyes. 
Unfortunately, only small amounts were still available at the time, thus it was given to a more advanced 
project, where it was confirmed that it inserts OmpF. 
 
 
Fig. 23: TEM images of 10x diluted samples. Left: samples produced via film rehydration; right: 
produced via direct dissolution (adding the same amount of ABCP directly to the stirred buffer). 
 
 
3.2.2 A14B25A14 
 
This is the second old ABCP. It was apparently synthesised in the hope of recreating A4B22A4, yet the 
hydrophilic part became significantly longer, thus changing the hydrophilic ratio from 27 to 53% which 
made it particularly hygroscopic. At such high ratios tubes and even micelles can be expected. It was 
still tested and peculiarly it dissolved significantly faster and better with the direct dissolution method, 
rather than using the film rehydration method (Fig. 24), very unlike most tested ABCPs. Regarding the 
exposed surface of solid ABCP this result is paradox and counter-intuitive. Moreover, it was the only 
ABCP tested that produced more and better vesicles using direct dissolution. These findings were 
confirmed by those scientists, that worked earlier with it. According to the publications it formed large 
vesicles, which became smaller and more homogeneous after sonication.[18] However, when I used it, 
it had started to deteriorate (slightly yellowish, unidentified, broad peaks in the NMR; possibly partial 
decomposition into diblockcopolymers) and the concentration of tubes and micelles increased over 
the concentration of vesicles. It was thus no longer suited for further experiments. 
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Another noteworthy finding is that A14B25A14 was reported to insert MPs such as OmpF simply by 
dropping the solution of the MP onto the ABCP pieces, adding water and stirring it overnight.[19] This 
could be done with no other ABCP tested since polymersomes are highly sensitive to detergents and 
MPs tend to precipitate rapidly once their solution is diluted well below the cmc. 
The causes of these findings can only be speculated. The relative ease of direct dissolution can be 
explained however regarding the relatively low molecular weight and the high hydrophilic ratio. These 
factors could be also responsible for stabilising MPs in solution before they precipitate. The reason film 
rehydration did not work might be that the films were dried too much and the process increased the 
crystallinity so that the solubility decreased. Experiments with other ABCP can only confirm that the 
humidity of the ABCP-films matters. ABCP that are too moist before being dissolved in ethanol formed 
often more micelles and films that were dried too thoroughly rehydrated only slowly if at all. 
Why the vesicle-formation withstood higher detergent concentrations might be explained through the 
short hydrophobic block. Liposomes are also less sensitive to detergents probably since the mismatch 
in length and physical-chemical nature of the detergent is less pronounced as in polymersomes. This 
effects most probably the way detergent interacts with ABCP, micelles and vesicles. For instance, it 
could be that the detergent inserts in liposomes evenly whereas it produces detergent domains in 
polymersomes which weaken the membrane. 
 
 
Fig. 24: Resulting structures produced via film rehydration (left) and direct dissolution (right) 
 
  
III Preparation of nano-reactors 
105 
3.2.3 A6B44A6 
 
This and the following ABCP were modelled on A4B22A4, maintaining the ratios, but without achieving 
the same length (approximately twice as long). It dissolved rather well using film rehydration and had 
a great preference towards vesicles.  
 
 
Fig. 25: vesicles encapsulating 0.25g/L HRP produced via film rehydration without (left) and with 
OmpF (right) stabilised in 3% OG.22  
 
The fact that the second sample contains a vast number of micelles and has on average smaller vesicles 
(but also far more homogeneous in size) is due to 0.15% OG introduced along with the OmpF. It is thus 
more sensitive to detergents than the ABCPs discussed earlier (Fig. 25). 
 
 
3.2.4 A8B49A8 
 
It is very similar to A6B44A6 but forms slightly better vesicles. However, they tended to remain below 
120nm in diameter (Fig. 3 Appendix). In cryoTEM, most appeared to be in the range of 40-60nm (Fig. 
26). It appears to be even more sensitive to OG than A6B44A6 (Fig. 27). It was thus tested if a gradual 
removal of detergent could result in functional vesicles, however detergent removal did not form 
vesicles at all, although it formed some spherical aggregates of micelles that appeared to be hollow 
(Fig. 28). 
 
                                                          
22 50µL of 1g/L OmpF was soaked into the film for 30min, then the PBS was added for film-rehydration. 
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Fig. 26: Cryo-TEM micrograph of A) HRP loaded PMOXA6-PDMS44-PMOXA6 polymersomes equipped 
with OmpF-C, NRC, and B) HRP loaded PMOXA6-PDMS44-PMOXA6 polymersomes without OmpF, NR-. 
Scale bar 100nm. 
 
The polydispersity increased greatly with the OG concentration (0,08 0%; 0.22 0.025%; 0.47 0.15%). 
Direct dissolution had a similar effect on the polydispersity (0.5). The diameter according to light 
scattering decreased in presence of 0.025% OG from 190nm to 100nm. Similarly, direct dissolution 
produced only vesicles with an average diameter of 166nm. 
 
 
Fig. 27: TEM micrographs revealing the influence of detergent concentrations below the cmc[20] on 
vesicle formation of PMOXA6-PDMS44-PMOXA6 when adding OmpF stabilized in 0.5 (left) and 3% 
OG (final concentration ca. 0.15 and 0.025% respectively). In both cases the OmpF solution was 
allowed to soak into the polymer film before film-rehydration. 
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Fig. 28: two TEM images of the same sample of vesicles encapsulating 0.25g/L HRP produced via 
detergent removal starting from 3% OG using Biobeads and 3-5kDa dialysis tubes. 
 
 
3.2.5 A20B38A20 
 
This was a commercially available ABCP. It is very similar to A14B25A14 regarding the hydrophilic ratio. 
However, it was 47% longer. Due to the similarities, it was expected to be rather water soluble and 
form vesicles, tubes and micelles. Peculiarly, it dissolved neither well in water, nor ethanol. Also, it did 
not dissolve in other organic, water miscible solvents. In fact, it was the ABCP that was the hardest to 
become fully solubilised of all discussed ABCPs. 
Changing from film rehydration (Fig. 29) over ethanol method to direct dissolution, the opaqueness of 
the samples increased. This finding is somewhat surprising since in case of the direct dissolution, the 
majority of the polymer did not dissolve in buffer. Moreover, DLS measurements indicate that film 
rehydration produced most vesicles, followed by direct dissolution, less than 10% of the aggregates. 
The ethanol method resulted only in micelles. 
Due to the astonishing low solubility, slow rehydration speed and low vesicle population and overall 
aggregate concentration, it was found to be not suitable for the production of NRs. The low solubility 
might be explained similar to A14B25A14, with the twist that the higher length results in a greater 
crystallinity (presumably stacked membranes) and hence lower solubility.[21] 
 
III Preparation of nano-reactors 
108 
 
Fig. 29: TEM image of vesicles produced via film rehydration (sample 10x diluted) 
 
 
3.2.6 A7B67A7 
 
From a point of hydrophilic ratio, it is similar to A4B22A4, A6B44A6 and A8B49A8, however it is even longer 
and has a somewhat lower hydrophilic content (17% vs 20-27%). It could be therefore expected to be 
poorly water soluble and rehydrate more slowly. Similar to A14B25A14, it became less soluble with film 
rehydration. In this case even after several days under vigorous stirring no noticeable opaqueness was 
reached (TEM indicates micelles and worms, but the film rehydration was not reproducible), whereas 
detergent removal (3% OG)23 produced some aggregates. The fact that extrusion did not change the 
size characteristics in DLS suggests that all structures and aggregates are significantly smaller than the 
pores of the extrusion membrane (200nm). Adding 1% POPS or TDOC to the ABCPs prior detergent 
removal reduced the samples ability to scatter light by a factor of 400. The idea of this additive was to 
add charge in order to facilitate self-assembly, but apparently due to the different chemical nature 
than liposomes, it had the opposite effect. While POPS did not affect the structural parameters (100nm 
diameter PDI of 0.3), TDOC reduced the size (36nm) and increased the PDI (1). In summary: A7B67A7 
was found utterly unsuited for further experiments. 
  
                                                          
23 All dissolved in 1% OG/PBS pH=7.4. OG removed via dialysis over 3 days using 10kDa MWCO tubes 
and 5x1L PBS. 
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3.2.7 A17B65A17 
 
This ABCP was also difficult to rehydrate from films and took often longer than 1 day. According to 
TEM it has the tendency to form multilamellar vesicles. Due to the low opaqueness of the samples and 
the slow rehydration speed detergent removal and addition of charged groups was tested as well (Fig. 
30 along with A7B67A7).24 As in the case with most ABCPs, detergent removal resulted in a tendency 
towards micelles and small vesicles. This experiment was the only instance where DLS and TEM 
differed significantly. The latter reveals that the number of small particles is much higher and the 
vesicles are even smaller. Moreover, in case of the film rehydration no reason for 600nm particles 
could be seen in TEM. However, extrusion through 200nm membranes reduced the particles diameter 
to 100nm (reducing also the PDI from 0.6 to 0.3). The fact that no vesicles of 200nm were found 
indicates that the larger structures must have been aggregates, as it is unlikely, that the ABCP would 
only form stable vesicles with a diameter above 200nm and below 100nm. As in case of A7B67A7 the 
charged additives (Fig. 31) increased the polydispersity further (film rehydration 0.3; DR. 0.2; 1% POPS 
0.3; 1% TDOC 0.6). Moreover, the number of smaller particles increased (film rehydration 0%; DR 19%; 
1% POPS 23%; 1% TDOC 39%). 
 
 
Fig. 30: left: Film rehydration without extrusion, right: detergent removal after extrusion 
 
                                                          
24 All dissolved in 1% OG/PBS pH=7.4. OG removed via dialysis over 3 days using 10kDa MWCO tubes 
and 5x1L PBS.  
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Fig. 31: detergent removal in presence of 1% POPS and (1% TDOC, right) both extruded through 
200nm membranes 
 
 
3.2.8 A16B72A16 
 
While this ABCP is superficially very similar to A17B65A17 it proved to be very different in its properties. 
It rehydrates much more readily than the other ABCP and forms very small vesicles and many micelles, 
so that it is often hard to distinguish between micelles and vesicles (Fig. 32). These factors result in a 
low encapsulation efficiency of e.g. sulforhodamine B. Furthermore, extrusion appears to reduce the 
number of vesicles and the encapsulation efficiency further. On the other hand, samples were stable 
towards concentration steps via filtration through 10kDa amicon at 6000rpm. This is something most 
liposomes are unable to withstand. However, it was found that dyes like Dylight488 rendered these 
polymersomes temperature sensitive. In FCS, the diffusion times decreased and the vesicle fraction 
decreased over time, very similar to sonication of polymersomes. 
 
 
Fig. 32: TEM of vesicles produced via film rehydration. 
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3.3 Discussion Vesicle-formation 
 
While liposomes are easily formed, they show a lack of stability at elevated temperatures and 
prolonged storage time. Some even deteriorated at room temperature during the time required for 
purification or measurement. Polymersomes are far more stable, but also far more challenging to work 
with. Films of ABCPs often dissolve only slowly due to the large hydrophobic surfaces and the stronger 
hydrophobic interactions between the ABCPs in the film results in longer rehydration times and often 
undissolved residues. The latter can also be caused by Factors such as the thickness of the film (and 
thus the concentration of ABCP in ethanol,[22] rate of ethanol removal, the shape of the vial and its 
rotation-speed) and the moisture of the film play thus a much larger role.[23] Too moist films rehydrated 
too fast resulting in more micelles, whereas completely dry films did not rehydrate at all. Sonicating 
the films in hope of initiating rehydration of poorly soluble polymer films usually resulted in very 
heterogenous self-assemblies, since it damages in particular larger vesicles or patches of membranes 
leaving micelles and worms behind. 
Another important set of parameters is the rehydration of the film. A film may be redissolved by 
rotating the vial, shaking the vial or putting a stirring bar inside. The harsher the rehydration procedure 
is, the faster it takes place potentially resulting in undesired structures,[24] as it was the case with 
sonication. For the ABCPs used, shaking or stirring proved to be adequate. However, even the size and 
the shape of the stirring bar appeared to matter. In particular ABCPs with long, hydrophobic B-blocks 
(PDMS) appear to be sensitive to oxygen stirred into the solution by a too large stirring bar or too high 
rotation speed. While it had no discernible impact on the polymersomes used in the main experiments, 
it proves once more how strongly the process and outcome of film-rehydration depends on the lengths 
of the amphiphiles. 
Unfortunately, even if the vesicle-formation process has been optimised and proven reliable, a new 
batch of the same ABCP (as observed with A6B44A6), or the same being aged (A14B25A14) can produce 
completely different structures or prevent MPs being inserted. One possible explanation is that the 
PDI of the ABCP may vary with each batch, but also the amount of AB in ABA, or the content of 
unreacted PDMS.[22a, 25] Similarly, aging could break up ABA in AB+A, or separate the blocks completely 
or alter them through oxidation. Oxazolines are furthermore known to irreversibly crystallise and 
become thus insoluble.[21] 
To complicate things further, polymersomes behave very differently from liposomes and even 
polymersomes can be very different from each other. This becomes most evident when attempting to 
insert MPs. A problem related to it, is the fact that polymersomes are more sensitive to detergents 
and some organic solvents (for reasons discussed at the end of the chapter).[22a, 25] Once a polymersome 
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is damaged, it appears that the chances of healing itself as liposomes are small, at least on the observed 
timescale. 
Even optimized vesicle-formation procedures failed at times to inconspicuous deviations. This included 
experimental errors as minute as traces of ethanol from washing the glass wear or detergent-residues 
from the washing machine. The latter could even be below the critical micelle concentration, thus not 
visible through foaming. It seems that small contaminations affect both vesicle-formation and vesicle-
stability. Another easily overlooked factor is that the time of introduction of these contamination 
matters as well. For instance, even 0.025% OG caused the prevalence of micelles during vesicle-
formation in case of A8B49A8, whereas already formed polymersomes persevered in presence of the 
same concentration of OG. Complicating it further, the contamination might not destroy or change the 
vesicles immediately but reduce their thermal stability, thus a tested detergent concentration 
appeared to have no impact, but after one-day half of the vesicles become micelles. Ironically, very 
low concentrations of detergents may help with film-rehydration, since detergents can break up dried 
films and overcome the hydrophobic barrier and also prevent aggregate formation due to charge 
repulsion. However, in most cases compounds like TDOC or POPS which help liposome formation and 
liposome stability, often proof detrimental to polymersomes, probably due to the mismatching lengths 
of hydrophobic sections and possibly weakening of polymersomes due to formation of unstable 
domains. This could be not just a matter of ABA-detergent distribution within a membrane, but also 
stabilisation of ABA in solution through detergent micelles, but also it could be that detergents induce 
a separation of AB in ABA. This could explain why some previous publications imply a much higher 
stability of similar polymersomes towards detergents. 
 
 
3.4 Insertion methods 
 
MPs are usually inserted either by adding it during vesicle-formation[26] (removing or diluting the 
stabilising detergent so that the MP has to interact with the membrane forming amphiphiles) or by 
weakening preformed vesicles and adding the MP in the hope that most inserts within the vesicle-
membrane before it precipitates out of solution. In the first approach, the vesicle-formation may be 
hindered or impeded by the involved detergents, whereas in the second approach, the vesicles have 
to be damaged for the insertion to work. This could be achieved by addition of detergents,[26] 
sonication,[26a, 26b] or freeze-thawing.[26a, 26b] All of these approaches are very harsh to polymersomes 
and can result in vesicles turning into micelles rather than repairing themselves. 
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Fortunately, OmpF is a special case among MPs. It is both exceptionally stable towards denaturating 
conditions (temperature,[1a] pH,[1b] detergents,[1a] urea,[27] solvents[28]…) and moreover able to refold 
itself without chaperones. It can thus be dried or dissolved in organic solvents such as ethanol enabling 
other approaches to MP-insertion (just not direct addition as gramicidin etc. since it is too big and 
would thus need to displace too many amphiphiles within the membrane). 
In older publications, [19] describing no longer available ABCPs, had very peculiar methods of vesicle-
formation and protein insertion. For instance, A12B55A12 was rehydrated by simply adding buffer to the 
ABCP and stirring it overnight. The involved proteins were added before the rest of the buffer and 
slowly diluted by the latter.[19] Unfortunately, this could not be reproduced with any available ABCP, 
as direct dissolution resulted in ill-defined structures (in particular micelles and worms), even in 
absence of OmpF and detergents. This method might work for liposomes and very few ABCPs. OmpF 
moreover does not belong to the ion channels that are able to insert themselves into preformed vesicle 
membranes, as e.g. gramicidine would. If OmpF is added to a vesicle solution it will simply precipitate 
due to the dilution of the stabilising detergent. 
In general, the efficiency and homogeneity of the vesicle formation and OmpF insertion depend on 
numerous factors (concentration, pH, temperature, presence of ions, surfactants, solvents…).[22, 25] OG 
was however necessary to prevent aggregation of OmpF (3% OG was used for extraction of OmpF and 
long-term storage, whereas 0.5% proved to be sufficient for short term storage).  
 
 
3.4.1 Vesicle-formation through film-rehydration 
 
The first idea to solve said problems was to use film-rehydration and soak the OmpF solution into the 
film prior rehydration with the buffer. That way OmpF could be stabilised through the ABCPs, 
increasing the chance of it being incorporated into vesicles. However, the small amount of stabilising 
detergents, added at this stage, did disturb vesicle-formation, in particular in case of polymersomes 
(Fig. 27). 
Experiments encapsulating FCS dyes (elaborated in chapter release experiments) did not reveal any 
significant difference between vesicles without OmpF and those allegedly with OmpF. These results 
were reproducible for various liposomes and polymersomes. However, it was noted, that in case of 
liposomes the vesicles had a tendency to be 10-20% smaller than those with OmpF. In terms of 
membrane permeability, most experiments were a failure. Only in case of experiments encapsulating 
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HRP in liposomes, occasionally vesicles with OmpF appeared to have a higher activity than those 
without. 
Due to these results, this method was abandoned in favour of more promising approaches, but 
eventually it was revisited with an important twist: The stabilising detergent of OmpF was removed 
and the solution was added directly to the ethanolic polymer solution before the film was dried. This 
method became viable, as it was observed that OmpF does not precipitate immediately, but within 
hours and due to the fact that OmpF is known[1a] to resist several solvents unlike most other proteins. 
These would denaturate irreversibly, thus requiring a less efficient, but milder method.[25a, 29] This 
variation removed not just the disruptive detergent, but allowed a more homogeneous mixture of 
OmpF and the ABCPs. It turned out to be the most reliable method for inserting OmpF in a variety of 
ABCPs. 
It was also observed that A8B49A8 and A6B44A6 inserted OmpF and A6B42A6 did not, despite its similar 
composition. This indicates that there might be other factors influencing the ability to insert membrane 
proteins, e.g. the content of PDMS without hydrophilic groups, or the content of AB in ABA, or simply 
the PDI of the ABCP. 
 
 
3.4.2 Detergent removal 
 
Since detergents are interfering with the process of vesicle-formation, their removal was the next 
logical step. Since they are initially required for the stability of OmpF in solution, three options are 
available: 
1) Reducing the detergent concentration to the bare minimum (approximately the cmc, 0.5wt% 
in case of OG), adding the OmpF to the ABCPs and further reducing the detergent 
concentration during the vesicle-formation 
2) Dissolving the ABCPs in a detergent solution and forming the vesicles through detergent 
removal. 
3) Producing the vesicles beforehand and adding the OmpF solution with enough detergent to 
destabilise the vesicle membranes so that OmpF can insert, but not enough to completely 
destroy the vesicles. Then the detergent has to be removed to stabilise the vesicles again. 
For all three variants two parameters have to be controlled: first the selected detergent, and second 
the method of the detergent removal. The choice of the detergent can have a huge effect on the 
interactions with the vesicles and proteins. This in combination with the individual cmc determines the 
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effective concentrations at which the MP remains stabilised in solution and the concentration at which 
the vesicles become weakened or destroyed. 
In general, there are several methods, how the detergent may be removed: it could be dialysed off, 
removed through size exclusion chromatography (mainly separating vesicles from micelles) or be 
removed through addition of adsorbents. While size exclusion chromatography would be the fastest 
method, the use of adsorbents is far more efficient at removing remaining detergents. It allows the 
use of detergents that would take forever to be removed through dialysis or size exclusion 
chromatography due to their low cmc, such as TrtX.[26a, 26b] It has moreover the advantage that the 
detergent removal rate can be precisely controlled through the number of additions and amount of 
adsorbent added and by controlling the temperature.  
 
The first two methods would be relatively straightforward. 2) would have the disadvantage that more 
detergent is used and has to be removed. 1) still hindered vesicle-formation resulting in more micelles 
and smaller vesicles but being considerably more effective than without detergent removal. The 
method had a poor overall reproducibility. It was moreover observed that an incomplete detergent 
removal produced vesicles slowly deteriorated into micelles. 2) was apparently the worst possible 
choice for ABCPs resulting in micelles only, but it was a very efficient method for insertion of OmpF 
into liposomes. The notable exception hereto were lipid mixtures with cholesterol, which resulted in 
demixing during detergent removal (see chapter on DSPC above). Comparing method 1) and 2) lipids 
and ABCPs indicates that they are mechanistically very different. 
Method 3) has the most parameters to optimise since the concentration and choice of detergent are 
far more important, since it is a delicate balance between weakening of pre-existent membranes just 
enough to be able to insert MP while at the same time keeping the concentration of detergent low 
enough that the MP becomes unstable in solution so that it can be inserted. Despite all these 
complications, it is well established for inserting various MPs into liposomes. It has also successfully 
been used for polymersomes using 0.5wt% TrtX, sonication and biobeads.[18] However, the known 
sensitivity of polymersomes towards detergents and the possibility of mechanistical differences 
reduces further the appeal of this method. Indeed, it was hard to insert MPs into polymersomes and 
it became apparent that the vesicles do recover much less from damage caused from sonication or 
detergent addition than liposomes did, resulting in very small particles/micelles and releasing 
whatever was encapsulated within the vesicles. 
An interesting finding was that OmpF could reproducibly be inserted in liposomes formed via detergent 
removal until a new batch of OmpF was produced (the old batch still worked, thus it has to be assumed 
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that it was related to the new batch). The new batch could be inserted in polymersomes, applying a 
different method (adding OmpF once the detergent was removed prior to the addition to the ethanolic 
polymer-solution). The difference between both batches was that OmpF was extracted in the prior 
using Octyl-POE and the latter using OG, since OG provided a higher yield. OG is however known to be 
a harsher detergent, which can denaturate some proteins and destroy vesicles more easily. It can be 
assumed that the change in the extraction procedure changed the ternary mixture, the bacterial lipids 
that surround OmpF and can be co-extracted.[26c] OG had the advantage that its concentration could 
be measured with the Möllisch assay, which allowed to reveal how much detergent was accidentally 
dragged along. It was also easier to remove the detergent. 
 
 
3.4.3 Detergent titration 
 
In case of MP insertion through detergent addition and removal on preformed vesicles, there is a way 
of estimating the required detergent concentration. Vesicles can be titrated with detergent and the 
scattering can be measured over time using a fluorimeter. The scattering is manly dependent on the 
number of vesicles, but increases slightly probably due to the swelling of vesicles.[26b, 26c] When vesicles 
become destroyed, the scattering intensity drops rapidly. Once the concentration is known at which 
vesicles start to disintegrate, it can be tested if MP inserts at said concentration in vesicles (and not in 
newly formed micelles) and whether enough vesicles survive the process. If the detergent 
concentration was too high, it is decreased e.g. by half, zeroing in within a few attempts the working 
concentration at which the vesicles are still stable, but the membrane able to accept MPs, can be 
found. This pre-experiment has however two minor flaws, that have to be considered. First and 
foremost, the interaction between vesicles and detergents may take some time. It was noticed for 
polymersomes, that the determined tolerable concentration after 2h of incubation, destroyed all 
vesicles overnight. Secondly, changing for example the vesicle concentration (which may happen 
accidently during the vesicle-formation or purification) changes the required detergent concentration, 
since the concentration of detergent micelles in solution drops considerably due to insertion of 
detergent molecules within vesicle membranes. 
In the following graphs two ABA with different length (3 A6B44A6 and 7 A17B65A17)25 are compared with 
each other and with liposomes (natural phosphatidylcholine with 10% cholesterol). The vesicles were 
                                                          
25 These experiments are actually not related to the OmpF project, but to the SGLT-project. The insertion of 
OmpF does not require the detergent addition and removal method, but SGLT is too sensitive to be treated the 
same. For the OmpF related experiments A6B44A6 proved to be the best, but since its supplies became low, 
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stirred in presence of the respective amount of detergent over night at 4°C. The following detergents 
were considered: 
 
Table 11.: various detergents and their critical micelle forming concentration 
Detergent cmc [mM] Mw [g/mol] cmc [wt%] Description 
DDM 0.15 510.62 0.01% Alkyl-Sugar 
TritonX-100 0.24 625 0.02% 
Aromatic-
PEG 
DM 1.6 482.56 0.08% Alkyl-Sugar 
TDOC 2 521.69 0.10% Chol-SO3- 
CHAPS 3 614.88 0.18% Chol-SO3- 
OPOE 6.6 245.38 0.16% Alkyl-PEG 
OG 20 292.37 0.59% Alkyl-Sugar 
 
Titrating liposomes with DM produces a negative parabolic correlation (Fig. 33). Since for the 
polymersomes lower detergent concentrations had to be evaluated, all following titration curves are 
half-logarithmic. Thus, the same graph is displayed twice for better comparison. Even then it can be 
clearly seen that the scattering increases initially with the detergent concentration. 
 
Fig. 33: Titration of POPC/POPS/cholesterol-liposomes with DM. Left: linear scale; right: log10-scale. 
                                                          
other ABCPs were investigated for this side project. This cancelled project is mentioned in this thesis, since it 
gives further insight in the stability and properties of various polymersomes. 
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Fig. 34: titration of polymersomes from a short ABCP 3 and a long ABCP 7. Note that DDM has only 
two CH2 groups more than DM. 
 
Fig. 34: titration of polymersomes from a short ABCP 3 and a long ABCP 7. Note: OG is only two CH2 
groups shorter than DM. 
 
Fig. 35: titration of polymersomes from a short ABCP 3 and a long ABCP 7. Note: OPOE has only a 
different head-group than OG. 
 
It becomes immediately clear that polymersomes behave differently than liposomes (Fig. 33) in that 
they are much more sensitive to detergents and that absorption does not initially increase (with the 
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notable exception of 7 titrated with DM or DDM) but rather decreases slowly. This indicates that the 
polymersomes do not swell but become unstable as soon as they interact with detergents.  
The second obvious result is that the titration curve depends much less on the cmc of the detergent 
(which only roughly correlates with the transition point) but on the chemical nature (Fig. 34, 35). Long 
chained alkyl-sugars and cholate derivatives show little effect and belong to the detergents that are 
known[26b, 26c] to mild detergents, that are non denaturating detergents when it comes to protein 
extraction and which are less harmful to liposomes. Short alkylsugars and short alkyl-PEG detergents 
are much harsher to the vesicles and result in sharp transitions. This difference is nicely demonstrated 
in the differences between OG, DM and DDM. One can even see a difference although they all differ 
by only two CH2 groups. Similarly, longer ABCPs appear to be more sensitive towards detergents as can 
be seen in the titration with the milder detergents. 
It appears that DM and DDM hardly affect the vesicles in the observed concentration range (0.0005-
3wt%). The scattering increases slightly along with the detergent concentration (with DM having a 
small maximum at 0.25%). The 3rd alkyl-sugar based detergent OG appears to be similar but the 
scattering drops sharp and low between 0.25 and 0.75%.  
The cholate based detergent TDOC has also only a weak trend but decreases the scattering gradually. 
It could be that the curve would drop drastically above 3%. Triton X100 has early a transition to low 
scattering between 0.01 and 0.5%. OPOE lies in between the before mentioned OG and TrtX, having a 
transition at 0.1 to 0.25%. Thus, all turning points with the possible exception of TDOC are around the 
cmc. This could be due to the fact that cholesterol based detergents do not form regular micelles.[26a] 
These results are noteworthy for two reasons. First, they indicate liposomes and polymersomes are 
mechanistically different, which manifests in a different stability but also in the fact that procedures 
regarding the insertion of MPs in liposomes cannot be translated to polymersomes. This is possibly 
due to the mismatch of the length of the hydrophobic block and the length of the alkylchain (thus only 
DDM might cause quelling of the vesicles). In the worst case, the pair of selected ABCP and detergent 
do not allow any insertion, but the detergent catalyses the destruction of the vesicles. Secondly the 
detergent which is used to stabilise OmpF in solution (OG or OPOE) are more destructive to the vesicles 
than TrtX which is traditionally used to destroy membranes. 
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Fig. 36: TEM images of the polymersomes produced via film rehydration from A17B65A17 (7). Left: 
0.25% OG added directly to the ABCP-film; right: the same amount of OG added after film 
rehydration. In both cases, the detergent was removed again via biobeads. 
 
As can be seen in Fig. 34 polymersomes of A17B65A17 (7) should be able to withstand up to 0.25% of OG. 
Yet, it became clear that the detergent was detrimental to vesicle-formation and the over-all stability 
and homogeneity of the vesicle-samples. At 0.25% of OG film rehydration did not start under normal 
conditions. Rehydrating the polymer-film at 4°C resulted in slow film rehydration, as indicated by the 
solution becoming slightly opaque. Only after addition of biobeads the turbidity increased significantly. 
The vesicles were half the size as in the absence of detergent. Further experiments imply that less 
denaturating detergents such as DM are a better choice and even there, the concentration should be 
25% below the maximal tolerated concentration. 
Adding the OG to preformed vesicles appeared to have no impact on the turbidity, nor on the average 
vesicle-size, but until the TEM-images were made, the samples had begun to clearly deteriorate. This 
process apparently continued after the removal of OG via biobeads indicating that even after multiple 
changes of biobeads, OG remained interacting with the ABCPs. Interestingly, the point of detergent 
addition determines the stability of the vesicles (see TEM Fig. 36). This indicates that OG can interact 
with ABCP in different ways and probably insert into membranes either homogeneously or in domains; 
the latter resulting in vesicle degradation. 
As noted earlier, liposomes became slightly larger in presence of OmpF. Since OmpF had no chance of 
displacing the ABCPs inside the membrane, but was added before its formation, it can be assumed that 
it has no direct influence on the vesicle-size. However, as a porin it has the ability to equilibrate osmotic 
pressure, which would otherwise compress vesicles and it has been observed especially in case of 
polymersomes and presence of detergents that OmpF might actually stabilise the membranes. The 
same was observed for SGLT1, a sodium-galactose symporter, which was used in a side-project: 
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Fig. 37: Size exclusion chromatography of A17B65A17 (7) polymersomes (encapsulating 100mM NaCl, 
0.05mM Galactose) in absence (left) and in presence (right) of SGLT1. 
 
In presence of 0.8% DM the size exclusion chromatography reveals that the vesicle peak measured by 
UV-absorption, developed a pronounced hunchback and even overlapped with a micelle-peak. Both 
disappear in presence of SGLT1 and the conductivity-measurement had a peak turning into a valley. 
The same could be observed for OmpF, but with the opposite sign: 
 
 
Fig. 38: Size exclusion chromatography of DSPC-mix liposomes encapsulating HRP in absence (left) 
and in presence (right) of OmpF. 
 
The reason for the change in conductivity remains unclear and was not further investigated but 
appears to be related to either the presence of micelles and or the amount of unencapsulated cargo. 
 
 
4 Conclusion 
4.1 OmpF-Mutants 
 
D12C, K89C, R270C, D12,K89C, D12,R270C and K89,R270C were successfully produced. Of these, all 
thiol groups were equally accessible, with the notable exception of D12C containing mutants, which 
were not even able to react with small compounds such as acrylodan. The rationale behind the 
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synthesis of the double mutants was to increase the probability that each pore contained at least one 
stimuli responsive group and ideally increasing the blockage by attaching two short stimuli responsive 
groups in place of a longer one. However, measurements via mass spectrometry indicate that this was 
not necessary to ensure labelling of every pore, moreover later kinetic measurements indicate that 
R270C-Gala3 and K89R270C-Gala3 OmpF-conjugates behave identically. 
 
 
4.2 Methods for measuring a DOL inside a pore 
 
Due to the low concentrations of the remaining thiol groups, common practice methods such as the 
Ellmans assay could not be used, moreover assays based on signal amplification cannot be applied to 
thiols that are partially hidden through pores. Thus, mass spectrometry has to be used to obtain 
reliable DOLs. However, this method is ill suited for quick reaction control purposes., thus a new assay 
had to be developed. While Thioglo-1 could be used for a qualitative prove of successful labelling, it 
was not particularly suited for quantification of DOL, regarding the background fluorescence and 
difficulty in sample purification. Furthermore, it proved to be highly sensitive to photobleaching even 
in rather dim ambient light. Acrylodan proved to be cheaper, smaller and more reliable. To the best of 
my knowledge, it is the first time acrylodan was reported to be used for quantification of thiol groups. 
Lastly, it should be noted that both methods cannot be compared directly, since they measure 
different types of DOL: mass spectrometry an individual DOL and acrylodan an overall DOL. 
 
 
4.3 ATRP based oligomers 
 
Little was published on the topic of short, but well-defined oligomers produced via radical 
polymerisation. Yet, during this PhD thesis it was shown that well defined oligomers of tert. butyl-
acrylic acid, in the range of 4-30 repeating units, could be synthesized through ATRP in moderate to 
good yields with PDIs ranging from 1.10 to 1.35. One procedure yielded a DP of 6-12 with a PDI of 1.3 
and another procedure a DP of 6-30 with a PDI of 1.1 (both up to 75% yield). In the prior case, the DP 
was controlled through the stoichiometry and in the latter case through reaction time. Those oligomers 
could behave very different from their respective polymers. Oligomers with less than ca. 20 repeating 
units were oils and could therefore not be precipitated and had an unexpected vapor pressure 
reducing effect. NIPAAM had no such issues, but the monomer proved to be hard to remove. 
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Oligo(vinyl-4-pyridine) was promising, but the pyridine-groups interferes with the ATRP and the 
oligomer is difficult to purify. 
The main problem with the oligomers seems to be caused by the initiator itself. Traces of presumably 
HBr degraded the initiator rapidly, impeded ATRP and slowly turned the oligomer insoluble in water. 
Since the bromine group could split off during storage, a nucleophilic substitution might be required, 
however at that point stimuli responsive peptides were already the point of focus. 
 
 
4.4 Stimuli responsive peptides 
 
Similar to oligomers, the required size creates several challenges. The stimuli response seen in larger 
peptide sequences will probably not exist under a certain number of sequence repeats (e.g. allowing 
stable helices). Moreover short, hydrophilic peptides are known to be difficult to purify and even more 
so peptides with many repeats of the same functional groups (having 1 or two carboxylic acids makes 
a far greater difference during purification than having 5 or 6). 
Another flaw in the design of stimuli responsive peptides is that they tend to be hydrophobic. The 
more hydrophobic they are at the conditions Michael additions are performed, the lower the success 
rate gets. 
Nonetheless, peptides were deemed the superior choice due to their tunability, their precise length 
and the absence of bromine. 
 
 
4.5 Determination of the DOL 
 
Oligo(acrylic acid) turned out to be particularly difficult to attach to OmpF. Due to its self-deactivation 
and high tendency to bind water, it was impossible to calculate the required concentrations. Due to 
the high number of charges, it can be assumed that labelling the same pore twice becomes unlikely. 
Moreover, it was found that the DOL decreases with increasing length of the oligo(acrylic acid). This 
effect was not observed with peptides which had similar lengths than the longer oligomers of 
oligo(acrylic acid). Furthermore, later kinetic experiments indicated that after reaching a certain length 
the pore becomes permanently blocked, without showing any stimuli responsiveness. The labelling 
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with peptides on the other hand worked well, as long as they remained sufficiently soluble (H6 only 
exception). 
 
 
4.6 Choice of the building material for Nanoreactors 
 
In principle, there is the choice between well-established liposomes and more stable and customisable 
polymersomes. However, experiments revealed that attributed characteristics depend on numerous 
factors and the transition between liposomes and polymersomes is more gradual. 
POPC has the highest willingness to form vesicles but is less stable (mechanically and thermally) than 
the DSPC-mix, which in turn is easier to make vesicles and less sensitive to detergents than ABCPs. 
Shorter ABCPs are closer to the DSPC-mix, whereas longer ABCPs represent the ideal polymersomes. 
With the length of the ABCP, the water solubility decreases, the mismatch to OmpF and detergents 
increases making OmpF harder to insert and causing the membranes to behave differently to 
detergents (and dyes, see chapter release experiments). Still, both liposomes and polymersomes tend 
to get smaller and become eventually micelles, when sufficient detergent concentrations are present. 
First POPC was used as the simplest solution. Due to the problem of HRP interaction and its removal 
in general, but also the desire for more stable samples a liposome mix (DSPC/POPS/cholesterol mix) 
was used that was optimised in these aspects. However, the OmpF insertion was too low. Thus, a 
different method was tried namely detergent removal using the already proven SM/POPS/cholesterol 
mix. The OmpF insertion was greatly improved as was the HRP removal via dialysis. Thus, much better 
kinetics were obtained. However, the liposomes used there were much less stable than the 
DSPC/POPS/cholesterol mix and seems to be also more permeable. 
Regarding ease of film rehydration, preference towards vesicles, the average vesicle size, the overall 
robustness and their likelihood of incorporating membrane proteins, the ABCPs can be sorted as 
follows: A4B22A4>A8B49A8>A6B44A6>A17B65A17/A16B72A16 (1>4>3>7>8). The rest was not worth further 
experiments (2 A14B25A14 might have worked previously, but its tendency to form vesicles is too low). 
It can be thus said that shorter ABCPs are preferable and that the hydrophilic ratio should be between 
20 and 30%. Interestingly, neither of these factors appears to determine the average vesicle size. Only 
few ABCPs allowed the formation of vesicles larger than 100nm in diameter. These included A4B22A4, 
A14B25A14 and A20B38A20 (1, 2 and 5). The length of the ABCPs had however some effect on the stability 
of the vesicles and the ease of their formation. The longer the ABCP the thicker the resulting membrane 
became, which in turn made the vesicles more stable, but more difficult to form (both slower 
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dissolution and reorganisation) and less stable towards detergents. Furthermore, thick membranes 
have to be considered less likely to insert membrane proteins. [18, 30] Interestingly, a higher hydrophilic 
ratio did not facilitate film-rehydration, but direct dissolution. This would indicate that these ABCPs 
can produce films that are easily dried too much so that they become poorly soluble (2 and 5). 
 
Table 12: list of polymers sorted first according to B then A; N= total monomer number hydrophilic 
ratio=2A/N 
No. Composition 
Hydro
philic 
ratio 
B/A N Structures 
OmpF 
Insertion 
Remarks 
1 A4B22A4 27% 5.5 30 vesicles yes  
2 A14B25A14 53% 1.8 53 
worms and 
micelles 
n.d. direct dissolution better 
3 A6B44A6 21% 7.3 56 vesicles yes similar to 4 
4 A8B49A8 25% 8.2 65 vesicles yes similar to 3 
5 A20B38A20 51% 1 78 
vesicles; micelles 
dominating 
n.d. 
Similar ratio to 2; similar 
results; less water soluble 
6 A7B67A7 17% 9.6 81 
worms and 
micelles 
n.d. similar in ratio to 3 and 4 
7 A17B65A17 34% 3.8 99 
many vesicles 
often 
multilamellar 
no similar to 8 
8 A16B72A16 31% 4.5 104 
small vesicles 
and micelles 
yes similar to 7 
 
As mentioned in the introduction, the formed structures can be predicted from the hydrophilic ratio. 
Thus, in Table 12, unfavourable ratios are marked red and favourable ratios green. Whenever, a ABCP 
formed decent vesicles, insertion of OmpF was tested (else it was n.d.: not determined). OmpF appears 
to insert independent of the length of the ABCP.  
 
Many factors are affecting the vesicle-formation experiments among them are nature of ABCP[23] and 
its block length ratio,[25a] the temperature during rehydration[22, 25b], the method of rehydration,[22b] the 
pH[22b] and the presence of additional ions.[22, 25b] 
When taking all these parameters into account it is possible to produce vesicles and even inserting 
MPs fairly reliably (ca. 95% chance for good vesicles and 75% chance of inserting the MP). To further 
improve the reliability, the samples have to be extruded with a membrane having pores close to the 
smallest naturally occurring vesicles to further homogenise their size. Additionally, bad batches have 
to be sorted out via light scattering and diluting the samples to the same vesicle concentration (using 
the samples ability to scatter light as indicator for vesicle density). 
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4.7 Insertion of OmpF 
 
OmpF is unable to force itself into membranes as the smaller channel proteins (or rather cell toxins) 
gramicidin, valinomycin etc. are. Like most MPs, OmpF has a significant hydrophobic surface, which 
makes it inherently unstable in water resulting in aggregation and precipitation. OmpF needs thus to 
be stabilised with a detergent. Detergents interact not just with the MP, but also with isolated 
amphiphiles and more importantly with membranes. This has been used to insert MPs in preformed 
vesicles, or to create proteo-liposomes via detergent removal. 
However, these interactions are very complex and sensitive. Two CH2-groups less, or a different 
headgroup can determine, whether vesicles or proteins are stable or become denaturated at a certain 
concentration. Detergents form micelles in solution, stabilise OmpF, isolated amphiphiles and insert 
into membranes. Thus, the final concentration in solution is hard to tell. To complicate things further, 
polymersomes are inherently more sensitive to detergents and appear to interact differently due to a 
larger mismatch between the hydrophobic groups of the ABCP and the detergent. Polymersomes 
appear to have less self-healing abilities and interact inherently different with detergents. It even 
makes a difference, if a detergent is added during film rehydration (impeding it), or after (damaging 
the vesicles and turning them slowly into micelles). Detergents are also practically impossible to 
remove completely, as they bind to membranes. 
On the other hand, MPs are apparently able to stabilise membranes. Their presence also affects the 
ratio of vesicles to micelles, the vesicle size and the encapsulation efficiency. Fortunately, the complex 
system can be avoided in case of OmpF, since it is able to refold itself after denaturation. Therefore, 
its stabilising detergent can be removed and it can be dissolved in organic solvents along with the 
ABCPs. Upon film rehydration, the ABCPs act as the detergent and stabilise the OmpF. 
In case of more sensitive MPs, mild detergents such as DM appear to be far better suited than OG, or 
TritonX (which have been used before as published by Graff et al[18]). Even then, one should stay at 
least 25% below the maximal tolerated detergent concentration. 
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The most straightforward way of testing the functionality of the OmpF conjugate, would be to insert it 
into a vesicle membrane and at the same time encapsulate a substance within the vesicles (Fig. 1). 
Then the presence of the substance within the vesicle has to be confirmed and the substance has to 
be released upon stimuli and detected outside the vesicle. This could be done with a fluorophore, 
where the diffusion time is observed in fluorescence correlation spectroscopy (FCS), or by measuring 
the fluorescence directly. The latter requiring encapsulation in self-quenching concentrations. There, 
the presence within the vesicles can only be tested indirectly, by the destruction of the vesicles. 
The difficult part is to prevent the premature release of the cargo; thus, the vesicles have to be formed 
under conditions where the pores are expected to be in their closed state. 
 
 
Fig. 1.: Scheme of vesicles containing a fluorescent dye in self-quenching concentrations, being 
released at pH 7.4 and becoming fluorescent due to dilution effect. 
 
Since vesicles without OmpF can release their cargo too, if the membrane is damaged, or the cargo 
lipophilic enough to diffuse through the membrane, a control without OmpF is required and since a 
complete release of cargo is unlikely, a second control with unmodified OmpF is required. These 
samples will be further labelled S, N and P: 
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S: sample featuring modified OmpF in the membranes 
N: negative control; without any OmpF 
P: positive control; a sample with unmodified OmpF inserted 
 
The abbreviation may be followed with the observed pH. These samples may also reveal various 
parameters affecting size, stability, of the vesicles. This will be discussed later in this and the following 
chapters. 
 
 
1 FCS release experiments 
 
FCS would allow to obtain more data from a single measurement than any other method. Asides from 
recording the diffusion of dye molecules through the membrane, it could give information about how 
much dye is encapsulated within the vesicles, how big or homogeneous the vesicles are and allows to 
compare the concentration of various samples. If the OmpF is labelled, it could also tell the number of 
OmpF pores per vesicle. 
 
 
1.1 Sulforhodamine B 
 
Sulforhodamine B is a relatively stable dye, whose fluorescence is not dependent on the pH from 3-
10.[1] It is one of the smallest and most affordable FCS dyes, but relatively sensitive to bleaching. 
However, it turned out, that attempting to encapsulate Sulforhodamine B into liposomes was very 
challenging since Sulforhodamine B strongly interacted with liposomes resulting mostly in micelles and 
small vesicles with calculated encapsulation efficiencies of up to 180 000%. Of 9 tested Sulforhodamine 
B concentrations only 2 formed POPC liposomes. There seems to be no correlation with the 
concentration since the cases where vesicles were found had mid- to high Sulforhodamine B 
concentrations (5µM and 1mM). 
It was thus tested, whether liposomes that feature additional charges and are furthermore PEGylated 
would perform better. The DSPC mixture, developed for its thermal stability meets these requirements 
and indeed features encapsulation efficiencies around 100% and being far more stable towards 
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Sulforhodamine B (yet the Rh decreased from 100nm to 55nm). Even in presence of 100µM 
Sulforhodamine B the vesicles proved to be stable over time, even at a pH of 1. It was thus used for 
further experiments eventually leading to encapsulating 100µM Sulforhodamine B in vesicles with 
D12,K89C-Gala3 OmpF,26 with two controls (one with unmodified OmpF, one without OmpF). The 
samples were measured in triplicates, then they were acidified and measured again 12h later. In the 
meantime, a kinetic was measured for the positive control at pH 7.4 and the D12CK89C-Gala3 sample 
was measured at pH 7.4 and 5.5. At the time, it was assumed that the OmpF pores would unblock, 
once the Gala3 OmpF transitioned from a random coil to a compact α-Helix, thus releasing the 
encapsulated dye in acidic conditions. 
 
Table 1.a: FCS data27 
 No OmpF (N) 
 
unmodified D12,K89C-
OmpF (P)  
D12,K89C-Gala3 OmpF 
(S) 
 pH=7.4 pH=5.5  pH=7.4 pH=5.5  pH=7.4 pH=5.5 
CR [kHz] 53.4 ±6.6 42.7 ±9.1  15 ±2.9
* 27.2 ±1.6  33.2 ±0.4 29.3 ±2.3 
CPM [kHz] 
310.1 
±25.6 
304.7 
±116.2  
133.5 ±22.1 56.6 ±9.0 
 
120.5 ±7.3 87.5 ±21.0 
F2 [%] 99.3 ±1.2 100 ±0  94.4 ±2.9 97.8 ±2.4  96.6 ±0.3 98.3 ±1.7 
τ2 [µs] 
4419.7 
±14.4 
3965.3 
±848.9  
4088.4 
±386.6 
3616.7 
±88.6  
4168.5± 
241.7 
4032.9 
±326.3 
Aggregates 
[] 
1.3 ±0.6 1.7 ±0.6 
 
1 ±1 1.3 ±1.2 
 
0 ±0 1 ±1.7 
Rh [nm] 60.6 ±2 54.3 ±11.6  56 ±5.3 49.6 ±1.3  57.1 ±3.3 55.3 ±4.5 
EE [%] 152 ±20** 239 ±177  90 ±30 51 ±4  73 ±13 59 ±21 
 
 
Table 1.b: relative change upon acidification 
  No OmpF (N) unmodified OmpF (P) D12,K89C-Gala3 (S) 
CR [kHz] 80% 182% 88% 
CPM [kHz] 98% 42% 73% 
F2 [%] 101% 104% 102% 
τ2 [µs] 90% 88% 97% 
Aggregates [] 125% 133% - 
Rh [nm] 90% 88% 97% 
EE [%] 157% 57% 81% 
  
                                                          
26 Note: this was the first attempt of a double mutant, but the D12C did not prove accessible, thus it was 
replaced by R270C followed by K89,R270C-OmpF. R270C was originally expressed as a milestone on the way to 
the double mutant and was kept for comparison. 
27 10x diluted samples; Neon-laser 543nm, 25% Output; 100nM free SRB gave a CR of 114.7 kHz, a CPM of 3.67 
kHz, a TF of 1.1% and a diffusion time of 43.2 µs 
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Measuring release with FCS (Table 1) yields records of many sample properties: 
The total count rate CR: the total fluorescence of the sample (vesicles and free dye) 
The counts per molecule CPM: the average fluorescence attributed to a particle of a certain diffusion 
speed such as free dye, dye in micelle, dye in vesicles (only the CPM of vesicles is listed in the table, as 
free dye was the only other significant species) 
The population of a fluorescent species F2: is percentage of the CPM in relation to the CR (fluorescence 
of enclosed Sulforhodamine B in relation to total fluorescence; F1 would be the fluorescence of free 
dye in relation to the total fluorescence). 
The diffusion speed τ2: the diffusion speed calculated by the machine from the fluctuations in 
fluorescence at the confocal volume (diffusion speed of vesicles; τ1 would be the diffusion speed of 
free dye). 
A typical FCS measurement consists of three sample drops measured in a row, each with 30 individual 
20s measurements (except for kinetic measurements; see materials and Methods for more details) 
that become averaged to one value as in the table above. The experimental error represents the 
deviation of the averages of each drop. However, the measurements tend to contain ca. 10% outliers, 
which are removed from the average by manual selection. These are called aggregates. They have 
diffusion speeds that match neither free dye nor vesicles (micelles, worms, but mostly aggregates of 
multiple vesicles). They are counted in the table as a secondary error. 
Furthermore, the hydrodynamic radius Rh: is calculated from the diffusion speed and ambient 
temperature and the encapsulation efficiency EE: is derived from the calculated Rh, the CPM and initial 
concentration of dye (number of dye molecules found in a vesicle divided by the expected number of 
dye molecules for the given volume). In table 1 red marks high errors and unusual values, whereas 
green marks expected changes. 
 
Regarding the CRs in Table 1.a one can see that the negative control contains far more Sulforhodamine 
B than the other samples. This extends to the encapsulated Sulforhodamine B, as the CPM indicate. 
CPM of the negative control is almost 3x higher than the other samples at pH 7.4. It also does not 
decrease unlike P5.5 and S5.5. As can be seen from Table 1.b, the positive control loses far more 
Sulforhodamine B than the actual sample. This could either mean that the sample containing modified 
OmpF is significantly less permeable, or regarding Table 1.a, that it stops releasing Sulforhodamine B 
after acidification as the CPM is at pH 7.4 significantly lower than the negative control but does not 
sink much further at pH 5.5. The latter indicates that the pores close at low pH, which implies that the 
stimuli-responsiveness is the opposite of the anticipated one. In that case, experiment should have 
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been prepared at low pH and then switched to pH 7.4. Experiments using enzyme kinetics support this 
theory (chapter enzyme kinetics, 4.2). 
The fact that the CR of the positive control increases (marked *), may be explained with significant 
portions of Sulforhodamine B being released and becoming more fluorescent due to a low 
concentration regime outside the vesicles resulting in less quenching. This does not apply for the actual 
sample, probably since far less Sulforhodamine B is released at low pH. Thus, most of the 
Sulforhodamine B released is removed via size exclusion, whereas P kept releasing Sulforhodamine B 
thereafter.  
Regarding the changes in CPM (Table 1b) it should be assumed that the percentage of Sulforhodamine 
B within the vesicles (F2) decreases proportionally, but this is unfortunately not the case, as individual 
Sulforhodamine B molecules are outshined by the vesicles by far and disappear in the background 
noise. The calculated encapsulation efficiency confirms that P releases more than S, however, in case 
of N, it increases (marked **) which is impossible, unless taking the shrinking of the vesicle into account. 
Especially not-permeabilised vesicles are exposed to the 50% increase of the Osmotic pressure. A 10% 
decrease in Rh results in 30% decrease in internal volume. Since the number of encapsulated 
Sulforhodamine B remained the same, the internal concentration and thus calculated encapsulation 
efficiency increases. For unknown reasons P was apparently shrinking to the same degree, but it lost 
at the same time Sulforhodamine B, thus overcompensating the shrinkage. 
 
 
Fig. 2: FCS kinetic on DSPC-mix liposomes28 left: development of the CPM over 3h; right: 
development of the free dye population over 3h.  
 
                                                          
28 3mg DSPC, 0.5 eq Cholesterol, 0.5 eq Chol-PEG600 and 0.1 eq POPS were dissolved in 1mL EtOH. The solvent 
was removed at 40C and 150mBar at 100rpm.The film was rehydrated in 1mL citrate buffer at pH=7.4 
containing 1mM SRB. 
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While it was expected that the stimuli response would manifest itself in a timescale of seconds to 
minutes, it was absolutely impossible to know for certain without testing it. Thus, not only samples 
were measured directly (in triplicates taking about 15min), but thereafter a kinetic was measured as 
well, observing changes of the sample for 3h. During that time, the CPM dropped from ca. 200 kHz to 
10kHz. This can be probably better attributed to photobleaching than further dye release, since even 
in the triplicates a decrease in CR and CPM was observed. Moreover, the sample volume decreased 
significantly in size due to evaporation due to the heat laser beam. 
Regarding the development of the fraction of Sulforhodamine B remaining within the vesicles F2, one 
would be tempted to conclude that S5.5 loses Sulforhodamine B, similar to P7.4, whereas S7.4 does 
not. However, as discussed earlier the dye fraction contained in vesicles (F2, Fig. 2) is a very poor 
indicator. The short-term development of the CPM actually contradicts the perceived stimuli-
responsiveness. However, under these circumstances N could reveal a higher Sulforhodamine B-
release rate than P, since P lost most of its Sulforhodamine B content prior size exclusion and lost even 
more Sulforhodamine B before the measurement finally started. Thus, N has much more 
Sulforhodamine B to lose at that point which may occur through trans-membrane diffusion, or vesicle 
disintegration, which are far slower processes than diffusion through OmpF pores. 
Initially, it was thought that WT-OmpF would make the vesicle membrane so permeable that 
Sulforhodamine B would be released before the sample was prepared for FCS. Sulforhodamine B is 
definitely small enough (559Da) to pass through the OmpF pore. However, due to its non-linear shape 
(see Fig. 3) it could be more difficult for it to pass through than some even heavier, but more linear 
molecules. In addition, it has four potentially charged groups and is zwitterionic at pH 7. This is a quite 
common trait of chromophores and in particular water-soluble chromophores. This however, is bound 
to bias the experiment. For one OmpF is known to be slightly cation-selective[2] and it can bind anionic 
and zwitterionic antibiotics within the pore, reducing its permeability.[3] This could explain, why OmpF 
did not release Sulforhodamine B as fast as anticipated and why acidification increased the 
permeability (giving Sulforhodamine B a positive net charge, or protonating carboxyl groups within the 
pore that initially interacted with Sulforhodamine B). Lastly, D12,K89C-Gala3 OmpF would constrict 
the pore and add additional negative charges that are likely to repel Sulforhodamine B. 
The kinetic (Fig. 2) might seem contradicting the triplicate measurements (Table 1) in that it shows 
that the OmpF conjugate S releases far more Sulforhodamine B than the positive control P. In fact, it 
shows that the OmpF conjugate becomes far more permeable at low pH. The positive control lies in 
between, but was only recorded for pH 7.4, thus it could be that it releases even more at low pH. In 
this case the conjugate would not be stimuli responsive but only a steric- or ionic hindrance. Thus, the 
pH dependent diffusion speed of the dye (due to different charge and thus solvation) is responsible for 
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the observed stimuli response, rather than changes at the OmpF-conjugate). It was not measured for 
the simple reason that it was impossible to create all three samples at the same time and do six kinetics 
at once.29 Measuring the samples consecutively over a day or more creates a potential systematic bias 
due to the dead time allowing unrecorded leakage. Splitting it in several batches would have had the 
disadvantage, that the measurements would not be comparable, since the sensitivity of the FCS 
changed in the course of several days changing the detected CR and CPM, but also the diffusion time 
(latter due to minor fluctuations of the room temperature). 
 
 
Fig. 3: The structure of Sulforhodamine B at pH 7. 
 
Since the positive control never released more than 70-80% of the Sulforhodamine B even after several 
days and even less so at pH 7.4, further experiments were conducted: three different types of vesicle 
samples had 1mM Sulforhodamine B added on the outside. Then after 30min of stirring the external 
dye was removed through size exclusion again. There are four possible scenarios: 
1) If there was no interaction between the vesicle and the Sulforhodamine B, then no dye should 
remain within, or bound to the vesicle.  
2) If the membrane is permeable to Sulforhodamine B, then some dye should be encapsulated 
leaking slowly out again.  
3) If it enters only through OmpF, but binds to it, then a low, persistent fluorescence could be 
anticipated.  
4) If the vesiclemembrane interacts with Sulforhodamine B however, then it should have a high 
and persistent fluorescence. 
  
                                                          
29 It would take over 26h: 18h for the kinetic; 2h for the other FCS experiments and ca. 6h for the SEC/sample 
preparation 
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To check these scenarios three samples were prepared: 
A:  Default DSPC/cholesterol/PEG mix corresponding to the negative control  
B:  The same type of vesicles as in A but made in the presence of detergent (0.15% OG, 
corresponding to 50µL 3% OG, as in case of the positive control) to check the influence of the 
detergent that would be introduced along with OmpF. It was expected to increase the 
permeability of the membrane.  
C:  The same as in A, but with OmpF inserted, corresponding to the positive control. 
 
Table 2: Interaction of Sulforhodamine B with empty vesicles (DSPC mix) 
 A: no 
additives 
B: 3% OG C: R270SH 
CR [kHz] 213 ±23.4 192 ±28.8 257 ±23.1 
CPM [kHz] 728 ±58.2 1050 ±231 929 ±148.6 
Ndye [] 197 ±47.3 284 ±99.4 251 ±57.7 
F2 [%] 97 ±4.9 99 ±3.0 100 ±2.0 
τ2 [µs] 6102 ±244 4508 ±316 5100 ±306 
Rh [nm] 86 ±10.3 63 ±5.0 72 ±5.0 
 
A brief look at Table 2, tells immediately that scenario 4) and not 1) applies. There is still a strong 
interaction between Sulforhodamine B and the liposomes, despite all the efforts to reduce said 
interaction. Due to this strong interaction, it can be also assumed that the membrane is permeable 
(scenario 2). Theoretically Sulforhodamine B could bind to the surface of the vesicles, but this seems 
to be unlikely firstly due to the fact that Sulforhodamine B is rather hydrophobic and secondly due to 
the negative charges from the POPS and the PEGylation. Even if the Sulforhodamine B is capable of 
permeating though the membrane, it would rather stay in it than going back into the aqueous phase. 
If it did accumulate in the internal cavity, then it could be assumed that sample C should have a lower 
CPM since it would leak out again due to the pores, which is however not the case. Due to this dye 
interaction, it cannot be said, whether OmpF binds Sulforhodamine B too (scenario 3). However, it is 
more than likely that the detergent softens up the membrane so that more Sulforhodamine B can 
interact with it, regarding the significantly higher number of dye molecules bound to B and C. Without 
repeating the experiment, it cannot be said, whether the difference in the CPM between B and C is 
significant. It could be that both also encapsulated some dye. In this case C released it again having the 
OmpF pores whereas B probably became less permeable after removing the external Sulforhodamine 
B through size exclusion due to partial removal of OG. This could explain why B binds more 
Sulforhodamine B than C, but it is highly speculative. Less speculative is the finding that the diameter 
of the vesicles decreases with the concentration of OG within the system. This observation was made 
over and over again with both liposomes and later polymersomes. Originally it was intended that B 
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and C have the same amount of OG, but the OmpF solution was more concentrated resulting in 22% 
less solution being used. Thus, B had a slightly higher OG concentration. This shift in diameter is 
probably a direct, indicator for the loss of stability in the membrane. 
While it was possible to create vesicles featuring OmpF that encapsulate Sulforhodamine B and are 
reasonably stable over time, the Sulforhodamine B still bound to the membrane and OG affected the 
vesicles size and the properties of the membrane. The experiments strongly indicate that the 
permeability of vesicles featuring OmpF is pH dependent and that the OmpF conjugate behaves 
differently. However, it did not prove any stimuli responsiveness of the OmpF conjugate.  
 
 
1.2 Testing other experimental set-ups for FCS-experiments 
 
Since the experimental set-up should work in polymersomes, which promise a higher long-term 
stability, it was tested to encapsulate 100µM Sulforhodamine B into polymersomes and it was found 
that A4B22A4 and A16B72A16 behaved completely different. In the presence of Sulforhodamine B, the 
shorter ABCP produced mainly micelles and small vesicles (Rh 25-50nm instead of 100nm) and 
encapsulation efficiency was calculated to 2600% (indicating absorption of dye from solution into the 
vesicle membrane/into the core of micelles) whereas the longer ABCP did not change its structure due 
to the presence of Sulforhodamine B and encapsulated only 2-3 dye molecules per vesicle (1% ee). In 
the latter case, the initial concentration of Sulforhodamine B could be varied from 10nM to 1mM 
without improving the encapsulation efficiency. 
Since many FCS experiments had the problem that the encapsulation efficiency was low and the 
background fluorescence of free dye relatively high, so that it could overload the detector. Using 
dialysis instead of size exclusion would take too long. Also, measuring the dye increase on the other 
side of the dialysis membrane was not feasible, due to the low concentration and diffusion across the 
dialysis membrane. A more practical approach would be to cause the vesicles to sediment and wash 
of the free dye. It was thus tested to make liposomes to precipitate by encapsulating 150mM sucrose 
but unlike giant vesicles no sedimentation could be observed, although the diffusion time increased 
by 50% (ca. 6000µs). It can be assumed that it works only with giant vesicles, due to emulsion effect. 
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1.3 Other dyes 
 
Due to the low encapsulation efficiency, apparent interaction with the membrane and due to the 
rather high photobleaching, other dies were tried. The fluorophore needs to be water-soluble, 
preferably as hydrophilic as possible in order to avoid membrane interactions. It needs to be pH stable, 
photostable and excitation must be around 405, 488, 545, or 633nm due to the lasers built into the 
FCS. Lastly, the dye has to fit through the OmpF pore and should be hence smaller than 550 Da. 
However, the molecular size is rather large in order to fit in the chromophore (unless it works as a 
complex, radical, or ion). The requirement for pH-stability also increases the shift towards more 
hydrophobic structures. Both Carboxyfluorescein and Oregon Green could be used, but are pH 
sensitive (Figure 4): 
 
Fig. 4: pH-dependency of the fluorescence according to the supplier[4]  
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Fig. 5: 1: Carboxyfluorescein (M=376,32 Da; excitation: 492nm); 2: Oregon green 488 (M=509.38 Da; 
excitation: 488nm); 3: Alexa 488 MI (M=720.66 Da; excitation 493nm; assumed structure); 4 Dylight 
488 MI (M= ca. 800 Da; excitation: 493nm; structure secret, but presumably as shown with an anchor 
group at R2); 5 Glutathion (used to deactivate reactive fluorescent probes and make them more 
water soluble) 
 
Dylight488 and Alexa488 are the most popular used fluorophores (Fig. 5), as they are known as very 
photo- and pH stable and for their brightness. In a fluorimeter 2µM of Dylight488 achieved the same 
fluorescence intensity as 20µM Sulforhodamine B. Alexa488 was 4x as bright as Sulforhodamine B. 
It was tried to encapsulate 50- and 300nM of Dylight488 in POPC-liposomes. In both cases micelles 
appeared to be dominant (only 7-11% vesicles) although the samples had the Tyndall effect and the 
micelle fraction should have been removed through size exclusion. Since the diffusion times and the 
vesicle fraction decreased over the course of the FCS measurements, it indicates that vesicles become 
micelles over time. This explains why size exclusion could not remove the vesicles. While liposomes 
apparently decomposed at room temperature over the course of 1h, A16B72A16 polymersomes were 
apparently stable, but even they changed during FCS measurements. This indicates that laser-beam 
heated the samples above room temperature thereby putting additional stress on the vesicle 
membranes. This is noteworthy, since this kind of polymersomes are temperature stable in absence of 
this dye. 
Assuming that this effect was due to the higher hydrophobicity of Dylight488 and Alexa488 in 
comparison to Sulforhodamine B, it was tried to make the fluorophore more hydrophobic by attaching 
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glutathione to the MI-functionalised variant of the dye (Fig. 5). The conjugation did not change the 
properties of Dylight, except the diffusion time, which increased from 33 to 49µs. Interestingly, 
liposomes filled with the Dylight488-glutathion conjugate did not perform any better; their population 
was actually even lower (1-2%) and the vesicles smaller (a diffusion time of 1000 instead of 3000µs). It 
could thus well be that the fluorophore could now act similar to a detergent. 
Alexa488 was very similar to Dylight488 in every aspect. Attempting to encapsulate 50nM Alexa488 
resulted in only 4-10% vesicles. Rather than observing the shifting diffusion time, a great variety of 
diffusion times was observed ranging from 700 to 3000µs indicating a very heterogeneous sample from 
the get go. 
Lastly, Oregon Green488 (Fig. 5) was tested for encapsulation within DSPC-mix liposomes and 
A16B72A16. It was a very bright and stable dye like the other two and had less effect on the vesicle 
stability, but the encapsulation efficiency was very poor (1.4%; ca. 1 molecule per vesicle; even less in 
case of the ABCPs) and it still changed the vesicle size (50nm instead of 100nm). 
 
Table 3: FCS measurement of DSPC-liposomes30 
  A B C 
CR [kHz] 9.4 ±0.66 5.5 ±2.15 57.8 ±7.61 
CPM [kHz] 242.6 ±38.3 260.07 ±112 12.64 ±0.89 
F2 [%] 100 ±0.0 100 ±0.0 9.7 ±8.56 
τ2 [µs] 4034.3 ±845 3136.9 ±2358 3104.7 ±1810 
Aggregates [] 7.7 ±0.47 14 ±0.82 0 ±0.0 
Rh [nm] 51.6 ±10.8 40.1 ±30.2 47.3 ±27.6 
Encap. eff. [%] 33.5 ±46.9 82.1 ±816 1.4 ±3.4 
Dilution [x] 100 0 100 
 
Sample A and B had 1mM Sulforhodamine B encapsulated. Sample B had Chol-PEG only added once 
the vesicle formation resulted in visible opaqueness, in the hope of inserting the Cholesterol with the 
PEG chains only facing outside. C had 1mM Oregon Green488 encapsulated. 
 
The experiment in Table 3 showed that adding Chol-PEG only after vesicle formation (B) resulted in 
different vesicles, which were far less stable towards Sulforhodamine B. The CPM decreased during 
the measurement of the triplicate from 412 to 146 kHz and the diffusion time decreased from 6446 to 
1127µs (not shown in table) indicating a shift from large vesicles to micelles. Moreover, the vesicle 
                                                          
30 Free dye: 100nM SRB CPM=39 kHz, CR=2.66 kHz, triplet fraction=1.5%, diffusion time=46.3 µs. 10nM OG488 
CPM=53.0 kHz, CR=10.78 kHz, triplet fraction=22.2 %, diffusion time=38.9 µs. Both cases: 25% laser output. 
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concentration had dropped after vesicle-formation and before the purification to such a degree that 
no sample dilution was required, whereas the other samples would cause a signal overload otherwise. 
The perceived high encapsulation efficiency is thus rather insertion of the dye into the vesicle 
membrane. Contrary to it, adding Chol-PEG directly (A), resulted in smaller, but far more stable 
vesicles, with no definite shift during the measurement. The same experiment, but with Oregon Green 
(C) resulted also in stable vesicles, but with a very broad size distribution and very low encapsulation 
efficiency. Concluding it can be said that only variant A was suited for release experiments, although 
not being ideal either. It demonstrates the impact of dyes on vesicles and Chol-PEG on the stability of 
vesicles and the repulsion of dyes. 
 
Concluding, it can be said that the encapsulation efficiency decreased from Sulforhodamine B over 
Alexa488 to Dylight488. Moreover, Alexa488 and even more so Dylight488 weakened the membrane 
of the liposomes, causing the vesicles to fall apart within 1h at low pH. The attachment of the 
hydrophilic glutathione did not improve the situation.31 Oregon Green 488 did not cause such 
problems, but the encapsulation efficiency was 20-50x lower than Sulforhodamine B at the same initial 
concentration. Another important aspect is that the size of the fluorophore increases in general from 
blue fluorescent to red-fluorescent dyes. Thus, only few are expected to be small enough to fit through 
the OmpF pore. Thus, FCS was considered to be not a valid option. 
 
 
2 Carboxyfluorescein release experiments 
 
Since, the FCS experiments turned out to be less promising, other methods were envisioned. Working 
with self-quenched dyes would be the most similar approach and it would be moreover very simple in 
its execution. While such measurements could suffer of the same problem of dye interacting with the 
vesicle membrane (especially regarding the high concentrations involved), several variations have 
been used successfully for similar applications involving liposomes. Ihle et al [5] used acridine orange 
to investigate pH dependent diffusion through OmpF mutants featuring six histidines within the 
constriction-site of the pore and Lin et al [6] used carboxyfluorescein to investigate the pH dependent 
                                                          
31 Fluorescent dyes with maleic imide groups were mixed as stock solutions with 1.5 eq. of glutathion 
and OG488 which was only available as activated ester was treated with 1.5. eq. of ethanolamine. In 
either case the solution was shook for 1h and then aliquoted. 
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diffusion of a membrane based on the Gala-peptide linked to fatty acids. Both dyes could be used in 
stopped-flow experiments, which would allow a more precise measurement of the diffusion speed, 
since the dead-time between mixing and measurement is fully under control.  
Acridine orange fluorescence is pH-dependent, but also dependent on the interaction with DNA or 
metal ions. Moreover, it could be that the positive charge of the dye results in it binding to the modified 
OmpF, thereby blocking it. Carboxyfluorescein (376,32 Da), is also pH dependent, but negatively 
charged and does not have DNA and ions as additional factors to consider. Furthermore, it can be used 
in FCS regarding its excitation and emission ranges. 
The concentration inside the vesicles was chosen to be so high, that the fluorescence is inhibited 
through self-quenching. When dye leaves the vesicle, it enters an environment of low concentration, 
thus enabling fluorescence. In the case, that concentration inside and outside the vesicle equilibrate, 
the concentration would be still below the self-quenching level. 
 
In order to obtain decent graphs displaying the fluorescence over time, the initial fluorescence I0 
stemming from leakage before the official start of the measurement has to be subtracted. To compare 
different samples, the fluorescence has to be put into relation with the maximal fluorescence Imax 
obtainable by the sample (eq. 1). This is measured by destroying all vesicles through addition of 10% 
TrtX. TrtX did not influence the fluorescence (which would be the case with e.g. acrylodan, or proteins). 
𝑅 =
𝐼−𝐼0
𝐼𝑚𝑎𝑥−𝐼0
 [%]      eq. 1 
 
However, there is one more factor that should be taken into account, which most papers apparently 
did not deal with: the pH-dependence of the sample. According to the supplier,[7] the turning point of 
the fluorescence lies midway between pH 7.4 and 5.5 (the two pH observed in the following 
experiments, but also in the two publications mentioned above). This means that while it was 
anticipated that at pH 5.5 the dye would be released manifesting in increased fluorescence, the pH will 
result in a sharp drop of the fluorescence, cancelling out the other effect. 
For the desired pH change from 7.4 to 5.5 the fluorescence drops to 25% (Table 4), which is in 
agreement with published data.[7] However, in several publications[6] it seems that no correction factor 
has been used. This was actually the reason for even considering carboxyfluorescein, but it turned out 
that the pH-dependence cannot be ignored.  
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Table 4: pH dependency of Carboxyfluorescein in citrate buffer measured via FCS:32 
pH 7.4 6.4 5.5 3.2 
CR [kHz] 83.3 53 21.1 3.5 
CPM [kHz] 2.57 1.47 0.62 0.08 
TF: 9.8 10.3 9.3 84.5 
τ1 [µs] 33.7 33.2 29.9 42 
 
FCS measurements confirmed the results from the fluorimeter. The count-rate drops dramatically with 
the pH (4x in the desired range and 20x from 7.4 to 3.2). At the same time, the counts per molecule 
decrease at the same rate. Furthermore, the experiments indicate that the photobleaching is 
acceptable for kinetics observe via Fluorimeter, but not for FCS. 
Another important, but related error source is the precision of the pH-adjustment. Using PBS as in the 
other publications allows even tiny changes in the acids volume create major changes in the final pH 
which in turn cause dramatic changes in the fluorescence. To counteract this error source citrate buffer 
was used instead of PBS, which does not have a sharp turning point in its titration curve as PBS has. 
 
 
Fig. 5: release kinetic of carboxyfluorescein filled liposomes, sample featuring R270C-Gala3 OmpF. 
 
                                                          
32 Note: the pH was adjusted from 1mL solutions by adding 0, 2.5, 5, 10µL conc. HCl respectively. 
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As seen in Figure 5, the negative control had the highest fluorescence, followed by the conjugate and 
by the positive control. With the exception of the positive control the fluorescence of the sample at 
pH 7.4 was higher. This might indicate that the correction factor of 4.0 was not high enough. 
Applying the equation 1 did not reveal any trend, moreover using the same Imax did not work, thus I 
used both the Imax for pH 7.4 and 5.5 (the prior was calculated by multiplying the Imax(pH 5.5) with 4, as 
the measurement resulted in a signal over-load. If the equation is only used for the endpoints33, then 
the dye release was clearly pH dependent, but not as expected (Table 5): 
 
Table 5: dye release calculated from the endpoints (average of two measurements) 
 
No OmpF 
(N) 
wt-OmpF 
(P) 
R270C-
Gala3 (S) 
pH 7.4 24.0% ±0.0 10.5% ±0.5 22.5% ±0.5 
pH 5.5 9.5% ±0.5 12.0% ±1.0 5.5% ±0.5 
 
It indicates that the positive control released independently of the pH, whereas the negative control 
leaked half as much at low pH and the conjugate even only ¼ as much. The fact that the negative 
control leaked more, could be explained through a combination of the dye weakening the membrane 
and osmotic pressure, but it appears to be most likely due to fact that the negative control still 
contained most of the encapsulated dye, whereas the other samples with OmpF lost a significant part 
during purification. This resulted in N releasing far more than S and P during the measurements. 
Instead of looking at the endpoint one can visualize it by rescaling every graph so that the release 
reaches 100%. This proofs that using the endpoint is dangerous (Figure 6):  
 
 
Fig. 6: rescaled graphs from Fig. 5, with all endpoints reaching 100 a.u. 
The low release of the positive control can be partially explained with the high statistic error of the 
positive control (which looked, for unknown reasons, as if the device switched for every second 
                                                          
33 The I0 was calculated from the average of the 4th to 9th data point; Imax at pH 5.5 was 1282 a.u. and the Imax at 
pH 7.4 was estimated to be 5131 a.u. 
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measurement point to the same sample but at a different pH). The reduced leakage in case of the 
negative control could be due to averaging effects. 
From Fig. 5. it was evident that the measurement had too much of a dead time and even the negative 
control leaked much too fast for this experiment. Hence, the experiment was repeated, reducing the 
dead-time between end of film rehydration and measurement as far as possible, making the 
purification ca. 3x faster:34 
 
Fig. 9: repetition of the experiment applying the changes discussed above.  
 
Unfortunately, the positive control was lost during purification. This measurement has much more of 
the initial slope preserved and shows clearly that the sample releases S7.4 more than the negative 
control N7.4 at pH 7.4 and that at pH 5.5 the difference is far smaller (although the starting point of 
S5.5 appears to be missing). At low pH, all samples become more permeable towards 
carboxyfluorescein. This has not been observed anywhere else and seems to be liposome specific. The 
liposomes themselves are able to withstand the lower pH. Moreover, the presence of 0.15% OG did 
not make any significant difference towards the permeability of the negative control. 
  
                                                          
34 The size exclusion column replaced with a minicolumn, which was moreover not relying on gravity, but on a 
constant pressure from a syringe. Instead of measuring all samples at once using a well plate, each sample was 
prepared and measured individually using a cuvette. Moreover, the SEC was set up next to the fluorimeter 
instead of its usual place in the neighbouring lab in order to save time. 
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It is also worth noting that all samples approach different saturation levels that are apparently 
independent of the encapsulated dye concentration (similar to later HRP-experiments, in the following 
chapter). Moreover, the measurement statistical error increased at low pH significantly. 
Photobleaching was no problem. However, at low pH full release would result in a signal overload. 
 
 
3 Conclusion 
 
In principle release experiments are the easiest experimental set-up, however, they proved borderline 
impossible to be used due to several experimental problems: 
- Most FCS stable dyes are too big to diffuse through OmpF 
- Fluorophores contained in vesicles outshine released fluorophores in FCS experiments 
- Most fluorophores had low encapsulation efficiencies, probably due to charge repulsion. 
Furthermore, increasing the fluorophore-concentration did not help, in most cases, it 
worsened the problem due to dye interactions with the membrane. 
- Most dyes and fluorophores are mostly hydrophobic, with the exception of one or two charged 
groups. They are thus able to interact with the hydrophobic segments of vesicles. Many dyes 
appear to prefer to go into the membrane rather than staying dissolved in water, even, if they 
are far from their theoretical solubility limit. These dye-membrane-interactions reduce also 
the encapsulation efficiency.  
- Dyes were found to act similar to detergents, hindering vesicle formation and destabilising 
vesicles by inserting themselves into the membrane. Moreover, the latter effect is also 
delayed, meaning that it can still occur after extrusion and size exclusion. Thus, a sample can 
consist primarily of micelles according to FCS although the micelle fraction had been removed 
prior the measurement. Unlike detergents, larger hydrophobic dyes turned out to be worse 
and polymersomes appear to be more robust towards their presence. This extends to DSPC-
mix liposomes being more resilient and long ABCPs being more resilient than shorter ones. 
Hence, it’s the very opposite of how vesicles behave to detergents. 
- Experiments with dye added to preformed vesicles, clearly show that even then, after the 
membrane formation, the dye is able to insert into the membrane and partially diffuse to the 
other side (but most staying within the membrane). 
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- The dyes ability to go into the membrane also enables them to diffuse through the membrane. 
Moreover, weakened membranes have to be assumed to be significantly more permeable and 
vesicles may also rupture releasing dye directly. 
 
All these problems make it hard to compare samples and the lack of stability decreases the 
dependability of release experiments. Thus, the experiments have a high statistical error. In addition, 
due to practical reasons, samples and controls have to be prepared in parallel and measured 
consecutively. This results in the first measurement being the most accurate and the last having the 
largest systematic error due to leakage and vesicle-changes during the dead-time until their 
measurement. 
Moreover, FCS measurements were plagued by an instable Argon laser, which needed 30-60min to 
warm up and run reliably. This could change the CPM of free dye from 2 to 10 and decrease the 
diffusion speed from 60 to 34 µs. Moreover, these values changed with the room temperature and 
apparently some other factors so that measurements under the same conditions were not 
comparable, if they were separated by a month in time or more. 
In case of FCS measurements only Sulforhodamine B and Oregon Green488 worked, but the latter 
suffering of a very low encapsulation efficiency. It appears that P releases more than S at 5.5, but the 
experiment would need to be repeated with film rehydration taking place at pH 5.5 in order to prove, 
that S releases more at pH 7.4 than at 5.5. Kinetic measurements made no sense, due to the fast 
release, unless it is to see the leakage through unmodified membranes or the overall stability of the 
vesicles. Due to the slow preparation N appeared to release most, since the other samples had not 
much left to release once the measurement started. 
Release experiments with carboxyfluorescein were similar. The experiments were extremely time 
sensitive. Only in very fast preparation it was possible to actually compare the release of N and P/S 
due to the starting point being easily missed. The experiment was easier comparatively speaking, but 
still very sensitive and the dye suffered of pH-dependency, diffusion through unmodified membranes 
and its poor solubility, which required it being encapsulated as a salt, thus reducing the internal pH of 
the vesicles. Especially Fig. 6 proves the risk of choosing the wrong value for normalisation. Still, 
experiments indicate again that S blocks at low pH whereas P keeps releasing irrespective of the pH.  
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As mentioned in the introduction, encapsulating enzymes and measuring enzyme kinetics would offer 
several advantages over plain release experiments. Theoretically one enzyme per vesicle would suffice; 
it could be stored and even reused. This makes varying the other experimental parameters significantly 
easier. However, enzymes introduce numerous new parameters that need to be controlled. 
The increase of fluorescence intensity nanoreactors (NRs, see Fig. 1) represents a direct measure for 
the transmembrane diffusion of the enzyme substrate. Its detection is as simple as measurement of 
release experiments using self-quenched fluorophores. It is moreover, not the reverse of a release 
experiment, since the produced dye is able to leave the vesicles as long as the reaction product remains 
soluble. 
The ideal enzyme should be very stable, active and water-soluble. It should be small and ideally not 
interact with itself, or with the vesicle-membrane. Charge repulsion would reduce the encapsulation 
efficiency, whereas aggregation of enzyme could disturb the enzyme kinetic and introduce a 
dependence on the local concentration that would be very hard to predict. Similarly, the enzymes 
stability and activity should be stable over a broad pH-range and not be influenced by the presence of 
detergents, lipids, etc. 
All these factors are only half of the requirements to meet. The other half depends on the enzyme 
substrate. Both enzyme and substrate need to be affordable/available and the substrate comes with 
its own set of requirements: The enzyme substrate, its co-substrate or product need to be quantifiable 
spectroscopically and stable. Again, the absorption or fluorescence are to be expected to be pH 
dependent and possibly depending on polarity of the environment etc. All these factors should have 
minimal impact on the experiment. The ideal enzyme substrate should be small, water soluble and 
stable. While undesirable, it was to be expected that no substrate was water-soluble and free of a net-
charge at the same time. Charged substrates, have to be expected to be pH dependent in their 
solubility and may be repelled by charges at the OmpF-pore, or even bind to the OmpF-conjugate and 
thereby block the pore. This also implies that even, if the experimental set-up appears to work, it might 
not be due to pH dependent conformation changes of the group attached to the OmpF pore, but due 
to substrate specific charge interactions (binding to the pore, being repulsed from the pore or peptide, 
or becoming more hydrophobic and thus going through the membrane directly), that cannot readily 
be extrapolated to other substrates. 
As with the release experiments described in the previous chapter, control experiments are necessary. 
For every fully functional NR with encapsulated enzyme and inserted OmpF-conjugate (NRC), a sample 
without OmpF (NR-) is required for establishing the baseline (background activity through damaged 
vesicles, free enzyme, or membrane permeability) and a sample with unmodified OmpF (NR+) is 
required to reveal the maximal possible response of the system. In several cases the influence of 
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detergent on the stability and permeability of the vesicle membranes was investigated as well. These 
samples are referred to as NRD 
 
 
Fig. 1.: Schematic representation of a bio-valve functioning by reversible pore opening and closing 
inside the membrane of nanocompartments to trigger an in situ reaction (left: closed state; right open 
state). Modified OmpF pore (violet; stimuli responsive group green) is inserted in the polymersome 
membrane that separates the encapsulated enzyme (HRP) from the environment. The in situ reaction 
is triggered by the bio-valve functionality, which allows the diffusion through the OmpF pores of the 
substrate Amplex Ultra Red (magenta spheres) and the subsequent release of the fluorescent products 
(yellow stars). 
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1 Horseradish peroxidase 
 
Horseradish peroxidase (HRP) is an affordable, comparatively stable enzyme, that is well established 
in enzymatic assays and functions over a rather broad pH range. It has thus an ample variety of 
substrates available. It is relatively small with 44kDa and well water soluble as a glycoprotein.[1] A 
further advantage is that it is not very specific and oxidises a great variety of substrates. It uses 
hydrogen peroxide as co-substrate. The heme-cofactor gives the enzyme a reddish-brown hue, 
allowing better measurement of enzyme concentration via absorbance (at 403nm[2]). It is stable from 
pH 5.0 to pH 9.0, but also known to be more active at pH 6.0 than pH 7.4.[3] Depending on the batch, 
HRP was 2-3x more active at pH 5.5 than 7.4. 
 
 
1.1 Potential substrates 
1.1.1 Amplex 
 
 
Fig. 2: conversion of amplex into the fluorophore resurufin. Please note that Amplex Ultra Red is an 
undisclosed derivative of Amplex Red. 
 
Amplex Ultra Red (Fig. 2) is one of the smallest available enzyme substrates (ca. 300 Da; 272 Da in its 
fluorescent form). HRP converts Ultra Amplex Red to a fluorophore (resorufin excitation 570nm, 
emission 585nm).[4] It is stable between pH 5-10[5] and the activity change is tolerable between pH 7.4 
and 5.5. However, when these claims were put to test, a different picture presented itself: 
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Fig. 3: Dependency of the fluorescence on pH and concentration.  
 
In order to determine the pH dependence of Amplex Ultra Red, 5mg/L HRP, 300µM H2O2 and 200nM 
Amplex Ultra Red were allowed to react. Then the pH was adjusted with a minimal amount of HCl and 
the fluorescence spectrum was measured at 570nm excitation. Since a part of the samples produced 
a signal overload, the samples were all diluted 5x and measured again. While according to the producer 
(Fig. 3) the turning point of the pH-dependent fluorescence was supposed to be around pH 4, it 
appeared to be around pH 6.5. Diluting the sample 5x shifted it further to pH 7.5. Since dilution should 
shift the pH towards basic conditions (ca. 0.5 pH-units) a higher fluorescence was to be expected. The 
fact that the opposite occurred indicated that the fluorescence of the undiluted sample was so high 
that the detector was incapable of quantifying it, thus it appeared only as a plateau, whereas in reality 
even beyond pH 7 the fluorescence was increasing. Thus, in the worst case, in a pH change from 7 to 
6, 80% of the fluorescence would be lost. Regarding the more diluted sample it appears that only 40% 
would be lost, but the fluorescence would be already well below its maximum. The exact experimental 
conditions from the producer were not given, but it can be assumed that they used far greater Amplex 
Ultra Red concentrations than those that are relevant for enzyme kinetics, as required for this thesis. 
The system HRP/Amplex produced numerous, unexpected problems, which will be discussed later 
(chapters 1.2.1, 1.2.2 and 3). Yet, after addressing all these issues, it provided one of the best systems 
available for testing the stimuli-responsiveness of the OmpF-conjugates. Investigation of the stimuli-
responsiveness will be addressed at the end of the enzymatic assays. 
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1.1.2 ABTS 
 
 
Fig. 4: ABTS oxidation to its diazo-benzothiazole form 
 
Due to the pH dependent fluorescence of Amplex Ultra Red, ABTS (2,2'-azino-bis(3-
ethylbenzothiazoline-6-sulphonic acid), Fig. 4) was tested as an alternative. The substrate is converted 
in a dye but not a fluorophore, hence the system is much less sensitive. While pH dependence, 
bleaching etc. are not a problem here, the substrate has to be added close to its solubility boundary 
(500µL 10mM ABTS compared to 40µL 5µM Amplex Ultra Red per 1mL cuvette). The reaction is much 
slower (1h observation time vs 5min) and despite the slow reaction saturation is reached much faster. 
In other words, to detect significant reaction, a large portion of the substrate has to be converted (Fig. 
5). Since the substrate is twice as big (514.62 g/mol), it can be expected to pass through OmpF much 
slower and it might be even more hindered in going through OmpF pores with attached peptides. 
 
 
Fig. 5: NRs containing HRP within DSPC-liposomes; left detection with Amplex ultra red; right with 
ABTS. Blank: buffer without HRP, or NRs; NR- vesicles without OmpF; NRC: D12K89C-Gala3 OmpF; 
NR+: D12K89C-SH OmpF. 
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This failed experiment (reasons why NR- had more activity than NR+ will be discussed in chapter 3) 
shows clearly the difference in reactivity and the problem of saturation. Originally, it was anticipated, 
that only NR+ would be the only sample reaching saturation, whereas NRC and NR- would show little 
conversion, until the samples are acidified, then NRC was expected to reach saturation too. However, 
in course of further experiments, it turned out that even samples produced under ideal conditions and 
using Amplex Ultra Red, there will be significant background activity (even for NR-). The individual 
samples activity is best measured in the initial slope and not in the signal-intensity a sample reaches in 
the end. Hence, the time until the saturation is reached is less relevant, unless multiple pH-changes 
are to be investigated.  
 
 
1.1.3 TMB 
 
Even after all apparent problems of the Amplex HRP polymersomes were fixed, NR- had still a visible 
activity, which could not be further reduced by any means. One plausible explanation hereto would be 
that the substrate Amplex Ultra red was hydrophobic enough to permeate the membrane causing the 
background activity. Similarly, the stimuli-responsiveness observed with Amplex and K89CR270C-
Gala3 could be attributed to charge repulsion instead of steric hindrance. Thus, a substrate with 
opposite charge (and different pH-dependence) could provide further insights. 
The only potential substrate available meeting the requirements was TMB (3,3’,5,5’-
tetramethylbenzidine, Fig. 6). It works like ABTS but is considerably smaller (240.3Da). Moreover, it 
was found that it is far more sensitive, reacts faster than ABTS and reaches saturation slower. Hence 
smaller amounts are required. The product absorbs depending on the protonation state either at 
650nm or 450nm (protonated).[6] Compared to Amplex, it requires still significantly more substrate 
(250µL undiluted TMB solution per 1mL compared to 40µL 5µM) and reaches saturation faster. It is 
moreover light sensitive, as it turns blue upon exposure to light.  
 
Fig. 6: Oxidation of TMB. 
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Fig. 7: Variation of the TMB content (96-well plate; 250µL total; 12.5µL DSPC-based nanoreactors; 
10µL 10mM H2O2); left absorption measured at 450nm; right measured at 650nm; N: NRs without 
OmpF; P: NRs with WT-OmpF 
 
There is a clear relation between concentration and sensitivity: The higher the TMB content is, the 
higher are the saturation limit and stability. However, above 25% of the total volume belonging to 
TMB solution the curves become less smooth (Fig. 7). 
At 650nm, the sensitivity (apparent saturation level) increases 3x. The reaction appears much faster 
(NR- 2x; NR+ 10x). Moreover, the curves drop again after saturation has been reached. This indicates 
that at pH 7.4 the protonated species prevails. However, the other species is produced and its 
detection is more sensitive. 
The working solution was tested on its own, since both the positive- and to a lesser extent the negative 
control became blue even before the addition of hydrogen peroxide. Fortunately, it does not interfere 
with the kinetic measurement. 
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Fig. 8: variation of the H2O2-concentration (96 well-plate; 250µL total; 62.5% TMB, 12.5µL NRs); left 
absorption measured at 450nm; right measured at 650nm; N: NRs without OmpF; P: NRs with WT-
OmpF 
 
The H2O2 concentration is apparently no rate limiting factor in the observed range from 250µM to 
10mM. A lower H2O2 concentration seems to make the saturated state more stable and slightly 
increases the difference between the positive and negative control by lowering the later (Fig. 8). Again, 
the reaction appears 2x as fast at 650nm; moreover, the signal is twice as strong. 
Changing form Amplex to TMB does not change the relative activity of samples (NR-, NRD, NR+). The 
activity of NR- was originally explained by Amplex permeating the vesicle membrane, but the fact that 
TMB gave a similar picture, make this theory dubious, although uncharged TMB might be even more 
hydrophobic. 
 
 
1.2.1 HRP separation 
 
The greatest challenge by far when working with HRP based systems turned out to be the suppression 
of the background activity. Initially, it was tried to remove HRP from vesicles, as fluorophores would 
be removed. Size exclusion works well for the latter, although dyes are known for their “stickiness”. 
However, it turned out that after the HRP fraction was eluted, even 5 more column volumes of elution 
buffer were not enough to clean the sepharose column. While the UV/conductivity-detectors did not 
reveal any contaminations, the eluted buffer had still a significant peroxidase activity (mixing a drop 
with a drop of TMB sufficed to prove it). Since the size exclusion is capable of separating micelles from 
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vesicles, the removal of HRP with an even larger discrepancy in size, should have been simple, but 
apparently HRP interacted both with the vesicles and the sepharose strongly. 
Since the HRP within vesicles should be protected from proteases, all undesirable HRP could in theory 
be deactivated through enzymatic digestion. Of the available proteinases, proteinase K was the most 
promising, diminishing the HRP activity by a factor of 1000 (regarding the slope measuring kinetics 
with Amplex). However, this method had some drawbacks: the digestion required 6-12h at 37°C, which 
restricted the choice of vesicles to those that withstand said conditions (DSPC-liposomes and most 
polymersomes). Moreover, it did not destroy the heme-cofactor, which precipitated, but was easily 
carried along due to resuspension. Thus, a second size exclusion was still necessary. For this purpose, 
a minicolumn sufficed. The first size exclusion was required to reduce the HRP-concentration to a level 
(<1µg/L), which the proteinase could deal with. Still, multiple additions of proteinase were required, 
due to cannibalism of the protease. 
Dialysis turned out to be the best solution. While it took at least 3 days with 5 buffer changes, it was a 
very mild method and required little labour. Sensitive liposomes, could be dialysed in the fridge at 4°C 
in order to minimize degradation and precipitation of vesicles. While even more HRP could be removed 
with a week of dialysis, increasing the dialysis time or number of buffer changes further did not reduce 
the background activity any further. This indicates that the model of residual activity due to free HRP 
is not entirely realistic. It could be thus either, that a part of the HRP can be found on the vesicle 
surface, or that the vesicles without OmpF are to some degree permeable either through the 
membrane itself or through defects. Lastly, it could be that some vesicles burst after the purification. 
Hence, the origin of the background activity was further investigated. 
 
 
1.2.2 HRP interactions 
1.2.2.1 Stability of nanoreactors over time 
 
While the activity of HRP containing samples did not decrease significantly over time, the activity of 
NR- increased indicating that the vesicles deteriorated (Fig. 9). This DSPC-mix did not reveal any signs 
of degradation in TEM or light scattering after treatment for 12h at 40°C or 3 months at RT. This could 
either imply that the membrane developed cracks without changing its overall structure, or that the 
vesicles completely disappear upon receiving damage so that only the remaining vesicles are visible. 
Since the latter would involve the formation of aggregates and precipitation and a significant decrease 
in vesicle concentration, the former appears more plausible. Moreover, the activity of NR+ did not 
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decrease as it would be the case, if vesicles precipitate, nor did the activity increase, as it could be 
assumed if the HRP was released and thus more accessible. 
 
Fig. 9: Change of activity of liposomes after storage for 6 days in the fridge.  
 
Polymersomes (Fig. 10) follow the same trend, albeit at a much slower pace: 
 
 
Fig. 10: Amplex Ultra Red conversion kinetics at pH 7.4. Stability of the HRP loaded polymersomes (NR-
, blue) and HRP loaded polymersomes equipped with OmpF-M (NR +, red) immediately (left) and after 
14 days (right). The left part is taken from the measurement displayed in Fig. 5 Appendix. 
 
While the activity of NR+ remains the same, NR- increases its activity due to damaged vesicles allowing 
access to HRP. This holds true for both lipo- and polymersomes. 
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1.2.2.2 Binding of HRP to membranes 
 
In order to investigate potential interactions of HRP with liposomes, the following samples were 
prepared: DSPC-liposomes without HRP, OmpF and detergent (NR-) and the same with additional 
detergent (NRD; 0.5% OG, simulating the insertion of OmpF) both had HRP added to the outside in the 
same concentration as it would have been used for the encapsulation of HRP during film-rehydration. 
A third sample consisted of HRP in buffer in absence of any vesicles (HRP). In each case a part of the 
sample was treated for 12h at 40°C, as it would have been the case, if HRP was digested with proteinase 
K. All samples were then dialysed in 100kDa tubes with 5x buffer changes over the course of three 
days. 
 
Fig. 11: Left: HRP kinetic using Amplex Ultra Red at room temperature at pH 7.4. Right: HRP kinetic at 
room temperature at pH 5.5.  
 
In absence of vesicles HRP was removed to the point where no activity could be detected (Fig. 11). 
However, all other samples had residual activity, albeit a low activity. The activity increased from 
vesicles in presence of OG to those without and increased independent of OG, when the vesicles had 
been exposed to heat. While it was anticipated that the presence of OG would make the vesicle 
membrane more fluid and prone to degradation and thus allow the release of HRP, the activity was 
lower. This could either imply that the vesicles were more stable than expected, or more likely that 
the vesicles released HRP, which was then removed through dialysis. In the latter case, HRP did 
probably not interact with the membrane. Heating the samples should have a similar effect in that 
vesicles release HRP, but then the released HRP should have been removed as well via dialysis, but the 
activity increased. This indicates that a different mechanism is involved here. Thus, it could be that the 
vesicle membrane became more permeable due to defects, or that HRP could bind to the membrane 
while its temperature dependent fluidity was temporarily increased. 
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According to the Zetasizer, the average diameter of the vesicles was 220nm, unless OG was present, 
in which case the diameter dropped to 161nm. However, it did not change the size distribution unlike 
exposure to heat did (polydispersity index going from 0.11 to 0.45; in case of OG only 0.21). All this 
indicates that the vesicles were less stable than anticipated. However, it seems that the presence of 
OG affected the vesicles so slowly, that it was not observed before. Most vesicles appeared to have 
survived the treatment with heat, but some aggregated and precipitated, thus removing themselves 
from size measurements, unless they resuspended.  
The increased activity at pH 5.5 has to be attributed to the pH-dependent activity of HRP itself and was 
anticipated, as it had been observed before and is well documented. However, the only exception here 
was the free HRP. Free HRP usually behaves the same but is also more sensitive to a variety of 
detrimental factors, such as a pH temporarily dropping below 5.5 due to non-instantaneous mixing. 
These two experiments indicate that Amplex can to some extent diffuse through vesicle membranes 
even in absence of OmpF. This applies both for liposomes and polymersomes. It was also tried to 
encapsulate Amplex into vesicles and add HRP outside, to see whether the substrate diffuses out. 
However, the experiment failed as not enough fluorescence could be observed even after destroying 
the vesicles with TritonX. The experiments however, still do not rule out HRP binding to the membrane. 
Thus, HRP was added to preformed polymersomes and the solution was stirred for 12h and then the 
samples were dialysed. 
 
Fig. 12: HRP-Amplex kinetic at pH 7.4 (default conditions), testing permeability and interaction of HRP 
with polymersome membranes. Ex vesicles that had contact with HRP only externally; X stands for 
treatment of the vesicles with 0.5% Triton X in order to release the HRP by destroying the vesicles. 
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As with other successful experiments, the difference between NR+ and NR- in terms of activity was 
around 11x (compare the initial slope in Fig. 12). Vesicles that were in contact with HRP on the outside 
had 5x lower activity than NR-, where HRP was encapsulated. Destroying both samples with 0.5% 
Triton X evens the difference out to a ratio of 1.3, which could imply that a very small portion of HRP 
is bound to the membrane, however, the HRP activity drops in presence of the detergent, making this 
finding less dependable. 
The autoxidation of Amplex in absence of HRP but in presence of H2O2 is not visible at pH 7.4 but in a 
similar range at pH 6.0 comparable to the activity of the vesicles that had been only superficially 
exposed to HRP prior the dialysis step. 
Concluding can be said that NR- is active either due to small defects or due to a residual permeability 
towards dyes. Adding HRP to the outside allows nearly all of it to be removed, but a small fraction 
clings to the membrane. 
 
 
1.2.2.3 Enzyme kinetics in combination with FCS 
 
Potential membrane interactions could also be detected using the fact that resorufin can be observed 
in fluorescence correlation spectroscopy (FCS). The experiment was conducted with NRs based on the 
DSPC-mix. 
Following the count-rate over time gives results very similar to normal fluorescence measurements 
(Fig. 13): 
 
Fig. 13: Kinetic under FCS using the same reaction conditions as for fluorimeter but scaled down in 
volume. 
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The high laser intensity causes bleaching and the absence of agitation make FCS less suited than normal 
fluorescence measurements. However, it allows to measure the vesicle size via its diffusion time and 
it gives an average number of fluorophores via the CPM (Fig. 14): 
 
Fig. 14: The same experiment, but CPM displayed instead of CR. 
The CPM does not increase over time, strongly indicating no accumulation in the vesicles or within the 
membrane. The CPM stays for all samples between 6 and 8 with the exception of NR- at pH 5.5. The 
CPM of free resorufin was 5.19 kHz indicating that the vesicles had 1.5 molecules of resorufin at any 
given point in time. 
It was anticipated that NR+ would have a higher CPM since the formation occurs within the vesicles, 
thus at any given time a few fluorophores should be within the vesicle. The NR- should only have a 
significant CPM, if Amplex manages to diffuse into the membrane or bind to it. The latter is probably 
pH dependent.  
Since it would also be interesting to know the number of HRP enzymes per vesicle and have a better 
indicator than light scattering for the vesicle concentration, it was attempted to label HRP with AL488, 
AL633 and OG488. However, even after multiple size exclusion, centrifugal filtration, dialysis, addition 
of biobead etc. the free dye could not be removed but was clearly visible in FCS. It appeared moreover, 
that only one dye molecule was attached covalently per HRP. This had to be expected since HRP has 
only three lysine sidechains on its surface that could serve as an anchor point.[7] 
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1.3 Enzyme stability 
 
Fig. 15: pH-cycling of free HRP (200ng/mL; detection with Amplex Ultra Red), showing that HRP is 
more active at pH 6.0 and that the activity decreases with each circle, above all for pH 7.4 
 
 
Fig. 16: HRP activity (200ng/mL) over multiple pH changes cycling 4 times (purple to cyan) from pH 
7.4 (left) to 6.0 (right) and back, measured with Amplex Ultra Red. The displayed fluorescence 
increase is the average of triplicates and the dotted lines represent the standard-deviation. Unlike 
Fig. 15, the graphs were all re-zeroed.  
 
Since HRP is more active at pH 6.0 than at 7.4, it is hard to see that acidification could be detrimental. 
Originally, it was intended to measure the stimuli responsiveness of OmpF-C at pH 7.4 and 5.5. At pH 
5.5 the activity is even higher than at pH 6.0, but the experiment reproducibility was poor. As it turned 
out, HRP becomes irreversibly deactivated below pH 5.0. Changing the pH causes multiple 
0 1 2 3 4 5
0
200
400
600
F
lu
o
re
s
c
e
n
c
e
 [
a
.u
.]
Time [min]
 pH 7.4 C1
 pH 6.0 C1
 pH 7.4 C2
 pH 6.0 C2
 pH 7.4 C3
 pH 6.0 C3
 pH 7.4 C4
 pH 6.0 C4
0 1 2 3 4 5 6
-10
0
10
20
30
40
50
pH 7.4 
F
lu
o
re
s
c
e
n
c
e
 [
a
.u
.]
Time [min]
 C1
 C2
 C3
 C4
0 1 2 3 4 5 6
-10
0
10
20
30
40
50
pH 6.0 
F
lu
o
re
s
c
e
n
c
e
 [
a
.u
.]
Time [min]
 C1
 C2
 C3
 C4
V Development of an Enzymatic Assay 
166 
experimental errors. This can be seen in particular in Fig. 15, where each consecutive curve becomes 
flatter. In Fig. 16, it can be seen that the initial drop in activity is the greatest. Primarily, it results in a 
volume increase. In order to minimise this effect, concentrated acid was used (reducing the volume 
increase in this example from 10mL to 10.18mL), which in turn creates highly acidic zones before 
homogenisation. These form temporary and local kill-zones for HRP. 
 
 
2 Other potential enzymes 
2.1 Lactoperoxidase 
 
LPO (77.5kDa) was considered as an alternative to HRP (44kDa) as it is reported to interact less with 
membranes and was labelled successfully with fluorescent dyes.[8] However, the encapsulation 
efficiency was too low for a fluorescence assay with Amplex Ultra Red (0.25g/L HRP had a 40x higher 
activity than 0.5g/L LPO). Moreover, the activity at low pH was too low (6x lower at pH 5.5). 
 
 
2.2 β-Galactosidase 
 
β-Galactosidase was tried as well, despite its massive size, weighting 465kDa as a tetramer, due to its 
pH-stability and small substrate. The nanoreactors featuring it, were surprisingly active (samples were 
100x diluted compared to HRP-NR and still produced a signal overload; see Fig. 17) and there was a 
distinct, but small difference between NR+ and NR-. The fluorescence decreases 5x when the sample 
is acidified from pH 7.4 to 5.5. The substrate, o-nitrophenyl β-D-galactopyranoside, had the 
unfortunate drawback that a significant portion hydrolysed with every thawing, but during the 
measurement itself, no further hydrolysis was observed in absence of enzyme. After two experiments, 
the substrate was unusable. 
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Fig. 17: Kinetic using NRs with 2.5g/L galactosidase encapsulated in DSPC-vesicles and 100x diluted; 
only pH 5.5 is shown, since pH 7.4 resulted still in a signal overload. 
 
 
2.3 Uricase 
 
Uricase is another possible alternative. It is weighting only 35kDa and known to be easier to separate 
via size exclusion from vesicles than HRP. Unlike HRP, Uricase utilises oxygen directly and produces 
H2O2 as byproduct. Its substrate is very small (168 Da) and a weak acid, however, despite all its polar 
groups, uric acid is only poorly soluble in water (ca. 6mg/L at 20°C). Moreover, there are no specialised 
enzyme substrates available, that would turn into fluorophores or dyes. However, uric acid absorbs at 
293nm whereas its product allantoin does not.[9] As with all absorption based methods, the assay is 
not very sensitive and hence requires significant concentrations of substrate, but in this case the 
concentration cannot be increased due to its poor solubility. To complicate matters further, the 
absorption is overlapping with most sample carriers and uricase has only 10% of the activity at pH 5 
compared to pH 7.4.[10] This is unfortunate, since even at pH 7.4 the activity is low. Increasing the 
temperature from 22°C to 37°C helps in two ways: 1) the enzyme activity increases; 2) the solubility of 
uric acid increases. 
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Fig. 18: Kinetic measurement or uric acid consumption using DSPC liposomes (encapsulating 1g/L 
uricase) at 37°C. 
 
Unlike all other kinetic experiments, the activity is observed as a decrease of absorbance. The 
experiment shows that uricase is ill suited. At pH 5.5 the activity is at best 1/5th of the activity at pH 7.4 
(Fig. 18). Moreover, the uricase conversion appears to stop prematurely. This might be caused by the 
byproduct hydrogen peroxide, which could inactivate the uricase. Thus, after 1h no further activity was 
observed at pH 7.4. At low pH, this effect is even more pronounced, as an initially sharp decrease in 
uricase could be observed which soon flattens. Another major problem is the fact that the difference 
between NR- and NR+ is very small. 
 
 
2.4 HRP Uricase tandem reaction 
 
Since uricase is not suitable for experiments on its own, a tandem reaction utilising the byproduct H2O2 
is necessary. This can be achieved with HRP. Since coencapsulation would be an unnecessary 
complication and uricase was investigated to avoid the problems with HRP in the first place, the only 
sensible experimental set-up is encapsulating uricase and then adding HRP and Amplex Ultra Red to 
the outside of the purified vesicles. This approach would solve all conceived problems with two 
exceptions: the pH-dependence of the enzymes and the possibility that the rate determining reaction 
step changes with the pH. 
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As anticipated at both pH uricase remains the limiting factor in terms of activity, which simplifies the 
evaluation of the experiment. This means also that at pH 5.5 the activity decreases, despite the fact 
that HRP would be more active at this pH. This has the consequence that at pH 5.5 the activity of the 
samples is akin to the rate of self-oxidation of Amplex at low pH and elevated temperature, making 
the assay borderline useless (Fig. 33, Fig. 34). 
 
 
2.5 Glucose dehydrogenase/oxidase 
 
Since most enzymatic substrates are based on dies, they are relatively big and hydrophobic. Moreover, 
there are no uncharged, water-soluble substrates of this type. Such a substrate could avoid various 
undesired interactions (charge repulsion; membrane interaction…). Sugars are a prime example for 
such enzyme substrates. To create a measurable reaction, a tandem reaction similar to Uricase-HRP is 
required. While this introduces experimental issues as discussed above, none of the enzymes needs to 
be encapsulated, eliminating a whole set of problems (low encapsulation efficiency, purification, 
measuring the encapsulation efficiency…). The only disadvantage is that NRs can stay far longer active 
than cargo releasing systems. Sugars are in general much easier to encapsulate and store than 
fluorophores or enzymes. The detection can be achieved with glucose oxidase-HRP (Fig. 19 B). A more 
elegant variation would be to use an enzyme which consumes a co-substrate, which can be followed 
spectrometrically (Fig. 19 C). glucose dehydrogenase falls into this category (NAD can be followed at 
339nm excitation and 460nm emission). However, glucose dehydrogenase requires basic conditions 
and elevated temperatures to operate. Moreover, NAD is much harder to detect than Amplex Ultra 
Red. This leaves still glucose or galactose oxidase in combination with HRP. 
  
V Development of an Enzymatic Assay 
170 
                 A 
            B 
 C 
Fig. 19: Possible enzymatic reactions involving sugars. Note that it is always the by-product which 
allows detection. Furthermore, all enzymes are specific to the shown anomer (which is in equilibrium 
in solution, as long as the alpha-hydroxy group is not reacted to an ether or ester).  
 
 
GOX-HRP Galactose detection 
 
 
Fig. 20: Testing the detection window of galactose using galactose oxidase-HRP tandem.35 
                                                          
35 Reaction conditions: 50μL of working solution containing 2 U/mL GOX, 0.1 U/mL and 50µM of Amplex Ultra 
Red in PBS pH 7.4 were added to 500µL sample; excitation/emission 530/590nm (at 22°C) 
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The disadvantage of coupling two reactions for an assay becomes apparent in Fig. 20. Depending on 
the galactose concentration, the rate determining step changes, resulting in a non-linear dependence 
between sugar concentration and fluorescence per time unit. Fortunately, this was not the case with 
the related glucose oxidase. 
 
Fig. 21: Amplex oxidation in dependence on pH and glucose concentration in [µL]. Detected with a 
system of glucose oxidase and HRP.36  
 
Glucose oxidase does not suffer from the same limitations (Fig. 21). The pH dependence of the reaction 
is visible, but at both pH the result is still comparable. The reaction is only 30% faster at pH 6.0. 
 
 
Fig. 22: Dependence on Glucose concentration and on pH. 
                                                          
36 150µL sample+50µL working solution: 0.2 U/mL HRP (275kU/g→727µg/mL) 2 U/mL GOX 
(208kU/g→9.62mg/mL) 50µM Amplex Ultra Red; excitation/emission 530/590nm (at 22°C) 
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Fig. 22: Has the slopes (first 30s) of Fig. 21 plotted as a function of the concentration of glucose 
concentration. For practical purposes this assay has an effective detection range of 0.5-50µM. Higher 
concentrations could be measured, but dead-time during sample preparation would become a major 
problem. As with HRP kinetics, the reactivity increases at low pH, but in case of this tandem reaction 
the activity increase is limited to less than 55% implying that the activity of the glucose oxidase 
decreases at low pH. All in all, this combination of enzymes appears promising for kinetic 
measurements. 
 
 
3 Experimental Problems 
 
Enzymatic systems are far more complex systems than experimental set-ups for release experiments. 
While they do not suffer of low encapsulation efficiency or leaking before the measurement as much 
as the release experiments, they do have quite a number of experimental error sources: 
- Cofactors need to be able to diffuse along with the enzyme substrate. For H2O2 as with HRP, 
LPO, or similar this is not an issue (except that it is a fairly aggressive oxidant, which can bleach 
fluorophores and damage proteins or lipids), but most co-substrates are bigger, like NADH 
(sugar dehydrogenases etc.). In case of uricase and GOX the problem is that the co-substrate 
is O2, which does not dissolve in water,37 as well as other substrates and the supply is 
dependent on temperature and agitation of the solution. If most of the O2 stems from bubbles, 
then there will be a lack thereof on the inside of the vesicles. 
- Enzymes may also stick to membranes or be otherwise hard to remove. Due to their catalytical 
nature, even traces may cause significant background activity. Similarly, a single bursting of 
vesicles could significantly alter the outcome of a measurement. 
- As with release experiments, it can be challenging to adjust the pH, but unlike release 
experiments, the system is much more sensitive to deviations of the pH. Changing the pH 
requires the addition of acids or bases, which will increase the sample volume and thus dilute 
the system. The more concentrated they are the higher the difference in local pH will be until 
the sample is thoroughly mixed (and even then, the pH on the inside of vesicles may take a 
                                                          
37 At atmospheric pressure and 25°C around 6mL oxygen dissolve in 1L of pure water (less in PBS), that results 
in less than 250µM. 
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while to adjust). The longer the mixing takes, the longer the dead-time will be and the more 
damage may occur to the sample. 
- Related to the last point, smaller volumes added have larger titration errors. Buffers were 
used to prevent accidental deviations from the pH, but also increase the amount of acid or 
base required. Moreover, no buffer has a straight titration curve. PBS for instance does not 
buffer at pH 5.5 at all, meaning that at this pH even small additions of acid will drop the pH 
considerably. Thus, citrate buffer was used for many experiments until it was found that it did 
apparently change the reaction mechanism in unknown ways (see Fig. 23). When HRP 
converted Amplex into a fluorophore, it gave a sudden jolt of fluorescence at the beginning in 
case of citrate buffer, which did not occur in PBS. It was not noticed for a long time, since the 
cuvettes were shaken more thoroughly resulting in a dead-time in which both systems 
equilibrated themselves independently resulting in a similar activity curve thereafter. 
- In case of multiple pH changes (pH-cycling experiments), the error accumulated. Due to the 
extended measurement time it also coincides with an accumulation of fluorophores and salts 
from the titration. The prior reduces the signal noise ratio (see Table 1), whereas the latter 
could potentially quench the fluorescence. In addition, cycling experiments require a very low 
conversion, or the saturation level will be reached within the experiment. 
- Also, besides the obvious limitations of all compounds regarding a certain pH range, the 
fluorescence of the product and the activity of the enzyme usually changes with the pH and it 
can further open new reaction pathways such as further oxidation of the fluorophore. It was 
observed for Amplex Ultra Red/HRP, that the concentration of H2O2 had to be reduced in order 
to reduce further oxidation of Amplex Ultra Red at low pH. This pH dependency also makes it 
impossible to compare the activity of an open and close pore NR directly. Thus, controls are 
stringent. 
The system HRP/Amplex Ultra Red proved to be the most reliable. Among the available substrates 
Amplex Ultra Red was chosen as enzyme substrate due to its size, pH stability and hydrophilicity. In 
case of kinetic measurements, the safest way of adjusting the pH was to dissolve the sample in buffer 
of the corresponding pH and adding the working solution (containing the Amplex Ultra Red) of the 
same pH as the buffer. For changing the pH during a measurement irrespective if only once or over 
multiple cycles, it was best to use minimal amount of acid or base and shake the sample immediately 
and thoroughly and then reinsert it into the detector. Changing the pH while caused more HRP 
deactivation, since the equilibration of the pH was slower. 
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Fig. 23: Liposomes via detergent removal containing HRP and OmpF; one made in citrate buffer (red) 
and the other in PBS (black). 
 
Table 1.: Example of how the background activity increases over four cycles 
cycle 
Fluorophore 
formed 
[µM]* 
Prexisting 
Fluorophore 
[µM]* 
Ratio [] 
1 5 0 100% 
2 5 5 50% 
3 5 10 33% 
4 5 15 25% 
*= this is just an example and not based on any measurements. 
 
It was intended to measure that the activity of a nanoreactor at one pH, then the pH would be changed 
and the measurement continued. The slope of the fluorescence increase representing the activity 
should change with the pH. This principle could be extended to multiple changes proving that the 
stimuli responsiveness was reversible. However, this was not achieved for a long time for multiple 
reasons. 
Due to the pH-dependence of the fluorescence, the activity of a NR cannot directly be compared at 
two different pH. Still, their activity can be compared to the activity of controls that represent closed 
pores and open pores. However, the activities of the respective samples/controls varied too much to 
be compared. 
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Another minor problem is the saturation effect. Over the time the reagents become depleted, thus 
the fluorescence reaches a maximum. Moreover, the detector has only a certain range of fluorescence 
which it can measure and multiple additions of reagent or adjustments to the pH will produce 
cumulative errors and at some point, the sample solution will become to concentrated with 
fluorophore and salts.  
At the beginning, all samples, including the controls appeared to react the same on pH change. At low 
pH, the NRs became more active. The samples and controls could however not be compared, since 
there was too much variation in their activities. Rescaling the kinetics to the same initial activity would 
not work for several reasons:  
1) the NR- should have a lower initial activity;  
2) a sample that had initially a low activity, but a higher activity at low pH would invariably result in a 
different perceived saturation point than a sample with an initially higher activity (see Fig. 24). 
 
 
Fig. 24: Oxidation of ABTS using DSPC-vesicles with D12C-K89C -Gala3 attached as NRC; left unweighted; right 
weighted such that the endpoint of the measurement at pH 7.4 is in all cases the same.  
 
The situation improved, when the vesicle-formation became more consistent. This was mainly the 
result of better control over the detergents present, in particular ensuring that during the purification 
and concentration of OmpF, the detergent was not concentrated as well. 
With better control over the vesicle size and concentration, but also HRP encapsulation (not directly 
measured, but clearly dependent on vesicle size and concentration) and OmpF insertion, the samples 
became comparable. The remaining variation in the vesicle concentrations could be evened out by 
diluting samples accordingly.  
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These improvements solved the most troublesome recurring observation that NR- was often more 
active at any given pH than NRC and NR+. This was apparently the result of a low OmpF-insertion 
efficiency combined with a low vesicle concentration due to the involved detergents in particular OG. 
NR- had on the other hand the highest vesicle concentration and in case of liposomes, the permeability 
of the membrane is significantly higher. Both facts together explain a significant HRP-activity. 
The only experimental set-up that was not plagued by interfering detergents was vesicle-formation of 
liposomes via detergent removal. This method gave the first results that not only showed a clear 
difference between NR- and NR+ but a clear stimuli response for NRC (R270C-Gala3). This can be 
explained by the fact that all samples had the same detergent concentration (and thus similar vesicle 
concentration and stability/permeability) and possibly by a better OmpF insertion compared to the 
rather crude method used for film-rehydration. 
However, when more R270C-Gala3 OmpF was produced the results could no longer be reproduced. 
The OmpF insertion failed. Apparently, the new batch of chemicals, or the changes in the purification 
of OmpF extraction made a difference. The latter could change the ternary mixture of bacterial lipids 
that are bound to OmpF.[11] Similarly, insertion of OmpF into DSPC-liposomes during film rehydration 
worked after reducing the OG concentration but failed with the new batch of R270C-Gala3. That both 
findings were caused by the batch of OmpF could be proven easily, since the old batch of WT-OmpF 
was still available and could be still inserted into membranes without a problem. 
Interestingly, the new batch of R270C-Gala3 OmpF worked for FRH with polymersomes, when the OG 
was removed. Still, at times, NR- became again the most active sample. It was unlikely that it was again 
a problem of free HRP contaminating the samples. It could have been that the dialysis tubes used for 
separating HRP, did not work as efficiently as before, but that should affect all samples equally. Even, 
if the OmpF did not insert again for some reason, all samples should have approximately the same 
activity. Also, the vesicle concentration and their homogeneity were much more closely watched. 
Thus, it had to be considered that there was a fundamental difference between NR- and all the other 
samples. Either in the ability of HRP to bind to the vesicle membrane; the permeability of the vesicle 
membrane itself or the stability of the liposomes. The presence of MPs in a membrane can stabilize it, 
affect its permeability and ability to bind enzymes. On the other hand, detergents and lipids dragged 
along with OmpF could affect the membrane. 
Hence, the permeability of the membranes towards Amplex Ultra Red was tested. Both liposomes and 
polymersomes revealed to have a significant residual permeability (ca. 1/10th of the permeability of 
OmpF-equipped membranes). Detergents such as OG, did not appear to change the permeability of 
the membranes to a significant extent, but deteriorate the vesicles over time. Interestingly, the 
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interaction between HRP and the membranes appear to be negligible, despite the fact that HRP was 
far more difficult than dyes to remove. Hence, it is unlikely, that HRP binds stronger to the surface of 
the vesicles in absence of OG. 
Another suspicious finding was that a part of the samples precipitated in the dialysis tubes and the 
sample volume decreased. This effect was often particularly strong for NRD. However, neither TEM 
nor Zetasizer revealed aggregates. Still, it could be possible, if aggregates precipitate before the sample 
can be measured, thus making them unavailable to sampling. Speaking against it, is the fact that the 
samples had both a similar ability to scatter light and similar values in vesicle size and homogeneity. 
Precipitation should decrease the samples concentration, unless larger aggregates falsely indicate 
higher concentrations. It could still be that different samples had higher rates of releasing HRP, but no 
degradation over time was observed via TEM or Zetasizer (15h 40°C, month on the shelf). If the NRs 
precipitated the activity should decrease. If the HRP was released, then the activity should increase at 
first, but then decrease again, because unprotected HRP deactivates faster. Neither of it was observed: 
NR+ activity remained relatively constant, whereas NR- activity increased over time. 
Changes in the volume upon dialysis, could indicate osmotic effects. Vesicles without pores should be 
far more vulnerable to osmotic pressure. However, increasing osmotic pressure by using 5x more 
concentrated buffers, did not alter the activity or vesicles. 
Later, the same problems occurred using polymersomes. Thus, it became far more plausible that it 
was a problem related to the OmpF, or associated detergents and lipids. Supporting this theory, it was 
observed that K89,R270C-OmpF inserted poorly compared to OmpF-WT and R70C-OmpF (Fig. 25). It 
first appeared around the time where I used a new batch of POPS and Chol-PEG600, but it turned out 
to be the same problem with polymersomes. The OmpF could be misfolded. Since OmpF is 
extraordinarily sturdy, this was deemed unlikely and CD-measurements did not indicate any unfolding. 
It was however observed that the first batch of K89C-R270C-OmpF had contaminations, either very 
fine cell-debris, or undigested DNA. Due to the sticky, viscous nature of the sample, the latter was 
assumed and the OmpF protocol improved. Later batches did not have these contaminations, but still 
inserted poorly. This only changed, when the OmpF samples were dialysed against buffer only, 
removing all of the OG. This made the OmpF instable in solution but allowed almost all the time 
successful insertion. This leaves the question why it worked before and without this step. The first 
OmpF-mutants were extracted with Octyl-POE instead of OG. The latter gave significantly higher yields 
but is a much harsher detergent. It is known to strip MPs of stabilizing lipids, denature proteins and 
was found to be much more detrimental to vesicle (see experiments in Preparation chapter 3.3.3).[11-
12] 
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Regarding the residual activity of NR-, even in absence of absence of the negative influences such as 
detergents, the remaining activity has to come either from the permeability of the membrane (either 
fluidity or defects), or from slow release of enzymes. Since the activity increased faster over time than 
decomposition was observed, it could be that the aged vesicles are stable in absence of detergents 
until the moment where they are exposed to shear forces during the pipetting of the sample 
preparation. This would explain why we see immediately a background activity of NR-, but rarely an 
increase over time unless the sample is remeasured after a week. 
 
To conclude the surprising activity of NR- was due to survivor bias. NR- was very different from all other 
samples in that the vesicles were never in contact with detergents. In many cases OmpF was apparently 
poorly inserted and the remaining detergents destroyed over time the vesicles. Thus, even if the 
permeability of the OmpF-free membrane and the rate of vesicles releasing HRP, due to degradation 
is low, the sheer number of NR- compared to e.g. NR+ compensated the higher permeability of NR+. 
In order to obtain reproducible and comparable results, one must: 
- Remove as much detergent as possible, unless detergent removal is used for vesicle-
formation. Especially removing the OG below 0.5% tended to be tedious and not fully 
reproducible, as different batches of dialyses tubes had different efficiencies. 
- Depending on the intended method of vesicle-formation, OmpF has to be extracted 
differently, as it changes its ternary mixture. Milder OPOE is needed for detergent removal, 
whereas film-rehydration OG can be used, but the detergent needs to be removed thoroughly. 
- All controls must have the same residual detergent concentration. This does not imply to add 
the detergent concentration, the other samples nominally have (0.5% OG directly from 
storage, or 0% if dialysed against buffer). Instead the detergent concentration has to be 
measured. Then, e.g. 0.5% OG can be dialysed against buffer along with the OmpF-variants 
(who had e.g. 0.4-0.6% OG), so that the remaining OG concentration is in the same order of 
magnitude. 
- Adding acid or base to a buffer in order to change the pH, should be avoided, as temporary 
high local concentrations can damage the sample. Instead the sample should be diluted in 
buffer of the corresponding pH (unless, pH cycling for testing reversibility is conducted). 
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Fig. 25: Amplex-HRP kinetic in order to test the insertion of WT-OmpF (red) and K89R270C-OmpF 
(purple) into DSPC-vesicles (without OmpF: blue; vesicles exposed to OG: black). Both OmpF variants 
were stored in 0.5% OG, but WT-OmpF was extracted with 3% OPOE (later dialysed against 0.5% OG) 
and K89R270C-OmpF was extracted with 3% OG. 
 
 
4 Testing Stimuli responsiveness 
4.1 oligo(acrylic acid) 
 
 
Fig. 26: Amplex-HRP kinetic testing K89R270C-OmpF with oligo(acrylic acid attached to it) inserted 
into DSPC-vesicles. NR- (black), NRC n=8 (green); NRC n=12 (blue), NR+ (WT-OmpF: red) 
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Fig. 27: HRP-Amplex kinetic testing K89R270C-OmpF with oligo(acrylic acid attached to it) inserted 
into A8B49A8-polymersomes. NR- (black), NRC n=6 (orange); NRC n=8 (green), NRC n=12 (blue), NR+ 
(K89R270C-OmpF: red) 
 
These experiments suffered of a very poor reproducibility. However, for both lipo- and polymersome 
NR (Fig. 26, Fig. 27 respectively) it can be said that no stimuli responsiveness was observed; 
acidification increased the activity of all samples without changing their relative activity between each 
other. In case of polymersome NR the activities of NRC were significantly lower in comparison to NR+, 
but increased relative to it on acidification, but not enough to speculate on pH responsiveness. 
Moreover, no clear trend could be seen regarding the length of the oligo(acrylic acid) conjugates. It 
appears to be rather a result of the degree of labelling (DOL). In case of the liposome NR the DOL was 
around 37% (according to acrylodan assay) and in case of the polymersome NR the DOL was above 
50%. Mass spectroscopy indicates a difference in DOL of at least 20%. Thus, the NRC were less 
permeable in the second experiment.  
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4.2 Gala3 
4.2.1 R270C-Gala3 OmpF in POPS/POPC-liposomes 
 
 
Fig. 28: HRP Amplex Ultra Red kinetic with the NR- (blue), NRC (green; R270C-Gala3) and NR+ (red; 
OmpF-WT) at pH 7.4 left and pH 5.5 (right) using POPS/POPC liposomes based on detergent removal. 
 
 
 
Fig. 29: Repetition of the experiment, with the only difference that the liposomes were dialysed in a 
fridge. 
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Fig. 30: Activity bars liposomes, combining the activities as seen from the initial slopes from Fig. 28 
and 29. 
Fig. 30: This was the first time (Fig. 28) that a clear stimuli responsiveness was observed and it could 
be reproduced twice in a row. The second time (Fig. 29), the vesicles were even in better condition, 
resulting in a very low activity of NR-. Furthermore, in the repetition NRC had a similar activity to NR+, 
since both samples had a similar vesicle concentration. 
However, the R270C-Gala3 was used up and Gala3-MI could not be resupplied by various companies 
in the required purity. Then, when the companies finally managed to resupply the Gala3-MI, the 
experiment could no longer be reproduced with a new batch of OmpF. With the new batch NR- had by 
far the highest activity indicating that no OmpF could be inserted and that most vesicles were 
damaged. 
 
 
4.2.2 K89R270-Gala3 in DSPC-liposomes 
4.2.2.1 Amplex 
 
Fig. 31: HRP Amplex Ultra Red kinetic with the NR- (blue), NRC (green; K89R270C-Gala3) and NR+ (red; 
K89R270C-OmpF) at pH 7.4 left and pH 6.0 (right) using DSPC-liposomes produced via film-rehydration. 
0 2 4 6 8 10 12 14 16
0
100
200
300
400
500
600
700 pH 7.4
F
lu
o
re
s
c
e
n
c
e
 [
a
.u
.]
Time [min]
 NR-
 NRC
 NR+
0 2 4 6 8 10 12 14 16
0
100
200
300
400
500
600
700
pH 6.0
F
lu
o
re
s
c
e
n
c
e
 [
a
.u
.]
Time [min]
 NR-
 NRC
 NR+
V Development of an Enzymatic Assay 
183 
 
Since the new batch of OmpF could no longer be inserted via detergent removal (probably due to 
changes in the ternary lipid mixture surrounding OmpF stemming from its purification;[11] see chapter 
5.2) and since the more stable DSPC-vesicles can only be produced via film-rehydration (or demixing 
will occur), film rehydration was used. It turned out that DSPC-liposomes are not just more stable than 
other liposomes but behave more like polymersomes in that they are more sensitive to detergents and 
other disrupting factors and that insertion of OmpF is particularly difficult. 
Once polymersomes with OmpF could be obtained with reasonable reproducibility, the experiments 
with DSPC were stopped. Hence no repeats of this experiment (Fig. 31) were performed. This 
experiment shows however even more clearly the stimuli responsiveness of K89R270C-Gala3. The 
difference in activity between NR- and NR+ is greater and so is the drop in activity of NRC with lowering 
the pH, which overrides the pH-dependent activity of HRP itself. The slope of the first 30s of NR+ (and 
free HRP) increases 3x from pH 7.4 to 6.0, whereas NRC is going from 4.5x the activity of NR+ to 0.74x 
the activity of NR+ 
 
 
4.2.2.2 TMB 
 
 
Fig. 32: HRP TMB kinetic measured at 370nm with the NR- (blue), NRC (green; K89R270C-Gala3) and 
NR+ (red; K89R270C-OmpF) at pH 7.4 left and pH 6.0 (right) using DSPC-liposomes produced via film-
rehydration. 
 
Measuring the same NRs with Amplex Ultra Red (Fig. 31) and TMB (Fig. 32) gives the same results 
(activity of NRC/NR+ goes from 1.2 to 0.56), although it is harder to see with TMB, due to the higher 
perceived reaction rate and due to the further reaction of the product. Moreover, NR- is considerably 
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more active. Still, it confirms the significant decrease in activity of NRC at pH 6.0 and confirms that 
NRC was more active (20%; the difference between the activities of the different samples is much less 
pronounced with this assay) at pH 7.4 than NR+. The latter could be due to inconsistencies of the NR 
formation, such as variations in vesicle size, concentration, HRP encapsulation, or OmpF insertion. NR+ 
scattered light 10% more than NRC and the Rh was 143nm compared to 122nm (NRC) and 137nm (NR-
) according to the Zetasizer. Both observed deviations are significant, but would rather increase the 
activity of NR+, hence it is more likely related to OmpF insertion or HRP encapsulation. 
It is noteworthy that while TMB changes in absence of HRP, in particular in presence of light, it does 
not cause the high activity of NR-. Thus, TMB is probably better at bypassing the liposome membrane 
due to its lower polarity. 
While the kinetic with TMB is not as appealing as the Amplex Ultra Red kinetic, it does reveal an 
important aspect: the blocking of the pore is most likely independent of the charge of the enzyme 
substrate. 
 
 
4.2.2.3 Uricase 
 
 
Fig. 33: Kinetics using uricase containing liposomes. NRC featured R270C-Gala3 and NR+ R270C-SH. 
NRD is NR- formed in presence of the same amount of OG as NR+ during its formation. 
 
The kinetic of uricase consumption (Fig. 33) was not conclusive since the difference between NR- and 
NR+ was not very pronounced and NRC remained in between. It is however interesting to note that 
NR- is visibly more active in presence of OG (NRD) at pH 7.4 and becomes far more active at pH 5.5. 
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Fig. 34: Kinetics using uricase containing liposomes in presence of HRP and Amplex Ultra Red. NRC 
featured R270C-Gala3 and NR+ R270C-SH. Blank refers to the buffer with the working solution (uric 
acid, HRP and Amplex Ultra Red) added. 
 
The first experiment (Fig. 33) did not reveal any stimuli responsiveness. Again, NR- had a higher activity 
than NR+ and NRC, although the experiment was performed with the intention to prevent enzyme 
sticking to the outside of the membranes (since uricase is known to be easy to remove). This indicates 
that something else must be responsible for the comparatively high activity of the negative control. 
Later experiments exploring the interactions between HRP and membranes confirmed this suspicion. 
It rather seems to be that the presence of detergents inactivated the NRs without decreasing the 
vesicle concentration or significant changes in their size distribution. This would further imply that NR- 
released uricase, or that the vesicles are permeable to uric acid. In addition, it was tested how OG 
affects the activity of NR-, when added in concentrations as found for the insertion of OmpF, though 
these experiments remained inconclusive (not shown; some more active, some less). The reason, why 
the blank (Fig. 34) had the highest activity at pH 5.5 of all samples remains unknown. Under normal 
circumstances no oxidation of Amplex Ultra Red was observed in absence of H2O2 at pH 7.4 and little 
to none at pH 5.5. This experiment, however is at a different time-scale (hours instead of minutes, as 
with regular Amplex oxidation kinetics). 
Another odd observation was that NR- had only a higher activity at pH 7.4 and this effect was not 
observed, if uricase was measured directly, without relying on Amplex Ultra Red/HRP. This is probably 
linked to the fact that the activity of uricase decreases dramatically at low pH whereas the activity of 
HRP doubles under the same conditions. 
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Fig. 35: Repetition of the experiment with the same samples with 10x lower HRP- and Amplex 
concentration and at 37°C instead of 22°C. Two additional samples were measured: a working 
solution with uricase added and one with uricase and OmpF solution. 
 
Surprisingly, minor changes of the experimental system changed the picture completely (Fig. 35). The 
intention was to increase the activity of the uricase by doubling the temperature. Since, HRP was far 
more active than uricase, the HRP concentration was reduced. The same is true for the Amplex Ultra 
Red concentration, since high concentrations thereof appear to be prone to auto-oxidation and are 
definitely prone to further oxidation (in particular at low pH and elevated temperatures). 
Implementing these changes, decreased the measured fluorescence by half, but significantly increased 
the observed activity of the NRs. This time NRC reveals a stimuli responsiveness, unfortunately, NR- 
does too and has still the problem of a too high activity at pH 7.4. Thus, the experiment is not 
conclusive. 
Unencapsulated uricase is highly active under the measured conditions. Full conversion is reached in 
less than 5 minutes. At low pH, further oxidation of Amplex Ultra Red can be seen and since no new 
Amplex Ultra Red is formed and since elevated temperatures are used, its further oxidation is drastic. 
In presence of OmpF and OG the same trends could be seen, but the reaction speed was somewhat 
higher. 
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4.2.3 K89R270-Gala3 in polymersomes 
4.2.3.1 Amplex 
 
In an attempt to design an experiment with immediate visual feedback for direct comparison and as a 
self-explanatory image for the publication, a pre-experiment was performed, NRC and its controls NR-
, NR+, but also buffer only and free HRP were added into a 96-well plate and the reaction was run by 
adding the working solution comprised of Amplex Ultra Red and H2O2. After the reaction produced 
visible coloration, a photo was taken. The idea was to allow a different perspective on the different 
activities of the samples. Unlike later kinetic measurements the concentration of both reagents and 
the reaction time had to be reduced in order to avoid a signal-overload. 
 
 
 
Fig. 36: Oxidation of Amplex Ultra Red in presence of H2O2 under different conditions. The pink colour 
indicates a high concentration of the resorufin derivative being formed. The first sample contains 
nothing but PBS, Amplex and H2O2 and serves as negative control. The second sample contains 
additional free HRP as positive control. The other three samples contain NRs: NR- without OmpF 
(revealing low background activity); NR+ with OmpF (revealing the maximal activity) and NRC with 
stimuli responsive OmpF-C. 
 
As expected, the qualitative evaluation of the colour change (Fig. 36) associated with the production 
of resorufin indicates negligible auto-oxidation of Amplex Red in PBS both at pH 7.4 and 6.0, similarly 
to NR- in which the compartment membrane had no OmpF. Free HRP had the highest activity of all 
V Development of an Enzymatic Assay 
188 
samples, with the sample at pH 6.0 being far more active than at pH 7.4. The reason why it is less 
deeply coloured being that it became red first and started to bleach through further oxidation of 
resorufin. On the other hand, NR+ at both pH and NRC at pH 7.4 were stained as free HRP at pH 7.4.  
The experimental conditions are unavoidably different, due to our less sensitive eye-sight. It still tells 
a few things: Stimuli responsiveness is visible and it has a low background reaction even in 
concentrated solutions. 
 
Fig. 37: Amplex Ultra Red conversion kinetics of HRP loaded polymersomes (NR-, blue), HRP loaded 
polymersomes equipped with K89R270C-Gala3 (NRC, green) and HRP loaded polymersomes equipped 
with K89R270C-OmpF (NR+, red) at pH 7.4 (left) and pH 6.0 (right).  
 
This experiment (Fig. 37) was repeated thrice and the initial activities of NRC are represented in Table 
4 (Appendix). The initial HRP activities of the NRs (NRC, NR-, NR+) were normalised for a simpler 
comparison, such that the highest activity of NR+ was set to 100%. (Fig. 38). HRP activity values 
represent the mean value of three independent measurements. The initial slopes taken from each 
experiment; normalised and volume corrected. Volume correction increased the fluorescence, or more 
precisely the slope by factor vt/v0.  
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Fig. 38: A) Activity of HRP based on the increase in fluorescence intensity of HRP product, measured at 
pH 7.4 and pH 6: free HRP (black), NR- (blue), NRC (green), and NR+ (red). The stars indicate the 
statistical significance (P value; Table 5 Appendix). B) Free HRP activity by changing the pH from 7.4 to 
6.0 and adding Amplex Ultra Red and H2O2 in each cycle. Green: pH 7.4 and red: pH 6.0. C) Bio-valve 
functionality of OmpF-C when inserted into the membrane of HRP loaded polymersomes (NRC) by 
changing the pH from 7.4 to 6.0 and adding Amplex Ultra Red and H2O2 in each cycle. Green: pH 7.4 
and red: pH 6.0. The activities were corrected by taking the volume increase into account.  
 
 
4.2.3.2 Glucose 
 
The effective detection range of glucose was determined to be 0.5-50µM. Therefore, 100mM glucose 
were used for encapsulation taking into account that only a fraction might be released within the 
measuring time. The non-encapsulated glucose was removed via size exclusion. The pH was adjusted 
by diluting the samples 20x the volume in buffer of the according pH. The experiment started at pH 
6.0 and the pH was only then changed to pH 7.4, since experiments with Amplex Ultra Red implied that 
OmpF-C blocks at pH 6.0. Otherwise, the vesicles would leak already during purification. 
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Fig. 39 Glucose release experiments using polymersomes and K89R270C-Gala3 OmpF 
 
The experiment (Fig. 39) revealed that vesicles without OmpF (NR-) released the least amount of 
glucose and vesicles with unmodified OmpF (NR+) released the most. This comes to no surprise (NRs 
follow the same pattern of activity), however, it has to be expected that NR+ releases glucose before 
the measurement. It could thus release less glucose than NR- in case most of the glucose diffused out 
of the vesicles, before the size exclusion took place, or NR+ could start with a high initial glucose 
concentration, which shows only minimal increase in case the diffusion out of the vesicles was slow 
enough so that most glucose remained encapsulated up to the size exclusion, but the diffusion was 
fast enough to release most of the glucose before the measurement. Thus, this result gives an 
indication about the diffusion speed. Due to the expected release, the NR+ sample was prepared last. 
The size exclusion took ca. 40min, of which the vesicles eluted during 7-12min and glucose came at 24-
30min. Since, the measurement was prepared a soon as the sample eluted, the sample had ca. 15min 
in which glucose could leak before the leakage was recorded. This corresponds very well to the offset 
seen in the measurement. However, the detector had apparently, a malfunction at pH 7.4 in case of 
NR+ at 28min resulting in a sudden drop of fluorescence. Lastly, since neither glucose nor water were 
supposed to diffuse through the polymersome membrane at all, thus, regarding NR- it has to be 
assumed that the membranes are by no means perfect. 
The vesicles featuring K89R270C-Gala3 (NRC) start at the same height as NR- and approach the height 
of NR+ at pH 7.4 and do the opposite at pH 6.0. The prior indicates that the pores open at pH 7.4. In 
the blocked-pore state NRC was expected to behave more like NR- than NR+. Since some leakage is 
still anticipated, a higher offset was to be expected and a somewhat higher slope than in case of NR-, 
thus resulting in NRC diverging from NR- further with time. Instead the NRC converges with NR-. This 
indicates that the rate of leakage was higher before the measurement (for unknown reasons). To 
complicate things further, NR- at pH 7.4 was remeasured resulting in an overlapping curve indicating 
that NR- stored at pH 6.0 did not release any significant amount of glucose during the 30min between 
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the measurements (the first measurement featured a jump too). These effects might be attributed to 
the fact that the fluorescence increase might not represent the increase of the glucose concentration 
at the time, but the conversion of glucose through the GOX. 
In order to prove that all three samples (NR-, NR+ and NRC) had the same amount of glucose (same 
concentration inside and same vesicle concentration) a third row was measured in which all samples 
had 0.5% TritonX added at pH 7.4. This measurement (Fig. 40) proved that all samples including NR+ 
had glucose encapsulated in fact, NR+ and NR- had approximately the same glucose concentration, 
but NRC had ca. 2x as much. Since the vesicles scattered light to the same degree, it has to be a higher 
encapsulation efficiency. 
 
 
Fig. 40.: The three samples with the vesicles destroyed and the glucose concentration measured 
thereafter. 
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4.3 HLG4 
4.3.1 HLG4 in DSPC-liposomes 
4.3.1.1 Amplex 
 
 
Fig. 41: Amplex Ultra Red kinetic using NRs featuring K89R270C-HLG4 OmpF in DSPC liposomes. 
 
The experiment (Fig. 41) reveals a clear stimuli responsiveness of NRC. Moreover, the HLG4-peptide 
has exactly the opposite effect as the Gala3-peptide. The curves are not particularly smooth since the 
stirrer of the cuvette failed. 
 
 
 
Fig. 42: Amplex Ultra Red kinetic of a new batch of HLG4-featuring NRs. 
 
The repetition (Fig. 42) confirmed the result although the magnitude of the stimuli response varied 
significantly compared to the prior measurement. 
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4.3.1.2 TMB 
 
 
Fig. 43: TMB kinetic using the same samples as in Fig. 42.  
 
Unlike the Amplex Ultra Red kinetic no stimuli responsiveness could be observed (Fig. 43). At both pH 
the NRs remained inactive. This is in sharp contrast to the Gala3-variant, which was tested in the 
same measurement (see Fig. 31 and Fig. 32). 
Since the same sample was measured in the Amplex Ultra Red kinetic, it cannot be explained by poor 
insertion of OmpF. It could be though that TMB interacts with HLG4 by charge repulsion, whereas 
Gala3 blocked Amplex Ultra Red and TMB predominantly due to steric hindrance. 
 
4.3.2 HLG4 in polymersomes 
 
Fig. 44: Amplex Ultra Red kinetic featuring polymersome NRs with K89R270C-HLG4. 
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While NRC clearly does not display a closed state at pH 7.4 it certainly opens its pores at pH 6.0, as the 
activities of NRC and NR+ overlap (Fig. 44). Unfortunately, something went wrong with NR- at pH 6.0. 
It appears as the vesicles were disintegrating at the beginning of the measurement. Before the 
measurement all samples had vesicles in the range of 120nm and none stood out in terms of size-
distribution (0.25). However, for some reason NR- had a 4x lower ability to scatter light than the other 
samples, which would hint an unusually low vesicle concentration. Adding 4x more NR- would result 
in the same activity as NRC at pH 7.4. 
 
 
5 Conclusion 
5.1 Choice of the Assay 
 
All the dye-release systems were not working, with the exception of carboxyfluorescein. However, it 
still interacted with the vesicle membrane and leaked fast making it impossible to measure the begin 
of the release. The only other release-based system worth mentioning, is Glucose in combination with 
enzymes for detection. Whilst being more complex, it appeared to be a far more stable system. 
The enzyme-based systems were much more reliable experimental platforms, but also much fickler in 
their nature, in particular towards pH-changes. There are far more parameters to consider than in case 
of dye-release systems, but, if all requirements are met, then the systems proved to be very stable 
providing significant experimental results. Of all the considered enzymes HRP proved to be the best 
choice, despite the difficulty in removing free enzyme. In particular, due to its stability and available 
enzyme substrates, it proved superior to other candidates. The only other enzymes worth mentioning, 
had still to be used in conjunction with HRP: uricase and glucose oxidase. Both allow a NR- that has a 
very low background activity but complicate the experimental set-up. In case of GOX, it offers the 
additional advantage that the diffusion is not influenced by charge (and by being much faster and less 
pH-dependent than uricase). As enzyme substrates for HRP, Amplex Ultra Red stood out, due to its 
size, stability and its ability to be detected via FCS. TMB was the second-best choice (due to its light 
and pH-sensitivity) and offered a substrate with the opposite charge. This is particularly interesting, 
since it could shed light on a general problem, that is not a technical problem but a shortcoming of the 
experimental design, which was not discussed yet: the observed stimuli response, could be the result 
of different mechanisms. The OmpF pore could be blocked for the substrates either by steric hindrance 
(as hoped for) or by charge repulsion. The latter would probably only block a specific charge, unless 
the opposite charge interacts strongly enough to block the pore. However, there are few comparable 
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enzyme substrates available with opposite charges to verify this mechanism (such as Amplex and TMB). 
There are no pre-fluorescent enzyme substrates that remain uncharged and water-soluble. This is 
where sugars become relevant substrates. 
 
 
5.2 Experimental results 
 
The HRP-Amplex Ultra Red system gave over all the best results, however for some reason it often 
occurred that NR- was the most active sample despite being the negative control (mainly Amplex Ultra 
Red experiments, but also uricase and uricase&Amplex). Obviously, results of such experiments could 
not be used. Contributing to the confusion was the finding that NRD produced in the same batch as 
NR- had the lowest activity, despite the fact that NRD were introduced to see, whether the presence 
of OG, as in the other samples NRC and NR+ increases the permeability or damages the vesicles, both 
would be expected to increase the activity. 
As mentioned in a prior chapter, detergents do negatively affect vesicle formation, the homogeneity 
and stability of vesicles. Still, in low concentrations detergents are tolerated, especially after removing 
as much as possible by dialysis.  
NRD was later relabelled NR-, since all relevant samples had contact with detergents. At the beginning 
of the experiments relying on film rehydration, 0.025% OG was added to the DSPC mix directly, 
whereas in the later experiments using polymersomes 0.5% OG (as used for stabilising OmpF) was 
dialysed off and then added to the polymer film, resulting in a much lower final OG concentration and 
better representing the actual OG interference with the membrane, since the OmpF samples were also 
dialysed against buffer, whereas in the earlier experiments the OmpF samples were used directly, 
containing 0.5% OG or more (since OG micelles can be concentrated, when OmpF is concentrated). 
While this alteration of the negative control formally solves the problem, it would be still interesting 
to know what exactly causes this behaviour, which occurred both with liposomes and polymersomes. 
Especially in case of liposomes low pH and the use of TMB increased the activity of NR- considerably. 
Also, the activity of NR- increased over time. In case of liposomes produced via detergent removal 
within several hours (at room temperature), in case of liposomes formed from the DSPC-mix via film 
rehydration within 6 days (at 4°C) and in case of polymersomes within 14 days (at 4°C). This is quite 
noteworthy, since the latter two appeared stable for at least 3 months at room temperature, or 12h 
at 40°C, according to light scattering and TEM. 
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It was thus tested, if HRP binds to the membrane, by adding it to preformed vesicles and then dialysing 
the mixture. Irrespective of whether liposomes or polymersomes were used, little residual activity 
remained. In case of DSPC-liposomes, it was observed that heating the sample and (paradoxically38) 
the absence of detergents increased the residual activity. In case of polymersomes, the difference 
between NR+ and NR- in terms of activity was around 11x. Vesicles that were in contact with HRP on 
the outside had 5x lower activity than NR-, where HRP was encapsulated. 
Concluding it can be said that the residual activity of NR- stems from the permeability of the membrane 
itself, or from cracks or other defects within it. While the less polar TMB had a higher residual activity 
than Amplex Ultra Red, even very polar substances like glucose were leaking from vesicles without 
OmpF. 
The autoxidation of Amplex in absence of HRP but in presence of H2O2 is not visible at pH 7.4 but in a 
similar range at pH 6.0 comparable to the activity of the vesicles that had been only superficially 
exposed to HRP prior the dialysis step. 
Another noteworthy observation was that the purification of OmpF determined whether or not OmpF 
could be inserted into vesicle membranes. The OmpF extracted with Octyl-POE could be used with 
POPC/POPS and detergent removal, whereas OmpF extracted with the more efficient OG could not, 
but allowed insertion in DSPC-mix and polymersomes, when the OG content was kept at a minimum. 
This speaks for the importance of coextracted bacterial lipids in the ternary mixture. It also showed 
again that the DSPC mixture liposomes are closer in their behaviour to polymersomes, which is 
probably explained by the fact that they become almost rigid at room temperature. 
The activity of free HRP increased from pH 7.4 to pH 6.0 about 2x and was even higher at pH 5.5 (2.5-
3x), but the experiments reproducibility was poor. As it turned out, HRP became irreversibly 
deactivated below pH 5.0. Cycling pH changes between 7.4 and 6.0 revealed that the free enzyme lost 
its activity very fast. Already after the ﬁrst full cycle of pH change, a drop in activity of the free HRP up 
to 12.5% of its initial value was observed, and it further decreased after the second complete pH 
change cycle. The decrease in enzymatic activity of the free HRP was mainly due to the adjustment of 
pH with small amount of concentrated HCl in order to avoid dilution (diluting a sample of 10mL to only 
10.18mL). A temporary, local pH decrease below the ﬁnal pH probably deactivated the enzyme before 
the pH could equilibrate through homogenisation of the solution.[3] Remarkably, this jump in activity 
did not carry over to NRs with unmodified OmpF. In some early (less reliable) experiments it was still 
                                                          
38 Detergents were expected to make the membrane more fluid, like heating the system, allowing HRP to 
better interact with the membrane or even become encapsulated, but instead detergents caused 
predominantly a decrease in vesicle concentration and hence less chance of HRP being dragged along with 
vesicles. 
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observed, but to a lesser degree (<50% increases) in liposomes. It is less surprising that the vesicles 
gave some protection against the pH changes, but it was anticipated that it would come at the cost of 
activity, due to a lower number of HRP and diffusion limitations, but HRP was apparently operating at 
its fullest potential irrespective of the pH. 
 
Oligo(acrylic acid)-conjugates were investigated using both lipo- and polymersomes and using Amplex 
Ultra Red-HRP, but the results were not conclusive. It seems that oligo(acrylic acid) of any length could 
block the pore independent of the pH and that the degree depended mostly on the degree of labelling 
and not on the length. 
Gala3-conjugates worked perfectly well as proven in POPC/POPS-liposomes, DSPC-mix liposomes and 
polymersomes. The experiments with liposomes had a higher statistic error and NRC did not close as 
much as in polymersomes thus NRC never overlapped with NR-. In polymersomes, NRC changed from 
a perfectly open state as NR+ to a perfectly closed state as NR- and the pH dependent change was 
reversible for multiple cycles. TMB gave the same result as Amplex Ultra Red although it has the 
opposite charge indicating that the pore is blocked rather by conformational changes than changes in 
its charge. Tests releasing glucose and detecting it via Glucose oxidase and HRP revealed the same 
trend offering additional proof, since glucose is uncharged and polar. The pH-responsiveness was also 
confirmed using Uricase in combination with HRP, but the experimental error was high and the trend 
rather weak. 
HLG4-conjugates provided the opposite stimuli response according to HRP-Amplex Ultra Red 
experiments, but not according to TMB, which indicates that the oppositely charged TMB apparently 
interacted with the peptide. 
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There were many things that would have been interesting to know in context of this thesis, but either 
impossible to measure, or not possible to measure within the constraints of this thesis. These questions 
can be categorised within two groups: composition and properties. 
Regarding composition, it would have been nice to know how many vesicles are present within 1mL of 
sample and how the nanoreactors actually look like, in particular how many enzymes and OmpF are 
found per vesicle. This would allow comparing NRs with free enzyme and discuss diffusion limitations, 
due to pore-size and total percentage of the vesicles-surface that is actually hollow. 
Regarding the properties, the questions revolve around three aspects: 
1) The behaviour of the enzyme: Why does it become more active at pH 6.0? Why do NRs stay 
active at pH 7.4? What exactly deactivates the enzyme in free solution and why does it not 
apply to NRs? Do enzymes aggregate at certain pH, or do they interact with the membranes 
and how? 
2) What explains the residual activity of the membrane? Does the substrate diffuse through it, or 
only through cracks? How much of the residual activity is caused by release of enzymes from 
vesicles? Why do liposomes and polymersomes behave differently to detergents? What 
mechanism weakens the membrane? How do detergents interact/distribute themselves in the 
system? 
3) How does the stimuli response actually work? Is it due to changes in charge (repulsion), or 
conformation (steric hindrance)? Do the stimuli responsive groups interact with the OmpF-
pore or the substrate? 
 
These questions are definitely worth discussing even without hard data. Some of these questions can 
be answered with educated guesses and by excluding the impossible. However, more value can be 
added to the discussion by estimating some of the properties that could not be measured during this 
PhD. 
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1 Estimating the composition of the NRs: 
1.1 Version A: Estimate based on surface 
 
If all the PMOXA6-b-PDMS44- b-PMOXA6 formed 125nm diameter polymersomes and all the OmpF was 
integrated in it, we obtain following ratio of OmpF to polymer: 
Polymer: 
100𝜇𝐿∗50𝑔 𝐿⁄
4488.43𝑔 𝑚𝑜𝑙⁄
= 111𝑛𝑚𝑜𝑙     (1a) 
OmpF: 
20𝜇𝐿∗0.8𝑔 𝐿⁄
39333𝑔 𝑚𝑜𝑙⁄
= 407𝑝𝑚𝑜𝑙      (1b) 
 
Thus, (dividing 1a, through 1b) for every OmpF, there are 2738 polymers surrounding it. Assuming that 
polymers require a circular area of 2Å in diameter and OmpF a circle of 20Å in diameter, within the 
surface of the vesicle, we can calculate how much of the surface belongs to OmpF: 
Surface OmpF: 407𝑝𝑚𝑜𝑙 ∗ 𝑁𝐴 ∗ 31.4Å
2 = 7.7𝑐𝑚2   (2a) 
Surface polymer: 111𝑛𝑚𝑜𝑙 ∗ 𝑁𝐴 ∗ 3.14Å
2 = 210.6𝑐𝑚2  (2b) 
Percentage: 
7.7𝑐𝑚2
7.7𝑐𝑚2+210.6𝑐𝑚2
= 3.7%     (2c) 
With the surface of a 125nm diameter vesicle being 49062.5 nm2, one can estimate the number of 
vesicles in solution per 1mL: 
Number of vesicles: 
218.3𝑐𝑚2
49062.5nm2
= 445 ∗ 109    (3a) 
Thus, the maximal number of OmpF per vesicle is: 
407𝑝𝑚𝑜𝑙∗𝑁𝐴
445∗109
= 550.5 (3b) 
 
In our group, fluorescently labelled OmpF has been used to determine how many OmpF molecules are 
inserted in reality.[1] In this publication, the same polymer and OmpF insertion procedure were used, 
with the small difference that 80µg OmpF instead of 16µg were used. They found that on average 55 
OmpF per 100nm diameter vesicle were inserted. In relation to the 1760 OmpF molecules theoretically 
present in a 100nm vesicle, the insertion efficiency is: 
55
1760
= 3.1%        (4) 
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Thus, for a 125nm diameter vesicle, with theoretically 550.5 OmpF, one can assume 17.2 OmpF to be 
inserted. 
 
 
1.2 Version B: Estimate based on density 
 
Assuming that the vesicle-membrane has the same density as dry ABCP, which is slightly heavier than 
water (ρ = 1.1 g/L), the number of polymers per vesicle can be calculated. The membrane volume is 
defined as: 
𝑉𝑣𝑒𝑠 = 𝑉(𝑜𝑢𝑡) − 𝑉(𝑖𝑛)       (5) 
The radius of the sphere is 125/2 nm and for the internal radius the membrane thickness of 10nm has 
to be subtracted.  
𝑉𝑣𝑒𝑠 =
4
3
𝜋 ((
125
2
)
3
− (
125
2
− 10)
3
)     (6) 
 
Now, the number or ABCPs per vesicle can be calculated using the molecular weight of the ABCP of 
Mpol= 4488.43 g/mol: 
𝑁𝑝𝑜𝑙
𝑣𝑒𝑠⁄
= 𝜌
𝑉𝑣𝑒𝑠
𝑀𝑝𝑜𝑙
 𝑁𝐴       (7) 
The number of polymer chains/vesicle is according to (7): 6.707x104 pol/ves. The number of vesicles in 
solution by considering that all polymer chains are involved in vesicles formation is obtained as 
1.4353x1012 vesicles. 
The maximum number of OmpF/vesicle, 𝑁𝑂𝑚𝑝𝐹
𝑣𝑒𝑠⁄
is obtained by dividing the amount of OmpF (407 
pmol) by the number of vesicles.  
𝑁𝑂𝑚𝑝𝐹
𝑣𝑒𝑠⁄
= 245 OmpF/ves 
As the insertion procedure and conditions are similar to that used by Einfalt et al when OmpF has been 
fluorescently labelled and determined by FCS,[1] we calculated the number of OmpF/ves taking into 
account that the initial amount of OmpF has been significantly lower (16µg OmpF instead of 80µg 
OmpF[1]). We obtain 11 OmpF/ves, which is indicating that in the present conditions there is a lower 
number of porin/polymersome. 
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1.3 Comparing both variants: 
 
Table 2: comparison of the results 
 
Estimate: A B 
Vesicles in solution 4.45·1011 1.44·1012 
Theoretical no. 
OmpF/Vesicle: 
555 245 
Assuming 3.1% inserted: 17.2 11 
Surface belonging to OmpF 0.13% 0.06% 
 
Both estimates yield surprisingly similar results with all values in the same order of magnitude and the 
maximum deviation at the theoretical number of vesicles (3.2x) and the smallest at the number of 
OmpF per vesicle (1.6x).  
 
 
1.4 Estimating the encapsulation efficiency of HRP from its activity: 
 
Once the HRP/Amplex Ultra Red was optimised with free HRP, it was tested with NR+. Since in most 
encapsulation experiments only 1-10% are encapsulated and most of the solution never becomes 
enclosed in vesicles, 100 0000x the concentration needed for optimal results with free HRP was used. 
Experiments with free HRP had an activity of 10a.u./min at pH 7.4 and 32a.u./min at pH 6.0 (1000x less 
HRP than used for encapsulation). Experiments with NR+ (polymersomes) had ca. 30a.u./min for both 
pH. Ignoring diffusion limitations or other effects of encapsulation on the enzymes activity, one has to 
assume that 0.1% of the enzyme has been encapsulated. 
Taking diffusion limitations into account one could assume a far higher encapsulation efficiency, but 
the fact that the activity was independent of the pH indicates that other effects have to be taken into 
account too which result in the enzyme operating at its fullest potential even at pH 7.4. Thus, the 
initially assumed 1-10% encapsulation efficiency are perfectly plausible. 
As a side-note: both the liposomes formed through detergent removal and from film-rehydration had 
similar activities (max 400 a.u./10 min), despite the fact that the liposomes had probably 10x more 
vesicles per sample. Why they did not have a higher activity cannot be said with certainty but will be 
discussed in the following chapter. 
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1.5 Estimating the number of HRP per vesicle from the initial concentration: 
 
The HRP concentration was 0.2 g/L, or 4.55µM (44kDa). Assuming the same concentration of HRP 
inside vesicles as outside, the number of HRP per vesicle can be calculated: 
 
𝑁 = 𝑉𝑉𝑒𝑠 ∙ 𝑐𝐻𝑅𝑃 ∙ 𝑁𝐴         (8) 
 
As calculated above (6), Vves for a 125nm diameter vesicle would be 5.887·10-19 L. Thus, the number of 
HRP per vesicle would be 1.613 and only assuming 100% encapsulation efficiency. 
 
 
1.6 Encapsulation efficiency: conclusion 
 
It was intended to actually measure the HRP concentration, via FCS, but it turned out to very 
challenging, for mainly two reasons: 
1) Of the few Lysines on the surface only 1 or two appeared to bind reactive dye. 
2) The excess of dye on the other side could only partially be removed (independent of SEC, 
dialysis, biobeads etc.) 
Thus, it was hard to tell how many dyes are encapsulated. Moreover, it would still be required to label 
the vesicles themselves in order to know the number of vesicles, in case some do not contain HRP. The 
only alternative would have been to destroy vesicles and then measure the HRP activity again, which 
would require that all enzymes are released and no HRP enzyme becomes deactivated, by the harsh 
treatment. 
Later, the labelling was done successfully by a colleague (using dozens of consecutive centrifugal 
filtrations in order to remove the non-covalently bound dye) with the result of 3-4 HRP molecules per 
100nm diameter vesicle.[1] 
The estimate based on the activity indicated that the HRP concentration decreased 1000x, indicating 
a very low encapsulation efficiency (0.1%). 
Contrary to it, the concentration-based estimate limits the number of HRP per vesicle to 1.6, which 
would require an encapsulation efficiency of 100% to even get close to the number of HRP found in 
FCS.[2] 
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The latter estimate heavily implies that a significant number of vesicles are actually empty. FCS cannot 
detect empty vesicles, unless the vesicles themselves are labelled with a different FCS-active dye. Thus, 
the latter estimate is plausible. 
Regarding the first estimate, it has to be said, that a loss of 99.9% of the HRP is still plausible. In order 
to understand this, it has to be considered what encapsulation efficiency actually means. If it is defined 
as the ratio of the concentration of enzyme found within the vesicle divided by the concentration of 
enzyme used during vesicle-formation, then it does not say anything about the total concentration of 
HRP in solution. 
As discussed above (equations 3a, 6, 7 and 8), we can assume that we have around 1·1012 Vesicles per 
1mL and that each vesicle has an internal volume of 5.887·10-19 L. This would imply that less than 0.06% 
of the sample solution is inside the vesicles. Thus, the majority of HRP is lost after purification of the 
vesicles. The 0.06% is actually surprisingly close to the estimated encapsulation efficiency of 0.1% 
based on the comparison of the enzyme activities. 
 
 
2 Theoretical calculations of Gala3-peptide protonation 
 
Neglecting the polarity of the environment and the interaction with other acid or base groups of the 
protein (which can have a significant effect on the acidity[3]), the degree of protonation can be 
estimated with a variation of the Henderson-Hasselbalch equation: 
𝑝𝐻 = 𝑝𝐾𝐴 + 𝑙𝑔 (
[𝐴−]
[𝐻𝐴]
) = 𝐾𝐴 + 𝑙𝑔 (
1−𝜃
𝜃
)  (9) 
It usually describes the pH as a function of the dissociation constant of the acid and the present 
concentration of the acid and corresponding base. The relation of those two concentrations can be 
described by the degree of protonation θ. Solving the equation for this parameter gives: 
𝜃 =
1
1+10𝑝𝐻−𝑝𝐾𝐴
  (10) 
The pKa value can be estimated. For carboxylic acid groups the pKa is typically between 4 and 5. 
According to computations using Marvinsketch, it is at the lower end: 
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Fig. 2: pKa values of individual amino acid residues of Gala3 peptide calculated with Marvinsketch 
15.10.19; the pI was calculated to be 0.16. 
 
Taking an average pKa for the carboxylic side-chain of Glu of 4.25 and 9.0 for the aromatic alcohol 
groups of Amplex and 6.4 for the oxidised product (both estimated with MarvinSketch version 
15.10.19) the following protonation can be expected: 
 
Table 4: estimation of the protonation degree of an individual acidic group (θ) depending on the pH 
and pKa (Calculated by Marvinsketch 15.10.19) Substrate: Amplex Ultra Red, Product: Resorufin 
 
   
Protonation 
(%)  
pH required for % 
of protonation 
 
pKa 
 
pH 
6.0 
pH 
7.4  
10% 90% 
Glu 4.25  1.75 0.07  5.2 3.3 
Substrate  8.9  99.87 96.93  9.9 7.9 
Product 6.35  69.12 8.18  7.3 5.4 
 
Regarding the substrate, Amplex (Table 4), one can assume that the fluorophore precursor is 
protonated until it is oxidised (>96% protonation at both pH). It then becomes predominantly 
negatively charged (91% at pH 7.4) unless the pH is changed to 6.0 at which point only 21% are 
charged.  
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Fig. 3: Protonation-degree of Gala3 peptide as a function of the pH calculated with Marvinsketch 
15.10.19 
 
From Table 4 and Fig 3, it can be assumed that the peptide will never be completely uncharged, 
especially at the investigated pH-range the peptide will vastly remain negatively charged. According to 
Table 4, even at pH 5.2 90% of the carboxylic groups will be deprotonated and it would take pH 3.3, to 
reduce it to 10% (inverse numbers of the table, since it depicts protonation). 
 
The number of peptides, with complete change of protonation state is exponentially lower, regarding 
the number of acid groups: 
Chance that no acid group is protonated: = (1-p)N    (11a) 
Chance that n acid groups are protonated: = (
𝑁
𝑛
) 𝑝𝑛 ∙ (1 − 𝑝)𝑁−𝑛  (12b) 
N: number of acid groups in peptide; n: the number protonated acid groups; p: the probability that the 
individual group is protonated. 
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3 Discussion 
3.1 Composition of nano-reactors 
 
Regarding the composition of the nano-reactors, pretty detailed calculations can be made giving 
interesting estimates, with implications that will be discussed later in this chapter. The main take-away 
is that the NRs appear to have only few HRP encapsulated and few OmpF molecules inserted, both of 
which should significantly slow down the substrate conversions, yet this was not observed 
experimentally. 
Both estimates regarding the OmpF-ABCP-ratio ignore that some of the ABCP-film remains undissolved 
(depending on the length of the ABCP probably between 5-40%) and that nearly all vesicle samples 
feature micelles or even aggregates as side product. These two facts probably explain why only a small 
fraction of the OmpF is actually inserted in vesicles. In case the MP is added to the solution, as other 
MPs would be, then the percentage has to be assumed even lower due to precipitation and 
denaturation. OmpF however, does not denaturate that easily and is already surrounded within a 
matrix of ABCP, which increase the likelihood of the OmpF being dragged along with the ABCP rather 
than precipitating out of solution. 
For these reasons, the question arises, why not use more OmpF and HRP, or use more concentrated 
solutions. In order to improve the number of HRP per vesicle, one could increase the concentration of 
the enzyme, but above 1g/L its solubility becomes a problem and experimentally it did not make sense, 
since the activity was more than sufficient. Alternatively, the ABCP-concentration could be increased 
or the sample volume decreased. All of these changes result however in thick solutions, which behave 
differently in vesicle-formation, resulting in more aggregates and micelles and increasing the need for 
higher OmpF-concentrations and thus amounts. 
It was never tested how thick an OmpF solution could be made. Extracted OmpF came often in a 
concentration range between 0.2-0.8 g/L and for practical purposes the solution was concentrated to 
0.5-1.2g/L. The concentrating process is however far less trivial than one may assume, as detergent 
micelles, the remaining DNA (after digestion), cell debris and in particular lipids and detergents 
dragged along with OmpF accumulate as well. This increases the viscosity of some samples 
considerably and makes the removal of detergents much harder. Lastly, OmpF-peptide conjugates 
were mostly produced in 1mL batches due to the price of the synthesised peptides. Smaller volumes 
would have been impossible to handle regarding dialysis tubes, thus further concentrating samples 
was often impossible. This explains why the most important batch K89,R270C-Gala3 OmpF was 
inserted in 4x lower concentrations as the same mutant in my colleagues experiments.[2] The 
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unmodified K89,R270C-SH OmpF was not the limiting factor, but having only 0.8mL of 0.5g/L 
K89,R270C-Gala3 OmpF, when the batch of the Gala-peptide was used up and it took 5 attempts to 
order the peptide as the purification of this peptide is challenging. 
 
 
3.2 Activity of the nano-reactors 
 
It has been observed previously that confining enzymes does not only protect them, but enhances 
their activity.[4] We can assume that our 125 nm diameter polymersome have about 10-20 OmpF 
molecules/vesicle corresponding to 0.06-0.13% of the vesicles surface and 1.6 molecules of HRP inside. 
In addition to these restrictions to the reaction, we have to take into account that the OmpF pore is in 
fact even 50% smaller and allows only molecules with less than 600 Da to pass through. If it was about 
a filter, then the pores of the membrane should be at least 2x the molecular weight cutoff of the 
substrate that should pass through and this does not take into account any charge interactions, or the 
orientation of an oblong molecules relative to the pore. Amplex Ultra Red is about 300 Da, but the 
Gala-peptide attached to the pore is itself already 1322.4 Da. This 12-amino acid long peptide would 
be 48Å long when fully stretched. That is 4x the actual pore size. For these three reasons, it has to be 
expected that OmpF does slow down diffusion significantly. 
Considering the few and small holes on the vesicle surface, it has to be assumed that it takes thousands 
of collisions until one substrate molecule diffuses in and then on the inside it must hit the enzyme and 
it has to collide with its active centre at the right orientation. The enzyme kinetic was investigated in 
FCS indicating that at any given point in time only 1.5 molecules of the fluorescent product are within 
the vesicle. 
 
All that being said, one should anticipate a lower activity due to the diffusion limitation, but the 
diffusion limitation is a blessing in disguise for three reasons: 
1) Upon pH change droplets of acids or base are dispersed in the buffer solution. During the time 
needed for homogenisation, a significant part of free enzyme would come into contact with 
these local zones of extreme pH which in turn will deactivate the enzymes permanently. In 
case of NRs, it takes some time for the inside and outside of the vesicle to equilibrate, thus 
giving the solution the time required for homogenisation, thus the encapsulated enzymes are 
not exposed to the extreme pH and last over much more cycles. 
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2) Once an enzyme substrate manages to diffuse into a vesicle, it can collide countless times with 
the vesicle wall and the enzyme encapsulated before having a chance of diffusing out again. 
This increases the duration of the substrate in proximity of the enzyme significantly. Since the 
vesicles are rather small the frequency of collisions with the substrate and enzyme are high. 
This in turn increases the frequency of substrates colliding with the active site in the required 
orientation allowing the substrate to be converted. 
3) In case only few enzymes are encapsulated, the odds of the enzyme aggregating are small 
eliminating a reason of low activity. This could potentially explain why NRs do not suffer a 
decreased activity at pH 7.4. 
It should be mentioned that this model is flawed since, the collisions are inelastic collisions[5] and long-
range interactions have to be taken into account. Enzymes have moreover been reported to guide 
substrates on their surface towards their active centre.[6] Lastly, it cannot be completely excluded that 
both enzyme and substrate slide along the surface of the vesicle membrane rather than bouncing and 
moving through the entire space of the vesicle interior. 
 
 
3.3 Membrane permeability 
 
Little can be predicted on the permeability of the membrane and its interactions with detergents. 
However, it was noticed repeatedly that hydrophobic molecules, in particular FCS dyes interact with 
the membrane and are able to diffuse in and out and are thus able to go through the membrane as 
well. 
Regarding AUR, it can be assumed that the uncharged version is hydrophobic enough (and also small 
and flat) to permeate through membranes. It was thus calculated how much of the substrate and 
product will be uncharged at pH 7.4 and 6.0. At both pH above 97% of the substrate should be 
uncharged and thus more likely to diffuse through the membrane. Since liposomes have thinner and 
more fluid membranes than polymersomes, this effect should be more pronounced there, explaining 
the higher activity of the negative control in case of liposomes. However, unlike polymersomes, 
liposomes are often charged in their hydrophilic surface. This could be more repelling for hydrophobic 
molecules than PEG or PMOXA groups of polymersomes. An alternative explanation would be the fact 
that liposomes are generally less stable and could thus release more enzymes. Either way it emphasises 
the relevance of a matching negative control (with similar contaminations etc. that might affect the 
membrane). As no significant pH-dependency was found the latter appears more plausible. Moreover, 
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the dominance of the protonated form speaks against charge repulsion between enzyme substrate 
and the stimuli responsive peptide.  
As experiments discussed in the prior chapter indicate, HRP has only limited capabilities of attaching 
itself to membranes. The activity of NR- thus must either stem from the membrane permeability itself 
(including defects) or from HRP release from breaking vesicles. Experiments never showed a sudden 
jump in the activity of NR-, but only a gradual increase over storage time. Thus, the membrane 
permeability becomes the more likely culprit. In addition, even experiments with glucose indicate that 
highly polar substances can escape vesicles, at least when detergents are involved (in concentrations 
that should not destroy the vesicles). 
 
 
3.4 On stimuli responsiveness 
 
Regarding the expected pKa of the asparagine groups of Gala3 being close to acetic acid (4.76), it can 
be further assumed that by decreasing the pH from 7.4 to 6.0 only few carboxylic groups become 
protonated. In fact, a significant change of the protonation state would be only expected for pH-values 
below 5. The iso-electric point can also be expected at around pH 3. However, as mentioned earlier, 
both GALA and oligo(acrylic acid) are known to present a stimuli responsiveness between pH 7.4 and 
5.0. 
In order to understand the behaviour of the GALA-peptide better calculations and Zeta potential 
measurements were undertaken. The peptide (1322.42g/mol) was dissolved in PBS yielding a 45.4µM 
solution. The pH was adjusted by taking 10µL of the peptide solution a diluting it 100x with buffer of 
the corresponding pH. 
 
Tab 5.a: Zeta potential of Gala3 at pH 7.4 to 4.5 (single measurement) 
Sample Name 
Zeta Potential 
(mV) 
Mobility 
(µcm/Vs) 
Conductivity 
(mS/cm) 
GALA3 pH 7.4 -20 -1.5 16.5 
GALA3 pH 6.5 -14.8 -1.1 16.3 
GALA3 pH 5.5 -5 -0.4 16.3 
GALA3 pH 4.5 -1.7 -0.1 16.6 
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Tab 5.b: Zeta potential of the buffer alone 
Sample Name 
Zeta Potential 
(mV) 
Mobility 
(µcm/Vs) 
Conductivity 
(mS/cm) 
PBS pH 7.4 -21.9 -1.7 16.6 
PBS pH 6.5 -8.4 -0.6 16.7 
PBS pH 5.5 -6.4 -0.5 16.7 
PBS pH 4.5 -4.6 -0.4 16.8 
 
Tab 5.c: Subtraction of the background (x.b) 
Sample Name 
Zeta Potential 
(mV) 
Mobility 
(µcm/Vs) 
Conductivity 
(mS/cm) 
pH 7.4 1.9 0.2 -0.1 
pH 6.5 -6.4 -0.5 -0.4 
pH 5.5 1.4 0.1 -0.4 
pH 4.5 2.9 0.3 -0.2 
 
No aggregation could be observed due to the low concentration, but the Zeta-potential changed 
considerably with the pH (Table 5.a). However, the changes of the buffer alone had to be taken into 
account (Table 5.b). The change in Zeta potential had to be expected since the pH decreases the effect 
of cations and vice versa.[7] Unfortunately, the change in Zeta potential was very small compared to 
the background caused by the ions of the buffer. Still, around pH 6.5 something appears to happen, as 
it was the only measured Zeta-potential with a negative voltage, which coincides with the anticipated 
turning point (middle between 7.5 and 5.5, Table 5.c).  
Regarding possible interactions of the peptide with the environment, it has to be said that OmpF-WT 
has 8 lysines inside the pore region and 10 outside; 9 arginines (2 outside); 9 glutamines (4 outside) 
and 11 asparagines (8 outside). Thus, it is nearly impossible to predict interactions of the peptide with 
the pore. The carboxylic groups of the Gala3-peptide could interact with lysine and arginine groups 
inside the OmpF pore, binding the peptide to the pore surface at pH 7.4. For example, negatively 
charged carbenicilin is known to bind in proximity to the K89C mutation.[8] On the opposite side of the 
pore, in mid distance between K89C and R270C, amino acids with carboxylic groups dominate that 
would probably interact in a competing fashion. On the part of the pore exposed to the membrane, 
tyrosines dominate. Binding interactions between the peptide and the inside of the pore would reduce 
the ability to sterically block the pore and to repel anionic substrates by charge repulsion. Another 
situation that would unblock the pore is if the peptide preferentially stood out and away from the 
pore. This could be caused by interactions with the rim of the OmpF or by structural changes. All these 
interactions appear less plausible than a change in conformation, since in the case of the double 
mutant it would have to apply for both peptide anchoring points. 
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Since R270C-Gala3 OmpF proved already a significant pH response, the experiment was once repeated 
in more stable polymersomes with results comparable to the measurements with K89CR270C-Gala3 
OmpF. This indicates that already one peptide attached to the OmpF can be enough to control the 
diffusion through the pore. According to the DOL measurements both mutation sites are equally 
accessible and hence labelled to the same extent. They could be therefore expected to work similarly, 
however the mutation at R270C allows the peptide to protrude more dominantly into the pore than 
from the K89C-site, which is placed above an internal loop of OmpF which effectively reduces the 
molecular cutoff. Thus, it would be more depending on the length of the peptide and its conformation.  
 
4 Conclusion 
 
We can assume that our 125 nm diameter polymersome have about 10-20 OmpF molecules/vesicle 
corresponding to 0.06-0.13% of the vesicles surface and 1.6 molecules of HRP inside. In addition, FCS 
experiments indicate that at any given time no more than 1-2 molecules of oxidised AUR are within 
the NRs. Regarding the fact that probably no more than 0.06% of the HRP enzymes were encapsulated 
an activity comparable to 0.1% of the concentration used for encapsulation, the activity is still very 
impressive. Since the vesicles provide considerable protection against temporary zones of extreme pH, 
diffusion limitations in this system are apparent. It is possible that multiple AUR molecules become 
trapped within the NRs in the sense that they bounce from wall to wall until they either collide with 
the enzyme or the OmpF pore and leave. Regarding collisions with the enzymes, it is likely that the 
substrate is guided to the active site, as it has been reported for other enzymes.[6] 
Regarding the stimuli responsiveness of Gala3-peptides, it can be said that charge repulsion can be 
excluded for two reasons: it worked against differently charged substrates and regarding the observed 
pH-range it is highly unlikely that major changes in protonation occur. It would take pH 3.3 to have 
over 90% of the glutamic acid groups protonated. While the OmpF pore would offer numerous ways 
of interacting with the peptide, the experiments with single and double mutants indicate that such 
effects do not have any crucial effect. 
Regarding the activity of NR- little further inside can be obtained from theoretical calculations. It 
appears that at both pH AUR is predominantly uncharged and thus rather hydrophobic. It thus is likely 
to diffuse though membranes directly, but it seems to be slow compared to diffusing though the few 
OmpF pores available. Repeating experiments with older samples indicate that HRP is released over 
time. However, this should not be a major issue with fresh samples, as long as detergent 
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concentrations are kept in check, as experiments with HRP/membrane interaction and HRP removal 
indicate. 
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1 Achievements 
 
The greatest challenge was that neither an established system nor analytical method existed and that 
one cannot confirm the well-defined nature of a system in absence of a reliable assay and vice versa. 
Thus, the task had too many variables for a straightforward optimisation process. Still, this complex 
system consists of many parts which can be individually analysed and optimised regarding yield and 
reproducibility. 
Various types of vesicles were produced under several different conditions and the influence of the 
insertion attempts, in particular the presence of detergents could be investigated. The results will be 
discussed later in this chapter. Concluding it can be said that several methods were found that could 
be used to insert OmpF and resulted in vesicles stable enough for the planned experiments. The 
vesicles were investigated via light-scattering, FCS, TEM and cryoTEM. All these methods gave 
information about vesicle concentration, hydrodynamic radius and size-distribution and had a 
different bias each. Combining all these methods, the errors cancel out and a conclusion can be 
reached confirming vesicles in case of Liposomes with 200nm diameter and in case of polymersomes 
with 100nm. In both cases the samples had been extruded through a membrane with pore size in the 
same range 
Similarly, various OmpF mutants could be produced. The mutations were confirmed via sequencing 
and after the expression by testing the accessibility of the thiol groups using acrylodan as a fluorescent 
label. The OmpF expression itself was confirmed using SDS-gel chromatography and indicated good 
purity, due to the lack of additional bands in the Coomassie stained gel. The occasionally observed 
splitting of the OmpF band (D12K89C, R270C, D12R270C) is attributed to the presence of residual 
signalling peptide (2000 Da as seen from the difference between the bands at 38 and 40 kDa, whereas 
the anticipated band was 39kDa), which was not cut in time in the E.coli cells due to the rapid 
overexpression.[1] A concentration of 0.75 ± 0.25 mg/mL (extract without further concentration steps) 
was determined by BCA total protein assay. D12C, K89C, R270C, D12CK89C, D12CR270C and 
K89CR270C were successfully produced. All thiol groups were equally accessible, with the notable 
exception of D12C containing mutants, which were not even able to react with small compounds such 
as acrylodan.  
Later, the degree of labelling (DOL) of the OmpF mutants was tested with the acrylodan assay. As an 
orthogonal assay, the protein was digested and analysed via mass spectrometry. As it turned out the 
acrylodan assay was more of a qualitative test, whereas mass spectrometry confirmed a high degree 
of labelling for most attached peptides. 
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Of all the tested groups only Gala3 and HLG4 stood out and both enzyme kinetics and release 
experiments indicated a stimuli responsiveness (details in the following subchapters). 
Besides achieving the set goals, other discoveries were made on the way: 
- Since the commercial thiol assays do not work on thiols located on the inside of the OmpF 
pore, a new assay had to be developed. This acrylodan assay utilises a fluorophore which 
apparently was not used before for this purpose despite its availability and aptitude. While 
mass spectrometry was used for obtaining dependable results, it was nowhere near fast and 
available enough as a quick screening, very unlike the new acrylodan assay. 
- While the originally intended oligo(acrylic acid) groups failed as a stimuli responsive group, the  
synthesis of the oligomer is the first to be described in literature, proving that ATRP can be 
used for such short oligomers (n = 4-30). Furthermore, my synthesis allowed unusually narrow 
molecular mass distribution (DPI = 1.1-1.3) oligomers through radical polymerisation. 
- While liposomes were used as a preexperiment, they proved inadequate regarding their 
stability. Thus, a liposome mix of unusual stability was created.  
- This new liposome mixture behaved in between other liposomes and polymersomes, thus 
giving further insights in vesicle stability and self-assembly. 
 
 
2 Discussions stimuli responsiveness 
2.1 Sulforhodamine B and carboxyfluorescein release experiments 
 
FCS turned out to be too slow for measuring the release so that it could only indicate that N lost less 
dye than P regarding the CPM of the vesicles (but not the percentage of free dye due to the vesicles 
outshining free dye) and that S was in between, with some indication that it stopped releasing at low 
pH. 
In case of carboxyfluorescein release experiments, using self-quenching concentrations worked far 
better, but were still not reliable enough. The experiments still suffered from a missing recording of 
the initial release making it impossible to quantify the release. They also suffered from a high statistical 
error regarding sample preparation and measurement. The negative control appeared to release the 
most, which has to be attributed to the other samples releasing most of the dye before the actual 
measurement. Still, it gave more information than the FCS in that it gave a clear indication that the 
sample had blocked pores at pH 5.5. 
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2.2 Liposomes vs polymersomes in HRP/Amplex Ultra Red kinetics 
 
Liposome based nanoreactors (Chapter enzyme kinetics 4.2) revealed a clear stimuli response of 
R270C-Gala3-OmpF in that the activity of NRC decreased on acidification to 46% (see Fig. 27 in chapter 
enzyme kinetics), thereby overruling the pH dependent activity of the free enzyme. The experiment 
was repeated with the same result; except that the NR- control had initially a lower activity until it 
became acidified indicating some release of HRP over time, otherwise the controls did not change their 
activity upon acidification (See Fig. 28 in chapter enzyme kinetics). Both findings regarding NR- can be 
attributed to the inadequate thermal stability of the vesicles. 
The experiments were repeated with the more stable DSPC-mix liposomes. In that case, K89R270C-
Gala3 OmpF was used instead of R270C-Gala3 OmpF, since the DOL of the OmpF conjugates appeared 
to be only moderate according to the acrylodan assay, a double mutant was developed, which 
achieved higher DOL. Also, the pH was only reduced to 6.0 instead of 5.5, since it was found that this 
makes the pH adjustment and thus the entire experiment more reliable. Here, the activity of NRC went 
down to 74%. Since the DSPC-mix was harder to work with and more challenging to insert OmpF, but 
also because the experimental graph (see Fig. 31 in chapter enzyme kinetics) had more noise, it can 
be assumed that the prior experiment is more trustworthy regarding the magnitude of the decrease 
in activity. 
While liposomes insert membrane proteins far more readily than most polymersomes (due to the 
thicker and more rigid membrane of polymersomes),[2] the reproducibility of the results was 
significantly higher once OmpF was successfully inserted in polymersomes (compare Fig. 30 and 38 in 
chapter enzyme kinetics). Whenever the hydrodynamic diameter and the polydispersity were similar 
according to the Zetasizer, the vesicle concentration could be estimated by the samples ability to 
scatter light. Thus, after concentration adjustments the reproducibility increased significantly. The 
remaining fluctuations between repeats may arise from different encapsulation efficiencies of HRP or 
different OmpF densities in the membrane. Polymersomes increased the stability of the enzyme 
kinetics considerably. The liposomes needed to be measured on the same day since the negative 
control was slowly releasing enzyme, whereas the polymersomes showed identical behaviour 
remeasuring samples after one week.  
In case of polymersomes, the activity of the NRC dropped to 16% of its activity at pH 7.4 (see Fig. 38 in 
chapter enzyme kinetics), thereby changing from an activity close to NR+ (90%) to an activity close to 
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NR- (90%). Thus, the pore of the OmpF conjugate underwent a change from an almost completely 
open state to a perfectly closed state (deviation in the realm of experimental error). 
Stimuli-response due to different permeability of the membrane, in particular phospholipids, can be 
excluded due to the NR- controls. Moreover, polymersomes had similar behaviour whilst lacking 
protonisable groups in the membrane.  
The residual activity of the NR- controls and the NRC at low pH (OmpF with blocked pores) was 
significantly higher in case of liposomes compared to polymersomes (the activity at pH 5.5 of NR- was 
twice as high as those found in the experiments with polymersomes). This could be either explained 
by a higher permeability of liposome membranes or a higher rate of breaking vesicles. The latter is 
more probable, as liposomes had to be measured on the same day, while polymersome samples could 
be measured one week later without significant increase of background activity (Fig. 9 and 10 in 
chapter enzyme kinetics). All these factors make polymersomes the superior choice as membrane. 
 
 
2.3 Amplex, TMB, glucose assays 
 
Originally, alternatives to Amplex Ultra Red/HRP were searched, due to the recurring problem that NR- 
had a higher activity than NR+ and due to the fact that the fluorescence of the product is strongly pH-
dependent. As it turned out, the problem with the controls lay elsewhere (as discussed above). 
However, it is still interesting since the substrates have different sizes, charges and should have 
different permeability regarding vesicle membranes. More importantly, it can give insight into the 
mechanism of the stimuli responsiveness. 
For instance, the stimuli responsiveness could be explained by mere charge repulsion, as it was in case 
of the previously published 6xHis OmpF mutant.[3] The Gala3 peptide has 5 carboxylic acid groups, 
which are negatively charged in solution except for very low pH and the oxidised Amplex Ultra Red is 
negatively charged as well for most pH. Thus, using a substrate with positive charge would be 
interesting to see, whether the pore is blocked as well and if so under the same experimental 
conditions. TMB is the only suitable substrate of this kind. The ideal substrate is however uncharged, 
but water soluble for all pH values. This is however technically impossible, since all fluorophores are 
hydrophobic, unless enough charged or polar groups are added. As it was seen from experiments of 
attaching glutathione to FCS-fluorophores, it may increase the solubility, but it ads mainly to the size 
and it does not prevent the hydrophobic part of going into membranes and disrupting them. The only 
feasible option to avoid this dilemma is implementing a tandem reaction which converts a hydrophilic 
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compound and the side product can be used for producing a fluorophore. Glucose oxidase/HRP is such 
a system. 
As mentioned before Amplex Ultra Red/HRP kinetics indicate that K89R270C-Gala3 OmpF goes from a 
fully open to a completely closed state from pH 7.4 to 6.0. Experiments with TMB revealed (see Fig. 32 
in chapter enzyme kinetics) the same trend, although the kinetic with TMB is not as appealing as the 
Amplex Ultra Red kinetic. It does reveal an important aspect: the blocking of the pore is most likely 
independent of the charge of the enzyme substrate. The Gluc/GOX/HRP system suffered of NR- being 
more active than NR+, but here it was evident beyond doubt, that most of the glucose was released 
from the NR+ before the actual experiment started. Tests releasing glucose from NRC and detecting it 
via glucose oxidase and HRP revealed the same trend offering additional proof to the aforementioned 
results. 
 
 
2.4 Oligo(acrylic acid), Gala3 and HLG4 
 
In the original concept, a short pH responsive oligomer was envisioned as a stimuli responsive plug. It 
was supposed to be a random coil with negative charges from carboxylic groups around pH 7. At low 
pH it was supposed to be protonated and uncharged making it hydrophobic. It should thus change 
from a random coil dangling around the pore effectively blocking it, to a compact dehydrated state, 
precipitated on the pore wall, thus opening the pore at low pH.  
Oligo(acrylic acid)-conjugates were investigated using both lipo- and polymersomes and using Amplex 
Ultra Red-HRP, but the results were not conclusive (Fig. 26 and 27 in chapter enzyme kinetics). It 
seems that oligo(acrylic acid) of any length could block the pore independent of the pH and that the 
degree depended mostly on the DOL and not on the length. 
Gala3-conjugates worked perfectly well as proven in POPC/POPS-liposomes, DSPC-mix liposomes and 
polymersomes (chapter 4.2 in enzyme kinetics). However, despite being functional analogues of the 
originally intended oligo(acrylic acid)-conjugates, they proved to have the very opposite stimuli 
response than anticipated. The experiments with liposomes had a higher statistical error and NRC did 
not close as much as in polymersomes thus NRC never overlapped with NR-. In polymersomes, NRC 
changed from a perfectly open state as NR+ to a perfectly closed state as NR- and the pH dependent 
change was reversible for multiple cycles. TMB gave the same result as Amplex Ultra Red although it 
has the opposite charge indicating that the pore is blocked rather by conformational changes than 
changes in its charge. Tests releasing glucose and detecting it via glucose oxidase and HRP revealed 
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the same trend offering additional proof, since glucose is uncharged and polar. The pH-responsiveness 
was also confirmed using uricase in combination with HRP, but the experimental error was high and 
the trend rather weak. 
HLG4-conjugates provided the opposite stimuli response according to HRP-Amplex Ultra Red 
experiments, as planned, but not according to TMB, which indicates that the oppositely charged TMB 
apparently interacted with the peptide (chapter 4.3 in enzyme kinetics). However, not enough 
experiments were performed to come to a final conclusion. Most importantly, the TMB experiment 
was not repeated, since TMB was not particularly interesting to prove the stimuli responsiveness of 
Gala3 (the other assays worked better). It could be thus that it was not due to the charge, but to a 
faulty assay. 
HLG4 seems to have the opposite behaviour, which contributes to the concept of a modular system, 
though the observed stimuli response was weaker. This could be for multiple reasons. For instance, 
the pKa of histamine is at 7 (chosen for a stronger change in the state of protonation) while the one of 
glutamine is at 4.3, thus the peptide is not a direct opposite of the acidic Gala3. The opposite behaviour 
is remarkable as it cannot be expected that it transforms from a random coil to a helix in the opposite 
direction complementing conveniently Gala3. If it did work the in the same way but had just a pKa 
around 7 instead of 4, then one could expect the turning point to be around pH 9 and not 6. In that 
case, it would be expected that at a transition from pH 7.4 to 6.0 the pore would switch from a half-
open to a completely open state, but it turned out to be the other way around: from a closed to a half-
open state. 
 
 
2.5 Anchor sites 
 
The mutation sites D12C (asparagine, the 12th amino acid of the OmpF amino acid sequence replaced 
by cysteine) K89C (lysine) and R270C (arginine) located inside the pore in the eyelet-region were 
replaced by cysteines (Fig. 1 in chapter preparation). These locations allow the attachment of 
molecular groups that can block the molecular flow at the beginning of the pore or point outwards 
without obstructing the pore, in different conditions. (Fig. 3 in chapter preparation).[4] The mutation-
sites are roughly equally distanced so that multiple anchor points could be used at once. Since the 
acrylodan assay indicated a low DOL, primarily the double mutant K89R270C-OmpF was used in order 
to increase the chance that a pore has one or more stimuli-responsive groups. 
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K89C and R270C work equally well as anchor point, but D12C was never labelled successfully by any 
oligo(acrylic acid). D12K89C and D12R270C-OmpF behaved like a single mutant, indicating that D12C 
is buried or shielded. This might be due by E2 and K46 which flank D12C, or possibly tyrosine Y14 
shields it. 
 
 
2.6 Single vs double mutants 
 
Since D12K89C- and D12R270C-OmpF failed as double mutants, only K89R270C-OmpF remained. In 
earlier experiments it was indicated that K89C and R270C OmpF behave identically, thus both anchor 
sites were expected to behave identically within K89R270C-OmpF. While the acrylodan assay did not 
indicate that the DOL of K89R270C-OmpF being the sum of the DOLs of K89C and R270C OmpF. 
However, the experiments using in-gel digestion and mass spectrometry leave little doubt that both 
groups are equally accessible (94 and 92% respectively). 
Before the high DOL was confirmed via mass spectrometry, the experimental set up was changed from 
R270C-OmpF to K89R270C-OmpF as a basis. Thus, experiments using Amplex Ultra Red/HRP and 
liposomes were conducted with the single mutant and those conducted in polymersomes were using 
the double mutant. From the results it appears that the single mutant OmpF-C did not block as well as 
the double mutant OmpF-C, however, when the experiment was repeated using R270C-Gala3 OmpF 
in polymersomes, no difference could be seen from K89R270C-OmpF. This indicates, that the lower 
stimuli response stems from the more permeable and fragile nature of liposomes and not from the 
blocking or DOL of the OmpF-C. 
 
 
3 Lessons learned 
3.1 OmpF insertion 
 
Due to OmpF’s exceptional stability and ability to properly refold (as long as the thiol groups cannot 
form a disulphide bridge), it can be inserted into vesicle membranes in ways otherwise impossible. It 
could thus be inserted in presence of high amounts of detergents using a detergent removal method 
for liposome-formation or it could be dried along with ABCP to a film for polymersome-formation (and 
DSPC-liposomes). However, the fact that some batches lend themselves only to one of these two 
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methods strongly indicates that other, easily overlooked factors play a role. It appears that OmpF 
extracted with Octyl-POE allowed the prior method, and OmpF extracted with OG could only be used 
for the latter method. This speaks for the importance of co-extracted bacterial lipids in the ternary 
mixture.[5] It also showed again that the DSPC mixture liposomes are closer in their behaviour to 
polymersomes, which is probably explained by the fact that they become almost rigid at room 
temperature. 
 
 
3.2 Vesicle stability 
 
It has been noticed that NPC and DSPC liposomes behaved very differently and the same could be said 
for short and long ABCPs. In many ways the DSPC-mix was far closer to polymersomes than the other 
liposomes. This trend obviously comes from the length of the hydrophobic parts and the density of the 
packing. In general, it can be said, the longer the hydrophobic section of the ABCP, the: 
- lower the solubility and rate of film-rehydration 
- slower the film-rehydration becomes (NPC 1-3h; DSPC 16-20h; ABA 16-24h) 
- higher the sensitivity towards oxygen during vesicle-formation (although unsaturated lipids 
are also sensitive, but due to photo-reactions and not due to perturbation of the self-assembly) 
- the higher the sensitivity towards detergents becomes during self-assembly. 
- less likely to co-assembly with lipids and additives such as cholesterol TDOC, etc.  
- harder insertion of OmpF becomes (mismatch in thickness, lacking mobility of the membrane 
and sensitivity towards stabilising detergents) 
- higher the stability of the vesicle-membranes regarding time and temperature. 
- lower the membrane permeability (thicker, less fluid membrane). 
- lower the sensitivity of membranes towards detergents becomes (but not as stable as 
liposomes in that regard). Similarly, the stability towards FCS-dyes increases (in this case 
outclassing liposomes). 
- less likely the vesicles are able to recover from damage (disruptive detergents, sonication, 
centrifugation … presumably because ABCPs are less likely to go from a micelle into solution 
and are less likely to insert themselves into a damaged membrane) 
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Asides from the ternary mixture surrounding OmpF, there is another factor greatly reducing 
reproducibility of experiments: Amphiphiles can age and in case of ABCPs, even nominally identical 
batches can differ in their PDI, the amount of AB in ABA, or the content of unreacted PDMS. Similarly, 
aging could break up ABA in AB+A, or separate the blocks completely or alter them through oxidation. 
PDMS is moreover known for hydrolysis catalysed either through acids or bases,[6] however, it is slow 
around pH 7. 
Why the vesicle-formation in case of liposomes withstood higher detergent concentrations might be 
explained through the short hydrophilic block. Liposomes are also less sensitive to detergents probably 
since the mismatch in length and physical-chemical nature of the detergent is less pronounced as in 
polymersomes. These effects most probably the way detergent interact with ABCP micelles and 
vesicles, stabilising one and destabilising the other. For instance, it could be that the detergent inserts 
in liposomes, evenly whereas it produces detergent domains in vesicles which weaken the membrane. 
Furthermore, it could be that detergents stabilise isolated ABCPs and thus alter the equilibrium or 
interact with AB-ABCPs within ABAs causing phase separation. 
Detergents are problematic for another reason as well: Detergents are also from a practical 
perspective impossible to removed completely, as they bind to membranes. Size exclusion 
chromatography, dialysis, the addition of biobeads etc. fails in that respect. The harmful effect is only 
observed to the full extent with delay. This explains that a detergent titration curve, vesicle analytics 
etc all imply that the polymersomes withstand e.g. 0.25% OG, but then perform very different to 
expectations in that the vesicle-formation is hindered and that over time the vesicles deteriorate. 
While detergents and dyes have the tendency to break vesicles up into micelles, it seems also that 
even remaining vesicles have a different behaviour than those vesicles that did not have contact to 
detergents. 
Interestingly, the time of the detergent addition has an equally great impact on vesicle stability as the 
detergent concentration does. It is possible to use a higher detergent concentration during film-
rehydration than, after completion of the process. In addition, while the film-rehydration is hindered, 
it is possible to apply dialysis or biobeads during vesicle-formation, which gradually remove the 
detergent, so that vesicle-formation starts and all the excess of detergent, which does not bind to the 
membrane is removed. While the presence of detergents increases the micelle-fraction considerably 
and reduces the average vesicle-size, it has been found to be better for MP-insertion than trying to 
destabilise polymersomes with detergents afterwards. 
In this context it was observed that MPs such as SGLT and presumably OmpF (regarding NR- with and 
without detergent) are able to stabilise polymersomes against the negative influence of detergents. 
This effect would be probably far more noticeable, if higher MP-concentrations would be used. This 
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would also imply that controls without OmpF, will never correctly represent the vesicle-membranes 
with blocked OmpF. 
Dyes were found to act similar to detergents, hindering vesicle-formation and destabilising vesicles by 
inserting themselves into the membrane (various interactions of dyes with lipid membranes was 
reported before, both above and below the phase transition temperature of the lipids).[7] Moreover, 
the latter effect is also delayed, meaning that it can still occur after extrusion and size exclusion 
chromatography. Thus, a sample can consist primarily of micelles according to FCS although the micelle 
fraction had been removed prior to the measurement. Unlike detergents, larger hydrophobic dyes 
turned out to be worse and polymersomes appear to be more robust towards their presence. This 
extends to DSPC-mix liposomes being more resilient and long ABCPs being more resilient than shorter 
ones. Hence, it’s the very opposite of how vesicles behave to detergents. 
 
 
4 Conclusion and outlook 
 
A new modular stimulus triggered system was successfully developed allowing to establishing control 
over the transport via membrane of self-assembled nanoreactors. In addition, a reliable assay for 
testing the functionality of the new biovalve was developed and further used. The developing of this 
new stimulus triggered biovalve opens new ways of using this artificial self-sustained nanoreactors for 
nanosensors and successful replacements of failed organelles in living cells. As a colleague proved, 
polymersomes of this type (same ABCP, same OmpF-mutant, same vesicle size), can be uptaken into 
cells and show low cell-toxicity,[8] while maintain the activity of the encapsulated enzyme. The modular 
system allows various stimuli responses based on conformational changes opening and closing the 
pore. 
The best results were obtained for Gala3 modified OmpF that showed a reliable transition from the 
opened to closed state triggered by a pH change of only 1.4 units from the physiological pH. The stimuli 
triggered response was so fast that the transition between the states could not be observed directly 
with the employed methods. Moreover, this transition is reversible so the nanoreactors containing 
Gala3 modified OmpF show practical infinite self-supporting activity of the entrapped enzyme. 
The discussed system is a significant advancement in the field of nanoreactors since the other stimuli 
responsive systems are either not reversible, lack control (reversible disassembly), do not regulate the 
flow of molecules except metal-ions, or require complex genetic engineering (multiple mutations that 
could affect structure or functionality). Our modification method with the selected peptides is reliable 
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and robust and can be used for any membrane porin with a single mutation for pores of the size of 
OmpF. The modification can be can be easily adapted to other stimuli responses peptides (changing 
Glu for His, Lys or Arg, or possibly even creating temperature responsive ELP-peptides). For enabling 
larger substrates to pass through, a larger pore would need to be used and multiple anchor sites 
introduced in order to maintain control. Our designed biovalve offers options of tailor made solutions 
for all possible problems. That is why our system opens the door for a new way of successful usage of 
nanoreactors as efficient, personalized, non-invasive alternative for cell metabolic diseases. 
 
 
5 References 
 
[1] M. E. Jackson, J. M. Pratt, N. G. Stoker and I. B. Holland, The EMBO Journal 1985, 4, 2377-
2383. 
[2] a) W. Meier, C. Nardin and M. Winterhalter, Angewandte Chemie-International Edition 2000, 
39, 4599-4602; 
b) F. Itel, M. Chami, A. Najer, S. Lörcher, D. Wu, I. A. Dinu and W. Meier, Macromolecules 
2014, 47, 7588-7596. 
[3] S. Ihle, O. Onaca, P. Rigler, B. Hauer, F. Rodriguez-Ropero, M. Fioroni and U. Schwaneberg, 
Soft Matter 2011, 7, 532-539. 
[4] a) R. Koebnik, K. P. Locher and P. Van Gelder, Mol Microbiol 2000, 37, 239-253; 
b) W. Grosse, L.-O. Essen and U. Koert, ChemBioChem 2011, 12, 830-839; 
c) H. Miedema, M. Vrouenraets, J. Wierenga, D. Gillespie, B. Eisenberg, W. Meijberg and W. 
Nonner, Biophys J 2006, 91, 4392-4400; 
d) H. Miedema, A. Meter-Arkema, J. Wierenga, J. Tang, B. Eisenberg, W. Nonner, H. Hektor, 
D. Gillespie and W. Meijberg, Biophys J 2004, 87, 3137-3147. 
[5] M. le Maire, P. Champeil and J. V. Moller, Bba-Biomembranes 2000, 1508, 86-111. 
[6] R. M. Hill, M. He, Z. Lin, H. T. Davis and L. E. Scriven, Langmuir 1993, 9, 2789-2798. 
[7] I. R. Calori, D. S. Pellosi, D. Vanzin, G. B. Cesar, P. C. S. Pereira, M. J. Politi, N. Hioka and W. 
Caetano, J Brazil Chem Soc 2016, 27, 1938-1948. 
[8] T. Einfalt, D. Witzigmann, C. Edlinger, S. Sieber, R. Goers, A. Najer, M. Spulber, O. Onaca-
Fischer, J. Huwyler and C. G. Palivan, Nature Communications 2018, 9, 1127. 
 
 
  
 227 
 
 
 
 
VIII Materials Methods
VIII Materials Methods 
228 
1 Chemicals and Consumables 
 
Reagents and materials were of the highest commercially available grade and used without further 
purification, unless indicated.  
 
 
1.1 OmpF-related 
 
The K89C-OmpF plasmid was produced previously in our group. The plasmid pXβG-ev1 was originally 
constructed by Gregory M. Preston. Omp8 E.coli/BL21-(DE3)omp8 was prepared by Prilipov et al 
1998.[1] Chemically competent XL1-Blue E.coli ultracompetent cells were obtained from Invitrogen. 
Subcloning Efficiency™ DH5α™ competent cells was obtained from Invitrogen. PfuTurbo DNA 
polymerase (No. 600254-52) was obtained from Agilent. Primers for the mutations came from 
Microsynth (quality: desalted), who also did the sequencing of the plasmids. DpnI was obtained from 
New England Biolabs. RNAse and DNAse were purchased from Roche. Trypton, Yeast-extract, LB-Agar 
and Terrific Broth were obtained from BD. Glycerol, SDS, ampicillin, IPTG, DTT were from Applichem. 
Pierce BCA Protein Assay Kit; X-Gal and HRP (No. 31491) were obtained from Fischer Thermoscientific. 
QIAprep Spin Miniprep Kit; QIAquick Gel Extraction Kit were purchased from Qiagen. Amplex Ultra 
Red was obtained from Invitrogen and stored as a stock solution of 1g/L in DMSO at -20°C. 
Octylglucopyranoside was obtained from Affymetrix. OPOE came from Enzo. Na2HPO4, KH2PO4, CaCl2 
(anhydrous granular), Trizima base, 30% H2O2 and the following solvents in HPLC-quality: Ethanol, 
DMSO, Chloroform, Methanol were obtained from Sigma Aldrich. NaCl was purchased from Merck. 
MgCl2 hexahydrate, MgSO4 heptahydrate, KCl were obtained from Fluka. Pure water was obtained 
from a Milli-Q Divect 8 from Milipore. Spectra/por Dialysis tubes: 3.5-5; 8-10; 100 and 300kDa MWCO 
CE 16mm were obtained from Spectrumlabs. 6-8kDa 850μL Gebaflex were purchased from Molecular 
Dimensions. Biobeads/SM-2 Adsorbents were obtained from Biorad. 
 
 
1.2 Oligomer related 
 
The technical grade solvents DCM, ethyl acetate, ethanol 96%, hexane and THF came from Brenntag 
Schweizerhall AG. Ethyl acetate, hexane and THF were distilled before use. Tert. butanol was 
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purchased from Fluka, MTBE from Alfa Aesar. anisole 99.7%, toluene, DMF, acetonitrile and DMSO 
were supplied by Sigma-Aldrich. Maleic anhydride 98% was supplied by Alfa Aesar, furan and 
bromoisobutyrylbromide 98% by Aldrich, ethanol amine 98% and triethylamine 99% by Sigma-
Aldrich. Copper (I) bromide and copper (II) bromide 99% were supplied by Aldrich. PMDETA and 
Me6Tren supplied by Alfa Aesar. Tert. butyl acrylate 98% and NIPAAM 97% were purchased by Aldrich. 
TFA 99% came from Alfa Aesar, TIPS 99% from Aldrich, NaHCO3 technical from Sigma-Aldrich. Silica gel 
P60 300 mesh came from Fluka, ALOX activated basic Brockmann from Sigma-Aldrich and the TLC 
plates from Merck (silica 60 F254 and ALOX neutral F254). The peptides modified at the N-terminus 
with 3-maleimidopropionic acid (CAS No: 7423-55-4) were supplied by Genscript. The peptide 
LAEALAEALAEA came in 97% purity and had later to be resynthesised by CPC scientific in 87%. The 
other Genscript peptides had a purity of 95% or more. 
 
 
1.3 Vesicle related 
 
The following solvents in HPLC-quality were obtained from Sigma Aldrich: ethanol, chloroform, 
methanol. Pierce HRP (no. 31491) was obtained from Fischer Thermoscientific. Spectra/por Dialysis 
tubes: 8-10 and 100 MWCO CE 16mm diameter tubes were obtained from Spectrumlabs. 
Biobeads/SM-2 adsorbents were obtained from Biorad.  
The ABA triblockcopolymers were previously synthesised in our group:[2] 
Amplex Ultra Red was obtained from Invitrogen and stored as a stock solution of 1g/L in DMSO at -
20°C. 30% H2O2 was obtained from Sigma Aldrich. ABTS was purchased from Sigma-Aldrich 
Natural phosphatidylcholine (P3556-25MG type XVI >99% TLC from egg yolk), SM (sphingomyelin from 
bovine brain TLC>97%), cholesterol (>99%) and cholesterol-PEG600 (polyoxyethyl-cholesteryl 
sebacate; C1145-1G) were obtained from Sigma Aldrich. POPS (1-palmitoyl-2-oleoyl-sn-glycero-3-
phospho-L-serine (sodium salt); 840034P) and DSPC (1,2-distearoyl-sn-glycero-3-phosphocholine; 
850365P) were obtained from Avanti Lipids. 
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1.4 Other Chemicals and Consumables 
 
Thioglo 1 and 3 came from Covalent Associates Inc. Acrylodan was purchased from Invitrogen. Bodypy 
FL and DyLight488 were obtained from Thermo Fisher Scientific. OregonGreen 488 and Alexa488 were 
obtained from Invitrogen. Sulforhodamine B was purchased from Sigma Aldrich. Phenol and H2SO4 
ACS grade were purchased from Sigma-Aldrich. FloatALyzer (200-400Da Cutoff) was obtained from 
Spectrumlabs. 6-8kDa 850μL Gebaflex were purchased from Molecular Dimensions and 10k-Amicons 
from Milipore. 
10x PBS pH 7.4: 80g NaCl (1.37M), 2g KCl (26.8mM), 14.4g Na2HPO4 (101mM) and 2.4g KH2PO4 
(17.6mM) were dissolved in 900mL of distilled water and filled up to 1L. No pH adjustment was 
required. 
10x Citrate Buffer pH 7.4: 56.8g Na2HPO4 (400mM), 57.6g citric Acid (300mM) were dissolved in 900mL 
of distilled water and the pH was adjusted with KOH (ca. 51.6g, or 100mL of 10M KOH). The solution 
was diluted with water, if required in order to reach 1L. 
Note: 10x buffers, are buffers that need to be diluted 10x prior use (10x in volume), but without 
further adjustment of the pH. 
 
 
2 Devices 
2.1 Vesicle analytics 
 
Zetasizer: For quality-control, vesicles samples were measured with a Malvern Zetasizer nano ZSP. The 
samples were diluted 10-100x (to the point where they were no longer visibly opaque in order to avoid 
multiple scattering). The DLS-measurements were carried out using the parameter recommended by 
the producer. 
Light scattering experiments were performed using an ALV goniometer (ALV GmbH, Germany) 
equipped with an ALV He -Ne laser (JDS Uniphase, wavelength λ = 632.8 nm). The vesicle solution (1.25, 
0.625, 0.313 and 0.156 g/L) was measured in a 10 mm cylindrical quartz cell at angles ranging from 30° 
to 150° at 293 K. ALV/Static & Dynamic FIT and PLOT program version 4.31 10/10 was used in the 
process. Static light scattering data were processed according to the Guinier-model. 
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Transmission electron microscopy: 5 μL polymer vesicle solution were negatively stained with 2% 
uranyl acetate solution and deposited on a carbon-coated copper grid. The samples were examined 
with a transmission electron microscope (Philips CM-100) operated at 80 kV. 
Vesicle concentration: After confirming the purity and homogeneity using Zetasizer, the vesicle 
concentration of different samples could be compared by observing their ability to scatter light using 
the Spectramax M5 in fluorescence mode (point-measurement at 650/650nm excitation/emission) in 
semi-micro fluorescence polystyrene cuvettes (VWR). 
 
 
2.2 Kinetic measurements 
 
For absorption and fluorescence semi-micro fluorescence polystyrene cuvettes from VWR were used. 
The fluorimeter LS 55 came from PerkinElmer and the Spectramax M5e, used in particular for 
absorbance measurements, from Molecular Devices (settings described in the methods section). It 
replaced also the previously used UV-Vis Specord 210 Plus from Analytik Jena.  
Note: the Spectramax was more convenient and faster to operate, allowed the use of well plates and 
had a larger measuring range, but was less sensitive than the specialised machines. NanoDrop 2000c 
from Witec AG was used for checking purity and concentration of plasmids and OmpF. 
 
 
2.3 Other devices 
 
Pure water for bioapplications was obtained from a Milli-Q Divect 8 from Milipore.  
The PCR machine was a Mastercycler gradient from Eppendorf.  
The cell culture flasks were 2.5L ultra high yield flasks with AirOtop seal from HTS-labs. The vortexer 
was a MS2 minishaker from IKA.  
For the sonication of small sample volumes an ultrasonic processor GE 130 from Cole-Parmer was used 
and for greater volumes a sonication bath type Bandelin from Sonorex.  
The tabletop centrifuge was a Minispin from Vaudaux Eppendorf, the default centrifuge was a 3-18K 
(using either a 19776 rotor or a 11180-13190 swing bucket rotor) from Sigma. The ultracentrifuge was 
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an Optima XE-90 ultracentrifuge with a 70.1Ti rotor from Beckman Coulter (using 38.5mL PC thick wall 
with thread tubes from Herolab).  
The French Press EmulsiFlex C3 came from Avestin.  
For vesicle extrusion an extrusion apparatus from Avanti Lipid was used with 1 ml Hamilton syringes 
(passed 10-20x through a 100 or 200nm membrane). For special cases a custom made, gas-powered 
barrel extruder was used. It consisted of three parts that could be screwed together similar to a vice. 
The lower part collected the flow-throw and pressed the membrane against the middle part which 
held the liquid and the headspace for applying pressure. The top had an inlet for the sample and for 
the pressurised air. The operating pressure was between 2-15mBar. The sample was passed 6x through 
400nm and 6x through a 100nm and then 6x through a 200nm membrane. The membranes were 
Nuclepore track-etch membrane from Whatman.  
Mass spectroscopy: LC-MS column ReproSil-Pur C18–AQ, 1.9 μm resin Dr. Maisch GmbH, Ammerbuch-
Entringen, Germany combined with a dual pressure LTQ-Orbitrap Elite mass spectrometer connected 
to an electrospray ion source (both Thermo Fisher Scientific) 
For MALDI-TOF a Microflex from Bruker with either MSP 96 target ground steel microScout Target or 
MSP Big Anchor Chip 96 from Bruker Daitonik GmbH were used. For analysing the oligomers 1mg of 
the sample was dissolved in 250µL 50% aqueous acetonitrile with 0.1% TFA. The sample was mixed 1:1 
with sinapinic acid (20mg in 1mL of the same solvent). The 10µL drop was allowed to dry for 30-60min 
and the sample was measured at 20% offset; 40% laser output and 90% laser intensity using the 
RN:peptide method (detecting negative charged ions and using a reflector). 
NMR Experiments 400 MHz: All NMR experiments were performed on a Bruker Avance III NMR 
spectrometer operating at 400 MHz proton frequency. The instrument was equipped with a direct 
observe 5-mm BBFO smart probe. The experiments were performed at 295 K and the temperature was 
calibrated using a methanol standard showing accuracy within +/- 0.2 K. 
LSM-FCS: measurements were performed on a confocal laser scanning microscope (Zeiss LSM 510-
META/Confocor2, Carl Zeiss, Jena, Germany). For 488 dyes an argon-2 laser with λ = 488 nm (15 mW 
output) and for sulforhodamine B a He-Ne laser (λ = 543 nm) and for confocal adjustments a He-Ne 
laser with λ = 633 nm (15 mW output) was used. 
For the 488 nm laser, a main dichromatic beam splitter (HFT 488/543/633), a secondary dichroic beam 
splitter (NFT 545) and a low pass filter (LP 505) were used. The laser intensity was typically tuned down 
to 40% using 10% transmission; 1% probleach. For the 543 nm laser, a dichroic beam splitter (DBS HFT 
543), a secondary dichroic beam splitter (NFT 545) and a band pass BP 560 - 615 nm filter were used. 
The laser intensity was typically tuned down to 60% (a second down-tuning step). The laser intensity 
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was typically tuned down to 20%. For 633 nm laser, a main dichromatic beam splitter (HFT 
488/543/633), a secondary dichroic beam splitter (NFT 545) and a low pass filter (LP 650) were used. 
The light was focused on the sample using a C-Apochromat 40x water immersion objective (NA=1.2). 
The default settings were: 20x10s measuring time for free dye and 30x20s for vesicles (30 points in 
30min for kinetics). For calibration 100nM SRB was used, applying a 1 component model else two 
component model was applied with a triplett relaxation time of 3 and a structural parameter of 5 and 
a 1e-6 cuttoff. The sample of at least 6µL was placed on a glass plate or in a 2x4 nunc glassbox with lid. 
The latter was used in particular for longer measurements using larger samples in order to reduce 
evaporation. 
GPC-measurements were conducted on a TDA305 from Viscotek using two 5um Mixed-C columns 
from Agilent and a Malvern detector equipped with UV-Vis, IR, 90° LS and viscometer. The samples 
were dissolved in THF, which was also used as eluent at 1 mL/min at 40°C. The system was calibrated 
with polystyrene-standards. 
 
 
3 Methods 
3.1 Oligomer Synthesis  
3.1.1 Synthesis of the ATRP-initiator 
3.1.1.1 Protected maleic anhydride 
 
The maleic anhydride was dissolved in toluene as a 2M solution (for 50mL a 100mL 3-neck round 
bottom flask equipped with stirring bar, condenser, thermometer and argon inlet were used). Oxygen 
was removed through brief bubbling with argon. The solution was then heated to 80°C. Under stirring 
1.2eq of furan was added and allowed to react for 3h. Then another 1.2eq. were added. After cooling 
down over 1h, the crystalline product was filtered off and washed with cold hexane. Ten grams of 
maleic imide yield about 16g of product (92%). 
Notes: the reaction does not require true Schlenk conditions, but too much would oxidise in presence 
of air. The reaction can be followed via TLC using 1:1 ethyl acetate/hexane and KMnO4-staining 
solution. The maleic anhydride has a RF of 0.67, the furan (poorly visible) 0.27 and the product 0.44. 
It appeared that the furan vapours were able to diffuse away thus another equivalent had to be added. 
This increased the yield dramatically (original literature had 42%[3]). During the reaction, the argon was 
supplied from the condenser to avoid vapours getting into the Schlenk-line. 
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The filtrate contains some product, but it is not the worth the time to purify it. The crystalline product 
was used without further purification. 
 
Fig. 1: 1H-NMR of Maleic anhydride; δ=6.58ppm (2H, m, CH=); 5.46 (2H, m, CH-O); 3.18 (2H, s, CH-CO); 
Note: 7.04ppm is the starting material maleic anhydride  
 
 
3.1.1.2 Protected maleic imide 
 
The starting material was dissolved in ethanol (2M solution; for 8g a 100mL round bottom flask 
equipped with a stirrer was used) and cooled with ice. Then 1.05eq of ethanol amine (10M solution) 
was added dropwise. After 30min the solution was allowed to warm up to room temperature (ca. 
30min). Then a condenser was attached and the solution refluxed for 6h at 85°C. After cooling down 
to 4°C, the product was filtered off. 8g of the starting material resulted in 7.1g product (75%). 
Notes: In order to obtain the yield described in the original publication[3] the reaction time, had to be 
extended and impure product had to be purified a second time as every purification resulted in high- 
and low-purity product. Washing the product with cold hexane reduces the yield somewhat. In the 
rare case that the product did not become pure enough, it was dissolved in DCM and washed with 
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water. Then, flash column chromatography using silica and ethyl acetate (TLC 100% ethyl acetate: 
RF=0.26) could be performed. 
 
 
Fig. 2: 1H-NMR of the maleic imide δ=6.53ppm (2H, m, CH=); 5.29 (2H, m, CH-O); 3.79-3.76 (2H, m, 
CH2-O); 3.72-3.70 (2H, m, N-CH2); 2.90 (2H, m, CH-CO); 2.1 br (1H, s, OH); Note: No traces of ethanol 
nor amino ethanol found 
 
 
3.1.1.3 Protected Initiator 
 
The starting material was dissolved in THF as a 0.1M solution (500mL round-bottom flask equipped 
with a stirrer for 1.6g of starting material). 1.1 eq. of triethylamine were added and the solution cooled 
to 0°C. 1.1eq. of bromoisobutyrylbromide as a 0.25M solution in THF was added in the course of 30min. 
The solution was stirred for further 3h at 0°C and 12h at room temperature. The resulting NEt3HBr was 
filtered off and the solution was concentrated and redissolved in ethyl acetate, which was then washed 
with NaHCO3 solution and brine. The organic phase was then concentrated again and dried together 
with silica, so that a thin layer of powder can be put on top of a silica column. The product was then 
eluted with a 1:1 mixture of ethyl acetate in hexane. 1.6g starting material gave 2g yield (71%). 
A
B
C
D
E
F
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Notes: if the triethylamine is coloured, it needs to be distilled. It seems to be more efficient to add less 
of the bromoisobutyrylbromid, even if the conversion gets reduced, because an excess it difficult to 
separate from the product. Moreover, remaining reagent seems to make the product unstable. The 
washing step was introduced to eliminate HBr that hinders ATRP. The bromoisobutyrylbromid-solution 
is added best via syringe as it tends to degrease the joints in dropping funnels. The conversion can be 
checked via TLC using 100% ethyl acetate and KMnO4 stain. The crude product is best dried with silica, 
as it is a sticky gel that can solidify within pipettes. Large quantities are better purified via two flash 
columns rather than using one big column and a long gradient. If the initiator blackens, it can be 
purified by dissolving it in 40mL THF and passing it through 5mL of celite and 25mL of basic ALOX (using 
a 50mL syringe as a makeshift column). It can be combined with a 45μm PTFE filter. 
 
 
 
 
Fig. 3: 1H-NMR of the initiator: δ=6.44 ppm (m, 2H, CH=), 5.20 (m, 2H, CH-O), 4.26 (m, 2H, CH2-O), 3.75 
(m, 2H, CH2-N), 2.80 (m, 2H, CH-CO), 1.83 (s, 6H, CH3); note: the acylation of the alcohol splits the 
multiplettes of the neighbouring groups. 
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3.1.2 ATRP 
3.1.2.0 General Remarks 
 
The ATRP were carried out under Schlenk conditions since oxygen stops the reaction. Water was not 
an issue, moreover the reaction seems to be robust enough that traces of oxygen are tolerated 
(decreasing somewhat the yield). For instance, it was possible to mix all components together and add 
the copper salt directly in a light counter argon flow thus starting the reaction without degassing the 
salt. 
Also, radical scavengers and substance such as HBr had to be avoided. Thus, pure solvents (dry or 
distilled) and distilled ligands were used. Distilled substances were stored under argon at -20°C. The 
monomer contains radical scavengers. It was initially distilled at 30°C and 30 Torr and stored in the 
freezer. Later the monomer was passed through basic ALOX (utilizing a syringe filled ALOX up to 2/3 of 
the volume over a thin layer of glass wool) twice thus avoiding the chance that a drop bypasses the 
minicolumn. The latter method lost probably even more monomer but was much faster to apply 
thereby allowing fresh monomer whenever needed. Similarly, yellowed ligands could be diluted in 
16mL DCM and passed through 2mL celite and 10mL basic ALOX using a 20mL syringe as a makeshift 
column. It can be further combined with a 45μm PTFE filter. 
Schlenk tubes were stored at 80°C and were assembled whilst being hot. They were evacuated and 
refilled with argon. Afterwards the cycle was repeated twice reheating the tubes with a heatgun. 
Copper salts and pulverized initiator were filled as powder in the Schlenk tubes. They were carefully 
evacuated and set under argon. This procedure was repeated twice taking about 15min unless the 
initiator appeared to be containing moisture or solvents.  
The initiator-monomer mixture and the copper-salts-ligand mixture were homogenised through 
sonication. The solutions were originally bubbled through with argon for 15min, as it is difficult to 
degas the monomer or ligand without losing much material. However, this resulted still in a volume 
loss (e.g. using MTBE) or in freezing of the solvent (tBuOH). Thus, the procedure was changed into the 
freeze thaw process (freezing the solution; evacuating and closing valve; thawing solution; quickly 
evacuating without making the solution boil; and allowing argon in; repeat once or twice until bubble 
formation was greatly reduced).  
Note: Freeze drying changes the colour of the copper-complex temporarily to violet, deep blue and 
green. During the ATRP it becomes an opaque malachite-green (in case of tBuOH as solvent). If the 
solution becomes reddish Cu2O is formed. This is probably caused through a bad initiator. 
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The wrong ALOX or glass-fritte can result in low yields, as the product can become stuck. The THF used 
for washing the ALOX should be distilled since technical THF contains methyl-di-tert.-butyl-phenol as 
stabilizer (often not mentioned on the label). This compound accumulates during the work up and 
overlaps with the 1H-NMR. 
The deprotected oligo acrylic acid is sensitive to moisture and heat. It has to be stored in the freezer.  
 
 
3.1.2.1 Oligo(acrylic acid) 
3.1.2.1 Method A (DP=12-30; PDI=1.1) 
 
The typical batch size was 100mg of initiator. For it, two 25mL Schlenk tubes were prepared. One was 
filled with the initiator (1eq., finely ground) and the other with 400mg CuBr (10eq) and 62mg CuBr2 
(1eq). The initiator was dissolved in 5.6mL dry anisole (producing a 0.05M solution) and 4.1mL tert.-
butyl acrylate (3xDP eq.) were added. The solution was further homogenised through sonication. In 
the other tube, 5.6mL anisole and 600µL PMDETA were added suspending the copper. Both solutions 
were stirred for 30min at 75°C, then 10vol% of the copper complex solution was added to the other 
tube. After 16h at 75°C the reaction was stopped by bubbling oxygen through the solution and passing 
the solution through a column of basic ALOX (filled up to 2-3x the column diameter). The solvent was 
removed and the oligomer was redissolved in a minimal amount of THF. The product was then 
obtained through precipitation in cold 80vol% methanol. 
The oligomer can be further purified with column chromatography (3x12cm SiO2, 200mL 2:1 
hexane/ethyl acetate; 300mL 1:1 hexane/ethyl acetate; 300mL ethyl acetate; 20mL-Fractions; TLC: 1:1 
hexane/ethyl acetate; stained with KMnO4). 
Note: using 100eq of monomer resulted in a DP of 31. With only 20eq. of monomer a DP of 6 is reached. 
It can be assumed that 3xDP corresponds to the required number of equivalents. However, the DP is 
dependent on the reaction time (unlike method B, where the reaction can be left longer). The shorter 
the oligomer the less likely precipitation works (below 12?). The product can appear as foam (higher 
PD makes this more likely). 
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Fig. 4: An example of a NMR spectrum of oligo(tert. butylacrylate) PD=15 with protected maleic imid 
group and unreacted monomer. In_a to In_f represents the signals from the initiator (which have not 
changed except for the resolution of the multiplette caused by the slower tumbling of the CH2-CH2-
group); P represents signals of the polymerised monomer, with P1 (m, 1H, CH-CO2; except CHBr-CO2), 
P2 (m, 1, CH,H-CHCO2), P3 (s, 9H, COO-tBu) and P4 (m, 1H, CH,H-CHCO2) and M_1 –M_4 represents 
the signals of the residual monomer. 
 
 
3.1.2.1 Method B (DP=6-12; PDI=1.3) 
 
For a batch of 100mg initiator, two 25mL Schlenk tubes were prepared. In one the initiator is placed 
(2eq., finely ground) and in the other 20mg of CuBr (1eq). Both tubes were evacuated carefully for 
5min and then slowly filled with argon. The freshly prepared monomer (2*DP equivalents) was then 
added to the initiator and the Me6tren (1eq.) to the CuBr. To both tubes 3mL of distilled tBuOH were 
added and homogenised through sonication. Traces of oxygen were removed by 2-3 freeze-thaw cycles 
from both tubes and the solutions were warmed to 30°C. Then a syringe was used to transfer the more 
homogeneous solution to the other and the mixture was stirred for 3h. The reaction was stopped by 
passing the solution through a column of basic ALOX (filled up to 2-3x the column diameter). The 
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solvent was removed and the oligomer was redissolved in a minimal amount of THF. The product was 
obtained through precipitation in cold 80vol% methanol. 
The oligomer can be further purified with column chromatography (3x12cm SiO2, 200mL 2:1 
hexane/ethyl acetate; 300mL 1:1 hexane/ethyl acetate; 300mL ethyl acetate; 20mL-Fractions; TLC: 1:1 
hexane/ethyl acetate; stained with KMnO4) 
Notes: Polymerisation seems to change the 1H-NMR signal of the N-CH2CH2-O group from two peaks 
to one. Adding 10eq. of ascorbic acid cause complete conversion. At a certain chain-length 
precipitation does not work any longer as the oligomers become oils (ca. DP<20).  
 
 
3.1.2.2 Retro-Diels-Alder reaction 
 
The maleic imide was deprotected by refluxing the oligomer in toluene as a 0.05M solution, under 
argon for 20h. The solvent was removed at 75°C and 2*10-2mBar. The yield was 95-100%. 
Notes: The evolving furan vapours will attack argon balloons, if not cooled sufficiently. Solvents like 
toluene, anisole and DMF experience a remarkable reduction in vapour pressure effectively denying 
the possibility of using a rotavapor. Instead a Kugelrohr can be used. Therefor for greater amounts it 
is recommended to use the bottom flask of a Kugelrohr device since rotating the flask is more efficient 
than stirring the thickening solution. For smaller quantities it is recommended to use a pear-shaped 
flask as the can be more readily redissolved in a minimal amount of THF.  
DMF leads to decomposition of the polymer and is furthermore even harder to remove. 
Isooctane seems to work and can be removed easily, but the conversion seems to be somewhat lower. 
The main problem was the poor solubility of the polymer and the high contamination with stabilizers 
(cresol produced the highest peaks in the 1H-NMR). 
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Fig. 5: An example of NMR (see method A for comparison) after deprotection of the maleic imide 
through a Retro Diels Alder reaction. The alkene signal is shifted from 6.5 to 6.7 and slightly decreases 
the integral through a side reaction. Furthermore, the peak at 5.2 disappears when the resulting furane 
is removed 
 
 
3.1.2.3 Deprotection of the carboxylic acids 
 
The carboxylic acid groups were deprotected by dissolving the oligomer in DCM (making a 0.1M 
solution), cooling it to 0°C and adding 2eq. TIPS, water and 20eq. of TFA per COOtBu group. The 
solution was stirred for 1h at 0°C and 5h at room temperature. The product was recovered through 
precipitation in cold hexane. For further purification it was redissolved in methanol which was then 
added dropwise to an excess of cold water precipitating contaminations. The product was finally 
lyophylised and stored at -20°C. The yield ranged between 40%-95%. 
Notes: the purification procedure removes TFA under mild conditions but separates also partially 
protected oligomers and monomers. The deprotection seems to fail on oligomers with a DP of less 
than 6, resulting in an ill-defined product. TFA vapours attack septums, thus Teflon stopper should be 
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used instead. The TFA has to be removed before the solution becomes concentrated as it would attack 
the other ester bond and possibly even other functional groups (thus the precipitation in hexane). The 
aqueous phase can be dried directly, risking however the crosslinking of the oligomer under these 
harsh conditions. Traces of acid (HBr from the initiator or TFA from this reaction step) render the 
product unstable causing it to crosslink (no visible changes, but insoluble) and turning slowly from a 
white solid over yellow and brown to a black oil. Attempts of dialysis failed, as the product seemed to 
polymerise. 
 
 
 
Fig. 6: An example of NMR (compare with method A and the first step of the deprotection) after the 
tert. Butyl of the carboxylic acids is removed with TFA. 
 
 
3.1.2.4 Oligo(NIPAAM) 
 
For a batch of 100mg initiator (finely ground), a 25mL Schlenk tube was prepared. The finely ground 
initiator was placed therein and was carefully evacuated for 5min and put under argon atmosphere. 
The NIPAAM (2*DP equivalents; purified via sublimation) and the Me6tren (1eq.) were then added to 
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the initiator. The tubes content was then dissolved in 5.6mL of dry tBuOH (0.1N) and homogenised via 
sonication. The solution was warmed to 30°C and briefly degassed through bubbling argon into the 
solution. The reaction was started by addition of 20mg of CuBr (1eq) in mild argon counter flow. The 
solution was stirred for 3h at 30°C. The reaction was stopped by passing the solution through a column 
of basic ALOX (filled up to 2-3x the column diameter). The solvent was removed and the oligomer was 
redissolved in a minimal amount of THF. The product was obtained through precipitation in 20mL of a 
cold mixture of 2:1 hexane and diethyl ether. The product was redissolved in n-propanol and dialysed 
with a 10mL FloatALyzer (200-400Da Cutoff) using 500mL of n-propanol. The solvent was exchanged 
every day for three days. The yield was ca. 40%. 
Note: Since even oligomers are able to crystalize, precipitation remains an option independent of the 
chain-length. However, the product is poorly soluble in tBuOH, causing precipitation already during 
the reaction. Moreover, the monomer cannot be removed in vacuum. Nor can the product be purified 
through column chromatography since the product remains stuck on silica. The product has therefore 
to be dialysed. N-propanol was the only organic solvent that did not damage the dialysis membranes. 
 
 
3.2 OmpF mutants 
3.2.1 Media and general remarks 
 
The growth media and related material were prepared before usage under sterile conditions: 
LB miller (10g of tryptone, 5g of yeast extract and 10g of NaCl per litre) 
2YT (20g of tryptone, 10g of yeast extract and 10g of NaCl per litre) 
LB-plates (LB medium with 15g/L Agar; optional: 300μM of ampicillin and 122μM of X-Gal) 
SOC: 2wt% tryptone, 0.5wt% yeast extract, 10mM NaCl, 2.5mM KCl, 10mM MgCl2, 10mM MgSO4 and 
20mM glucose 
1000x ampicillin: 300mM in 50% aqueous ethanol 
1000x IPTG 0.4M in water 
 
The OmpF mutants were kept as a library of DH5α E.coli (in LB-medium with 10% Glycerol stored 
at -80°C) which is optimised for plasmid amplification. For expression of the protein, the plasmid was 
transfected into Omp8 E.coli, a custom strain suited for protein over expression (using IPTG) lacking 
several membrane proteins that would interfere with the Omp8 purification. In every case ampicillin 
resistance was used for selection. X-Gal was used to make colonies more visible for picking, but more 
VIII Materials Methods 
244 
importantly to make sure that Omp8 for transfection was without plasmid, as these E.coli did not have 
an ampicillin resistance and had to be freshly grown for electroporation.  
Bacteria were generally thawed on ice and kept there (especially as long as the bacteria were needed 
to be alive). Thawed bacteria were not pipetted or vortexed as they are particularly sensitive (unlike 
freshly grown E.coli). E.coli samples were never frozen without 10% glycerol or 5% DMSO (or in pellet 
form) in order to avoid freezing induced cell damage. 
The expressed OmpF is extracted in the final step with 3% detergent. For many vesicle-formation 
methods this can decrease the performance. However, the concentration can be lowered to about 
0.5g/L via dialysis (for instance with 7.5kDa cutoff Gebaflex) without causing precipitation, although it 
is below the cmc. 
The expressed OmpF featured at times two bands in SDS-gels (in particular D12K89C, R270C and 
D12R270C) approximately at 38- and 40kDa, whereas the expected weight was 39kDa. Excluding 
cysteine bridges (could only apply for double mutants) and OmpA (37kDa, but not present in Omp8) it 
might stem from the overexpression resulting OmpF with partially remaining signalling peptide (2000 
Da). 
 
 
3.2.2 PCR and introduction of single mutations 
 
The following describes the mutation of K89C-OmpF to R270CK89C-OmpF. R270C-OmpF was produced 
in analogous fashion from wt-OmpF bearing E.coli. The plasmid was obtained by growing Omp8 E.coli 
containing the plasmid with K89C-OmpF in LB-Amp (10μL stock solution in 10mL LB-Amp in a 50mL 
Falcon tube shaken overnight at 37°C at 200rpm). After centrifugation for 5min at 6654 rcf (8000rpm) 
a MiniPrep kit was used. The plasmid was amplified by transfecting it into DH5a using the heatshock 
procedure (as recommended by the supplier)39 and repeating the procedure for obtaining the plasmid. 
The mutations were introduced via site-directed mutation using a two-step PCR protocol based on 
Wang W, Y.[4]: Two PCR reactions were run; one for the forward and one for the reverse primer. To 
25.5μL of nuclease free water 5μL 10X Pfu-Buffer, 2.5μL 10mM dNTPs, 1μL plasmid (K89C-OmpF, 
50ng/μL), 6μL 2.5μM primer (R270C), 2.5μL DMSO (facilitating unbinding) and 1.5μL Pfu polymerase 
                                                          
39 Thaw an aliquot of DH5α on ice and take 30μL from the aliquot. Add 50-100ng DNA. Keep it for 30min at 0°C, 
then heat it for 45s to 42°C and cool it again to 0°C for 2min. Add 200μL of LB-Medium and incubate it for 1h at 
37°C and smear 30μL across a LB-Amp plate the rest of the solution using glass-beads on a second plate (in case 
the cellular uptake is low).  
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were added and gently mixed. The following temperature program was used for the PCR: 5min 95°C 
hotstart; cycle 10x(1min 95°C melting; 1min 63°C annealing, 10min 68°C elongation). The content of 
both tubes was then mixed and split again for a second round using the same temperature program 
but for 25 cycles and a 30min 68°C final elongation. Thereafter 1μL each of DPNI was added and the 
sample was incubated for 1h at 37°C.  
The product was purified via electrophoresis using a 1% agarose gel (TAE-buffer, see Fig.7), cutting the 
relevant band and applying the gel-extraction kit. Since the plasmid is no longer coiled a much more 
efficient E.coli was required for transfection. The uptake into XL1-Blue ultra-competent cells was done 
as follows: A LB-Amp-plate was preincubated for 30min at 37°C and an aliquot of the ultra-competent 
cells was thawed on ice. 8μL 0.2M DTT and 10μL of plasmid were added and the mixture was incubated 
for 15min on ice. The entire volume was smeared on the preincuabted plates and incubated for 
another 12h. Colonies were picked with Eppendorf tips and regrown in 10mL LB-Amp in a 50mL falcon 
tube (cap screwed on loosely) overnight at 37°C and 200rpm.The samples were centrifuged and the 
plasmid was obtained as described before. Note: 50% of the sample were saved as stock solution by 
adding 10% glycerol and storing them at -80°C. The correct sequence of the plasmid was verified. 
 
List of primers for the mutations (altered tricodon made bold): 
K89C 
A 5'-CGC-GGG-TCT-TTG-CTA-CGC-TGA-CGT-TGG-3'  
B 5'-CCA-ACG-TCA-GCG-TAG-CAA-AGA-CCC-GCG-3'  
 
R270C 
A 5'-GTG-TAA-GCG-ATG-GAC-GGG-CAC-AGA-CCG-AAA-TCG-3'  
B 5' CGA-TTT-CGG-TCT-GTG-CCC-GTC-CAT-CGC-TTA-CAC-3'  
 
D12C 
A-5‘-GAT-GGC-AAC-AAA-GTA-TGC-CTG-TAC-GGT-AAA-GCT-GTT-GG-3’ 
B-5’-CCA-ACA-GCT-TTA-CCG-TAC-AGG-CAT-ACT-TTG-TTG-CCA-TC-3’ 
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Fig. 7: 1% Agarose gel displaying the PCR-product of K89R 270C OmpF mutant produced at 4 different 
annealing temperatures. The product was not purified nor digested with Dpn1 at this point, the 
template R is thus still visible. The shift in the run-time of the plasmid stems from the supercoiled 
nature of the template. 
 
Table 1: Sequenced part of the DNA of the final product after amplifying it in XL1 ultra competent cells 
translated to the corresponding amino acids. The underlined cysteine residues are the K89R270 
mutation sites. 
… L A F A G L C Y A D V G S F D Y G R N Y G V V Y D A L G Y T D M L P E F G G D 
T A Y S D D F F V G R V G G V A T Y R N S N F F G L V D G L N F A V Q Y L G K N E 
R D T A R R S N G D G V G G S I S Y E Y E G F G I V G A Y G A A D R T N L Q E A Q 
P L G N G K K A E Q W A T G L K Y D A N N I Y L A A N Y G E T R N A T P I T N K F 
T N T S G F A N K T Q D V L L V A Q Y Q F D F G L C P S I A Y T K S K A K D V E G I 
G D V D L V N Y F E V G A T Y Y F N K N M S T Y V D Y I I N Q I D S D N K L G V G 
S D D T V A V G I V Y Q F Stop 
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3.2.3 Insertion in Omp8 
 
The plasmid was inserted into Omp8 E.coli using the following procedure: 20-50μL of the Omp8 E.coli 
were plated on LB-plates without ampicillin (with blue-white-staining) using glassbeads. The plate was 
incubated overnight at 37°C. The colonies were carefully scratched off and suspended in 1mL of Elga 
water. Then the suspension was centrifuged at max-speed for 30s using a tabletop centrifuge. The 
pellet was resuspended in 10% glycerol and the centrifugation was repeated. The pellet was 
resuspended in 100μL of 10% glycerol. The solution was put for 10min on ice (along with the 
electroporation cuvette and the thawed SOC-medium) and 2μL (ca. 200ng/μL) of the plasmid were 
added. The solution was mixed briefly with a vortexer and 40μL of the solution were placed in the 
cuvette. The outside of the cuvette was wiped clean and placed in the device. The solution was pulsed 
2x at 2500V. Immediately thereafter 1mL of SOC medium was added and mixed through pipetting up 
and down. The culture was incubated for 1h at 37°C in a water bath. The culture was centrifuged and 
4/5 of the supernatant was removed so that the pellet was resuspended in ca. 200μL. 30μL were 
smeared across an LB-Amp plate. The rest of the solution was applied on another plate using glass-
beads on a second plate (in case the cellular uptake is low). Colonies were picked and E.coli stock was 
prepared as described above. This time however IPTG was added and half was pelleted and sonicated 
in minimal amount of PBS with 10% SDS to produce a sample for running a SDS-gel. 
 
 
3.2.4 OmpF expression and purification 
 
The procedure is based on Grzelakowski 2009.[5] Grow E.coli Omp8 on LB-Amp plate overnight at 37°C 
(can be skipped for fresh and pure aliquots, by adding 10μL of the aliquot directly to the preculture). 
Select a colony using a 200μL plastic pipette tip. Add it to 50 ml of LB-Amp in a 250 ml Erlenmeyer flask 
with lid. Incubate the culture with vigorous shaking (250 rpm) overnight at 37°C. Incubate 1000 ml of 
2YT-Amp in 2.5-litre cell culture flask with 12-15 ml of overnight culture to yield OD600=0.1. Incubate 
with vigorous shaking (250 rpm) at 37 °C until the culture has reached the mid-log phase of growth 
(OD600=0.5-0.8, ca. 2.5-3h). Induce the OmpF overexpression by addition of IPTG (final concentration 
0.4mM). A (for K89C-OmpF): pellet it at 4250 RCF for 10min at 4°C after 6h (OD600=2-3); B (for 
K89R270C-OmpF) let it cool to room temperature and add mercaptoethanol (final concentration 1mM) 
and shake it for 20h at 300rpm at 25°C. Continue as above. Both procedures yield about 20-25g pellet 
which has to be stored at -20°C. 
Lysis of the cell: Resuspend the cell pellet in 10 ml Lysis buffer (200mM TrisCl pH=8; 25mM MgCl2; 
1mM CaCl2) per g cell pellet. Put the solution on ice and treat it with the sonicator A (3x2min pulses of 
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2s period 50 Hz and 2min wait). Press it 3x though the French Press using 1000bar. Add a spatula tip 
of DNAse and RNAse and shake it 30min at 25°C. Add 1ml 20 % SDS per 10 ml cell suspension and 
incubate it for 1 h at 60 °C with gentle stirring in a water bath. Ultracentrifuge it at 22’000 rpm at 4°C 
for 60 min and keep the pellet. 
Pre extraction: Rinse the pellet with 20 mM phosphate buffer pH 7.4 to remove residual SDS. Add 5 
ml/g cell pellet 0.125wt% OG in phosphate buffer. Homogenize the pellet by using a Potter-Elvehjem 
homogenizer and shake it for 1 h at 37 °C. Ultracentrifuge it at 4 °C for 40 min and keep the pellet. 
Extraction: Add 3 ml/g cell pellet 3wt% OG in phosphate buffer and homogenize the pellet by using a 
Potter-Elvehjem homogenizer. Shake it for 1 h at 37 °C and ultracentrifuge it at 40’000 rpm at 20 °C for 
40 min and keep the solution. 
The purity was verified with 12% SDS-Gels and the concentration was measured both with Nanodrop 
2000c (Witec Ag; with the settings E=5.21; M=39.33) and a BCA-Kit (measured with a Spectramax M5 
from Molecular Devices). 
Notes: 15g of E.coli pellet can yield 30mL 1g/L OmpF. In case that it is more dilute it is advisable to use 
Vivapore 7.5kDa over 10kDa Amicons (who would also concentrate the detergent). The concentration 
was determined via Nanodrop and BCA-Assay. In case of further concentration steps the detergent 
concentration should be determined through a colorimetric assay.[6] 
 
 
Fig. 8: 12 % SDS gel (200V 50min stained with Coomassie blue), showing the purification steps of the 
OmpF double cysteine mutant OmpF K89R270C (OmpF-M): L Benchmark ladder; 3 R270C-OmpF as 
reference; 5 supernatant of the first ultracentrifugation; 6 supernatant of the second 
ultracentrifugation; 8 product; 9 product (different 1L-cell culture flasks with similar OD600) 
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The occasionally observed splitting of the OmpF band is attributed to the presence of residual signalling 
peptide (2000 Da).[7] 
 
 
Fig. 9: 4-12% gradient SDS Gel (run at 200V for 35min stained with simple blue; 10µL Ladder; mutants 
ca. 4-6µg) comparing the unmodified and labelled OmpF-2M with OmpF-WT and single mutations: L 
Benchmark ladder; 2 OmpF-WT, 3 K89C-OmpF, 4 R270C-OmpF, 5 K89R270C-OmpF/OmpF-M, 6 Gap, 7 
R270C-Gala3-OmpF, 8 K89R270C-Gala3-OmpF/OmpF-C, 9 K89R270C-HLG4-OmpF Note: this gel was 
made one year after the synthesis of the samples, thus some signs of degradation can be seen 
 
 
 
Fig. 10: 12 % SDS gel (200V 50min stained with Coomassie blue), showing various OmpF-conjugates: 
1) Benchmark Ladder, 2) K89R270C-SH OmpF as reference, 3) R270C-(acrylic acid)6 OmpF, 4) R270C-
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(acrylic acid)12 OmpF, 5) R270C-Gala3 OmpF, 6) K89R270C-HL3 OmpF, 7) K89R270C-GHLL3 OmpF, 8) 
R270C-SH OmpF as reference, 9) gap, 10) ladder 
 
 
3.2.5 Reactivating old OmpF samples 
 
After keeping the OmpF at 0% OG in the fridge for one month only little difference in activity could be 
seen compared to the negative control. Since there was no other R270C-Gala3 left an attempt was 
made to reactivate the sample: 
OG was dissolved within the sample until it reached 3wt%. Then it was sonicated for 5min at room 
temperature and shaken for 1h at 37°C. The sample was then dialysed against buffer again in order to 
remove the OG. 
As it turned out the samples prepared thereafter had almost the same concentration and the same 
activity as those prepared with the fresh sample. 
 
 
3.2.6 Molish assay 
 
50µL of buffer containing OG was mixed with 250µL 5wt% phenol. Then 600µL concentrated sulphuric 
acid was added. The solution was stored in a dark container and was allowed to cool down for 15min. 
Then the absorption was measured at 489nm. 
Notes: The Molish assay was used for determining the remaining OG concentration after dialysis or 
concentration steps (as OG inhibits vesicle-formation). It is based on the works of Urbani et al..[6] To 
obtain optimal results the OG concentration has to lie between 0.05-0.6wt%. At least 6 known 
concentrations and 3 sample dilutions should be done. The accuracy increases if the sample is vortexed 
(in a closed 2.5mL glass vial) after each step including immediately before measurement. Since the 
sulphuric acid releases gas, most pipetting systems fail. However, a 1mL plastic syringe (without 
needle) worked well. 
Attention: this reaction is quite exothermic, spilling or splashing of hazardous chemicals may occur 
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3.2.7 Michael addition of Peptide to OmpF 
 
In a GC-vial 50μL peptide (16mM in DMSO; 3x20eq.) were added dropwise to 1mL 0.5g/L OmpF-mutant 
(30μM). The solution was stirred at room temperature for 12 h. The sample was dialysed twice against 
1L of buffer containing 0.5% OG using Midi GEBAflex-tube 50-800μL; 6-8kDa MWCO. The solution was 
concentrated 2x using 10kDa Amicons (8000rpm). 
The reaction was carried out at a pH between 6.5-8 and the DOL was estimated with the acrylodan 
assay and measured via in gel-digestion and LC-MS. 
Notes: For basic peptides a pH of 6.5 improved the DOL significantly (due to better solubility). 
 
 
3.2.8 Acrylodan Assay for determining the DOL 
 
Typically, 5μL of a 0.5g/L mutant OmpF sample were diluted to 30μL using phosphate buffer containing 
3%OG. 10eq per thiol group of 1mM acrylodan in DMSO were added and the solution was shaken for 
2h at room temperature. Then the solution was diluted to 500μL using 1% OG in citrate buffer and the 
solution was stirred overnight at 4°C. The fluorescence was detected at 380nm excitation in the range 
of 450-550nm (maximum around 492nm) using 15nm slit size and 50nm/s scanning speed (triple 
measurement).  
Subtracting the background fluorescence (WT-OmpF), the ratio between the intensity of the sample 
and the OmpF control (featuring the same mutations) gave the DOL: 
𝐷𝑂𝐿 = 1 −
𝐼𝑐𝑜𝑛𝑗𝑢𝑔𝑎𝑡𝑒−𝐼0
𝐼𝑚𝑢𝑡𝑎𝑛𝑡−𝐼0
 (1) 
Rather than using triplicates several dilutions were measured in the range of 2-5 mg/L. This reduces 
the risk of artefacts caused by sample concentrations outside the optimal range. 
Remarks: 0mg/L is below the best fit line, since acrylodan changes its fluorescence upon reaction with 
thiol groups and should therefore not be included. The calibration curve changes its slope at 2mg/L 
and below. At this point the concentration is too low for the measurement. 
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Fig. 11: Acrylodan-assay of K89R270C-Gala3 OmpF (squares) using K89R270C-OmpF for calibration 
(excluding concentrations below 2.5mg/L the DOL was calculated to be 68%) 
 
 
3.2.9 Mass spectroscopy 
 
Mass spectroscopy was used to measure the degree of labelling of the OmpF-peptide conjugates. The 
spectrometer consisted of a LC-MS column (liquid chromatography-mass spectrometry) ReproSil-Pur 
C18–AQ, 1.9 μm resin Dr. Maisch GmbH, Ammerbuch-Entringen, Germany combined with a dual 
pressure LTQ-Orbitrap Elite mass spectrometer connected to an electrospray ion source (both Thermo 
Fisher Scientific). The in gel digestion is based on Glatter 2012.[8] Briefly, the band of interest was cut 
out of the SDS-gel and the sample was cut to tiny cubes. The Coomassie was washed out and the 
protein was alkylated with iodoacetamide and digested using trypsin. The peptides were then washed 
out and desalted with C18 reversed phase spin columns Microspin, Harvard Apparatus. After drying, 
the samples were redissolved and subjected to LC–MS analysis using a linear gradient from 95% solvent 
A (0.15% formic acid, 2% acetonitrile) and 5% solvent B (98% acetonitrile, 0.15% formic acid) to 28% 
solvent B over 40 min at a flow rate of 0.2 μl/min. The 20 most intense ions were released from the 
linear ion trap and subjected to a MS-MS analysis. The intensity of the mutation carrying fragment was 
put into relation with another fragment of the same sample to eliminate the dependence on the 
concentration and the ratio was then compared to the same ratio of OmpF with free thiol groups. 
Note: the peptide fragment bearing the conjugate introduced by Michael addition itself could not be 
seen probably due to its hydrophobic nature. 
𝐷𝑂𝐿 = (
𝐼𝑆𝐻−𝑓𝑟𝑎𝑔𝑚𝑒𝑛𝑡
𝐼𝑜𝑡ℎ𝑒𝑟−𝑓𝑟𝑎𝑔𝑚𝑒𝑛𝑡
)
𝑐𝑜𝑛𝑗𝑢𝑔𝑎𝑡𝑒
(
𝐼𝑆𝐻−𝑓𝑟𝑎𝑔𝑚𝑒𝑛𝑡
𝐼𝑜𝑡ℎ𝑒𝑟−𝑓𝑟𝑎𝑔𝑚𝑒𝑛𝑡
)
𝑚𝑢𝑡𝑎𝑛𝑡
⁄  (2) 
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3.3 Creation and testing of the Nanoreactors 
3.3.1 Liposomes via film rehydration 
 
In a 20mL glass vial 3mg of DSPC; 0.5eq cholesterol-PEG600 (50g/L in chloroform), 0.5eq. cholesterol 
(50g/L in Ethanol) 0.1eq. POPS (10g/L in chloroform) were added. It was then filled up to 1mL with 
ethanol and the solution was homogenised through sonication. Then the OmpF (50-100μg e.g. 50μL 
1g/L in 0.5% OG containing PBS) and another 1mL ethanol were added and the solution was vortexed. 
The solvents were then removed in a rotary evaporator at 40°C and 150mBar. The resulting film was 
slowly rehydrated by adding 1mL of buffer (containing fluorophore or enzymes) and putting it in the 
incubator at 37°C shaking it at 180rpm for 20h. The vesicles were extruded whilst being warm by 
pressing it 20x through a 400nm and 200nm membrane. The sample was then dialysed 8x against 
1000x the volume of buffer using 100kDa cut-off tubes. 
Remarks: Since DSPC does not feature unsaturated carbons it has a transition temperature of 55°C, 
which is lowered by the other additives, however film-rehydration does still require more than room 
temperature. At 37°C it takes about 17-20h for rehydration, whereas unsaturated lipids may form 
vesicles at room temperature in less than one hour. On the other hand, extended periods at elevated 
temperatures cause a reduction on opaqueness indicating the decline of the vesicle population. Even 
warm the vesicles are hard to extrude. Thus, the use of a gas operated barrel extruder is advisable. 
The mixtures film rehydration is sensitive to detergents (not as much as polymersomes, but notably 
more than other lipids tried). Using OmpF in 3% OG rather than 0.5% results thus in less and more 
heterogeneous vesicles. 0.5% is around the cmc of the detergent and the lowest concentration OmpF 
is stable in. Attempting detergent removal (which works to a limited extend also with polymersomes) 
fails due to demixing of the components. 
 
 
3.3.2 Liposomes via detergent removal 
 
In a 20mL vial 4mg of sphingomyelin (0.8eq. 10g/L in 66vol% chloroform and 34vol% methanol), 0.2eq. 
of POPS (10g/L in chloroform) and 0.5eq. of cholesterol (25g/L in chloroform) were added and the 
solvent was removed using a rotary evaporator at 40°C and 450mBar. The film was redissolved in 2mL 
buffer containing 3% OG and 100µg/mL OmpF (lipid:protein ratio 1000:1) and 0.25 g/L HRP, shaking it 
30min at 37°C. The solution was dialysed over night against buffer containing 200mg Biobeads using 
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3-5kDa-dialysis tube. The solution was rediluted to 2mL. The vesicle solution was pressed twice 
through a 1000nm filter, thrice through a 400nm filter and 6x through a 200nm filter using a barrel 
extruder. The sample was then dialysed over three days using a 100kDa tube exchanging the buffer 7 
times. 
 
 
3.3.3 Polymersomes 
 
To 100μL 50g/L polymer in ethanol and 15μg OmpF (15-75μL) were added in a 5mL pear shaped flask. 
The film was dried 1h at 150mBar and 40°C and 175rpm and 30min at 0mBar at the Rotavap. 1mL of 
0.2g/L HRP in PBS pH 7.4 (freshly dialysed against pure PBS to remove OG) was added and the film 
along with a small stirring bar. The film was allowed to rehydrate within 12h stirred at 100rpm. The 
vesicles were then passed 21x through a 100nm membrane using a syringe driven extruder. The sample 
was then dialysed against 1000x the volume in PBS with 2x buffer changes per day for 3.5 days. 
Important: the vesicle-formation is impeded by traces of detergents. The OmpF had thus to be freshly 
prepared through dialysing the protein 1x against 0.5% OG (1000x the volume; over-night) and 2x pure 
PBS (2h each). 
 
 
3.3.4 HRP Kinetics 
 
All samples were diluted to the same final vesicle concentration in case that the scattering varied 
among the samples. The kinetic were measured at 530/590nm excitation/emission using 7.5nm slits 
for 600s (300 datapoints). The reaction was started by mixing 500μL PBS; 40μL 0.2µM H2O2, 30μL 10µM 
Amplex Ultra Red and 30μL vesicle-sample (ca. 3 g/L) in a disposable 1mL PS cuvette equipped with a 
3mm stirring bar. The measurements were carried out in PBS at pH 7.4 and 6.0 (working solution was 
also adjusted to the pH). 
 
 
3.3.5 Carboxyfluorescein encapsulation 
 
Carboxyfluorecein was neutralised with NaOH and diluted in citrate buffer until it had a concentration 
of 100mM. The solution was then used to rehydrate a film of the DSPC-mix and the 20mL vials were 
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covered in aluminium to exclude light. The samples were processed as described earlier and the 
external carboxyfluorescein was removed via minicolumns. 
From all samples 10µL were added to 1mL buffer with the corresponding pH. The kinetic was measured 
at RT for 3h at pH 7.4 and 5.5 (4.62µL concentrated HCl added). Default settings: excitation: 480nm; 
emission 520nm; slit 5nm; 60nm/min 
Note: just as with HRP, carboxyfluorescein contaminates the column to such an extent that it should 
not be used for anything else. 
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Chapter II 
1 Characterisation of SM-mix NRs; see Fig. 17 
 
Table 1: Characterisation of SM-mix NRs by DLS using a Zetasizer 
Sample 
Scattering 
intensity at 
650nm [a.u.] 
Concentration/ 
scattering ratio [] 
diameter 
[nm] 
Intensity/fraction of 
population [%] 
Polydispersity 
[] 
NR- 56581 1.4 190 100 0.08 
NR+ 52633 1.3 221 100 0.11 
NRC 40203 1 208 100 0.11 
 
The samples in table 1 refer to kinetic experiments (see chapter kinetics; Fig. 29). All three samples 
encapsulated 0.2g/L HRP. In addition, NR+ had R270C-OmpF inserted and NRC had R270C-Gala3 OmpF 
inserted. The scattering refers to measuring the sample in a fluorimeter at 650nm “excitation” and 
650nm “emission” (in truth only scattering occurred and no fluorescence). It allows a comparison of 
the vesicle concentration. Of these three samples TEM images were also made: 
 
 
Fig. 1a: NR-  at pH 7.4 (left) and 6.0 (right) 
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Fig. 1b: NRC at pH 7.4 (left) and 6.0 (right) featuring R270C-Gala3 OmpF 
 
 
Fig. 1c: NR+ pH at 7.4 (left) and 6.0 (right) 
 
It is worth noting, that most TEM made in this thesis were of poorer quality and contained more 
artefacts, when the samples were acidified. It seems to increase the tendency of vesicles to aggregate 
and increases the salt concentration. This and possibly the pH, in turn seem to affect the sample 
preparation/fixation for TEM, where other salts are added. 
 
 
2 Characterisation of DSPC-Mix NRs see Fig. 19 
 
For the enzyme kinetic (eponymous chapter; Fig. 31 and Fig. 41), SLS-DLS and TEM of the samples 
were measured: 
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Fig. 2a: NR- at pH 7.4 (left) and 6.0 (right)  
 
Fig. 2b: NRC1 featuring R270C-Gala3 OmpF at pH 7.4 (left) and 6.0 (right)  
 
Fig. 2c: NRC2 featuring R270C-HLG4 OmpF at pH 7.4 (left) and 6.0 (right)  
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Fig. 2d: NR+ featuring R270C-OmpF at pH 7.4 (left) and 6.0 (right)  
 
At pH 7.4 it seems that the vesicles are slightly larger and numerous than at pH 6.0 (with the exception 
of the positive control). It should be noted that TEM images were made after the SLS-DLS-
measurements and thus the vesicle samples were approximately 1 day at room temperature and 3 
resp. 6 days in the fridge. 
 
Table 2: Light Scattering analysis of the DSPC-mix vesicles; pH 7.4 left; pH 6.0 right; A: negative 
control; B R270C-Gala3 OmpF; C: R270C-HLG4 OmpF; D: R270C-SH OmpF 
  pH 7.4  pH 6.0 
  A B C D  A B C D 
Rh [nm] 131 125 105 112  132 133 125 127 
Rg [nm] 95.7 90 85 88  96 93 87 92 
ρ 0.73 0.72 0.81 0.78  0.73 0.7 0.7 0.72 
 
Although all samples were extruded through 100nm filters, their average diameter appears to be 180-
260nm (regarding Rg or Rh). According to TEM, the liposomes appear to be smaller than 200nm rather 
100-150nm. Moreover, the large aggregates that were indicated in the light scattering could not be 
seen in the TEM images. 
 
 
3 Characterisation of polymersome NRs see Fig 26 
 
The vesicle samples from chapter enzyme kinetics (Fig. 37) and the cryoTEM in the chapter 
preparation (Fig. 26) were characterised via SLS-DLS and TEM: 
IX Appendix 
261 
 
Fig. 3.a: TEM micrographs of HRP40 loaded polymersomes, NR-, at pH 7.4 (A) and 6.0 (B). Scale bar 
100nm.  
 
Fig. 3.b: TEM micrographs of HRP loaded polymersomes equipped with OmpF-M, NRC at pH 7.4 
(A) and 6.0 (B). Scale bar 200nm. 
  
                                                          
40 See chapter enzyme kinetics 
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Fig. 3.c: TEM micrographs of HRP loaded polymersomes equipped with OmpF-WT, NR+, at pH 7.4 
(A) and 6.0 (B).  
 
 
Fig. 4.a: Guinier plot representation of SLS data for. HRP loaded polymersomes at pH 7.4 (left) and 
6.0 (right) 
 
Fig. 4.b: Guinier plot representation of SLS data for HRP loaded polymersomes equipped with OmpF-
M at pH 7.4 (left) and 6.0 (right). 
(q²+kc) × µm² × 10
4
0,0 1,5 3,0 4,5 6,0
ln
(K
c
/R
),
 K
c
/R
 i
n
 m
o
l/
g
-18,00
-17,20
-16,40
-15,60
-14,80
Mw(c): 4.922e+07 g/mol Mw(q²): 4.927e+07 g/mol
A2: 4.038e-08 mol dm³/g² Rg: 1.812e+02 nm
(q²+kc) × µm² × 10
3
0,00 6,00 12,00 18,00 24,00
ln
(K
c
/R
),
 K
c
/R
 i
n
 m
o
l/
g
-18,00
-17,20
-16,40
-15,60
-14,80
Mw(c): 5.948e+07 g/mol Mw(q²): 4.560e+07 g/mol
A2: 6.222e-08 mol dm³/g² Rg: 1.004e+02 nm
(q²+kc) × µm² × 10
4
0,0 1,0 2,0 3,0 4,0
ln
(K
c
/R
),
 K
c
/R
 i
n
 m
o
l/
g
-19
-18
-17
-16
-15
-14
Mw(c): 4.513e+07 g/mol Mw(q²): 2.124e+08 g/mol
A2: 5.763e-08 mol dm³/g² Rg: 2.178e+02 nm
(q²+kc) × µm² × 10
3
0,00 6,00 12,00 18,00 24,00
ln
(K
c
/R
),
 K
c
/R
 i
n
 m
o
l/
g
-19
-18
-17
-16
-15
Mw(c): 1.684e+08 g/mol Mw(q²): 1.596e+08 g/mol
A2: 1.893e-08 mol dm³/g² Rg: 1.890e+02 nm
IX Appendix 
263 
 
Fig. 4.c: Guinier plot representation of SLS data for HRP loaded polymersomes equipped with OmpF-
WT at pH 7.4 (left) and 6.0 (right).  
 
Table 3: Light scattering parameters of: HRP loaded polymersomes (NR-), HRP loaded polymersomes 
with inserted OmpF-C (NRC), and HRP loaded polymersomes with inserted OmpF-M (NR+). 
 
 
pH 7.4   pH 6.0  
 NR- NRC NR+  NR- NRC NR+ 
Rg [nm]  61±8 58±4 61±3  61±1 62±2 63±2 
Rh [nm]  64±8 61±4 64±3  66±2 65±2 67±2 
ρ []  0.96 0.94 0.95  0.93 0.95 0.93 
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Chapter III 
1 Additional kinetics used for Fig. 38 
 
 
Fig. 5 Amplex Ultra Red conversion kinetics (of the second batch freshly prepared vesicles) of HRP 
loaded polymersomes (NR-, blue), HRP loaded polymersomes equipped with K89R270C-Gala3 (NRC, 
green) and HRP loaded polymersomes equipped with K89R270C-OmpF (NR+, red) at pH 7.4 and pH 
6.0.  
 
Fig. 6: Amplex Ultra Red conversion kinetics (third batch) of HRP loaded polymersomes (NR-, blue), 
HRP loaded polymersomes equipped with K89R270C-Gala3 (NRC, green) and HRP loaded 
polymersomes equipped with K89R270C-OmpF (NR+, red) at pH 7.4 and pH 6.0. 
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Fig. 7: Amplex ultra red conversion kinetics (fourth batch) of HRP loaded polymersomes (NR-, blue), 
HRP loaded polymersomes equipped with K89R270C-Gala3 (NRC, green) and HRP loaded 
polymersomes equipped with K89R270C-OmpF (NR+, red) at pH 7.4 and pH 6.0. 
 
 
 
Fig. 8: Amplex red conversion kinetics of HRP loaded polymersomes equipped with K89R270C-Gala3 
in relation to pH cycling (using batch 4, see Fig. 39, enzyme kinetics). green: pH 7.4, ochre: pH 6.0 After 
every cycle new Amplex and H2O2 was added to the same sample.  
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Table 4: Activity change (slopes) of the pH cycling experiment 
 Initial slopes: Slopes corrected by taking dilution into account: 
Cycle Batch 0 Batch 1 Batch 2 Batch 3 Vtotal [μL] Batch 0 Batch 1 Batch 2 Batch 3 
C1 pH 7.4 100 100 100 100 1000 100 97.9 100 100 
C1 pH 6.0 0 6.9 4.8 3.8 1046.4 4.36 7 5 4 
C2 pH 7.4 74.2 93.2 90 85.9 1095.2 87.32 100 98.6 94.1 
C2 pH 6.0 8.3 9.4 12.6 11.2 1141.6 13.97 10.5 14.4 12.8 
C3 pH 7.4 40.7 69.6 42.9 72.5 1190.4 57.12 81.2 51.1 86.3 
C3 pH 6.0 5.3 4.9 7.9 8.3 1236.8 10.15 5.9 9.8 10.3 
C4 pH 7.4 46.5 60.9 68.7 49.8 1285.6 73.92 76.7 88.4 64 
C4 pH 6.0 0.4 6.6 10.2 5.9 1332 4.89 8.5 13.6 7.8 
 
This experiment (chapter enzyme kinetics, Fig. 37) was repeated thrice and the initial activities of NRC 
are represented in Table 4. The initial HRP activities of the NRs (NRC, NR-, NR+) were normalised for a 
simpler comparison, such that the highest activity of NR+ was set to 100%. (Fig. 38). HRP activity values 
represent the mean value of three independent measurements. The initial slopes taken from each 
experiment; normalised (left) and volume corrected (right). Volume correction increased the 
fluorescence, or more precisely the slope by factor vt/v0. C# refers to the cycle no. #. Batch 0 provided 
Fig. 37, the three repeats were used for Fig. 38. 
In addition, ANOVA was performed regarding pH (Fig. 38), respectively. It has been demonstrated 
(Table 5) that the influence of the pH factor is significant (statistically the averages are not the same) 
F critical < F experimental in the case of NRC (catalytic nanocompartments with reconstituted pH 
triggered gate protein-conjugate). In addition, two factor analysis (Table 5) confirmed again 
significance of pH influence on NRC system and revealed insignificant of experimental cycles. 
 
Table 5: Single factor analysis 
pH variation HRP SS df MS F 
P-
value F crit 
Treatment 2400 1 2400 626.087 
1.51E-
05 7.708647 
Residuals 15.33333 4 3.833333    
       
Total 2415.333 5         
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pH variation NR- SS df MS F P-value F crit 
Treatment 4.167 1 4.167 0.14109 0.726269 7.708647 
Residuals 118.127 4 29.532    
       
Total 122.2933 5         
 
       
pH variation NRC SS df MS F P-value F crit 
Treatment 6680.007 1 6680.007 101.6486 0.000544 7.708647 
Residuals 262.867 4 65.7167    
       
Total 6942.874 5         
 
       
pH variation NR+ SS df MS F P-value F crit 
Treatment 213.6067 1 213.6067 7.067998 0.056474 7.708647 
Residuals 120.8867 4 30.22167    
       
Total 334.4934 5         
 
 
In table 5, SS stands for the sum of squares (name derived from the equation of the variance of the 
measurement): Df for the degrees of freedom (number of independent pieces of information that went 
into the estimate); MS for mean squares; P-value for the probability for a given statistical model that 
the null hypothesis is true (two observed parameters independent) and the F-value: is based on the F-
test (F-distribution under the null-hypothesis) and is used as a secondary test to see whether the 
results are significant. For that F must be smaller than F-crit. On the final graph, the P-value becomes 
illustrated with stars, which are referred to as the significance, as defined in table 6: 
 
Table 6: P-value and significance 
Significance P-value 
0 P > 0.05 
* P ≤ 0.05 
** P ≤ 0.01 
*** P ≤ 0.001 
****  P ≤ 0.0001 
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